data_2kgk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kgk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.2 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 61.43 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.12 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 73.23 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 74.51 110.134 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 74.32 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 74.44 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 62.34 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 72.4 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 64.51 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.03 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HE ' ' C ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 73.12 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 15' ' ' ILE . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.45 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 ' N ' HG12 ' A' ' 14' ' ' VAL . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 73.23 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 71.34 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 75.44 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 70.2 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.21 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.44 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.681 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.42 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 75.33 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CH2' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 74.52 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.31 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.31 111.471 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 74.13 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.15 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.609 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 75.42 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.45 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 75.25 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 74.42 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 75.01 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 75.53 110.727 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.04 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 74.12 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 72.33 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.546 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.1 110.596 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.41 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.22 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.386 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.42 110.483 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.737 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 74.24 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.1 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 44' ' ' GLY . 6.1 p30 -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.34 110.486 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CE1' ' O ' ' A' ' 52' ' ' GLY . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.04 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.13 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.615 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 64.0 110.891 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 74.33 110.456 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.22 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.45 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.43 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 72.14 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.42 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 70.12 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.33 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 73.32 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 73.25 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.402 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.15 110.781 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 69' ' ' TYR . 55.9 m-70 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.23 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.41 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 73.32 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.51 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.43 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 75.12 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.736 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.4 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.12 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.13 110.611 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 104' ' ' LEU . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 73.05 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.32 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 72.01 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 74.4 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.04 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.22 110.61 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 73.05 110.728 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.34 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 74.24 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.04 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.14 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.15 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.4 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.44 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.34 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.21 111.268 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.44 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 70.21 110.89 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.978 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.472 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 75.13 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 74.24 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 64.31 110.584 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 75.24 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.51 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 74.14 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 72.23 111.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 73.32 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 75.2 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 71.01 111.175 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 71.23 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.24 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.23 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 75.41 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.24 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 72.44 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.24 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.41 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 71.33 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 75.32 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.52 109.889 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 71.24 110.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 73.21 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 75.44 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 73.11 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 75.24 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 75.22 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 65.23 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.411 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 73.25 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.24 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.11 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 71.45 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.13 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 151' ' ' TYR . 25.2 m-80 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 70.32 110.617 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.15 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 149' ' ' ASN . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.42 110.566 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.55 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.02 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.3 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 74.31 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 62.34 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 75.42 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 72.52 110.394 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.54 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.42 110.512 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 70.52 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.884 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 64.24 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 75.52 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 74.22 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 63.42 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.53 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 72.1 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 73.04 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.72 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 74.13 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.23 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 14' ' ' VAL . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.41 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 64.41 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 71.35 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 71.13 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 7.7 m-20 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.54 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.41 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.722 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.22 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.699 ' CG ' ' N ' ' A' ' 24' ' ' ARG . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 75.43 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.21 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.636 ' CD ' HD22 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.13 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.44 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.32 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HB2' ' NE1' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 75.21 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 72.4 111.598 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 74.13 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 73.04 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.03 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 75.22 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.32 110.789 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.45 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 72.1 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.45 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.32 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD13 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 75.21 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 72.3 110.637 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.22 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 55.34 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 74.24 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 75.42 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.435 ' ND2' HD12 ' A' ' 51' ' ' ILE . 2.1 t-20 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.22 109.982 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.23 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.43 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.41 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 74.22 110.975 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.965 0.412 . . . . 74.42 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.12 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.04 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.12 110.479 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.1 110.734 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.615 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.637 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.22 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 74.53 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 63.23 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 71.45 110.654 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 72.31 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.13 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 62.24 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.01 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.44 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.569 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.958 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.3 110.716 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.22 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.23 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.4 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.55 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.917 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.433 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.35 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 74.33 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.22 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.24 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 72.24 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.4 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 75.41 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.42 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 61.14 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.42 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.41 110.322 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.912 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.51 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.72 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.21 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 73.05 110.903 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 74.22 111.056 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 75.24 111.356 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.32 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.43 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 106' ' ' LEU . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.408 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.01 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.2 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 75.24 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 65.02 110.94 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 74.43 110.666 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.54 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 73.22 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.13 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 73.44 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.553 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 71.2 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.43 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.01 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.32 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.72 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.24 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.22 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.54 111.176 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.447 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.14 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 73.34 110.093 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 74.25 110.43 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.23 110.515 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 73.14 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.542 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.32 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 72.43 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.22 110.3 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.43 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.24 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.41 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.23 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 73.4 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.636 HD22 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.54 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.3 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 72.04 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 74.44 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 74.13 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.1 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.13 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.14 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.34 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 71.32 110.294 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.611 ' CD ' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 74.24 110.706 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 63.31 110.588 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.31 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 74.23 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 75.53 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 74.13 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.45 110.705 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 70.14 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 55.51 110.457 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.35 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 73.32 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 72.23 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.21 110.93 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 74.01 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HB ' ' N ' ' A' ' 127' ' ' PHE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 75.53 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.41 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.14 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 74.12 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.44 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m120 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.21 110.094 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 74.23 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.724 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.11 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.43 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 73.33 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 71.21 109.901 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' CD1' ' HH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 74.33 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 74.11 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.15 110.163 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.42 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.41 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 61.23 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.42 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.33 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.42 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 35' ' ' THR . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.3 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.43 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.23 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 72.44 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 73.23 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.13 110.905 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.13 110.204 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.32 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 74.5 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.48 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.44 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.22 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 73.14 110.262 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 72.41 110.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 73.42 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.22 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 51' ' ' ILE . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 73.23 110.007 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.32 111.436 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 75.42 109.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 75.21 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.45 110.446 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.42 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.32 110.582 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.5 110.79 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 74.51 110.536 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 63.52 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 14.6 m-80 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 75.21 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.31 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.34 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 73.11 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 74.41 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.21 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 75.43 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 62.1 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 72.24 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.53 110.659 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.893 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 75.42 110.67 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.646 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.41 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.35 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 71.51 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 73.53 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.42 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 64.22 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.21 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 75.14 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 75.13 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.53 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.42 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 71.05 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.58 ' OE1' ' CD1' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.45 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.58 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.23 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.52 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.24 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.43 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.34 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.31 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 110' ' ' ASP . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 74.42 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 109' ' ' VAL . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.2 110.647 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 65.1 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 135' ' ' TRP . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 75.12 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 73.2 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 73.55 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 64.35 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.31 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 75.42 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.24 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 73.15 110.921 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.444 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.42 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.12 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 75.03 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 75.11 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 15.7 t80 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.34 109.775 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.349 . . . . 72.54 110.631 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.482 ' CE2' HD12 ' A' ' 112' ' ' LEU . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.44 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' NZ ' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 64.31 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 139' ' ' PHE . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 74.4 110.684 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.53 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 70.01 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.45 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.53 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.51 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.55 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.426 ' HG1' ' HA ' ' A' ' 150' ' ' PRO . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.52 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.14 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 64.4 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HG1' ' A' ' 145' ' ' THR . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 72.32 112.073 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 74.13 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.42 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.442 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.23 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 74.23 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 64.43 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 75.22 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 71.14 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.01 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.604 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 71.21 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.4 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.31 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 72.43 111.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.2 110.683 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.32 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.506 ' C ' HD21 ' A' ' 12' ' ' ASN . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.54 112.072 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.552 HD21 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.34 111.397 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.499 HH21 ' HA ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 74.13 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 15' ' ' ILE . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 75.03 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.518 ' N ' HG12 ' A' ' 14' ' ' VAL . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 74.52 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 74.35 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.12 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 20' ' ' ASN . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.41 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 72.02 110.356 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.23 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.751 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.31 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 73.03 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.572 ' CD1' ' N ' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.42 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.53 110.222 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 75.0 109.979 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 72.13 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 73.34 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 74.44 109.677 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 75.04 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 74.01 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 37' ' ' MET . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 73.02 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 72.31 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.4 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.669 ' HG1' ' CD2' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.35 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.32 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 72.25 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.669 ' CD2' ' HG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 74.14 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.52 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.31 110.116 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.44 ' H ' HD11 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.33 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 74.43 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.34 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.752 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.21 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.32 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.207 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.02 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 74.2 111.136 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 ' CG1' HD22 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 73.41 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 74.3 111.273 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.034 -0.358 . . . . 74.51 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.24 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.22 110.534 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.543 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.611 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.752 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 74.51 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 73.32 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 74.31 110.571 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.11 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.23 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.666 ' HH ' ' NH2' ' A' ' 45' ' ' ARG . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 74.54 110.561 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.3 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.31 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 73.23 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.48 ' HA ' HD22 ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.12 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.4 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 77' ' ' ALA . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.4 110.269 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.51 110.554 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.21 111.04 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.43 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.12 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 73.14 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.44 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.32 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.451 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 75.31 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.508 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.05 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 74.1 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.43 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.13 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.41 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.12 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.703 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 74.32 110.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 74.02 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.457 ' O ' ' C ' ' A' ' 97' ' ' GLY . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 72.4 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.14 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.12 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.44 110.673 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.22 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.44 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.54 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.23 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.704 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.55 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 74.22 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 110' ' ' ASP . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.42 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 109' ' ' VAL . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 73.21 110.056 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 72.34 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.2 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.445 ' CE1' ' CG1' ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.1 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 74.42 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 115' ' ' THR . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 60.34 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.33 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 73.45 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.24 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 74.53 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 75.53 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.53 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.1 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.53 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 72.42 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.12 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.53 110.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.72 0.295 . . . . 63.32 111.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 73.52 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 75.2 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.54 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 75.33 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.41 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.12 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HE2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.31 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 72.21 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 75.03 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.34 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.01 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.11 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.24 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 10.2 p30 -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.13 110.625 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.04 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.24 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 71.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.32 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 74.0 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 74.23 110.441 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.673 ' NE2' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.23 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.445 ' CG1' ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.42 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.11 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 74.15 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.4 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.489 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.41 110.439 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.11 110.538 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.33 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.58 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.34 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.14 110.353 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.32 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.34 111.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.34 110.032 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 74.51 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 70.03 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 73.05 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.22 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.14 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 127' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 75.32 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG12 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.22 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.43 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 73.12 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 75.12 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.036 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 23' ' ' TRP . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.55 110.365 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.11 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.494 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 74.15 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD11 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 63.55 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.41 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 64.44 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' H ' HD11 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.2 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 74.42 110.671 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.43 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 75.54 110.946 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.12 110.733 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.2 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.51 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.02 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 4.8 m170 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 70.22 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.51 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 75.34 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.03 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.43 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.771 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 63.44 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.643 ' NH1' ' HZ3' ' A' ' 46' ' ' LYS . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.21 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.11 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.771 HD21 ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.4 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.466 ' CE2' HG12 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 73.33 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.42 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.23 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 75.45 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 64.3 111.706 179.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 75.51 111.048 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 74.11 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 73.44 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 74.43 110.65 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 75.2 110.85 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.22 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.52 110.636 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.22 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 74.24 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 51.41 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 74.24 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.43 110.373 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 70.23 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.05 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 52.42 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.32 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.216 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 54.32 111.155 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 70.04 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.13 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.34 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 83' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 71.54 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.14 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.24 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.3 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.13 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.31 111.075 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 65.44 110.656 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ASN . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 61.54 110.862 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.1 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 87' ' ' CYS . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 74.42 110.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.43 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.43 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.43 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.53 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.15 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.55 110.344 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.12 111.714 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 73.21 110.15 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 75.31 110.582 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 74.41 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.25 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.43 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.4 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 104' ' ' LEU . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.32 111.272 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 74.13 111.452 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 73.55 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.11 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.54 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.969 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.04 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.21 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 74.23 111.136 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.449 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 74.52 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 74.33 110.616 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 60.24 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 64.24 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.13 110.745 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 74.2 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 71.21 110.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.13 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 72.14 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.45 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.408 ' HG1' HD11 ' A' ' 15' ' ' ILE . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 75.21 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.499 ' C ' ' CG2' ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.3 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.53 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.34 109.955 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.531 0.205 . . . . 74.32 111.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.33 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 75.51 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 74.54 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 75.54 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.21 111.03 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 65.12 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.24 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 74.15 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 61.42 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.43 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.32 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 74.12 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 72.41 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.53 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.65 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 55.4 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 75.52 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 74.1 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.5 110.869 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.449 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.21 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.11 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 74.53 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.776 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.44 110.821 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 75.21 110.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.22 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.11 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.23 110.544 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 74.4 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 96' ' ' PHE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.35 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.4 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.23 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.33 110.557 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.53 111.037 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 64.32 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 74.33 111.349 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.502 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.42 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.4 110.82 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.41 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.51 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.24 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 74.22 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.32 110.799 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 74.13 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 72.54 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 63.34 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 75.33 109.947 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 74.34 110.314 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 71.52 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.14 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' C ' ' CD ' ' A' ' 28' ' ' GLU . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.592 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 74.31 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 75.41 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.12 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.44 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.53 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.03 111.086 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 74.04 110.761 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.3 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 62.53 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.22 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.2 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.45 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.43 ' N ' HD11 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 73.11 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.869 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 75.32 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.52 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.44 110.087 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.453 ' ND2' HD13 ' A' ' 51' ' ' ILE . 12.2 t-20 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.15 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 75.04 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.34 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' ND2' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 72.01 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.13 110.862 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 74.51 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.431 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.35 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.42 110.214 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 72.23 110.989 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.43 110.929 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 73.51 110.43 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 62.44 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 13.6 m-20 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.4 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.44 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.22 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.33 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.44 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 64.23 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 64.5 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.31 110.152 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 77' ' ' ALA . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 73.4 111.227 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 76' ' ' VAL . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.14 109.871 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.42 110.657 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.02 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 73.12 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.1 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.13 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 73.45 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 73.31 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.44 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 74.05 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 71.45 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.41 ' H ' ' CG ' ' A' ' 91' ' ' GLU . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.23 110.465 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.69 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 73.52 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.467 HG21 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.4 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.53 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 74.11 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 70.45 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 74.52 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.55 110.582 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 73.1 110.237 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.41 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 75.52 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.436 ' N ' HD11 ' A' ' 104' ' ' LEU . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 75.05 111.407 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 75.15 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.43 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 71.51 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 71.21 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.558 ' N ' ' CG2' ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.41 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 74.31 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 64.42 110.695 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CZ ' HG12 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 117' ' ' ILE . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.1 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.437 ' H ' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.52 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 73.04 110.514 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 74.24 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.54 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.51 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.43 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.43 110.082 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.418 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.04 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.7 p90 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.34 110.128 178.097 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.78 0.324 . . . . 74.13 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.05 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 75.22 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.02 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 75.34 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.75 ' HZ2' ' CB ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 72.33 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 75.32 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.21 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.31 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 145' ' ' THR . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.33 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.44 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 74.1 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 9.2 p30 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 73.11 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.4 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.1 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 70.45 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.51 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.03 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.46 HG12 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 75.45 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.04 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 73.35 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.12 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 73.32 110.659 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 74.53 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 74.21 110.901 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.1 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.462 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 73.44 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 54.32 110.608 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 72.32 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 73.04 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.41 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.24 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.764 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 73.11 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 65.31 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.634 ' CG1' ' H ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 74.25 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.634 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.3 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.31 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.33 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.14 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.1 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 74.01 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.22 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.24 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.53 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.4 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.12 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 74.04 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 71.43 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 74.05 110.401 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 74.53 111.045 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.24 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.23 110.284 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.4 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.13 110.551 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.434 ' CG ' ' O ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.32 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 55.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.13 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 65.12 112.621 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 74.54 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 42' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 75.21 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.21 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.55 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 75.23 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.34 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 70.24 110.755 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.54 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 73.24 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.52 110.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 51' ' ' ILE . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.399 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.32 110.979 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 121.06 0.457 . . . . 75.13 111.045 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 72.53 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.54 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 75.14 110.807 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 62' ' ' ILE . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 75.12 110.118 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.554 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.32 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.42 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.43 110.441 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.2 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.43 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.43 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.44 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.1 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 53.53 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.45 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 77' ' ' ALA . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 73.45 110.854 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 74.1 110.09 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.862 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 64.15 111.577 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' VAL . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 75.3 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.04 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 74.3 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.599 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.21 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.12 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 73.55 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 73.51 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 73.03 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.741 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.44 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.11 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 97' ' ' GLY . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.34 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.11 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.574 ' CA ' HE22 ' A' ' 100' ' ' GLN . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 63.4 110.422 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 73.0 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.924 ' NE2' ' H ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.924 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 75.43 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 101' ' ' ILE . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.31 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 73.31 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 73.52 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 74.33 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 111' ' ' LYS . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.51 110.311 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 75.02 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.21 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 74.3 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 72.22 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 64.13 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.01 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 117' ' ' ILE . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 75.03 110.585 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 73.25 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.14 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 75.31 110.696 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.764 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 72.22 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 63.11 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.42 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.34 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.458 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.52 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.43 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.13 110.116 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.814 0.34 . . . . 64.41 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.43 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.14 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.34 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 73.32 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 74.24 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 75.14 110.354 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 72.11 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.44 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 71.1 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 74.34 109.774 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.34 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.4 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 23' ' ' TRP . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.53 110.403 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.42 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.04 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.01 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.44 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.31 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 72.41 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 74.45 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.22 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.54 110.572 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 74.34 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 75.03 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.22 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CE2' ' CG2' ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.12 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.33 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.307 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 7' ' ' VAL . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.702 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.35 110.917 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 65.45 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.31 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 64.13 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 75.03 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 15' ' ' ILE . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.23 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' H ' HG12 ' A' ' 14' ' ' VAL . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.11 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.631 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.22 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' NZ ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 74.25 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 70.52 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' ASP . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 75.24 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' H ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.44 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.503 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.44 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.346 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 70.11 110.279 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 64.1 111.727 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.3 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 74.5 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 64.22 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 74.41 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 74.53 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.44 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.41 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.13 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.565 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.52 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 55.32 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.44 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HH21 ' A' ' 59' ' ' ARG . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.44 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.14 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 ' N ' HD11 ' A' ' 42' ' ' ILE . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.23 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.41 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 64.32 110.6 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.14 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.13 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.514 HD21 ' N ' ' A' ' 44' ' ' GLY . 2.0 m-80 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 71.21 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.54 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 64.34 110.327 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 75.54 110.15 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.12 112.217 179.365 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.326 -0.249 . . . . 75.43 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.456 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.31 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 53.12 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 70.12 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 74.32 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 74.03 111.043 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.673 ' HG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.53 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 74.12 110.631 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.673 ' ND2' ' HG1' ' A' ' 64' ' ' THR . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.22 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.21 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.472 HG12 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.01 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 70.22 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 74.14 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 77' ' ' ALA . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.657 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.42 110.266 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.45 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.528 ' N ' ' OG ' ' A' ' 79' ' ' SER . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.35 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.32 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 70.5 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.53 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 62.31 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 74.2 110.536 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 75.41 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 75.41 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.03 110.279 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.32 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 75.12 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 39' ' ' HIS . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.51 110.751 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 73.31 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.13 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.45 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.01 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.55 110.548 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.403 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 72.1 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 64.53 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.12 110.755 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.03 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 73.11 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 73.24 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 5' ' ' PHE . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 70.45 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.45 110.238 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 75.14 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 75.23 111.563 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 75.4 109.993 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.676 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 74.55 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 62.02 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 73.22 110.844 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.21 109.96 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' C ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.13 111.227 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.31 110.414 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.3 111.118 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.45 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.31 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 55.24 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 72.25 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.33 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.53 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.04 109.854 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.87 0.367 . . . . 73.45 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 73.41 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 73.33 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.493 ' OE1' ' OH ' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.4 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.24 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.32 110.974 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.34 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 72.13 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.33 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.24 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.15 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.05 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.51 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 75.14 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.41 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.23 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 72.34 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.41 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 74.12 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.493 ' OH ' ' OE1' ' A' ' 137' ' ' GLU . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.293 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.35 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 75.31 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.15 110.558 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 73.44 109.332 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.13 110.298 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.55 110.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.53 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.54 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.15 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 8' ' ' ALA . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 75.14 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.4 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HA ' ' HZ3' ' A' ' 116' ' ' LYS . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 75.22 112.088 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 3.9 m-80 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.34 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.33 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 8' ' ' ALA . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 71.34 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.532 ' H ' HG12 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.33 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.33 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 75.43 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 72.35 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.33 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.41 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.41 110.368 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.13 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' H ' ' ND2' ' A' ' 149' ' ' ASN . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 73.45 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 74.34 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.11 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.12 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 74.44 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 75.2 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.24 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' OG1' ' A' ' 36' ' ' THR . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 75.41 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.13 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.24 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.23 110.605 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 32' ' ' VAL . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.43 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.1 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 73.1 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.4 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 HD11 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.2 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 71.15 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 63.11 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.14 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.713 HH21 ' CB ' ' A' ' 64' ' ' THR . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.34 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.03 110.227 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.45 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.43 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.44 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 62.43 110.454 -179.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' ASN . 26.4 mtp180 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.126 -0.324 . . . . 71.03 110.126 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.01 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 74.2 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 73.15 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 71.14 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.713 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 73.02 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.11 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.649 ' ND2' ' HG1' ' A' ' 64' ' ' THR . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 64.34 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 74.12 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 73.23 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.3 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.24 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.2 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 73.31 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.43 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.41 110.652 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.12 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 74.23 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 75.53 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.55 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 75.23 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 72.51 110.882 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.22 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.32 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.45 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 73.01 110.509 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 43.15 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.55 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.31 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 75.31 110.717 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.44 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 72.43 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.34 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.05 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 72.02 110.302 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 73.42 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.45 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.157 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 73.32 111.915 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 73.53 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 74.02 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 74.03 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 71.13 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 74.13 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 72.55 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 74.15 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 74.23 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HZ3' ' HA ' ' A' ' 11' ' ' GLU . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 75.11 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 75.21 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.447 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.12 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 51.41 110.332 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.33 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 72.33 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 74.13 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 73.03 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.497 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.21 110.2 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 72.53 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.03 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.23 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.14 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 73.5 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 65.54 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 74.04 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 74.21 110.838 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 74.4 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.54 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 72.25 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.34 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 14.6 m-80 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 73.32 110.846 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 74.44 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.13 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 72.54 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 75.23 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.51 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.45 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.44 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.14 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 73.04 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 72.55 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.632 ' CD ' ' H ' ' A' ' 161' ' ' GLN . 5.8 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.32 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.32 110.615 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 74.03 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.411 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 75.15 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 110' ' ' ASP . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.02 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.1 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.4 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.24 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.14 110.077 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.42 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.459 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.54 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.11 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 1.8 m120 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 64.52 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.703 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.11 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.566 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 62.22 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.43 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 72.24 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.05 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 10.2 p30 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 65.21 109.154 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.692 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.43 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 75.0 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.33 111.28 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.15 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' H ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.3 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 74.44 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.12 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.2 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.32 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' N ' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.4 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.34 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 75.33 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 71.4 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 74.32 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 70.3 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 74.51 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 71.22 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 72.14 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 63.21 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 74.41 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 42' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.34 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.979 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.53 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 75.4 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.12 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.12 111.057 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 63.21 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 74.05 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 74.33 110.673 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.497 ' CG ' HH11 ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.911 0.386 . . . . 71.41 110.444 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.13 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.51 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' H ' HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 72.01 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 65.31 110.442 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 74.2 110.872 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 71.42 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 73.32 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 6.1 m120 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.32 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.52 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.14 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 74.34 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 72.41 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 75.14 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.411 ' SG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 72.4 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 77' ' ' ALA . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 74.25 111.203 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.13 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 74.15 110.795 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.54 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 75.14 110.681 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.44 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.3 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.44 110.978 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 74.14 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 74.21 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 75.43 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.23 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.1 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.452 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.2 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.474 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.592 ' CG ' ' O ' ' A' ' 96' ' ' PHE . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 71.3 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 73.0 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 72.4 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 44.04 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 5.0 pt20 -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 75.03 110.637 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.436 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 72.55 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.24 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.11 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 73.44 110.577 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 74.1 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.15 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.01 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 5' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.41 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.495 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.25 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 74.44 110.641 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 73.03 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 118' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.424 ' N ' HG22 ' A' ' 117' ' ' ILE . 7.4 t-160 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.964 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.567 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.1 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 72.35 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 72.04 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.703 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 75.14 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.12 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.33 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.472 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.329 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.823 0.344 . . . . 63.11 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 74.44 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.31 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 71.45 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.2 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.437 HG23 ' HD1' ' A' ' 156' ' ' HIS . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 74.52 110.728 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.24 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 73.14 110.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.15 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 74.13 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.411 ' HG1' ' N ' ' A' ' 146' ' ' ASP . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.727 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.411 ' N ' ' HG1' ' A' ' 145' ' ' THR . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.507 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.12 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.529 ' C ' HD21 ' A' ' 149' ' ' ASN . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 65.14 110.627 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.529 HD21 ' C ' ' A' ' 148' ' ' LYS . 2.0 m-80 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.31 110.538 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.53 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.12 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.54 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.02 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 74.23 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 74.31 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.415 ' HZ1' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 75.13 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.44 110.51 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.53 110.567 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 73.34 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 73.22 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.358 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 63.41 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.52 110.418 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.454 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 73.02 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.22 110.74 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.21 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 74.25 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 74.32 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.808 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.13 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 15' ' ' ILE . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.43 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.42 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 71.44 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.03 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 74.25 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 71.13 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.43 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.33 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 70.32 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NE ' HG22 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.44 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 75.33 110.36 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.31 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 74.53 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 43.33 110.573 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.24 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.13 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 73.1 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.475 ' HG1' ' CD2' ' A' ' 39' ' ' HIS . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 74.32 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.21 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.53 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.475 ' CD2' ' HG1' ' A' ' 36' ' ' THR . 0.4 OUTLIER -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.11 110.369 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.43 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 75.11 109.988 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.43 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 64.24 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.33 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 72.34 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.1 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 62.45 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 75.51 110.948 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.43 111.366 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.316 0.579 . . . . 73.21 109.979 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.662 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 61' ' ' ILE . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 74.21 110.715 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 62' ' ' ILE . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 74.34 110.113 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.12 110.986 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.484 ' OG1' ' NE ' ' A' ' 45' ' ' ARG . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.2 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 73.55 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CZ ' ' NH2' ' A' ' 45' ' ' ARG . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 71.23 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.14 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 72.35 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.34 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.2 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.1 110.409 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.12 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 72.22 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 63.23 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.24 110.65 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.22 110.878 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 81' ' ' GLU . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 74.43 110.597 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 80' ' ' VAL . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 63.35 110.634 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.2 110.752 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 74.14 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.23 110.71 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.477 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.53 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 75.34 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.11 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.31 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.577 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.13 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 71.43 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.31 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 71.32 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 64.52 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 71.2 110.189 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.12 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.31 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.12 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 104' ' ' LEU . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.198 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.42 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.22 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 74.14 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.54 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.01 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.11 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 74.14 110.787 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.44 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.54 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.422 HG22 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.15 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 117' ' ' ILE . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.52 110.657 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.44 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.35 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.14 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.808 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 70.14 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 64.32 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.32 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.24 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 71.52 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.12 109.753 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.736 0.303 . . . . 73.32 110.813 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.427 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 75.45 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 73.13 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 74.5 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.55 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 74.31 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 75.33 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.12 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.41 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 72.12 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 64.15 110.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.24 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.14 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.44 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.15 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.14 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.45 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.43 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.23 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.53 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.41 ' C ' ' CD2' ' A' ' 156' ' ' HIS . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 75.44 110.4 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 156' ' ' HIS . 3.2 m-70 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.53 110.679 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.23 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.33 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.12 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.427 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.625 ' H ' ' NE2' ' A' ' 161' ' ' GLN . 1.7 pm0 -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 75.35 110.576 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.03 110.515 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 72.35 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.14 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.34 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.11 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 72.43 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 75.23 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 64.51 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 74.41 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.51 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 75.13 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.41 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.627 ' NE ' ' O ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 70.33 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 15' ' ' ILE . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 75.44 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' H ' HG13 ' A' ' 14' ' ' VAL . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 74.21 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.24 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 70.01 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.67 ' ND2' ' O ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 71.03 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 73.03 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.676 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 75.34 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.31 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.2 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.657 HH11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 72.34 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.657 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 75.01 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 72.24 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.463 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.45 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 55.2 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.23 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.23 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.11 110.592 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.51 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.22 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 75.31 110.48 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.14 110.455 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.05 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 71.15 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.11 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 74.44 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 75.21 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 73.5 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 73.42 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 71.12 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 74.45 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 74.43 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 92.0 m-20 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.42 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 74.23 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.32 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' CG1' ' OD1' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.21 110.487 -179.556 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.038 0.447 . . . . 75.51 110.841 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 74.13 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 71.54 110.878 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.33 110.456 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.3 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.42 111.546 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 73.15 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.2 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 16.0 m-80 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.22 110.531 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.2 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.02 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 72.45 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 64.01 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 74.14 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.54 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 72.34 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 74.11 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 74.31 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.41 110.741 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.3 110.715 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.13 110.413 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.14 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.3 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.534 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.44 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 84' ' ' PHE . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 72.52 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 71.25 111.016 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.12 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.51 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.13 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 5' ' ' PHE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.3 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' O ' ' C ' ' A' ' 97' ' ' GLY . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 75.41 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 74.31 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CD2' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.2 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 64.14 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.828 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.41 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.655 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 72.41 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.12 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 73.34 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.52 110.407 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.42 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 70.54 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 73.41 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.02 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 75.14 110.733 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.04 109.819 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 73.21 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 75.21 110.708 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CE2' HG13 ' A' ' 157' ' ' VAL . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.2 110.546 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.753 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 60.22 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.3 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.5 HD13 HG22 ' A' ' 117' ' ' ILE . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.43 110.53 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.42 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.53 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.53 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.627 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.44 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 64.45 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 74.53 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.23 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.42 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.49 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.24 110.149 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.832 0.349 . . . . 74.31 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.535 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.12 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.15 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 74.31 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 73.43 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.02 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' TYR . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.24 110.685 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 74.1 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.21 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 70.11 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 71.14 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.32 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 75.02 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.573 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 72.43 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 70.34 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.42 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 75.12 110.546 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 141' ' ' GLU . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.14 110.919 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.42 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 113' ' ' TYR . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 74.22 110.292 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 74.33 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 73.33 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.12 110.391 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.546 ' CD ' ' N ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.21 110.618 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 74.22 110.647 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.01 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.45 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.3 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.404 ' CZ ' ' CG2' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.58 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.44 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 64.02 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HB1' HH21 ' A' ' 24' ' ' ARG . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.2 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 72.01 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 64.45 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.32 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 75.21 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.461 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 74.55 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 15' ' ' ILE . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 73.13 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 ' H ' HG11 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.51 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' ILE . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.31 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 72.52 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 64.11 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.45 109.891 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.515 HD22 ' CG1' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.22 110.306 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.703 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.41 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.44 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.04 110.535 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.58 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.21 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.466 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.11 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.44 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.44 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 75.03 111.096 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 73.42 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 74.41 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.52 111.301 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.42 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.15 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.23 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 75.14 110.59 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.03 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.44 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 63.24 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 73.44 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 71.32 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 72.32 110.53 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 74.4 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 63.01 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.31 110.454 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 65.54 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.456 ' OD1' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.23 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.44 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 72.5 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 20' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 75.14 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.515 ' CG1' HD22 ' A' ' 20' ' ' ASN . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 73.22 109.793 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.32 111.382 179.448 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.513 0.197 . . . . 74.2 110.713 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.32 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.24 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 71.32 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.21 111.03 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 71.35 110.86 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.641 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 1.2 m120 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.52 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.45 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.52 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 2.3 p80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 73.54 110.536 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 75.33 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.1 110.645 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 65.13 110.703 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 61.33 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.12 110.824 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 73.13 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 73.31 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 74.23 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.931 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 74.5 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 71.35 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 65.12 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.33 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 73.42 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 74.25 110.118 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.11 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 95' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 72.41 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 97' ' ' GLY . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.12 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.14 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.43 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 52.1 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.12 111.27 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 74.24 111.15 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 75.0 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.22 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 74.02 111.172 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 74.11 111.172 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 71.33 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.44 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 73.53 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 110' ' ' ASP . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 73.34 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.13 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.01 110.673 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.14 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 64.4 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.13 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.403 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.43 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.04 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.13 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 73.34 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.35 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.52 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.461 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.14 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.12 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.44 111.038 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.33 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.411 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.42 109.901 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.848 0.356 . . . . 73.41 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.409 ' CH2' ' CG ' ' A' ' 160' ' ' LYS . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.02 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.53 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 73.3 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.21 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 74.25 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 73.45 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.53 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 74.4 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.53 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 72.2 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.31 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 75.43 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.13 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.11 111.434 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.44 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 74.4 m80 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.23 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 74.2 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 73.52 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.32 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 73.22 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 74.05 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.04 110.572 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.22 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.43 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.15 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 64.43 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 75.24 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.22 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 72.22 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.15 109.317 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.44 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.13 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 75.14 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.32 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 74.42 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.613 ' H ' HG12 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.52 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 62.4 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.34 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 20' ' ' ASN . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.35 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.32 109.336 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 18' ' ' ASP . 9.0 p30 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.35 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.651 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.13 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 72.21 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.419 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 75.31 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 25' ' ' LEU . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.4 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.41 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.04 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.34 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 75.3 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.583 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.51 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.45 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.51 110.366 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 74.34 111.274 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.3 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.53 110.527 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.51 110.95 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 71.33 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.45 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 74.14 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.43 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.32 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.23 110.578 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.21 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.611 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 52.11 110.771 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 75.03 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 73.25 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 44' ' ' GLY . 3.0 m-80 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 73.41 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 75.15 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 47' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.23 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' ILE . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 71.53 110.662 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.23 111.147 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.687 0.279 . . . . 74.32 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.42 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.964 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 61' ' ' ILE . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 62' ' ' ILE . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.307 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 72.42 111.067 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 75.35 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 9.4 m-80 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 71.12 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 43.1 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.12 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 74.24 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.42 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.02 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 63.44 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 70.12 109.99 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 74.12 110.877 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.43 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 70.55 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 71.44 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.42 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.33 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.11 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 75.02 110.654 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.01 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.34 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.55 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.43 110.502 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 74.12 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 95' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.53 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.1 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.21 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.436 ' H ' HD12 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 63.43 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 73.43 111.105 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.25 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.02 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.4 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.421 ' N ' HD21 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 75.21 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.04 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 74.22 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 75.2 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 74.3 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 72.54 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.34 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 75.23 110.394 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 73.23 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' NE2' ' A' ' 156' ' ' HIS . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 64.25 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 72.12 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 117' ' ' ILE . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.546 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.15 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.15 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 74.44 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 75.11 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.42 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.14 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.43 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.01 110.4 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 73.34 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 73.04 109.689 179.036 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.751 0.31 . . . . 72.41 110.804 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 74.42 110.483 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.51 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.53 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.03 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.464 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.34 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.52 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.521 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.33 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.41 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 74.25 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.772 ' HG1' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 75.11 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.772 ' N ' ' HG1' ' A' ' 145' ' ' THR . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.05 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.14 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 72.52 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.44 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.21 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 73.3 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 72.54 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.45 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.692 ' ND1' ' C ' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.13 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 73.42 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.35 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.54 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 72.14 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' ' NE2' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.31 110.591 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' H2 ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.24 109.42 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 110.651 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.53 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 61.04 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 74.35 110.249 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 72.54 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 63.32 110.747 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.41 110.891 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.34 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.04 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 12' ' ' ASN . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.4 111.858 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 11' ' ' GLU . 3.2 m-80 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 75.04 111.9 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.791 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.35 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.32 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.32 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.464 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.52 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.35 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.15 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.51 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.13 110.393 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 74.42 110.017 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.31 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.02 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 72.31 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.33 110.224 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 73.22 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.13 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.23 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 75.31 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.41 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 74.32 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.15 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 74.15 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.53 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' MET . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.44 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.52 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.35 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.41 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.42 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.23 110.54 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 71.43 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 34.43 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 75.21 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.12 110.604 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.42 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 73.45 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 HG12 HD22 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 72.33 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.21 110.71 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.699 0.285 . . . . 73.41 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 73.13 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 73.04 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.25 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 62' ' ' ILE . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 74.44 110.649 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.03 110.697 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 74.25 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.558 ' HE ' ' CA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 72.55 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 8.9 m-80 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.12 110.794 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 73.32 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.23 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.43 110.518 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.21 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.42 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 64.11 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.32 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.44 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 63.03 110.595 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 74.51 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.656 ' N ' ' OG ' ' A' ' 79' ' ' SER . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 74.55 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 73.12 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.532 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 71.43 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.55 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.2 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.894 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 73.44 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.53 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.42 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.42 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 74.54 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.54 110.211 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.31 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.53 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 70.32 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 72.31 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.43 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 74.21 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.51 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.33 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.14 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.13 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CZ ' HG11 ' A' ' 80' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.34 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.41 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 64.22 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.42 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.302 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.405 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.43 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HZ2' ' HB2' ' A' ' 159' ' ' GLU . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 71.5 110.06 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 72.12 111.139 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 73.32 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.52 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 75.12 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.43 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.13 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 70.22 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 65.51 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 75.51 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 61.31 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.791 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 73.33 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 71.24 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.1 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.498 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.11 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.404 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.4 110.227 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.727 0.299 . . . . 72.1 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.449 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.4 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 74.23 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.34 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 72.12 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 73.32 111.012 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.22 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.11 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.31 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.53 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 145' ' ' THR . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.01 110.427 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.2 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.54 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.23 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.43 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 72.13 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 74.11 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.53 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.33 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.13 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.41 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 72.25 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 72.12 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 75.15 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 71.11 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.2 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 61.43 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.12 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 73.23 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 74.51 110.134 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 74.32 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 74.44 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 62.34 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 72.4 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 64.51 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.03 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HE ' ' C ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 73.12 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 15' ' ' ILE . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.45 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 ' N ' HG12 ' A' ' 14' ' ' VAL . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 73.23 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 71.34 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 75.44 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 70.2 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.21 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.44 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.681 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.42 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 75.33 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.708 ' CD1' ' C2 ' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 74.52 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.31 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.31 111.471 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 74.13 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.15 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.609 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 75.42 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.45 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 75.25 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 74.42 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 75.01 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 75.53 110.727 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.04 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 74.12 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 72.33 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.546 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.1 110.596 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.41 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' H ' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.22 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.386 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.42 110.483 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.737 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 74.24 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.576 ' HE ' HO3A ' A' ' 173' ' ' NAP . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.1 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.737 ' ND2' ' H ' ' A' ' 44' ' ' GLY . 6.1 p30 -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.34 110.486 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CE1' ' O ' ' A' ' 52' ' ' GLY . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 72.04 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.13 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.487 HD12 HH21 ' A' ' 53' ' ' ARG . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.615 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . 96.83 -70.02 0.82 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 64.0 110.891 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.701 ' NE ' ' C18' ' A' ' 174' ' ' N22 . 60.1 mtt180 55.01 138.58 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 121.008 -0.277 . . . . 71.24 110.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.25 -85.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.288 1.992 . . . . 73.03 111.897 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.93 61.44 3.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.313 0.578 . . . . 75.33 109.972 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.39 116.81 4.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.714 2.276 . . . . 74.32 111.556 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.51 73.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.313 -1.115 . . . . 72.21 110.313 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 54.08 17.78 1.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 74.33 110.456 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.22 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.45 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.43 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 72.14 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.42 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 70.12 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.33 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 73.32 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 73.25 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.402 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.15 110.781 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 69' ' ' TYR . 55.9 m-70 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.23 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.41 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 73.32 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.51 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.43 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 75.12 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.736 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.4 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.12 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.512 ' HG ' ' C2A' ' A' ' 173' ' ' NAP . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.13 110.611 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.419 ' CG1' HD12 ' A' ' 104' ' ' LEU . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 73.05 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.32 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 72.01 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 74.4 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.04 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.22 110.61 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 73.05 110.728 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 74.34 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 74.24 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.04 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.14 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.15 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.4 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.44 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.34 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.21 111.268 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.44 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 70.21 110.89 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.636 ' NE2' ' C5B' ' A' ' 173' ' ' NAP . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.978 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.472 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 75.13 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 74.24 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 64.31 110.584 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.471 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 75.24 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.51 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 74.14 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 72.23 111.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 73.32 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 75.2 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 71.01 111.175 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 71.23 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.24 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.23 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 75.41 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.24 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 72.44 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.24 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.41 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 71.33 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 75.32 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -165.66 95.93 0.81 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.52 109.889 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.16 179.84 6.13 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.442 2.095 . . . . 74.34 112.637 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -59.48 94.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.802 -0.635 . . . . 74.25 110.796 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.8 mtp -106.66 -49.17 3.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.44 110.455 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -159.76 111.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.44 110.599 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.456 ' SD ' ' OH ' ' A' ' 158' ' ' TYR . 26.8 ptt? -131.09 19.64 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 74.2 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -68.87 -23.41 64.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 63.25 110.645 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -59.03 -24.26 62.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.57 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 73.21 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 75.44 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 73.11 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 75.24 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 75.22 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 65.23 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 73.25 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.24 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 63.11 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 71.45 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.13 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 151' ' ' TYR . 25.2 m-80 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 70.32 110.617 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.15 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' H ' ' C ' ' A' ' 149' ' ' ASN . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.42 110.566 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.55 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.02 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.3 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 74.31 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 62.34 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 75.42 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 72.52 110.394 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.54 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.42 110.512 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.636 ' C5B' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.708 ' C2 ' ' CD1' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 70.52 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.884 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 64.24 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 75.52 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 74.22 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 63.42 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.53 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.41 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 72.1 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 73.04 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.72 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 74.13 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 ' H ' ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.23 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 14' ' ' VAL . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.41 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 64.41 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 71.35 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 71.13 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 7.7 m-20 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.54 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.41 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.722 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 74.12 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.22 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.706 ' CD2' ' C7 ' ' A' ' 174' ' ' N22 . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 75.43 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.21 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.636 ' CD ' HD22 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.13 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.44 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.32 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' HB2' ' NE1' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 75.21 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 72.4 111.598 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 74.13 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 74.25 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 73.04 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.03 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 75.22 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.32 110.789 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.45 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 72.1 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD1' ' H ' ' A' ' 39' ' ' HIS . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.45 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.32 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 HD13 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 75.21 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 72.3 110.637 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.22 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 55.34 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.518 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 74.24 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 75.42 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.435 ' ND2' HD12 ' A' ' 51' ' ' ILE . 2.1 t-20 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.22 109.982 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.23 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.43 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.41 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.54 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.86 -122.51 3.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 74.22 110.975 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -131.06 61.41 59.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 73.02 110.776 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.52 151.92 33.34 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.049 2.5 . . . . 75.23 112.137 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.32 35.72 0.26 Allowed Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 120.647 -0.421 . . . . 74.32 111.737 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 5.8 Cg_endo -49.49 109.7 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.791 2.327 . . . . 74.1 112.071 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.33 4.94 63.98 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.137 -0.785 . . . . 71.23 111.137 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 49.48 38.11 13.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 74.42 110.64 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.12 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.04 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 74.11 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.12 110.479 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.1 110.734 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.02 110.615 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.23 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.51 110.637 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.22 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 74.53 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 63.23 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.41 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 71.45 110.654 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 72.31 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.13 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 62.24 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.01 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.44 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 70.42 110.569 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.532 ' OG ' ' C2A' ' A' ' 173' ' ' NAP . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 74.34 110.958 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.3 110.716 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.22 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.23 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.4 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.55 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.44 110.917 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.433 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.35 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 74.33 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.22 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.24 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 72.24 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.4 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 75.41 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.42 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 61.14 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.42 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.41 110.322 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.912 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.51 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.72 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.21 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 73.05 110.903 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 74.22 111.056 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 75.24 111.356 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.32 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.43 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 106' ' ' LEU . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 75.54 110.408 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 HG23 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.01 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.2 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 75.24 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 65.02 110.94 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 74.43 110.666 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.54 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 73.22 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.13 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 73.44 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.553 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 71.2 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.43 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.32 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.01 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.32 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.72 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.24 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.22 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.54 111.176 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.447 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.14 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -165.13 133.59 2.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 73.34 110.093 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.09 -163.53 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.343 2.028 . . . . 73.22 112.004 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.74 122.71 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 70.31 110.45 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 27.4 mtp -129.7 -55.01 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 63.02 110.728 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 4.0 m-20 -73.22 82.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 72.11 110.694 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -124.15 -23.36 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.549 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.0 t -79.08 -31.96 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 63.51 110.676 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.96 -27.94 54.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.43 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.23 110.515 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 73.14 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.542 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.32 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 72.43 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.22 110.3 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.43 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.24 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.41 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.23 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.23 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 73.4 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.636 HD22 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 72.12 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.54 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.3 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 72.04 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 74.44 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 74.13 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.1 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.13 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.52 110.868 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.14 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.34 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 71.32 110.294 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.611 ' CD ' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 74.24 110.706 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 63.31 110.588 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.749 ' O3 ' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.706 ' C7 ' ' CD2' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.31 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 74.23 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 75.53 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 74.13 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.495 ' HG2' ' N7 ' ' A' ' 174' ' ' N22 . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.45 110.705 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 70.14 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.596 ' CB ' ' N7N' ' A' ' 173' ' ' NAP . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 55.51 110.457 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.35 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 73.32 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 72.23 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.21 110.93 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 74.01 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HB ' ' N ' ' A' ' 127' ' ' PHE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 75.53 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.41 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.14 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 74.12 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.44 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 m120 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.21 110.094 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 74.23 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.724 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.11 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.43 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 73.33 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HD3' ' N4 ' ' A' ' 174' ' ' N22 . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 71.21 109.901 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' CD1' ' HH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 74.33 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 74.11 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.682 ' OE1' ' N8 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.15 110.163 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.42 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.41 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 61.23 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.42 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.33 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 36' ' ' THR . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.42 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 35' ' ' THR . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.3 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.43 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.23 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 72.44 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 73.23 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.13 110.905 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.13 110.204 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.32 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 74.5 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.44 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.22 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.668 HD22 ' C6N' ' A' ' 173' ' ' NAP . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 73.14 110.262 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 72.41 110.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 73.42 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.22 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.656 ' C ' ' H ' ' A' ' 53' ' ' ARG . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 73.23 110.007 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.14 1.79 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.32 111.436 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.656 ' H ' ' C ' ' A' ' 51' ' ' ILE . 26.9 mtt-85 -113.49 103.69 55.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 121.029 -0.269 . . . . 75.41 111.095 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' O ' ' C4 ' ' A' ' 174' ' ' N22 . 44.0 Cg_endo -76.02 -166.58 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.275 1.983 . . . . 73.13 111.294 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 57' ' ' GLY . 0.9 OUTLIER -118.2 114.14 36.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.315 -0.554 . . . . 73.51 111.374 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -69.38 2.78 3.02 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.579 1.519 . . . . 75.11 110.849 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 58' ' ' ARG . . . -76.69 2.52 58.73 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.917 -1.273 . . . . 75.4 109.917 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER 157.48 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 75.42 109.939 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 75.21 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.45 110.446 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.42 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.32 110.582 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 74.5 110.79 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 74.51 110.536 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 63.52 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 14.6 m-80 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 75.21 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.31 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.34 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 73.11 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 74.41 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.21 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 75.43 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 62.1 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 72.24 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.53 110.659 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.51 110.893 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 75.42 110.67 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.646 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.41 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.35 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 71.51 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 73.53 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 74.14 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.42 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 64.22 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.42 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.21 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.35 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 75.14 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 75.13 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.53 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.42 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 71.05 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.592 ' OE1' ' O5B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.45 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.58 ' CD1' ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.23 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.52 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.24 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.43 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.34 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.407 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.31 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 110' ' ' ASP . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 74.42 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 109' ' ' VAL . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.2 110.647 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 65.1 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 135' ' ' TRP . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 75.12 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 73.2 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 73.55 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 64.35 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.31 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 75.42 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.24 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 73.15 110.921 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.444 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.42 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.12 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 75.03 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.456 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 75.11 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.646 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 15.7 t80 -101.62 123.32 44.62 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.34 109.775 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.646 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 41.0 Cg_endo -71.7 -164.71 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.276 1.984 . . . . 73.15 112.22 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -130.76 105.94 8.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 72.33 110.458 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 10.4 mtt -134.37 -75.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 62.24 110.578 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -175.05 165.46 3.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 74.35 110.84 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -151.05 26.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 73.45 110.47 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.8 t -75.88 -28.5 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.607 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -41.63 -44.68 3.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 72.54 110.631 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.482 ' CE2' HD12 ' A' ' 112' ' ' LEU . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.44 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' NZ ' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 64.31 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 139' ' ' PHE . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 74.4 110.684 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.53 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 70.01 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.45 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.53 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.51 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.55 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.426 ' HG1' ' HA ' ' A' ' 150' ' ' PRO . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.52 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.14 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 64.4 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HG1' ' A' ' 145' ' ' THR . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 72.32 112.073 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 74.13 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.42 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.442 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.23 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 74.23 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 64.43 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 75.22 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 71.14 110.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.668 ' C6N' HD22 ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.682 ' N8 ' ' OE1' ' A' ' 28' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.01 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.604 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 71.21 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.4 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.31 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 72.43 111.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.564 ' CB ' ' N7N' ' A' ' 173' ' ' NAP . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.2 110.683 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 74.02 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.32 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.506 ' C ' HD21 ' A' ' 12' ' ' ASN . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.54 112.072 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.552 HD21 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.34 111.397 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.499 HH21 ' HA ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 74.13 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 15' ' ' ILE . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 75.03 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.518 ' N ' HG12 ' A' ' 14' ' ' VAL . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 74.52 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 74.35 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.12 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 20' ' ' ASN . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.41 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 72.02 110.356 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.23 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.751 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.31 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 73.03 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.572 ' CD1' ' N ' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.42 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.53 110.222 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 75.0 109.979 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 72.13 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 73.34 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 73.52 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 74.44 109.677 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 75.04 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 74.01 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 37' ' ' MET . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 73.02 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 72.31 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.4 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.669 ' HG1' ' CD2' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.35 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.32 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 72.25 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.669 ' CD2' ' HG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 74.14 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.52 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.31 110.116 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.44 ' H ' HD11 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.33 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 74.43 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.34 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.752 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.21 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.32 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.612 HD22 ' C6N' ' A' ' 173' ' ' NAP . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.23 110.207 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.02 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 74.2 111.136 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 ' CG1' HD22 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 73.41 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.88 -137.47 41.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 74.3 111.273 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' N ' ' CD ' ' A' ' 53' ' ' ARG . 7.6 mpt_? 61.91 150.25 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 63.12 110.387 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.75 -155.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.714 2.276 . . . . 74.45 112.406 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -146.87 58.58 4.42 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 121.1 0.476 . . . . 53.51 110.555 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' ARG . 22.8 Cg_endo -63.06 119.06 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.046 2.497 . . . . 73.33 112.57 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.6 22.42 0.09 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.909 -0.876 . . . . 73.12 110.909 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' PRO . 4.2 ttt-85 -110.83 164.34 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.034 -0.358 . . . . 74.51 110.034 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.24 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.22 110.534 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.54 110.543 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.611 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.752 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 74.51 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 73.32 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 74.31 110.571 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.11 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.23 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.666 ' HH ' ' NH2' ' A' ' 45' ' ' ARG . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 74.54 110.561 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.3 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.31 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 73.23 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.48 ' HA ' HD22 ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.12 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.4 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 77' ' ' ALA . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.4 110.269 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.51 110.554 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.49 ' OG ' ' C2A' ' A' ' 173' ' ' NAP . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.21 111.04 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.43 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.12 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 73.14 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.44 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.32 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.451 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 75.31 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.508 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.05 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 74.1 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.43 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.13 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.41 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.12 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.703 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 74.32 110.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 74.02 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.457 ' O ' ' C ' ' A' ' 97' ' ' GLY . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 72.4 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.14 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.12 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.44 110.673 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.22 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.44 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.54 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.23 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.704 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.23 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.55 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 74.22 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.45 HG21 ' N ' ' A' ' 110' ' ' ASP . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.42 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' N ' HG21 ' A' ' 109' ' ' VAL . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 73.21 110.056 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 72.34 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.2 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' CE1' ' CG1' ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.1 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 74.42 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 115' ' ' THR . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 60.34 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 75.34 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.33 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 73.45 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.24 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 74.53 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 75.53 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.53 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.1 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.53 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 72.42 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.12 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.47 134.93 2.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.53 110.476 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.11 -170.35 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.494 2.129 . . . . 75.15 112.456 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.93 160.48 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 75.55 110.296 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 15.1 ptm -155.08 -161.55 1.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 74.11 110.68 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.1 145.95 40.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.45 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.513 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.8 mtp -141.52 35.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 74.44 110.729 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -50.33 -10.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 74.44 110.463 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 132' ' ' MET . 6.0 m120 -67.06 -17.52 64.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.131 -0.486 . . . . 63.32 111.033 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 73.52 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 75.2 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.54 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 75.33 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.41 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.12 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.51 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HE2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.31 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 72.21 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 75.03 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.34 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.01 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.11 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.24 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 10.2 p30 -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.13 110.625 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.04 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.24 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 71.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.32 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 74.0 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 74.23 110.441 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.673 ' NE2' ' CD1' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.23 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.445 ' CG1' ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.42 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.11 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 74.15 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.4 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.489 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.41 110.439 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.11 110.538 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.735 ' O3X' ' NH1' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.33 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.58 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.34 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.14 110.353 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.32 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.34 111.252 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.34 110.032 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 74.51 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 70.03 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 73.05 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.22 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.14 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 127' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 75.32 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.493 HG21 ' N7N' ' A' ' 173' ' ' NAP . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.22 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.43 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 73.12 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.711 ' N ' ' O2D' ' A' ' 173' ' ' NAP . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 75.12 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.676 HD22 ' C2 ' ' A' ' 174' ' ' N22 . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.22 111.036 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 23' ' ' TRP . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.55 110.365 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.11 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.494 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 74.15 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD11 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 63.55 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.41 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 64.44 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' H ' HD11 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.2 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.475 ' CB ' ' C7 ' ' A' ' 174' ' ' N22 . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 74.42 110.671 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.43 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.42 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG22 ' N8 ' ' A' ' 174' ' ' N22 . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 75.54 110.946 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.12 110.733 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.2 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.51 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.02 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 4.8 m170 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 70.22 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.51 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 75.34 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.03 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.43 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.771 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 63.44 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' NE ' HO3A ' A' ' 173' ' ' NAP . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.21 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.11 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.771 HD21 ' N ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.4 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.466 ' CE2' HG12 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 73.33 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.42 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.23 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 75.45 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.8 40.59 8.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 64.3 111.706 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.17 139.31 96.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.82 -0.352 . . . . 72.44 110.486 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.7 -91.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.547 2.165 . . . . 74.23 111.737 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tp 172.94 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 71.42 110.778 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 11.8 Cg_endo -55.63 93.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.434 2.089 . . . . 74.13 112.019 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.14 -32.37 1.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.85 -0.691 . . . . 53.54 111.381 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 141.14 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 75.51 111.048 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 74.11 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 73.44 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 74.43 110.65 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 75.2 110.85 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.22 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.52 110.636 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.22 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 74.24 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 51.41 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 74.24 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.43 110.373 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.466 HG12 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 70.23 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.05 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 52.42 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.32 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.216 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 54.32 111.155 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 70.04 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.13 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.34 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 83' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 71.54 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.14 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.24 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 74.3 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.13 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.31 111.075 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 65.44 110.656 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ASN . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 61.54 110.862 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.1 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 87' ' ' CYS . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 74.42 110.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.43 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.43 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.43 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.53 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.15 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.405 ' HB3' ' C4N' ' A' ' 173' ' ' NAP . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.55 110.344 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' O ' ' C5N' ' A' ' 173' ' ' NAP . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.12 111.714 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 73.21 110.15 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 75.31 110.582 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.582 ' OE1' ' C5B' ' A' ' 173' ' ' NAP . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 74.41 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.25 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.43 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.4 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 104' ' ' LEU . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.32 111.272 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 74.13 111.452 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 73.55 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.11 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.54 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.969 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.04 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.21 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 74.23 111.136 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.449 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 74.52 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 74.33 110.616 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 60.24 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 64.24 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.13 110.745 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 74.2 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 71.21 110.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.13 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.13 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 72.14 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.45 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.408 ' HG1' HD11 ' A' ' 15' ' ' ILE . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 75.21 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.499 ' C ' ' CG2' ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.3 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.53 ' N ' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -115.97 137.26 23.23 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.34 109.955 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.35 176.79 3.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.468 2.112 . . . . 74.03 112.517 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -69.08 86.86 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 75.01 110.588 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.463 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 24.0 ptm -159.56 162.22 35.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.338 -0.392 . . . . 70.41 110.67 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 130' ' ' MET . 0.4 OUTLIER -167.52 119.75 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 74.42 110.334 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 32.1 mtt -153.1 59.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 75.34 110.538 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -48.14 -53.11 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 73.45 110.367 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 65.03 14.98 9.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.32 111.165 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.433 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.33 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 75.51 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 74.54 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 75.54 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.21 111.03 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 65.12 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.24 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 74.15 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 61.42 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.43 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.32 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 74.12 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 72.41 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.53 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.65 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 55.4 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 75.52 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 74.1 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.5 110.869 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.449 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.21 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.11 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 74.53 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.776 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.44 110.821 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 75.21 110.565 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.711 ' O2D' ' N ' ' A' ' 19' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.676 ' C2 ' HD22 ' A' ' 20' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.22 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.11 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.23 110.544 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 74.4 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 96' ' ' PHE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.35 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.4 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.23 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.33 110.557 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.53 111.037 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.441 ' OD2' ' NH2' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 64.32 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.34 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 74.33 111.349 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.502 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.42 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.4 110.82 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.41 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.51 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.24 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 74.22 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.32 110.799 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD1' ' C ' ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 74.13 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 72.54 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 63.34 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.617 ' HE ' ' C8 ' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 75.33 109.947 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 74.34 110.314 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 71.52 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.14 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' C ' ' CD ' ' A' ' 28' ' ' GLU . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.592 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 74.31 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 75.41 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.12 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.44 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 75.53 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.03 111.086 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 74.04 110.761 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.3 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 62.53 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.22 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.2 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.45 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.43 ' N ' HD11 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 73.11 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.869 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 75.32 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.52 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HZ3' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.44 110.087 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.705 ' ND2' ' C2D' ' A' ' 173' ' ' NAP . 12.2 t-20 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.15 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 75.04 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.34 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 71.34 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' ND2' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 72.01 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.92 -114.7 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.13 110.862 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -153.26 67.18 6.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 73.53 110.449 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.85 154.11 26.09 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.008 2.472 . . . . 71.52 112.799 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER 176.39 -47.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.487 -0.779 . . . . 72.42 110.635 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 45.4 Cg_endo -71.86 88.32 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.688 1.592 . . . . 73.14 111.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.7 9.14 55.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.816 -0.914 . . . . 73.04 110.816 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -118.77 -53.76 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 74.51 110.379 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.4 110.431 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.35 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.42 110.214 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 72.23 110.989 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.43 110.929 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 73.51 110.43 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 62.44 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 13.6 m-20 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.4 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.44 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.22 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.33 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.44 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 64.23 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 64.5 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.31 110.152 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 77' ' ' ALA . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 73.4 111.227 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 76' ' ' VAL . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.14 109.871 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.42 110.657 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.02 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 73.12 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.1 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.13 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 73.45 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 73.31 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.44 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 74.05 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 71.45 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.41 ' H ' ' CG ' ' A' ' 91' ' ' GLU . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.23 110.465 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.42 110.69 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 73.52 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.467 HG21 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.4 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.53 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 74.11 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 70.45 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 74.52 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.692 ' NE2' ' C5B' ' A' ' 173' ' ' NAP . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.55 110.582 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 73.1 110.237 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.41 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 75.52 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.436 ' N ' HD11 ' A' ' 104' ' ' LEU . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 75.05 111.407 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.499 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 75.15 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.43 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 71.51 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 71.21 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.558 ' N ' ' CG2' ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.41 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 74.31 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 64.42 110.695 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' CZ ' HG12 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 74.14 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.491 HD13 HG23 ' A' ' 117' ' ' ILE . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.1 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' H ' HG21 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.52 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 73.04 110.514 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 74.24 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.54 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.51 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.43 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.43 110.082 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.418 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.04 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 128' ' ' PRO . 1.7 p90 -142.27 136.6 14.96 Favored Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.34 110.128 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 127' ' ' PHE . 61.1 Cg_endo -74.5 -160.65 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.627 2.218 . . . . 74.54 112.709 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.46 90.37 6.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 75.4 110.385 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.9 ptp -153.95 24.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 75.03 110.687 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.38 85.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 71.41 110.472 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.18 35.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 73.32 110.806 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 t -56.64 -53.63 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 71.23 110.296 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 57.97 16.57 3.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 74.13 110.835 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.05 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 75.22 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.02 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 73.53 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 75.34 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.75 ' HZ2' ' CB ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 72.33 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 75.32 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.21 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.31 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' N ' ' OG1' ' A' ' 145' ' ' THR . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.33 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.44 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 74.1 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 9.2 p30 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 73.11 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.4 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.1 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 70.45 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.51 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.03 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 HG12 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 75.45 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.04 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 73.35 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.12 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 73.32 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.705 ' C2D' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.617 ' C8 ' ' HE ' ' A' ' 24' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 74.53 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 74.21 110.901 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 74.13 110.1 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.31 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.462 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.13 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 73.44 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 54.32 110.608 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 72.32 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 73.04 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.41 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.24 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.764 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 73.11 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 65.31 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.634 ' CG1' ' H ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 74.25 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.634 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.3 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.31 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.33 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.14 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.1 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD21 ' N ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 74.01 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.22 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.24 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.53 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.4 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.12 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 74.04 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 71.43 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 74.05 110.401 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 74.53 111.045 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.24 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.23 110.284 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 75.3 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.4 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.13 110.551 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.434 ' CG ' ' O ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.32 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 55.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.13 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 65.12 112.621 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 74.54 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 42' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 75.21 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.21 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.446 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.55 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 75.23 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.34 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.481 ' CG ' ' C6N' ' A' ' 173' ' ' NAP . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 70.24 110.755 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.54 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 73.24 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.52 110.466 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 51' ' ' ILE . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.399 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' ARG . . . 76.99 158.42 8.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.32 110.979 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 51.56 152.88 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 110.063 -0.347 . . . . 74.11 110.063 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -67.22 -175.82 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.643 2.229 . . . . 73.51 113.147 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 57' ' ' GLY . 2.5 tt -103.75 123.78 40.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.749 -0.66 . . . . 74.1 110.154 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.47 -38.24 94.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.781 1.654 . . . . 73.14 112.697 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' N ' HD23 ' A' ' 55' ' ' LEU . . . -51.37 -14.31 1.41 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.158 -0.777 . . . . 74.24 111.158 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER 68.37 160.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 75.13 111.045 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 72.53 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.54 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 75.14 110.807 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 62' ' ' ILE . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 75.12 110.118 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 75.44 111.554 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.32 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.42 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.43 110.441 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.2 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.43 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 74.43 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.44 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.1 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.13 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 53.53 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.45 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 77' ' ' ALA . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 73.45 110.854 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 74.1 110.09 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.11 110.862 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 64.15 111.577 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' VAL . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 75.3 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.04 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 74.3 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.599 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.13 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.21 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.12 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 73.55 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 73.51 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 73.03 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.44 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.741 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.44 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.11 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.59 ' CE1' ' O7N' ' A' ' 173' ' ' NAP . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.34 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.607 ' O ' ' C5N' ' A' ' 173' ' ' NAP . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.11 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.574 ' CA ' HE22 ' A' ' 100' ' ' GLN . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 63.4 110.422 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 73.0 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.924 ' NE2' ' H ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.924 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 75.43 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 73.14 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 101' ' ' ILE . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.31 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 73.31 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 73.52 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 74.33 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 111' ' ' LYS . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.31 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.51 110.311 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 75.02 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.21 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 74.3 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 72.22 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 64.13 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.01 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 117' ' ' ILE . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 75.03 110.585 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 73.25 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.14 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 75.31 110.696 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.764 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 72.22 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 63.11 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.42 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.34 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.458 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.52 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.43 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.68 121.4 0.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.13 110.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 -166.21 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.314 2.01 . . . . 74.34 112.165 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.94 115.52 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 74.5 110.633 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.401 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 1.1 mtt -77.27 -69.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.256 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' A' ' 133' ' ' THR . 1.0 OUTLIER -172.52 -55.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.981 -0.554 . . . . 74.42 110.543 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 131' ' ' ASP . 4.0 ptt? 27.86 35.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 65.22 110.535 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.653 ' N ' ' O ' ' A' ' 131' ' ' ASP . 11.9 t -69.67 -13.98 62.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.989 -0.55 . . . . 73.13 110.747 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -49.14 -35.59 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 64.41 110.742 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.43 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.14 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.34 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 73.32 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.22 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 74.24 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 75.14 110.354 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 72.11 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.44 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 71.1 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 74.34 109.774 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.34 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.4 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.444 ' OH ' ' O ' ' A' ' 23' ' ' TRP . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.53 110.403 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.42 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.04 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.01 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.44 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.31 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 72.41 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 74.45 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.22 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.54 110.572 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.736 ' O1A' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 74.34 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.54 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 75.03 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.22 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CE2' ' CG2' ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.12 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.33 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.42 110.307 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 7' ' ' VAL . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.702 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.35 110.917 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 65.45 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.31 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 64.13 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 75.03 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' H ' ' A' ' 15' ' ' ILE . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.23 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' H ' HG12 ' A' ' 14' ' ' VAL . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.11 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.631 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.22 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' NZ ' ' CB ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 74.25 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 70.52 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 18' ' ' ASP . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 75.24 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' H ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.44 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.503 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.44 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.606 ' HE1' ' C2 ' ' A' ' 174' ' ' N22 . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.346 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 70.11 110.279 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 64.1 111.727 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.3 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 74.5 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 64.22 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 74.41 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 74.53 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.44 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.41 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.13 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.565 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.52 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 55.32 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.44 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HB3' HH21 ' A' ' 59' ' ' ARG . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.44 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.14 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 ' N ' HD11 ' A' ' 42' ' ' ILE . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.23 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.41 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 64.32 110.6 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.14 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.13 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.586 ' OD1' ' O2A' ' A' ' 173' ' ' NAP . 2.0 m-80 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.33 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 71.21 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.54 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 64.34 110.327 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.626 ' C ' ' H ' ' A' ' 53' ' ' ARG . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 75.54 110.15 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.53 1.34 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.12 112.217 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.626 ' H ' ' C ' ' A' ' 51' ' ' ILE . 10.3 mtp180 -110.07 147.7 36.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 117.224 0.512 . . . . 72.52 110.951 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.12 -159.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.074 2.516 . . . . 73.41 112.901 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 20.4 tp 179.78 71.81 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 121.209 0.528 . . . . 64.41 110.216 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.5 16.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.955 2.436 . . . . 75.31 112.928 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.74 -10.75 18.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.462 -1.055 . . . . 71.45 110.462 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 -150.51 125.44 9.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.326 -0.249 . . . . 75.43 110.326 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.456 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.31 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 53.12 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 70.12 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 74.32 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 74.03 111.043 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.673 ' HG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.53 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 74.12 110.631 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.673 ' ND2' ' HG1' ' A' ' 64' ' ' THR . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.51 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.22 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.21 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG12 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.01 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 70.22 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 74.14 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 77' ' ' ALA . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.657 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.42 110.266 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.45 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.528 ' N ' ' OG ' ' A' ' 79' ' ' SER . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.35 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.32 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 70.5 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 74.11 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.53 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 62.31 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 74.2 110.536 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 75.41 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 75.41 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.03 110.279 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 74.21 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.32 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 75.12 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 39' ' ' HIS . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.51 110.751 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' CG2' ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 73.31 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.13 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.45 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.01 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.604 ' NE2' ' C5B' ' A' ' 173' ' ' NAP . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.55 110.548 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.403 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 72.1 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 73.2 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 64.53 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.12 110.755 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.03 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 73.11 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 73.24 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 5' ' ' PHE . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 70.45 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.45 110.238 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 75.14 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 75.23 111.563 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 75.4 109.993 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.676 ' CD1' ' N ' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 74.55 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 62.02 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 73.22 110.844 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.21 109.96 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' C ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.13 111.227 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.31 110.414 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.3 111.118 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.45 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.31 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 55.24 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 72.25 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' CG1' ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.33 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.53 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.53 95.47 0.83 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.04 109.854 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 130' ' ' MET . 53.8 Cg_endo -76.32 174.02 13.51 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.445 2.097 . . . . 74.34 112.158 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.4 89.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 75.05 110.512 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.441 ' N ' ' O ' ' A' ' 128' ' ' PRO . 7.6 mtp -87.22 -53.59 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.472 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.26 113.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 63.41 110.445 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.1 0.75 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 75.53 110.68 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -47.19 -21.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.281 -0.418 . . . . 74.33 110.385 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -57.79 -25.54 60.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 73.45 110.247 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 73.41 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 73.33 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.493 ' OE1' ' OH ' ' A' ' 158' ' ' TYR . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.606 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.4 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.24 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.32 110.974 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.34 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 72.13 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.33 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.24 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.15 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.05 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.51 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 75.14 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.41 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.23 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 73.41 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 72.34 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.41 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.33 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 74.12 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.493 ' OH ' ' OE1' ' A' ' 137' ' ' GLU . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.293 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.35 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 75.31 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.15 110.558 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.626 ' O5D' ' O2A' ' A' ' 173' ' ' NAP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.606 ' C2 ' ' HE1' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 73.44 109.332 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.13 110.298 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.55 110.893 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.53 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.54 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.15 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 8' ' ' ALA . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 75.14 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.4 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.34 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HA ' ' HZ3' ' A' ' 116' ' ' LYS . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 75.22 112.088 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 3.9 m-80 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.34 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.33 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.587 ' O ' ' O ' ' A' ' 8' ' ' ALA . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 71.34 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.532 ' H ' HG12 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.33 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.33 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 75.43 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 72.35 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.33 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.41 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' HB3' ' N7N' ' A' ' 173' ' ' NAP . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.41 110.368 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.13 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 74.45 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' H ' ' ND2' ' A' ' 149' ' ' ASN . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 73.45 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 74.34 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 73.11 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.12 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 74.44 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 75.2 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.24 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' OG1' ' A' ' 36' ' ' THR . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 75.41 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.13 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.24 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.23 110.605 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 32' ' ' VAL . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.43 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.1 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 73.1 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.4 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD11 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.2 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 71.15 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 63.11 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.14 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.718 ' NH1' ' O3B' ' A' ' 173' ' ' NAP . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.34 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.03 110.227 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.45 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.33 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.43 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 51' ' ' ILE . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.44 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 43.01 -147.5 0.74 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 62.43 110.454 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' C4 ' ' A' ' 174' ' ' N22 . 17.6 tpp180 50.94 92.74 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 C-N-CA 120.721 -0.392 . . . . 74.22 110.718 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.95 149.58 13.84 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.998 2.465 . . . . 74.54 112.119 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -129.69 96.26 27.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 73.55 110.437 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.27 20.43 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.183 1.922 . . . . 72.33 111.702 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -113.08 -12.21 12.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.464 -1.054 . . . . 70.41 110.464 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 60' ' ' ASN . 26.4 mtp180 -129.81 113.07 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.126 -0.324 . . . . 71.03 110.126 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.01 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 74.2 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 73.15 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 71.14 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.713 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 73.02 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 75.11 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.649 ' ND2' ' HG1' ' A' ' 64' ' ' THR . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 64.34 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 74.12 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 73.23 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.3 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.24 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.2 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 73.31 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.43 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.41 110.652 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.12 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 74.23 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 75.53 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.55 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 75.23 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 72.51 110.882 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.22 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.32 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.45 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 73.01 110.509 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 43.15 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.55 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.31 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 75.31 110.717 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.44 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 72.43 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.34 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.05 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 74.14 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 72.02 110.302 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 73.42 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.45 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.41 111.157 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 73.32 111.915 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 73.53 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 74.02 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.44 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.478 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.23 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 74.03 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 71.13 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 74.13 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 72.55 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 74.15 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 74.23 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HZ3' ' HA ' ' A' ' 11' ' ' GLU . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 75.11 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 75.21 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.12 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.04 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 51.41 110.332 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.33 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 72.33 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 74.13 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 73.03 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.497 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 -166.49 133.61 2.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.21 110.2 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.71 176.34 8.33 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.306 2.004 . . . . 72.22 112.332 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -91.86 69.71 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 75.31 110.43 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 13.8 mmm -114.18 -174.05 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.638 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 43.06 64.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 62.11 110.777 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.423 ' HG3' ' N ' ' A' ' 133' ' ' THR . 24.3 ptt? -120.53 -33.14 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.42 . . . . 74.1 110.586 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 134' ' ' ASN . 1.9 t -49.0 -33.43 11.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.542 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 133' ' ' THR . 56.5 m-20 -59.3 -21.68 60.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 72.53 110.382 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 74.03 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.23 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.22 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.14 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.44 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 73.5 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 65.54 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 74.04 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 74.21 110.838 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 74.4 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.54 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 72.25 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.34 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 14.6 m-80 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 73.32 110.846 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 74.44 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.13 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 72.54 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 75.23 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.51 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.54 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.45 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.44 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.14 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 73.04 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.445 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 72.55 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.632 ' CD ' ' H ' ' A' ' 161' ' ' GLN . 5.8 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.32 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.32 110.615 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.718 ' O3B' ' NH1' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.457 ' C4 ' ' O ' ' A' ' 53' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 74.03 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 75.15 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HB ' ' H ' ' A' ' 110' ' ' ASP . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.02 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.1 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.03 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.4 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.24 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.14 110.077 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.42 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.459 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.54 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.11 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 1.8 m120 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 64.52 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.703 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.11 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.566 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 62.22 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.566 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.43 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 72.24 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.05 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 10.2 p30 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 65.21 109.154 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.692 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.43 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 75.0 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.643 ' NE1' ' C14' ' A' ' 174' ' ' N22 . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.33 111.28 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HD3' HH11 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.15 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' H ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.3 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 74.44 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.12 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.2 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.32 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' N ' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.4 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.34 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG22 ' N8 ' ' A' ' 174' ' ' N22 . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 75.33 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 71.4 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 74.32 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 70.3 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 74.51 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 71.22 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 72.14 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 63.21 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 74.41 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 42' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.34 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.675 ' SD ' ' C4 ' ' A' ' 174' ' ' N22 . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.979 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.53 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 75.4 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.12 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.704 ' ND2' ' C6N' ' A' ' 173' ' ' NAP . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.12 111.057 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 63.21 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 74.05 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.22 -99.83 0.26 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 74.33 110.673 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 66.63 2.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.991 0.424 . . . . 72.42 110.464 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.71 178.84 7.08 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 122.982 2.455 . . . . 74.24 112.174 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.9 tp -176.3 51.27 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 116.428 -0.351 . . . . 71.2 110.868 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 43.8 Cg_endo -68.81 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 75.3 111.89 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.14 5.63 49.53 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.405 -0.678 . . . . 65.33 111.405 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.497 ' CG ' HH11 ' A' ' 58' ' ' ARG . 0.0 OUTLIER 50.14 47.06 24.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.911 0.386 . . . . 71.41 110.444 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.13 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.51 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' H ' HD11 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 72.01 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 65.31 110.442 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 74.2 110.872 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 71.42 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 73.32 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 6.1 m120 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.32 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.52 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.14 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 74.34 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 72.33 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 72.41 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.41 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 75.14 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.411 ' SG ' ' HB ' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 72.4 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.14 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 77' ' ' ALA . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 74.25 111.203 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' N ' HG11 ' A' ' 76' ' ' VAL . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.13 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 74.15 110.795 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.54 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 75.14 110.681 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.44 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.3 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.2 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.44 110.978 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 74.14 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 74.21 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 75.43 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.33 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.23 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.1 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.2 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.474 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.708 ' CZ ' ' C4N' ' A' ' 173' ' ' NAP . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 71.3 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.6 ' O ' ' C5N' ' A' ' 173' ' ' NAP . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 73.0 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 72.4 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 44.04 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.679 ' NE2' ' C8A' ' A' ' 173' ' ' NAP . 5.0 pt20 -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 75.03 110.637 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.436 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 72.55 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.24 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.11 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 73.44 110.577 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 74.1 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.15 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.01 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 5' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.41 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.495 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.25 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 74.44 110.641 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.44 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 73.03 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 118' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.424 ' N ' HG22 ' A' ' 117' ' ' ILE . 7.4 t-160 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.12 110.964 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.567 ' O ' ' OE2' ' A' ' 11' ' ' GLU . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.1 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 72.35 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 72.04 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.703 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 75.14 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.12 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.33 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 74.0 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.472 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 -106.69 137.64 19.53 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.329 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.71 176.39 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.345 2.03 . . . . 75.14 111.224 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.44 179.74 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.615 -0.434 . . . . 73.24 110.218 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.0 mtp 61.27 102.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 74.22 110.653 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 132' ' ' MET . 0.4 OUTLIER -127.98 178.23 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 61.34 110.359 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.55 ' C ' ' O ' ' A' ' 131' ' ' ASP . 7.0 ptt? 27.6 45.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 70.14 110.543 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.4 t -62.31 -34.02 75.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 71.34 110.747 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.41 50.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 63.11 110.469 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.4 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 74.44 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.31 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 71.45 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.2 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.437 HG23 ' HD1' ' A' ' 156' ' ' HIS . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 74.52 110.728 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.24 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 73.14 110.753 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.15 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 74.13 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.411 ' HG1' ' N ' ' A' ' 146' ' ' ASP . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.727 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' N ' ' HG1' ' A' ' 145' ' ' THR . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.507 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.12 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' C ' HD21 ' A' ' 149' ' ' ASN . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 65.14 110.627 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.529 HD21 ' C ' ' A' ' 148' ' ' LYS . 2.0 m-80 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.31 110.538 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.53 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.12 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.54 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.41 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.02 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 74.23 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 74.31 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.415 ' HZ1' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 75.13 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.44 110.51 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.53 110.567 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.708 ' C4N' ' CZ ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.675 ' C4 ' ' SD ' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 73.34 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 73.22 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.358 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 63.41 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.52 110.418 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.485 ' HE1' ' N8 ' ' A' ' 174' ' ' N22 . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 73.02 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.513 ' CB ' ' N7N' ' A' ' 173' ' ' NAP . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.22 110.74 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.21 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 74.25 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 74.32 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.808 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.13 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 15' ' ' ILE . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.43 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.42 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 71.44 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.03 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 74.25 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 71.13 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.43 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.33 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 70.32 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' NE ' HG22 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.44 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 75.33 110.36 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.31 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 74.53 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG12 ' N8 ' ' A' ' 174' ' ' N22 . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 43.33 110.573 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 74.24 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.13 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 73.1 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.475 ' HG1' ' CD2' ' A' ' 39' ' ' HIS . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 74.32 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.21 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.53 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.475 ' CD2' ' HG1' ' A' ' 36' ' ' THR . 0.4 OUTLIER -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 75.11 110.369 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.43 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 75.11 109.988 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.592 ' CD1' ' N ' ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.44 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.43 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 64.24 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.33 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 72.34 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.1 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 62.45 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' CG2' ' C14' ' A' ' 174' ' ' N22 . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 75.51 110.948 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.96 51.04 0.34 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.43 111.366 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 58.79 76.06 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.996 0.427 . . . . 74.41 111.014 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -89.01 172.29 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.431 2.754 . . . . 74.45 112.106 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -164.75 49.29 0.21 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 120.843 -0.343 . . . . 74.2 111.319 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 17.7 Cg_endo -59.76 69.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.202 2.601 . . . . 73.54 112.807 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 130.98 14.73 1.8 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.736 -0.745 . . . . 64.14 111.518 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 59.72 11.55 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.316 0.579 . . . . 73.21 109.979 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 55' ' ' LEU . 1.3 p30 -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.662 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 61' ' ' ILE . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 74.21 110.715 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 62' ' ' ILE . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 74.34 110.113 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.12 110.986 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.484 ' OG1' ' NE ' ' A' ' 45' ' ' ARG . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.2 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 74.44 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 73.55 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.488 ' CZ ' ' NH2' ' A' ' 45' ' ' ARG . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 71.23 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.14 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 72.35 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.34 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.2 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.1 110.409 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.12 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 72.22 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 63.23 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.24 110.65 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.22 110.878 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 81' ' ' GLU . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 74.43 110.597 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' HG12 ' A' ' 80' ' ' VAL . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 63.35 110.634 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.2 110.752 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 74.14 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.23 110.71 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.477 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.53 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 75.34 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.11 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.31 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.32 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.577 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.13 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 71.43 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.31 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 71.32 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 64.52 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.682 ' NE2' ' C5B' ' A' ' 173' ' ' NAP . 3.6 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 71.2 110.189 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.12 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.31 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.12 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 104' ' ' LEU . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.31 111.198 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' O ' ' CG2' ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.42 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.22 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 74.14 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.54 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.01 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.11 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 74.14 110.787 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.44 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.54 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.422 HG22 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.15 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.469 HD13 HG21 ' A' ' 117' ' ' ILE . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.52 110.657 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.44 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.35 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.14 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.808 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 70.14 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 64.32 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.32 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.24 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 71.52 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 -165.6 151.92 8.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.12 109.753 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.21 -174.78 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.425 2.084 . . . . 61.32 111.901 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 130' ' ' MET . 3.2 pt-20 -131.59 167.68 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 72.33 110.776 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 129' ' ' GLU . 76.4 mtp 38.73 62.38 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 73.42 110.603 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.82 101.02 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 70.51 110.678 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 5.1 mtp 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.665 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 134' ' ' ASN . 1.7 t -61.49 -49.61 76.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.05 110.62 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 133' ' ' THR . 32.4 t30 78.27 -8.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 73.32 110.813 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.427 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 75.45 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 73.13 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 74.5 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.55 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 74.31 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 75.33 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.12 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.41 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 72.12 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 64.15 110.444 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.24 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.14 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.44 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.15 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.14 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.45 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.43 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 75.14 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.23 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.53 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.41 ' C ' ' CD2' ' A' ' 156' ' ' HIS . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 75.44 110.4 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 156' ' ' HIS . 3.2 m-70 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.53 110.679 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.23 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.33 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.12 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.427 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.23 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.625 ' H ' ' NE2' ' A' ' 161' ' ' GLN . 1.7 pm0 -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 75.35 110.576 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.03 110.515 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.682 ' C5B' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.492 ' N8 ' HG12 ' A' ' 32' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 72.35 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.14 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.34 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 63.11 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 72.43 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 75.23 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.42 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 64.51 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 74.41 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.51 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 75.13 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.41 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.627 ' NE ' ' O ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 70.33 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 15' ' ' ILE . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 75.44 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' H ' HG13 ' A' ' 14' ' ' VAL . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 74.21 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.24 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 70.01 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.693 HD22 ' C2 ' ' A' ' 174' ' ' N22 . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 71.03 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.63 ' ND2' ' C8 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 73.03 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.676 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 75.34 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.31 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.2 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.657 HH11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 72.34 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.657 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 75.01 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 72.24 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.463 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.45 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.711 ' OE2' ' N8 ' ' A' ' 174' ' ' N22 . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 55.2 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.23 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.23 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.11 110.592 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.51 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.22 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 75.31 110.48 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.14 110.455 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.05 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 71.15 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.11 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 74.44 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 75.21 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' A' ' 97' ' ' GLY . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 73.5 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 73.42 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 71.12 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 74.45 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 74.43 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.586 ' ND2' ' C6N' ' A' ' 173' ' ' NAP . 92.0 m-20 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.42 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 74.23 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.32 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' CG1' ' OD1' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.6 -111.83 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.21 110.487 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -126.94 54.65 12.6 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.376 . . . . 75.42 110.759 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 56.6 Cg_endo -72.33 156.0 55.23 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.949 2.433 . . . . 70.33 111.937 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.717 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.6 pt? -161.25 38.45 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.024 0.44 . . . . 75.51 110.655 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 11.1 Cg_endo -57.51 79.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.967 2.445 . . . . 74.41 112.38 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 137.3 0.19 2.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.952 -0.859 . . . . 71.23 110.952 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 48.17 44.86 19.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 75.51 110.841 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 74.13 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 71.54 110.878 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.33 110.456 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.3 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.42 111.546 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 73.15 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.2 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 16.0 m-80 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 75.22 110.531 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.2 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 75.02 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 72.45 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 64.01 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 74.14 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.54 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 72.34 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 74.11 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 74.31 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.41 110.741 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.3 110.715 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.13 110.413 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.14 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.3 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 73.34 110.534 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.44 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' N ' ' CG ' ' A' ' 84' ' ' PHE . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.44 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 72.52 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 71.25 111.016 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.12 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.14 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.51 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.13 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.44 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 5' ' ' PHE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.3 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.522 ' O ' ' C ' ' A' ' 97' ' ' GLY . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 75.41 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 74.31 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CD2' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.2 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 64.14 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.828 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.41 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.655 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 72.41 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CD2' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.12 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 73.34 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.52 110.407 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.42 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 70.54 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 73.41 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.02 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 75.14 110.733 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.04 109.819 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 73.21 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 75.21 110.708 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CE2' HG13 ' A' ' 157' ' ' VAL . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.2 110.546 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.753 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 60.22 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.3 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.5 HD13 HG22 ' A' ' 117' ' ' ILE . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.43 110.53 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.42 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.53 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.53 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.627 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.41 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.44 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 64.45 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 74.53 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.543 ' OG1' ' O2D' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.23 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.42 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.49 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 -166.12 130.57 1.73 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.24 110.149 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.81 176.92 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.456 2.104 . . . . 73.0 112.226 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -98.16 107.92 20.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 72.11 110.519 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 39.6 mmm -96.83 -58.17 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 72.45 110.599 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 132' ' ' MET . 13.1 t70 -177.02 161.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 63.21 110.414 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.781 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -161.15 42.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 72.21 110.642 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.587 ' C ' ' H ' ' A' ' 135' ' ' TRP . 5.9 t -68.39 -23.09 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 71.41 110.337 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -57.0 -0.99 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 74.31 110.543 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.587 ' H ' ' C ' ' A' ' 133' ' ' THR . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.535 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.12 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.15 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 74.31 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 73.43 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.02 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 155' ' ' TYR . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.24 110.685 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.42 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 74.1 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.21 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 70.11 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 71.14 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.32 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 75.02 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.573 ' OD1' ' O ' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 72.43 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 70.34 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.42 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 75.12 110.546 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 141' ' ' GLU . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.14 110.919 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.42 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' CE2' ' A' ' 113' ' ' TYR . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 74.22 110.292 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 74.33 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 73.33 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.12 110.391 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.546 ' CD ' ' N ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.21 110.618 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 74.22 110.647 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.686 ' O1A' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.711 ' N8 ' ' OE2' ' A' ' 28' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.01 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.45 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.3 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.404 ' CZ ' ' CG2' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.41 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.58 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.44 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 64.02 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB1' ' N7N' ' A' ' 173' ' ' NAP . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.2 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.403 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 72.01 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 64.45 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.32 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 75.21 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.461 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 74.55 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 15' ' ' ILE . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 73.13 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 ' H ' HG11 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.51 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' N ' ' CG1' ' A' ' 15' ' ' ILE . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.31 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 72.52 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 64.11 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.45 109.891 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.515 HD22 ' CG1' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.22 110.306 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.703 ' CD1' ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.41 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.44 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' HE1' ' C15' ' A' ' 174' ' ' N22 . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.04 110.535 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.58 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.21 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.466 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.11 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.44 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.44 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 75.03 111.096 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 73.42 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 74.41 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.52 111.301 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.42 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.15 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.23 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 75.14 110.59 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.03 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.44 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 63.24 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 73.44 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 71.32 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 72.32 110.53 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 74.4 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 63.01 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' O3X' ' A' ' 173' ' ' NAP . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.31 110.454 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 65.54 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.579 ' ND2' ' C6N' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.23 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.44 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 72.5 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 20' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 75.14 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.515 ' CG1' HD22 ' A' ' 20' ' ' ASN . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 73.22 109.793 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.27 141.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.32 111.382 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 53' ' ' ARG . 2.7 mtp180 61.79 86.82 0.14 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 65.14 111.274 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -80.24 168.03 18.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.143 2.562 . . . . 74.12 112.151 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 57' ' ' GLY . 2.4 mm? -96.24 118.31 65.61 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 73.44 110.295 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -71.15 40.46 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.17 1.914 . . . . 74.54 111.752 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -131.81 -22.23 0.95 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.2 -1.16 . . . . 70.21 110.2 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -116.18 105.91 13.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.513 0.197 . . . . 74.2 110.713 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.32 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.24 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 71.32 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.21 111.03 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 71.35 110.86 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.53 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.641 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 1.2 m120 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 73.43 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.52 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.45 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.52 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 2.3 p80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 73.54 110.536 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.02 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.14 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 75.33 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.1 110.645 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.32 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 65.13 110.703 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 61.33 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.12 110.824 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 73.13 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 73.31 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.11 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 74.23 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.33 110.931 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 74.5 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 71.35 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 65.12 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.33 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 73.42 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 74.25 110.118 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.11 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 95' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 72.41 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.631 ' CE1' ' O7N' ' A' ' 173' ' ' NAP . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.12 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.14 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' HA3' ' O1A' ' A' ' 173' ' ' NAP . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.43 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 52.1 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.12 111.27 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 74.24 111.15 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 75.0 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.22 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 74.02 111.172 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 74.11 111.172 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 71.33 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.44 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 73.53 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 110' ' ' ASP . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 73.34 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.13 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.01 110.673 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.14 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 64.4 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.13 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.403 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.43 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.04 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.13 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 73.34 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.35 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.52 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.461 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.14 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.12 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.44 111.038 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.33 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.69 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 2.1 t80 -100.59 127.53 32.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.42 109.901 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.69 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 35.7 Cg_endo -68.35 -162.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.292 1.995 . . . . 72.41 112.553 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -97.45 70.66 2.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 75.34 110.563 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 28.2 mtp -126.62 57.36 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 71.24 110.547 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -66.49 110.25 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 61.12 110.367 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 ptm -178.25 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 61.42 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 134' ' ' ASN . 9.9 t -46.19 -49.23 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 74.2 110.311 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.485 ' N ' ' CG2' ' A' ' 133' ' ' THR . 12.8 m-20 60.86 54.73 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 73.41 110.561 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.409 ' CH2' ' CG ' ' A' ' 160' ' ' LYS . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.02 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.53 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 74.33 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 73.3 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.21 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 74.32 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.54 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 74.25 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 73.45 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.53 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 74.4 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.53 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 72.2 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.31 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 75.43 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.13 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.11 111.434 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.44 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 74.4 m80 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.23 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 74.2 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 73.52 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.32 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 73.22 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 74.05 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.04 110.572 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.631 ' O7N' ' CE1' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.619 ' C15' ' HE1' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.22 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.43 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.15 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 64.43 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 75.24 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.22 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 72.22 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.503 ' CB ' ' N7N' ' A' ' 173' ' ' NAP . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.15 109.317 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.44 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.13 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 75.14 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.32 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 74.42 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.613 ' H ' HG12 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.52 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 62.4 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.34 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 20' ' ' ASN . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.35 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.32 109.336 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 18' ' ' ASP . 9.0 p30 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.35 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.651 ' CD2' ' N ' ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.13 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 72.21 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.419 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 75.31 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 25' ' ' LEU . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.4 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.41 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.04 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.34 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 75.3 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.583 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.51 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.45 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.51 110.366 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 74.34 111.274 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.3 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.53 110.527 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.51 110.95 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 71.33 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.45 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 74.14 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.43 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.32 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.23 110.578 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.21 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.611 ' N ' HD21 ' A' ' 47' ' ' ASN . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 52.11 110.771 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.481 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 75.03 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 73.25 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.611 HD21 ' N ' ' A' ' 44' ' ' GLY . 3.0 m-80 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 73.41 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 75.15 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 47' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.23 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 51' ' ' ILE . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 71.53 110.662 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.95 -94.18 0.2 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.23 111.147 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -136.69 68.49 59.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 64.13 110.669 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.8 130.67 5.1 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 123.005 2.47 . . . . 74.42 112.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD1' ' NH2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -146.16 49.41 0.87 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 75.33 110.189 179.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 20.2 Cg_endo -63.32 58.4 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.178 2.586 . . . . 75.13 112.231 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 58' ' ' ARG . . . 150.13 32.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.346 -0.702 . . . . 62.35 111.346 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.681 ' NH2' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 26.12 52.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.687 0.279 . . . . 74.32 111.291 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.42 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.964 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 61' ' ' ILE . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 62' ' ' ILE . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 75.21 110.307 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 72.42 111.067 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 75.35 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 75.35 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 9.4 m-80 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 71.12 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 43.1 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.12 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 74.24 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 64.42 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.02 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 63.44 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 74.2 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 70.12 109.99 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 74.12 110.877 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.43 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 70.55 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 74.22 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 71.44 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.42 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.33 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.11 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 75.02 110.654 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.01 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.34 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.55 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.43 110.502 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.24 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 74.12 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.499 HD12 HG22 ' A' ' 95' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.53 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.1 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.21 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.436 ' H ' HD12 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 63.43 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.689 ' NE2' ' O4B' ' A' ' 173' ' ' NAP . 8.6 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 73.43 111.105 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.25 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.02 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.4 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.421 ' N ' HD21 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 75.21 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 75.51 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.04 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 74.22 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 75.2 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 74.3 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 72.54 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.34 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 75.23 110.394 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 73.23 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' NE2' ' A' ' 156' ' ' HIS . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 64.25 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 72.12 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.422 HD13 HG23 ' A' ' 117' ' ' ILE . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.546 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.15 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.15 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 74.44 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 75.11 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.42 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.14 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.43 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.01 110.4 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 73.34 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 3.9 t80 -104.61 124.42 37.07 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 73.04 109.689 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 39.8 Cg_endo -70.8 -171.5 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.068 1.846 . . . . 74.35 112.332 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' O ' ' SD ' ' A' ' 130' ' ' MET . 2.9 pt-20 -86.74 64.99 8.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 44.11 110.76 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 129' ' ' GLU . 21.9 mmt -132.84 59.48 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 61.21 110.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.28 89.33 7.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 75.12 110.686 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.5 mmt -133.09 33.29 3.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.51 110.605 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 135' ' ' TRP . 1.2 t -45.74 -59.77 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 65.44 110.584 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.425 ' H ' ' CG2' ' A' ' 133' ' ' THR . 32.2 t-20 75.46 -0.23 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 72.41 110.804 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.696 ' H ' ' HG1' ' A' ' 133' ' ' THR . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 74.42 110.483 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.51 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.53 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.03 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.464 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.34 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.52 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.521 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.33 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.41 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 74.25 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.772 ' HG1' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 75.11 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.772 ' N ' ' HG1' ' A' ' 145' ' ' THR . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.05 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.14 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 72.52 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.44 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.21 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 73.3 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 72.54 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.45 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.692 ' ND1' ' C ' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.13 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 73.42 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.35 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.54 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 72.14 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.509 ' H ' ' NE2' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.31 110.591 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.689 ' O4B' ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.455 ' C11' ' C2 ' ' A' ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' H2 ' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.24 109.42 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 72.33 110.651 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.53 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 61.04 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 74.35 110.249 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 72.54 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 63.32 110.747 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB3' H71N ' A' ' 173' ' ' NAP . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.41 110.891 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.34 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.04 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 12' ' ' ASN . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.4 111.858 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 11' ' ' GLU . 3.2 m-80 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 75.04 111.9 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.791 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.35 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.32 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.545 ' CG2' ' O ' ' A' ' 14' ' ' VAL . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.32 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.464 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.52 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.35 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.15 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.51 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.13 110.393 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 74.42 110.017 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.31 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.02 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 72.31 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.33 110.224 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 73.22 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.13 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.23 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 75.31 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.41 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 33' ' ' LYS . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 74.32 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.15 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 74.15 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.53 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 37' ' ' MET . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.44 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.544 ' CG ' ' O ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.52 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.35 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.41 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.42 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 75.1 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.23 110.54 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 71.43 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 34.43 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.67 ' NH2' ' O3X' ' A' ' 173' ' ' NAP . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 75.21 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.34 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.557 ' OD1' ' C2D' ' A' ' 173' ' ' NAP . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.12 110.604 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.41 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.42 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 73.45 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 HG12 HD22 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 72.33 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.94 -104.07 2.1 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.21 110.71 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -127.87 69.23 76.44 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-O 120.967 0.413 . . . . 74.24 110.729 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -74.6 162.8 37.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.712 2.274 . . . . 72.1 112.084 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.0 tp -158.27 42.85 0.15 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.282 -0.417 . . . . 75.2 110.962 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -67.34 134.12 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.469 2.113 . . . . 72.21 111.044 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 59' ' ' ARG . . . 77.14 0.18 69.6 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.822 -0.911 . . . . 71.41 110.822 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 69.89 -6.25 1.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.699 0.285 . . . . 73.41 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 73.13 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 73.04 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.25 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 62' ' ' ILE . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 74.44 110.649 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.03 110.697 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 74.25 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.558 ' HE ' ' CA ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 72.55 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 8.9 m-80 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.12 110.794 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 73.32 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.23 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.43 110.518 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.44 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.21 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.42 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 64.11 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.24 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.32 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.44 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 63.03 110.595 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 74.51 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.656 ' N ' ' OG ' ' A' ' 79' ' ' SER . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 74.55 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 73.12 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 73.33 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.532 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 71.43 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.55 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.2 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.894 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 73.44 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.53 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.42 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.23 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.42 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.42 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 74.54 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.54 110.211 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.755 ' CZ ' ' N7 ' ' A' ' 174' ' ' N22 . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.31 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.53 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 70.32 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 72.31 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' OE1' ' O3 ' ' A' ' 173' ' ' NAP . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 74.21 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.43 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.51 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.33 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.14 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.13 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CZ ' HG11 ' A' ' 80' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.34 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.41 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 64.22 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.42 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.302 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.405 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.43 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HZ2' ' HB2' ' A' ' 159' ' ' GLU . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 71.5 110.06 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 72.12 111.139 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 73.32 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.52 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 75.12 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.43 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 74.03 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.13 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 70.22 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 65.51 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 75.51 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 61.31 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.791 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 73.33 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 71.24 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.1 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.498 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.11 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.404 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 -96.02 138.81 21.62 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.4 110.227 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 -166.19 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.491 2.128 . . . . 74.32 112.028 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 130' ' ' MET . 4.7 pt-20 -107.22 -160.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.11 110.454 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.473 ' C ' ' O ' ' A' ' 129' ' ' GLU . 25.6 ptt? 34.62 38.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 64.2 110.703 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.7 p30 -57.62 150.95 18.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 72.43 110.353 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.08 62.79 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 72.34 110.813 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 134' ' ' ASN . 5.4 t -61.96 -51.62 67.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 65.45 110.457 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.436 ' N ' ' CG2' ' A' ' 133' ' ' THR . 59.7 t30 57.79 15.27 2.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 72.1 110.781 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.449 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.4 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 74.23 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.34 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 72.12 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 73.32 111.012 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.22 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.11 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.31 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.53 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 145' ' ' THR . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.01 110.427 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.2 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.491 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.54 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.23 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.43 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 72.13 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 74.11 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.53 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.33 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.13 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.41 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 72.25 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 72.12 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 75.15 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 75.22 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 71.11 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' NAP . . . . . 0.67 ' O3X' ' NH2' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' N22 . . . . . 0.755 ' N7 ' ' CZ ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.200000000000003 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 53.530000000000001 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.120000000000005 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 54.009999999999998 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' A' ' 112' ' ' LEU . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 72.310000000000002 110.134 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 62.399999999999999 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 70.329999999999998 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 42.32 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 55.219999999999999 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.030000000000001 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 63.219999999999999 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 125' ' ' THR . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.450000000000003 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 99' ' ' ALA . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 54.130000000000003 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 61.420000000000002 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 71.329999999999998 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.430000000000007 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.439999999999998 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.420000000000002 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 65.219999999999999 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CH2' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 71.140000000000001 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 29' ' ' LEU . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.310000000000002 111.471 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 63.43 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.019999999999996 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.829 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.450000000000003 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 44.210000000000001 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 70.319999999999993 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 72.319999999999993 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 72.219999999999999 110.727 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 65.439999999999998 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 71.340000000000003 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.099999999999994 110.596 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.409999999999997 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 62.43 110.386 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.420000000000002 110.483 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 52.149999999999999 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.099999999999994 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.75 ' ND2' ' N ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.340000000000003 110.486 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.75 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 64.430000000000007 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 53.039999999999999 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.474 HD11 HD11 ' A' ' 21' ' ' LEU . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.615 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 51.43 110.891 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 73.129999999999995 110.456 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.219999999999999 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.450000000000003 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.430000000000007 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 63.219999999999999 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.420000000000002 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 65.049999999999997 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 63.310000000000002 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 71.319999999999993 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.209999999999994 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 71.349999999999994 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.150000000000006 110.781 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HA ' HG21 ' A' ' 76' ' ' VAL . 64.0 m80 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.230000000000004 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.319999999999993 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.239999999999995 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.510000000000005 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.430000000000007 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 70.549999999999997 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 70' ' ' HIS . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.736 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.399999999999999 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.119999999999997 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.129999999999995 110.611 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 62.520000000000003 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.219999999999999 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.040000000000006 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 86' ' ' LEU . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.219999999999999 110.61 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 65.400000000000006 110.728 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 64.409999999999997 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.040000000000006 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.149999999999999 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.439999999999998 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.0 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.209999999999994 111.268 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.439999999999998 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 44.420000000000002 110.89 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.978 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.472 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 72.430000000000007 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 64.209999999999994 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 52.409999999999997 110.584 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.510000000000005 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 65.420000000000002 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 105' ' ' PHE . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 70.129999999999995 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 70.109999999999999 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 64.230000000000004 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 5' ' ' PHE . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 52.200000000000003 111.175 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 54.130000000000003 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.239999999999995 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.340000000000003 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 72.5 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 70.219999999999999 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.239999999999995 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.329999999999998 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.698 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 43.229999999999997 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 64.109999999999999 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 109.889 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 71.239999999999995 110.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 63.310000000000002 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 50.310000000000002 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 72.420000000000002 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 63.549999999999997 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 70.239999999999995 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.149999999999999 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 54.219999999999999 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 53.130000000000003 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 60.200000000000003 110.617 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.150000000000006 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.420000000000002 110.566 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.549999999999997 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.019999999999996 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.299999999999997 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 74.319999999999993 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 61.200000000000003 110.394 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.540000000000006 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.420000000000002 110.512 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 63.109999999999999 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 93' ' ' ILE . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.884 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 62.020000000000003 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.936 ' CE1' HG22 ' A' ' 109' ' ' VAL . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 73.219999999999999 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 70.150000000000006 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 53.229999999999997 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.049999999999997 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 70.230000000000004 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 71.409999999999997 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 44.329999999999998 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.230000000000004 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 99' ' ' ALA . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.409999999999997 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 24.449999999999999 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 70.0 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 63.210000000000001 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 3.3 m120 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.540000000000006 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.409999999999997 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.897 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.219999999999999 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.699 ' CG ' ' N ' ' A' ' 24' ' ' ARG . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.209999999999994 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.67 ' CD ' HD21 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.129999999999995 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.439999999999998 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 32' ' ' VAL . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.319999999999993 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HB2' ' NE1' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 62.049999999999997 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 45.32 111.598 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 71.319999999999993 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 71.239999999999995 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.030000000000001 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 74.340000000000003 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 32' ' ' VAL . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.140000000000001 110.789 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 44.140000000000001 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 41' ' ' LEU . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.450000000000003 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.319999999999993 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 70.120000000000005 110.637 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.219999999999999 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 24.219999999999999 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 40.43 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 71.150000000000006 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 109.982 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.230000000000004 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.319999999999993 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.409999999999997 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HA ' HD21 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 53.43 110.975 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.120000000000005 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.040000000000006 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 71' ' ' VAL . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.120000000000005 110.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 78' ' ' HIS . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 110.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.010000000000005 110.615 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 p30 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.637 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.219999999999999 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 50.130000000000003 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 61.210000000000001 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 62' ' ' ILE . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 61.340000000000003 110.654 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 61.25 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 52.229999999999997 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.129999999999995 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.130000000000003 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.010000000000005 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.439999999999998 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.717 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 62.140000000000001 110.569 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 54.520000000000003 110.958 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.299999999999997 110.716 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.219999999999999 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.229999999999997 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.400000000000006 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.549999999999997 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.917 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.349999999999994 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 43.43 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.219999999999999 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.239999999999995 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 71.549999999999997 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.400000000000006 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 64.140000000000001 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.020000000000003 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 30.149999999999999 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.420000000000002 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 110.322 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.510000000000005 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.705 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.209999999999994 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' A' ' 106' ' ' LEU . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 54.350000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 63.030000000000001 111.056 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 70.120000000000005 111.356 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.319999999999993 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.430000000000007 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 71.239999999999995 110.408 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.936 HG22 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.010000000000005 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 74.230000000000004 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 114' ' ' ILE . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 54.140000000000001 110.94 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 157' ' ' VAL . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 50.109999999999999 110.666 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.209999999999994 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 53.409999999999997 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 52.229999999999997 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.553 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 61.240000000000002 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.430000000000007 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.010000000000005 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.319999999999993 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.755 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.239999999999995 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.219999999999999 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.540000000000006 111.176 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.469 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.140000000000001 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 71.120000000000005 110.093 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 74.25 110.43 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CH2' ' HG3' ' A' ' 160' ' ' LYS . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 110.515 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 71.420000000000002 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.319999999999993 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 61.240000000000002 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 64.519999999999996 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.219999999999999 110.3 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.430000000000007 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.239999999999995 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.230000000000004 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.67 HD21 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 64.510000000000005 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.540000000000006 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.299999999999997 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.349999999999994 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 62.43 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 73.420000000000002 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.129999999999995 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 113' ' ' TYR . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.519999999999996 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG3' ' CH2' ' A' ' 135' ' ' TRP . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 70.129999999999995 110.294 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.668 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 0.6 OUTLIER -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 64.540000000000006 110.706 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 50.329999999999998 110.588 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.109999999999999 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 73.219999999999999 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 64.230000000000004 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 73.349999999999994 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.450000000000003 110.705 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 44.119999999999997 110.457 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 64.420000000000002 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 65.439999999999998 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 121' ' ' PHE . 14.1 p-10 -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.93 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 63.210000000000001 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 HG12 ' A' ' 15' ' ' ILE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 65.450000000000003 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.842 HG12 HG13 ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.409999999999997 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.140000000000001 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 65.409999999999997 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.629 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 12.4 m-20 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 110.094 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 64.400000000000006 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.086 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.430000000000007 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' CH2' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 71.200000000000003 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 70.430000000000007 109.901 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 65.129999999999995 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 73.5 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.150000000000006 110.163 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.021 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.420000000000002 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.409999999999997 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 51.43 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.420000000000002 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.329999999999998 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.420000000000002 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.299999999999997 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.430000000000007 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.230000000000004 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 71.540000000000006 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 72.040000000000006 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.109999999999999 110.905 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.129999999999995 110.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.319999999999993 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 41.43 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.439999999999998 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 72.140000000000001 110.262 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CB ' HG21 ' A' ' 62' ' ' ILE . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 70.019999999999996 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 71.019999999999996 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.219999999999999 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 70.040000000000006 110.007 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.319999999999993 111.436 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 61.310000000000002 109.939 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 70.319999999999993 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 1.1 p30 -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.450000000000003 110.446 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.420000000000002 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.44 HG21 ' CB ' ' A' ' 48' ' ' TYR . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.319999999999993 110.582 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 78' ' ' HIS . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.79 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 76' ' ' VAL . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.536 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 53.039999999999999 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 4.3 m120 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 74.409999999999997 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.310000000000002 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.340000000000003 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 71.439999999999998 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 62.229999999999997 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.049999999999997 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 72.349999999999994 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 64' ' ' THR . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.753 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.530000000000001 110.659 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 83' ' ' VAL . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 74.140000000000001 110.67 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.409999999999997 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 51.530000000000001 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 60.399999999999999 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.420000000000002 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 63.439999999999998 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' CD ' ' N ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.209999999999994 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.349999999999994 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 72.109999999999999 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.530000000000001 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.420000000000002 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 70.109999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' OE1' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.450000000000003 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.683 HD11 ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.230000000000004 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.519999999999996 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.239999999999995 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.430000000000007 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.340000000000003 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.210000000000001 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 5' ' ' PHE . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 64.030000000000001 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.200000000000003 110.647 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 64.109999999999999 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD22 HD11 ' A' ' 114' ' ' ILE . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 73.230000000000004 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 62.420000000000002 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 54.210000000000001 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.310000000000002 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 73.109999999999999 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.239999999999995 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.52 ' C ' HD22 ' A' ' 12' ' ' ASN . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 71.030000000000001 110.921 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.420000000000002 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.120000000000005 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.795 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 73.310000000000002 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.464 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 15.7 t80 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.340000000000003 109.775 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.349 . . . . 72.540000000000006 110.631 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.425 ' CZ3' ' N ' ' A' ' 160' ' ' LYS . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 51.119999999999997 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' ' HD3' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 53.140000000000001 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 54.539999999999999 110.684 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 140' ' ' VAL . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 52.140000000000001 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.450000000000003 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.530000000000001 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.510000000000005 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.200000000000003 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 145' ' ' THR . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.519999999999996 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.140000000000001 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 53.299999999999997 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 55.109999999999999 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 53.420000000000002 112.073 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 70.400000000000006 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.420000000000002 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.528 ' OH ' HD13 ' A' ' 25' ' ' LEU . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.230000000000004 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 65.109999999999999 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.219999999999999 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 73.540000000000006 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 43.149999999999999 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 53.350000000000001 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.010000000000005 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.604 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HB2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.400000000000006 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.310000000000002 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 114' ' ' ILE . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 61.229999999999997 111.394 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HA ' HG22 ' A' ' 115' ' ' THR . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.200000000000003 110.683 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 61.130000000000003 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 112.072 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 3.5 m-20 -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.340000000000003 111.397 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' NH2' ' H ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 72.319999999999993 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 125' ' ' THR . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 74.519999999999996 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG12 HG13 ' A' ' 14' ' ' VAL . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 64.409999999999997 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 45.43 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 122' ' ' GLU . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.618 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 62.140000000000001 110.356 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.585 HD22 ' HA ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.230000000000004 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.848 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.310000000000002 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 63.210000000000001 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 25' ' ' LEU . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.530000000000001 110.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.399999999999999 109.979 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 43.43 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 64.239999999999995 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 62.25 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 53.130000000000003 109.677 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 73.540000000000006 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 73.510000000000005 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 62.43 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 62.240000000000002 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.400000000000006 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.608 ' OG1' ' CG ' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.349999999999994 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.319999999999993 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 64.519999999999996 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.608 ' CG ' ' OG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 70.25 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.519999999999996 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.310000000000002 110.116 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 73.099999999999994 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.340000000000003 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.77 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.209999999999994 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.319999999999993 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.207 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.019999999999996 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 65.319999999999993 111.136 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.585 ' HA ' HD22 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 55.439999999999998 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 73.329999999999998 111.273 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.034 -0.358 . . . . 72.129999999999995 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.239999999999995 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.495 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 1.2 p-10 -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.219999999999999 110.534 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 61.509999999999998 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 62' ' ' ILE . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.540000000000006 110.543 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 78' ' ' HIS . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 60.299999999999997 110.611 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.77 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 2.3 m-20 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.509999999999998 110.571 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.230000000000004 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 61.439999999999998 110.561 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 50.140000000000001 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.119999999999997 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 70.510000000000005 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.400000000000006 110.269 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.099999999999994 110.554 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.209999999999994 111.04 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.430000000000007 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 61.020000000000003 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 71.510000000000005 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.010000000000005 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 72.409999999999997 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.049999999999997 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 53.32 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.430000000000007 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.409999999999997 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 95' ' ' ILE . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.703 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.509 ' HB2' HD22 ' A' ' 41' ' ' LEU . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 73.409999999999997 110.36 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 93' ' ' ILE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 70.400000000000006 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 6' ' ' MET . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 70.310000000000002 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.140000000000001 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.120000000000005 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.439999999999998 110.673 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.219999999999999 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.540000000000006 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.230000000000004 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.802 HD23 ' C ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.549999999999997 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 72.140000000000001 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 5' ' ' PHE . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 62.200000000000003 110.056 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 64.439999999999998 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.200000000000003 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.666 ' CE1' HG13 ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.904 HD13 ' CE1' ' A' ' 156' ' ' HIS . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 8' ' ' ALA . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 52.32 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 73.120000000000005 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 71.439999999999998 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.239999999999995 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 70.209999999999994 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.099999999999994 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.530000000000001 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 64.230000000000004 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.120000000000005 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.530000000000001 110.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.72 0.295 . . . . 63.32 111.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 64.430000000000007 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 63.229999999999997 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.540000000000006 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 70.040000000000006 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.409999999999997 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.120000000000005 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.310000000000002 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 64.120000000000005 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 74.510000000000005 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.310000000000002 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.010000000000005 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.109999999999999 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.239999999999995 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.8 OUTLIER -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.109999999999999 110.625 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.039999999999999 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 63.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.319999999999993 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 72.25 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.445 ' HH ' ' HD1' ' A' ' 113' ' ' TYR . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 73.030000000000001 110.441 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.904 ' CE1' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.109999999999999 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 71.299999999999997 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.409999999999997 110.439 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.109999999999999 110.538 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.329999999999998 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.562 HG12 HG23 ' A' ' 109' ' ' VAL . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.58 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.129999999999995 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.140000000000001 110.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.319999999999993 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' ALA . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.340000000000003 111.252 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.340000000000003 110.032 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 73.310000000000002 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 40.130000000000003 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 63.210000000000001 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.219999999999999 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.494 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.140000000000001 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.821 HG23 ' CA ' ' A' ' 126' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 43.210000000000001 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG12 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.219999999999999 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 54.130000000000003 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 64.319999999999993 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.036 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.549999999999997 110.365 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.109999999999999 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.494 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 60.340000000000003 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.409999999999997 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 63.229999999999997 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.666 ' H ' HD12 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.200000000000003 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 71.329999999999998 110.671 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.430000000000007 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.946 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' N ' HG13 ' A' ' 32' ' ' VAL . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.120000000000005 110.733 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.510000000000005 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.019999999999996 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 5.1 m-70 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 62.350000000000001 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.510000000000005 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 72.040000000000006 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.030000000000001 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.430000000000007 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 54.009999999999998 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.521 ' NH1' ' HZ3' ' A' ' 46' ' ' LYS . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.209999999999994 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.784 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.400000000000006 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CE2' HG11 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.420000000000002 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.230000000000004 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 73.329999999999998 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 51' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 53.109999999999999 111.706 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 75.510000000000005 111.048 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 72.409999999999997 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.723 ' C ' HD13 ' A' ' 61' ' ' ILE . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 54.32 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.65 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' TYR . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 71.019999999999996 110.85 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.219999999999999 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 64' ' ' THR . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.519999999999996 110.636 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.219999999999999 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 64.430000000000007 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 22.25 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 72.140000000000001 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HA ' HG21 ' A' ' 76' ' ' VAL . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 110.373 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 64.420000000000002 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.049999999999997 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 33.520000000000003 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' ILE . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.216 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 70' ' ' HIS . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 44.32 111.155 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 55.340000000000003 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.129999999999995 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.340000000000003 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 80' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 61.0 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.140000000000001 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 63' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 53.229999999999997 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.310000000000002 111.075 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 62.43 110.656 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 45.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.099999999999994 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 54.109999999999999 110.413 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.430000000000007 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.430000000000007 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.430000000000007 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.150000000000006 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.549999999999997 110.344 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.120000000000005 111.714 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 52.509999999999998 110.15 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 31.199999999999999 110.582 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 71.239999999999995 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 55.439999999999998 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.129999999999995 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.400000000000006 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 111.272 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 65.299999999999997 111.452 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 71.420000000000002 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.109999999999999 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.539999999999999 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 3' ' ' VAL . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.969 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.040000000000006 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.209999999999994 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 114' ' ' ILE . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 72.310000000000002 111.136 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.742 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 73.040000000000006 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD11 HD21 ' A' ' 112' ' ' LEU . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 72.430000000000007 110.616 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 54.43 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 42.450000000000003 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 153' ' ' TYR . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.129999999999995 110.745 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 117' ' ' ILE . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 55.240000000000002 110.667 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.129999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.219999999999999 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.446 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 61.200000000000003 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.450000000000003 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 99' ' ' ALA . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.821 ' CA ' HG23 ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.219999999999999 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.777 ' HB2' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.340000000000003 109.955 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.531 0.205 . . . . 74.319999999999993 111.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.329999999999998 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 60.399999999999999 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 63.43 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 72.400000000000006 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG23 ' ND1' ' A' ' 156' ' ' HIS . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.03 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 64.239999999999995 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.239999999999995 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 52.210000000000001 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 53.020000000000003 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 71.349999999999994 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 153' ' ' TYR . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.65 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 54.130000000000003 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 63.229999999999997 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 52.229999999999997 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.486 ' ND1' HG23 ' A' ' 140' ' ' VAL . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.140000000000001 110.869 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.742 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.109999999999999 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 71.299999999999997 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 110.821 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 74.25 110.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.219999999999999 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 HD11 ' A' ' 93' ' ' ILE . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.230000000000004 110.544 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 64.439999999999998 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 95' ' ' ILE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.349999999999994 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.400000000000006 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.230000000000004 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.329999999999998 110.557 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.464 ' HB2' HG22 ' A' ' 114' ' ' ILE . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 111.037 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.329999999999998 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 72.319999999999993 111.349 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.517 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.420000000000002 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 ' CA ' ' A' ' 126' ' ' PHE . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.400000000000006 110.82 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG13 ' H ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.409999999999997 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.510000000000005 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.239999999999995 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 71.109999999999999 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.2 p-10 -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 110.799 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.933 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 71.299999999999997 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 63.210000000000001 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 53.039999999999999 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.409999999999997 109.947 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 54.210000000000001 110.314 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 53.43 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.140000000000001 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 54.329999999999998 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 61.420000000000002 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 71.120000000000005 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.030000000000001 111.086 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 32' ' ' VAL . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 64.010000000000005 110.761 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.299999999999997 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 42.200000000000003 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.219999999999999 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.200000000000003 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.450000000000003 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 52.100000000000001 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 61.140000000000001 110.869 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 64.430000000000007 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.519999999999996 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.439999999999998 110.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' HD13 ' A' ' 51' ' ' ILE . 12.2 t-20 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.150000000000006 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.340000000000003 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 55.420000000000002 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 60.340000000000003 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.129999999999995 110.862 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 65.150000000000006 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' HH11 ' A' ' 59' ' ' ARG . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.431 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.349999999999994 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 75' ' ' GLU . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.310000000000002 110.214 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' A' ' 74' ' ' CYS . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 71.25 110.989 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 78' ' ' HIS . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 110.929 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' THR . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 70.510000000000005 110.43 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 61.140000000000001 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 3.9 m120 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.019999999999996 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.329999999999998 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.109999999999999 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.5 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 55.520000000000003 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 62' ' ' ILE . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 51.340000000000003 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HB3' HG23 ' A' ' 61' ' ' ILE . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.119999999999997 110.152 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 65.530000000000001 111.227 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 109.871 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.340000000000003 110.657 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 65.030000000000001 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.099999999999994 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 64.530000000000001 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 72.510000000000005 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.439999999999998 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HG ' HG12 ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 64.120000000000005 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.465 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.150000000000006 110.69 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.530000000000001 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 72.340000000000003 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 62.210000000000001 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 41.43 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.549999999999997 110.582 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.487 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 35.340000000000003 110.237 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.140000000000001 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 72.5 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 72.109999999999999 111.407 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 102' ' ' TYR . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 73.0 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.430000000000007 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 70.540000000000006 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.723 ' N ' HG22 ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.409999999999997 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 65.209999999999994 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 114' ' ' ILE . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 63.549999999999997 110.695 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.794 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 119' ' ' HIS . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.099999999999994 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.514 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.019999999999996 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 70.329999999999998 110.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 61.100000000000001 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.540000000000006 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.509999999999998 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.430000000000007 110.082 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.673 ' CA ' HG23 ' A' ' 14' ' ' VAL . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.040000000000006 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.651 ' HD1' HG22 ' A' ' 14' ' ' VAL . 1.7 p90 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.340000000000003 110.128 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.437 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 1.8 t30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.78 0.324 . . . . 61.539999999999999 110.835 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.049999999999997 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 72.409999999999997 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.019999999999996 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 42.310000000000002 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 74.439999999999998 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.589 ' CB ' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 70.530000000000001 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 61.539999999999999 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.209999999999994 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.310000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 149' ' ' ASN . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.329999999999998 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.439999999999998 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 73.329999999999998 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 2.8 p-10 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.400000000000006 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 53.399999999999999 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.510000000000005 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 63.439999999999998 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.040000000000006 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 65.109999999999999 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.120000000000005 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 61.43 110.659 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 2' ' ' ILE . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.901 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.1 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 70.200000000000003 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 42.520000000000003 110.608 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 70.040000000000006 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.744 ' OD1' ' HB2' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 70.540000000000006 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.149999999999999 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.239999999999995 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.779 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 64.310000000000002 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 55.240000000000002 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 71.5 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.299999999999997 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.310000000000002 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.329999999999998 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.140000000000001 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.099999999999994 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 62.219999999999999 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.219999999999999 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.239999999999995 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.530000000000001 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.400000000000006 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.120000000000005 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 63.240000000000002 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 64.420000000000002 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 62.409999999999997 110.401 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.459 ' N ' HD23 ' A' ' 29' ' ' LEU . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 65.25 111.045 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.239999999999995 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 36' ' ' THR . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.230000000000004 110.284 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 60.450000000000003 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.400000000000006 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.551 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.319999999999993 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 45.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.663 ' HG2' HG22 ' A' ' 93' ' ' ILE . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 41.030000000000001 112.621 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 64.040000000000006 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.209999999999994 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.549999999999997 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 73.219999999999999 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.25 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 65.439999999999998 110.755 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.540000000000006 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 62.100000000000001 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.519999999999996 110.466 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.399 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.219999999999999 110.979 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 121.06 0.457 . . . . 52.350000000000001 111.045 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 71.439999999999998 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.540000000000006 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 64.450000000000003 110.807 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.200000000000003 110.118 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 78' ' ' HIS . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 111.554 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.239999999999995 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.483 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 4.3 m-20 -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.009999999999998 110.441 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.200000000000003 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.430000000000007 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 72.329999999999998 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.439999999999998 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.099999999999994 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 52.340000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.450000000000003 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 64.430000000000007 110.854 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 54.030000000000001 110.09 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.624 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.862 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 63.329999999999998 111.577 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 63.130000000000003 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.039999999999999 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' N ' ' OE1' ' A' ' 82' ' ' GLU . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.120000000000005 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 70.129999999999995 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 53.210000000000001 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 63.229999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' C ' HD13 ' A' ' 93' ' ' ILE . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.741 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 63.200000000000003 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.439999999999998 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.109999999999999 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 97' ' ' GLY . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.109999999999999 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 62.439999999999998 110.422 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 71.420000000000002 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 1.03 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.200000000000003 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 62.420000000000002 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.310000000000002 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 62.420000000000002 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 72.400000000000006 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 71.430000000000007 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PHE . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' H ' HG23 ' A' ' 3' ' ' VAL . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.109999999999999 110.311 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 73.319999999999993 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.616 ' N ' HD13 ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 52.219999999999999 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 51.329999999999998 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.010000000000005 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 64.25 110.585 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 70.150000000000006 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.140000000000001 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 55.32 110.696 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.779 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 54.409999999999997 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 52.229999999999997 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.420000000000002 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.340000000000003 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.503 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.519999999999996 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.430000000000007 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.130000000000003 110.116 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.814 0.34 . . . . 64.409999999999997 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.430000000000007 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 62.200000000000003 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 64.140000000000001 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 53.130000000000003 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.354 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 60.549999999999997 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.439999999999998 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 62.109999999999999 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 65.319999999999993 109.774 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.340000000000003 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.400000000000006 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 149' ' ' ASN . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 61.109999999999999 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 144' ' ' LEU . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.530000000000001 110.403 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.429 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.420000000000002 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.040000000000006 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.010000000000005 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.439999999999998 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.310000000000002 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 71.019999999999996 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 71.430000000000007 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.540000000000006 110.572 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 50.530000000000001 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 61.130000000000003 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.120000000000005 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.329999999999998 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.307 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 63.240000000000002 110.702 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB2' HG22 ' A' ' 114' ' ' ILE . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 110.917 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 63.299999999999997 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.310000000000002 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 61.439999999999998 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 72.420000000000002 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 125' ' ' THR . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.230000000000004 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' VAL . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.109999999999999 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.657 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.219999999999999 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 44.130000000000003 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.627 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.319999999999993 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 153' ' ' TYR . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.346 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 55.030000000000001 110.279 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 25' ' ' LEU . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 63.25 111.727 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.299999999999997 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 34.229999999999997 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 52.329999999999998 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 73.030000000000001 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.456 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 50.210000000000001 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.120000000000005 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.409999999999997 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 70.209999999999994 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.52 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 53.520000000000003 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.439999999999998 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' HG22 ' A' ' 93' ' ' ILE . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.439999999999998 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.140000000000001 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 63' ' ' VAL . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.230000000000004 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 50.43 110.6 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.140000000000001 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.4 m120 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 65.209999999999994 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.540000000000006 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 52.530000000000001 110.327 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 55.039999999999999 110.15 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 112.217 179.365 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.326 -0.249 . . . . 75.430000000000007 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.310000000000002 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 50.520000000000003 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 64.340000000000003 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 78' ' ' HIS . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 71.010000000000005 111.043 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.507 ' OG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.530000000000001 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 72.109999999999999 110.631 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.219999999999999 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.209999999999994 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.400000000000006 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 52.329999999999998 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 43.340000000000003 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 64.519999999999996 110.657 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.420000000000002 110.266 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.654 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.349999999999994 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.319999999999993 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 43.130000000000003 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 71.519999999999996 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 54.329999999999998 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 82' ' ' GLU . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 53.219999999999999 110.536 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 61.340000000000003 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.200000000000003 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 93' ' ' ILE . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.030000000000001 110.279 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.319999999999993 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 64.329999999999998 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 110.751 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 65.420000000000002 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.129999999999995 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.450000000000003 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.010000000000005 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.099999999999994 110.548 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.458 HG21 ' HA3' ' A' ' 97' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 53.299999999999997 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 63.109999999999999 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.619 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 63.149999999999999 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.120000000000005 110.755 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 109' ' ' VAL . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 71.230000000000004 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 72.109999999999999 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 65.430000000000007 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 106' ' ' LEU . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 63.109999999999999 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 109' ' ' VAL . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.420000000000002 110.238 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 5' ' ' PHE . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 64.140000000000001 111.563 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.417 ' C ' HD12 ' A' ' 114' ' ' ILE . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 109.993 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.961 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 64.319999999999993 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 52.210000000000001 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 9' ' ' MET . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 64.150000000000006 110.844 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' OD1' ' A' ' 10' ' ' ASP . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.209999999999994 109.96 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.129999999999995 111.227 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.421 ' H ' HG22 ' A' ' 117' ' ' ILE . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.414 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.299999999999997 111.118 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.25 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.310000000000002 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 52.43 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 54.039999999999999 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.329999999999998 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.530000000000001 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.040000000000006 109.854 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.87 0.367 . . . . 73.450000000000003 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.435 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 72.140000000000001 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 71.099999999999994 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.109999999999999 110.606 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.239999999999995 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.319999999999993 110.974 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.340000000000003 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 55.25 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.329999999999998 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.239999999999995 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.049999999999997 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.510000000000005 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 72.099999999999994 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 72.030000000000001 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.409999999999997 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.230000000000004 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 65.209999999999994 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 72.5 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.010000000000005 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 63.140000000000001 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 65.549999999999997 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.150000000000006 110.558 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 44.109999999999999 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.419 ' H ' ' HB3' ' A' ' 1' ' ' MET . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 110.298 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.549999999999997 110.893 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.530000000000001 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.540000000000006 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.150000000000006 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 114' ' ' ILE . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 71.319999999999993 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.400000000000006 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 44.439999999999998 112.088 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 2.4 m120 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.340000000000003 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.25 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 125' ' ' THR . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 55.130000000000003 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 HG13 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.329999999999998 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.329999999999998 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 70.319999999999993 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.329999999999998 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.409999999999997 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.409999999999997 110.368 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.129999999999995 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 63.420000000000002 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 31.440000000000001 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 72.540000000000006 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 71.129999999999995 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.239999999999995 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 72.430000000000007 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.129999999999995 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.239999999999995 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 36' ' ' THR . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.109999999999999 110.605 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 35' ' ' THR . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.430000000000007 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.099999999999994 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.109999999999999 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.239999999999995 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.200000000000003 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 64.200000000000003 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 61.299999999999997 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.140000000000001 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.729 HH21 ' CB ' ' A' ' 64' ' ' THR . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 63.130000000000003 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.476 ' O ' HD13 ' A' ' 51' ' ' ILE . 6.4 t-20 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.030000000000001 110.227 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.450000000000003 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.329999999999998 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 54.130000000000003 110.454 -179.717 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.512 ' NE ' HD12 ' A' ' 41' ' ' LEU . 26.4 mtp180 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.126 -0.324 . . . . 64.310000000000002 110.126 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.010000000000005 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 72.409999999999997 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 62.530000000000001 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 61.329999999999998 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 78' ' ' HIS . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.729 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 64.150000000000006 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 64.549999999999997 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 42.25 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 61.149999999999999 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 61.219999999999999 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.299999999999997 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.239999999999995 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.200000000000003 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 62.109999999999999 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.430000000000007 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.526 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.310000000000002 110.652 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.120000000000005 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 52.399999999999999 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 71.409999999999997 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 63.140000000000001 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.549999999999997 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 64.219999999999999 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 64.219999999999999 110.882 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.319999999999993 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.450000000000003 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' ILE . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 71.230000000000004 110.509 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 41.399999999999999 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.310000000000002 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 95' ' ' ILE . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 63.219999999999999 110.717 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 61.219999999999999 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.340000000000003 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.049999999999997 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 52.420000000000002 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.678 HG22 ' CZ ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 41.32 110.302 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 65.340000000000003 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.450000000000003 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 104' ' ' LEU . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 62.340000000000003 111.157 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 62.219999999999999 111.915 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.564 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 64.430000000000007 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 63.32 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 3' ' ' VAL . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 71.129999999999995 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 70.150000000000006 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 54.32 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 71.230000000000004 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 54.130000000000003 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 60.229999999999997 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 117' ' ' ILE . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 74.319999999999993 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.120000000000005 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.040000000000006 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 12' ' ' ASN . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 41.130000000000003 110.332 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 17' ' ' LYS . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 71.129999999999995 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 61.109999999999999 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 64.450000000000003 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.209999999999994 110.2 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 63.329999999999998 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 70.530000000000001 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.229999999999997 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.140000000000001 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 71.310000000000002 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 62.439999999999998 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 54.109999999999999 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 71.310000000000002 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.430000000000007 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 65.030000000000001 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 70.420000000000002 110.846 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 61.299999999999997 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.129999999999995 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 70.530000000000001 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 73.239999999999995 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.140000000000001 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 72.5 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 60.119999999999997 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.696 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 1.1 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.319999999999993 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.319999999999993 110.615 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 63.43 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 64.340000000000003 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 93' ' ' ILE . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.019999999999996 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.099999999999994 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.400000000000006 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.239999999999995 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.140000000000001 110.077 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.420000000000002 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 24.1 m-20 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 42.340000000000003 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.109999999999999 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 125' ' ' THR . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 52.25 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.799 HG12 HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.430000000000007 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 70.129999999999995 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.049999999999997 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.7 OUTLIER 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.430000000000007 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 63.109999999999999 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.329999999999998 111.28 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.150000000000006 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.674 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.109999999999999 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 72.109999999999999 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.120000000000005 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.629 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.209999999999994 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.778 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.400000000000006 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.340000000000003 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 33' ' ' LYS . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 64.530000000000001 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' N ' HG13 ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 70.0 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 72.109999999999999 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 64.439999999999998 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 54.450000000000003 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 64.200000000000003 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 53.43 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 62.009999999999998 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 62.030000000000001 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 95' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.979 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.530000000000001 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 74.140000000000001 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.120000000000005 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.120000000000005 111.057 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 62.219999999999999 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 73.109999999999999 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 62.329999999999998 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 71.239999999999995 110.673 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.911 0.386 . . . . 63.100000000000001 110.444 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.129999999999995 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.510000000000005 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 65.120000000000005 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 74' ' ' CYS . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 53.539999999999999 110.442 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 78' ' ' HIS . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 63.310000000000002 110.872 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 70.540000000000006 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 63.509999999999998 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 60.8 m-20 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.519999999999996 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.140000000000001 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 74.209999999999994 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 62.229999999999997 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 63.329999999999998 111.203 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.129999999999995 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 72.329999999999998 110.795 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.540000000000006 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 72.109999999999999 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.439999999999998 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.299999999999997 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 85' ' ' GLU . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 110.978 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 63.420000000000002 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 64.010000000000005 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 61.549999999999997 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.329999999999998 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.230000000000004 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.099999999999994 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.200000000000003 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 42' ' ' ILE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 96' ' ' PHE . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 62.039999999999999 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 62.030000000000001 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 42.240000000000002 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 43.329999999999998 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 5.0 pt20 -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 72.109999999999999 110.637 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.461 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.239999999999995 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.109999999999999 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.776 ' O ' HG12 ' A' ' 109' ' ' VAL . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.577 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 72.540000000000006 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.150000000000006 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 105' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.447 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.409999999999997 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.430000000000007 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.495 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 62.299999999999997 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 112' ' ' LEU . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 71.230000000000004 110.641 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 119' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 71.129999999999995 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.964 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.636 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.099999999999994 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 62.43 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 70.010000000000005 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.821 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 74.239999999999995 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.120000000000005 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.803 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.491 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.329 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.823 0.344 . . . . 63.109999999999999 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 70.140000000000001 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.310000000000002 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 62.32 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.200000000000003 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.728 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.239999999999995 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 54.43 110.753 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.150000000000006 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 63.039999999999999 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.230000000000004 110.727 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.507 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.120000000000005 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.627 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.310000000000002 110.538 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.530000000000001 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.120000000000005 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 71.349999999999994 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.540000000000006 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 42.200000000000003 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 62.450000000000003 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 74.109999999999999 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.439999999999998 110.51 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.530000000000001 110.567 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 63.130000000000003 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 63.25 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 93' ' ' ILE . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 54.520000000000003 110.358 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 55.100000000000001 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 110.418 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 63.039999999999999 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.219999999999999 110.74 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 71.129999999999995 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 63.43 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.825 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.129999999999995 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 125' ' ' THR . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.030000000000001 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.420000000000002 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 54.329999999999998 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.030000000000001 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 64.219999999999999 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.140000000000001 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 51.219999999999999 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.129999999999995 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' OD1' ' A' ' 149' ' ' ASN . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 61.340000000000003 110.36 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.310000000000002 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.140000000000001 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 60.229999999999997 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 72.340000000000003 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 36' ' ' THR . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 32.200000000000003 110.573 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 70.030000000000001 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 62.240000000000002 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 65.530000000000001 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.150000000000006 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.530000000000001 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.369 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.430000000000007 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 42' ' ' ILE . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 71.140000000000001 109.988 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.430000000000007 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 60.020000000000003 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.329999999999998 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.099999999999994 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 54.420000000000002 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 72.420000000000002 110.948 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.430000000000007 111.366 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.316 0.579 . . . . 73.209999999999994 109.979 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 65.049999999999997 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.662 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 72.25 110.715 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 63.310000000000002 110.113 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 78' ' ' HIS . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.120000000000005 110.986 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.547 HG21 ' CD2' ' A' ' 69' ' ' TYR . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.200000000000003 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 64.340000000000003 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 64' ' ' THR . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 64.120000000000005 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 62.200000000000003 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.200000000000003 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.099999999999994 110.409 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.120000000000005 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 51.119999999999997 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 30.129999999999999 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.585 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.239999999999995 110.65 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.219999999999999 110.878 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 70.540000000000006 110.597 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 42.210000000000001 110.634 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 86' ' ' LEU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 53.109999999999999 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 110.752 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 72.439999999999998 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.230000000000004 110.71 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.431 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.530000000000001 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 64.540000000000006 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.109999999999999 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.310000000000002 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 3' ' ' VAL . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.577 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 42.329999999999998 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 54.200000000000003 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 63.420000000000002 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 51.140000000000001 110.189 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.310000000000002 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.198 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.875 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.420000000000002 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.219999999999999 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 70.329999999999998 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.540000000000006 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.010000000000005 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.109999999999999 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 5' ' ' PHE . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 73.230000000000004 110.787 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.616 HG21 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.150000000000006 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 55.439999999999998 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 60.219999999999999 110.657 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.349999999999994 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.140000000000001 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.825 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 62.229999999999997 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 44.539999999999999 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.319999999999993 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.753 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 65.329999999999998 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.120000000000005 109.753 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.736 0.303 . . . . 73.319999999999993 110.813 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 72.019999999999996 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 64.450000000000003 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.310000000000002 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 73.299999999999997 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 54.119999999999997 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.409999999999997 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 64.140000000000001 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 144' ' ' LEU . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 63.100000000000001 110.444 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.239999999999995 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.150000000000006 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.140000000000001 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.450000000000003 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.430000000000007 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.230000000000004 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 62.149999999999999 110.4 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.530000000000001 110.679 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.230000000000004 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.329999999999998 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.427 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 63.310000000000002 110.576 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.030000000000001 110.515 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 44.219999999999999 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.340000000000003 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 45.020000000000003 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 71.299999999999997 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 52.0 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 72.040000000000006 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.510000000000005 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.140000000000001 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 42.350000000000001 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 125' ' ' THR . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 73.230000000000004 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 125' ' ' THR . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 54.340000000000003 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.239999999999995 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 63.329999999999998 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.67 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 70.329999999999998 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 19' ' ' ASN . 0.5 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 63.520000000000003 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 63.409999999999997 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.209999999999994 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.200000000000003 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 71.409999999999997 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.755 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 73.310000000000002 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 64.140000000000001 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.450000000000003 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 53.340000000000003 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.230000000000004 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.230000000000004 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 110.592 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.510000000000005 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.219999999999999 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 63.100000000000001 110.48 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 32' ' ' VAL . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.140000000000001 110.455 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.049999999999997 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 65.010000000000005 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.109999999999999 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 63.200000000000003 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 95' ' ' ILE . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 64.140000000000001 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 54.109999999999999 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 44.310000000000002 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 72.049999999999997 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 54.109999999999999 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 92.0 m-20 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.420000000000002 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 71.010000000000005 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.319999999999993 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.445 HD11 ' ND2' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 45.420000000000002 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.209999999999994 110.487 -179.556 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 110.841 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 70.319999999999993 110.878 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.456 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.299999999999997 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' HIS . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.420000000000002 111.546 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 72.030000000000001 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 5.1 m120 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 70.400000000000006 110.531 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.200000000000003 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 61.119999999999997 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 63.5 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 61.549999999999997 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 64.25 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 70.540000000000006 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 54.43 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 72.420000000000002 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.799 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.409999999999997 110.741 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.299999999999997 110.715 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.129999999999995 110.413 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.140000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.299999999999997 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 83' ' ' VAL . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 70.510000000000005 110.534 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.439999999999998 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.109999999999999 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 61.039999999999999 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 93' ' ' ILE . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 62.210000000000001 111.016 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.510000000000005 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.129999999999995 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.532 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' ILE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' O ' ' C ' ' A' ' 97' ' ' GLY . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 54.039999999999999 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.200000000000003 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 55.439999999999998 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.909 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.636 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 55.049999999999997 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.120000000000005 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 72.140000000000001 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.537 ' CD2' HG11 ' A' ' 80' ' ' VAL . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.407 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 60.109999999999999 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 54.310000000000002 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.019999999999996 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 109' ' ' VAL . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 53.329999999999998 110.733 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.4 ' N ' HG22 ' A' ' 109' ' ' VAL . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.040000000000006 109.819 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 72.549999999999997 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' CD2' HD11 ' A' ' 114' ' ' ILE . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 74.239999999999995 110.708 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.200000000000003 110.546 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 112' ' ' LEU . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 110.753 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 50.43 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.299999999999997 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.430000000000007 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.420000000000002 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.530000000000001 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' H ' HH21 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.409999999999997 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.439999999999998 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 62.109999999999999 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 71.340000000000003 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.693 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.420000000000002 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.511 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.239999999999995 110.149 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.832 0.349 . . . . 73.219999999999999 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.535 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.120000000000005 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.150000000000006 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 71.230000000000004 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 71.140000000000001 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.200000000000003 110.685 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 61.310000000000002 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.209999999999994 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 62.439999999999998 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.319999999999993 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.573 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 71.439999999999998 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 64.109999999999999 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.420000000000002 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.691 ' OH ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.546 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 110.919 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.420000000000002 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 63.020000000000003 110.292 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 73.239999999999995 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.391 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 3.8 pm0 -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.209999999999994 110.618 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 44.119999999999997 110.647 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.010000000000005 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 93' ' ' ILE . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 71.329999999999998 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.598 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.439999999999998 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 44.450000000000003 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' HH21 ' A' ' 24' ' ' ARG . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 64.25 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 54.25 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.319999999999993 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 72.010000000000005 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 70.310000000000002 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 125' ' ' THR . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 63.409999999999997 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 HG13 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.510000000000005 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.310000000000002 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 63.210000000000001 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 55.340000000000003 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.450000000000003 109.891 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.219999999999999 110.306 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.978 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.409999999999997 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.439999999999998 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.040000000000006 110.535 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.598 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.209999999999994 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 153' ' ' TYR . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 110.466 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.109999999999999 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.439999999999998 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.439999999999998 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 61.210000000000001 111.096 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 60.5 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 73.25 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.519999999999996 111.301 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.420000000000002 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.150000000000006 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.230000000000004 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 110.59 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.030000000000001 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.439999999999998 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 55.439999999999998 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 71.109999999999999 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.020000000000003 110.53 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 71.439999999999998 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 42.100000000000001 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.310000000000002 110.454 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 63.200000000000003 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.456 ' OD1' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.230000000000004 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.439999999999998 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 64.239999999999995 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 72.310000000000002 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 72.140000000000001 109.793 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.319999999999993 111.382 179.448 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.513 0.197 . . . . 73.140000000000001 110.713 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.319999999999993 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.239999999999995 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 63.149999999999999 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 74' ' ' CYS . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.210000000000001 111.03 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 78' ' ' HIS . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 64.420000000000002 110.86 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.541 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 12.3 m-20 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 52.039999999999999 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.519999999999996 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.450000000000003 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.519999999999996 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 70.019999999999996 110.536 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.140000000000001 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 74.409999999999997 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.099999999999994 110.645 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 64' ' ' THR . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 51.340000000000003 110.703 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 60.020000000000003 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.120000000000005 110.824 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.6 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 33.109999999999999 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.6 ' N ' ' OG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 61.030000000000001 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.140000000000001 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.433 HG21 HG21 ' A' ' 63' ' ' VAL . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.931 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 55.509999999999998 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 70.400000000000006 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 63.420000000000002 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.329999999999998 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 71.439999999999998 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.099999999999994 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 3' ' ' VAL . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 72.519999999999996 110.118 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.109999999999999 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 42' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 54.530000000000001 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 97' ' ' GLY . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.140000000000001 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.329999999999998 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 45.539999999999999 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.120000000000005 111.27 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 73.120000000000005 111.15 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 64.439999999999998 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.219999999999999 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 105' ' ' PHE . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 65.409999999999997 111.172 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 65.340000000000003 111.172 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 62.049999999999997 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.439999999999998 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 61.329999999999998 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 105' ' ' PHE . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 65.439999999999998 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.511 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.129999999999995 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.010000000000005 110.673 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.140000000000001 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 112' ' ' LEU . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 60.329999999999998 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.129999999999995 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.040000000000006 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.349999999999994 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 64.519999999999996 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.447 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.140000000000001 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.120000000000005 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.439999999999998 111.038 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.329999999999998 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.420000000000002 109.901 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.848 0.356 . . . . 70.239999999999995 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.497 ' CZ2' HD12 ' A' ' 112' ' ' LEU . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.019999999999996 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.109999999999999 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 61.030000000000001 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 73.230000000000004 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 54.530000000000001 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.210000000000001 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 73.019999999999996 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 72.329999999999998 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 62.32 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.530000000000001 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 62.049999999999997 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.530000000000001 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.310000000000002 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 74.5 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 25' ' ' LEU . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.109999999999999 111.434 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.439999999999998 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 92.2 m-70 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 72.219999999999999 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 64.349999999999994 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.319999999999993 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 65.25 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 62.539999999999999 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.040000000000006 110.572 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.219999999999999 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.430000000000007 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.150000000000006 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CE1' HG13 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 71.140000000000001 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.219999999999999 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.150000000000006 109.317 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.439999999999998 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.129999999999995 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 65.209999999999994 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.319999999999993 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG12 ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 72.450000000000003 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.519999999999996 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 52.329999999999998 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.0 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.319999999999993 109.336 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 18' ' ' ASP . 1.1 p-10 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.349999999999994 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.864 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.129999999999995 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 62.219999999999999 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 72.019999999999996 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 25' ' ' LEU . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.400000000000006 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.040000000000006 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.32 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 73.530000000000001 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.510000000000005 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 70.510000000000005 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.450000000000003 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 33' ' ' LYS . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.510000000000005 110.366 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 32' ' ' VAL . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 62.350000000000001 111.274 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.299999999999997 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.530000000000001 110.527 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 35' ' ' THR . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.140000000000001 110.95 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 62.109999999999999 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.450000000000003 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 71.519999999999996 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.430000000000007 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.319999999999993 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.010000000000005 110.578 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.209999999999994 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 25.149999999999999 110.771 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 71.400000000000006 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 72.450000000000003 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 50' ' ' ALA . 2.9 m120 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 62.119999999999997 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.230000000000004 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 70.120000000000005 110.662 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.230000000000004 111.147 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.687 0.279 . . . . 70.409999999999997 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.420000000000002 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 110.964 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 77' ' ' ALA . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 51.030000000000001 110.307 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' HIS . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 52.399999999999999 111.067 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 73.299999999999997 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 72.129999999999995 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 3.0 m120 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 43.009999999999998 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 34.109999999999999 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 62.130000000000003 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.019999999999996 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 32.329999999999998 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.349999999999994 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 55.420000000000002 109.99 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.657 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 73.200000000000003 110.877 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 64.420000000000002 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.420000000000002 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.329999999999998 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.109999999999999 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 62.25 110.654 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.010000000000005 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.340000000000003 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 52.219999999999999 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.549999999999997 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.430000000000007 110.502 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 65.329999999999998 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.57 ' CD1' HD13 ' A' ' 42' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.099999999999994 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.209999999999994 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.492 ' H ' HD11 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 41.210000000000001 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 65.310000000000002 111.105 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.239999999999995 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.019999999999996 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.400000000000006 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.635 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 61.43 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.040000000000006 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 63.310000000000002 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 71.439999999999998 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 72.209999999999994 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 51.530000000000001 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 73.200000000000003 110.394 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 72.549999999999997 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.719 HD11 HD13 ' A' ' 112' ' ' LEU . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 52.399999999999999 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 63.119999999999997 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.546 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.109999999999999 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 62.43 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.420000000000002 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.140000000000001 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.430000000000007 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.679 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.010000000000005 110.4 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 70.209999999999994 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 70.329999999999998 109.689 179.036 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.751 0.31 . . . . 71.040000000000006 110.804 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 110.483 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.510000000000005 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 61.049999999999997 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.340000000000003 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.519999999999996 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.099999999999994 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.409999999999997 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 145' ' ' THR . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 72.239999999999995 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.049999999999997 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.140000000000001 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 65.409999999999997 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.209999999999994 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 70.439999999999998 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 65.310000000000002 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.450000000000003 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.692 ' C ' ' ND1' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.310000000000002 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.540000000000006 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 70.299999999999997 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.310000000000002 110.591 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.239999999999995 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 2' ' ' ILE . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.651 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.530000000000001 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 55.119999999999997 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 64.25 110.249 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 61.310000000000002 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' ALA . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 60.539999999999999 110.747 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 7' ' ' VAL . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 110.891 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.040000000000006 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.400000000000006 111.858 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 74.129999999999995 111.9 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.85 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.349999999999994 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.692 HG13 HG12 ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.319999999999993 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.692 HG12 HG13 ' A' ' 14' ' ' VAL . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.319999999999993 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.099999999999994 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.349999999999994 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.150000000000006 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.510000000000005 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.497 HD22 ' HA ' ' A' ' 51' ' ' ILE . 4.4 m-20 -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.393 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 62.439999999999998 110.017 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.310000000000002 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.019999999999996 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 61.119999999999997 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.329999999999998 110.224 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 71.430000000000007 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.129999999999995 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 74.109999999999999 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.409999999999997 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 36' ' ' THR . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 65.140000000000001 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' N ' HG13 ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.150000000000006 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 72.349999999999994 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.530000000000001 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.439999999999998 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.544 ' O ' ' CG ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.519999999999996 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.350000000000001 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.409999999999997 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.420000000000002 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.486 HG23 HG23 ' A' ' 63' ' ' VAL . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.230000000000004 110.54 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 64.239999999999995 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 25.449999999999999 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 55.229999999999997 110.604 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.420000000000002 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 44.039999999999999 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' HA ' HD22 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 71.109999999999999 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.209999999999994 110.71 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.699 0.285 . . . . 73.409999999999997 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 63.539999999999999 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 71.030000000000001 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 65.129999999999995 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 72.340000000000003 110.649 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 78' ' ' HIS . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.030000000000001 110.697 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.585 ' CA ' ' HE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 61.299999999999997 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.794 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 72.519999999999996 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.230000000000004 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 64' ' ' THR . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.239999999999995 110.518 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.209999999999994 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.420000000000002 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 63.450000000000003 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.596 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 62.450000000000003 110.595 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.673 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 60.399999999999999 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 64.510000000000005 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 70.510000000000005 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.200000000000003 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.894 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.530000000000001 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.420000000000002 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.420000000000002 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.662 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.540000000000006 110.211 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.310000000000002 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.530000000000001 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 43.509999999999998 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 65.120000000000005 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.442 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.219999999999999 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.140000000000001 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 109' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.340000000000003 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.409999999999997 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 63.549999999999997 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 105' ' ' PHE . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.302 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.430000000000007 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 63.340000000000003 110.06 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.139 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 55.509999999999998 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 112' ' ' LEU . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.519999999999996 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 62.420000000000002 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.340000000000003 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 70.329999999999998 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.129999999999995 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 54.5 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 71.299999999999997 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 55.439999999999998 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.85 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 61.32 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 64.019999999999996 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.643 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.099999999999994 110.574 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.109999999999999 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.227 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.727 0.299 . . . . 64.420000000000002 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.467 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.400000000000006 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 61.119999999999997 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.340000000000003 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 63.119999999999997 111.012 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.219999999999999 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.109999999999999 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.310000000000002 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.530000000000001 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.010000000000005 110.427 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.200000000000003 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.540000000000006 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.230000000000004 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.430000000000007 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 62.420000000000002 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 71.049999999999997 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 45.350000000000001 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.530000000000001 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.409999999999997 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 71.230000000000004 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 70.530000000000001 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.200000000000003 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 53.530000000000001 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.120000000000005 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 54.009999999999998 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' A' ' 112' ' ' LEU . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 72.310000000000002 110.134 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 62.399999999999999 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 70.329999999999998 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.701 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 42.32 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 55.219999999999999 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.030000000000001 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 63.219999999999999 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 125' ' ' THR . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.450000000000003 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 99' ' ' ALA . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 54.130000000000003 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 61.420000000000002 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 71.329999999999998 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.430000000000007 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.439999999999998 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.420000000000002 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 65.219999999999999 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 1.182 ' CD1' ' H2B' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 71.140000000000001 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 29' ' ' LEU . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.310000000000002 111.471 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 63.43 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.019999999999996 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.829 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.450000000000003 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 44.210000000000001 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 70.319999999999993 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 72.319999999999993 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 72.219999999999999 110.727 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 65.439999999999998 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 71.340000000000003 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.099999999999994 110.596 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.409999999999997 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 62.43 110.386 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.420000000000002 110.483 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' N ' ' OD1' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 52.149999999999999 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.099999999999994 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.008 ' CB ' ' H2D' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.340000000000003 110.486 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.75 ' N ' ' ND2' ' A' ' 47' ' ' ASN . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 64.430000000000007 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 53.039999999999999 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.56 HD13 ' NH2' ' A' ' 53' ' ' ARG . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.615 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . 96.83 -70.02 0.82 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 51.43 110.891 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.082 ' NH2' H11A ' A' ' 174' ' ' N22 . 60.1 mtt180 55.01 138.58 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 121.008 -0.277 . . . . 71.239999999999995 110.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 55' ' ' LEU . 53.4 Cg_endo -74.25 -85.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.288 1.992 . . . . 73.030000000000001 111.897 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -152.93 61.44 3.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.313 0.578 . . . . 72.239999999999995 109.972 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.39 116.81 4.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.714 2.276 . . . . 74.209999999999994 111.556 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.51 73.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.313 -1.115 . . . . 61.200000000000003 110.313 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 54.08 17.78 1.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 73.129999999999995 110.456 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.219999999999999 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.450000000000003 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.430000000000007 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 63.219999999999999 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.420000000000002 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 65.049999999999997 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 63.310000000000002 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 71.319999999999993 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.209999999999994 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 71.349999999999994 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.150000000000006 110.781 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HA ' HG21 ' A' ' 76' ' ' VAL . 64.0 m80 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.230000000000004 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.319999999999993 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.239999999999995 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.510000000000005 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.430000000000007 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 70.549999999999997 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 70' ' ' HIS . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.736 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.399999999999999 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.119999999999997 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.467 ' OG ' ' C2A' ' A' ' 173' ' ' NAP . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.129999999999995 110.611 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 62.520000000000003 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.219999999999999 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.040000000000006 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 86' ' ' LEU . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.219999999999999 110.61 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 65.400000000000006 110.728 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 64.409999999999997 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.040000000000006 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.149999999999999 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.439999999999998 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.817 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.0 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.209999999999994 111.268 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.439999999999998 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 44.420000000000002 110.89 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.065 ' NE2' H52A ' A' ' 173' ' ' NAP . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.978 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.472 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 72.430000000000007 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 64.209999999999994 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 52.409999999999997 110.584 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.510000000000005 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 65.420000000000002 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 105' ' ' PHE . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 70.129999999999995 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 70.109999999999999 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 64.230000000000004 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 5' ' ' PHE . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 52.200000000000003 111.175 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 54.130000000000003 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.239999999999995 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.340000000000003 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 72.5 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 70.219999999999999 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.239999999999995 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.329999999999998 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.698 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 43.229999999999997 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 64.109999999999999 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -165.66 95.93 0.81 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 109.889 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.16 179.84 6.13 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.442 2.095 . . . . 71.239999999999995 112.637 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -59.48 94.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.802 -0.635 . . . . 55.420000000000002 110.796 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.8 mtp -106.66 -49.17 3.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.439999999999998 110.455 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -159.76 111.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.599 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.456 ' SD ' ' OH ' ' A' ' 158' ' ' TYR . 26.8 ptt? -131.09 19.64 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 73.519999999999996 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -68.87 -23.41 64.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 52.420000000000002 110.645 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -59.03 -24.26 62.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.57 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 63.310000000000002 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 50.310000000000002 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 72.420000000000002 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 63.549999999999997 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 70.239999999999995 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.149999999999999 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 54.219999999999999 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 53.130000000000003 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 60.200000000000003 110.617 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.150000000000006 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.420000000000002 110.566 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.549999999999997 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.019999999999996 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.299999999999997 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 74.319999999999993 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 61.200000000000003 110.394 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.540000000000006 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.420000000000002 110.512 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.065 H52A ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 1.182 ' H2B' ' CD1' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 63.109999999999999 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 93' ' ' ILE . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.884 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 62.020000000000003 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.936 ' CE1' HG22 ' A' ' 109' ' ' VAL . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 73.219999999999999 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 70.150000000000006 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 53.229999999999997 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.049999999999997 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 70.230000000000004 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 71.409999999999997 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 44.329999999999998 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.230000000000004 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 99' ' ' ALA . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.409999999999997 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 24.449999999999999 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 70.0 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 63.210000000000001 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 3.3 m120 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.540000000000006 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.409999999999997 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.897 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.219999999999999 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 1.098 ' CD2' ' H7 ' ' A' ' 174' ' ' N22 . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.209999999999994 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.67 ' CD ' HD21 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.129999999999995 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.439999999999998 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 32' ' ' VAL . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.319999999999993 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD1' ' H7A' ' A' ' 174' ' ' N22 . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 62.049999999999997 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 45.32 111.598 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 71.319999999999993 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 71.239999999999995 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.030000000000001 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 74.340000000000003 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 32' ' ' VAL . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.140000000000001 110.789 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 44.140000000000001 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 41' ' ' LEU . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.450000000000003 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.319999999999993 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 70.120000000000005 110.637 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.219999999999999 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 24.219999999999999 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.518 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 40.43 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 71.150000000000006 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 57.2 t30 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 109.982 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.230000000000004 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.319999999999993 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.409999999999997 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HA ' HD21 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.86 -122.51 3.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 53.43 110.975 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -131.06 61.41 59.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 73.019999999999996 110.776 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.52 151.92 33.34 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.049 2.5 . . . . 75.230000000000004 112.137 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.32 35.72 0.26 Allowed Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 120.647 -0.421 . . . . 64.140000000000001 111.737 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 5.8 Cg_endo -49.49 109.7 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.791 2.327 . . . . 62.200000000000003 112.071 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.33 4.94 63.98 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.137 -0.785 . . . . 53.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 49.48 38.11 13.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.64 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.120000000000005 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.040000000000006 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 71' ' ' VAL . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.120000000000005 110.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 78' ' ' HIS . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 110.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.010000000000005 110.615 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 p30 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.637 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.219999999999999 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 50.130000000000003 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 61.210000000000001 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 62' ' ' ILE . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 61.340000000000003 110.654 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 61.25 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 52.229999999999997 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.129999999999995 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.130000000000003 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.010000000000005 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.439999999999998 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.717 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 62.140000000000001 110.569 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.736 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 54.520000000000003 110.958 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.299999999999997 110.716 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.219999999999999 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.229999999999997 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.400000000000006 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.549999999999997 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.917 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.349999999999994 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 43.43 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.219999999999999 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.239999999999995 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 71.549999999999997 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.400000000000006 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 64.140000000000001 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.020000000000003 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.803 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 30.149999999999999 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.420000000000002 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 110.322 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.510000000000005 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.705 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.209999999999994 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' A' ' 106' ' ' LEU . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 54.350000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 63.030000000000001 111.056 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 70.120000000000005 111.356 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.319999999999993 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.430000000000007 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 71.239999999999995 110.408 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.936 HG22 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.010000000000005 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 74.230000000000004 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 114' ' ' ILE . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 54.140000000000001 110.94 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 157' ' ' VAL . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 50.109999999999999 110.666 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.209999999999994 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 53.409999999999997 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 52.229999999999997 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.553 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 61.240000000000002 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.430000000000007 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.010000000000005 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.319999999999993 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.755 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.239999999999995 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.219999999999999 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.540000000000006 111.176 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.469 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.140000000000001 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -165.13 133.59 2.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 71.120000000000005 110.093 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.09 -163.53 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.343 2.028 . . . . 63.140000000000001 112.004 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.74 122.71 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 70.310000000000002 110.45 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 27.4 mtp -129.7 -55.01 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 63.020000000000003 110.728 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 4.0 m-20 -73.22 82.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 72.109999999999999 110.694 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -124.15 -23.36 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 70.329999999999998 110.549 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.0 t -79.08 -31.96 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 63.020000000000003 110.676 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.96 -27.94 54.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.43 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CH2' ' HG3' ' A' ' 160' ' ' LYS . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 110.515 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 71.420000000000002 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.319999999999993 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 61.240000000000002 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 64.519999999999996 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.219999999999999 110.3 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.430000000000007 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.239999999999995 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.230000000000004 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.67 HD21 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 64.510000000000005 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.540000000000006 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.299999999999997 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.349999999999994 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 62.43 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 73.420000000000002 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.129999999999995 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 113' ' ' TYR . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.519999999999996 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG3' ' CH2' ' A' ' 135' ' ' TRP . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 70.129999999999995 110.294 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.668 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 0.6 OUTLIER -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 64.540000000000006 110.706 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 50.329999999999998 110.588 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.803 ' H5N' ' O ' ' A' ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 1.098 ' H7 ' ' CD2' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.109999999999999 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 73.219999999999999 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 64.230000000000004 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 73.349999999999994 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.786 ' HG2' ' HN7' ' A' ' 174' ' ' N22 . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.450000000000003 110.705 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.812 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 44.119999999999997 110.457 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 64.420000000000002 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 65.439999999999998 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 121' ' ' PHE . 14.1 p-10 -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.93 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 63.210000000000001 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 HG12 ' A' ' 15' ' ' ILE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 65.450000000000003 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.842 HG12 HG13 ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.409999999999997 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.140000000000001 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 65.409999999999997 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.629 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 12.4 m-20 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 110.094 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 64.400000000000006 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.086 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.430000000000007 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.641 ' HA ' ' H8 ' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 71.200000000000003 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HG2' ' H7 ' ' A' ' 174' ' ' N22 . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 70.430000000000007 109.901 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 65.129999999999995 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 73.5 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.682 ' OE1' ' N8 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.150000000000006 110.163 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.021 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.420000000000002 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.409999999999997 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 51.43 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.420000000000002 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.329999999999998 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.420000000000002 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.299999999999997 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.430000000000007 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.230000000000004 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 71.540000000000006 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 72.040000000000006 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.109999999999999 110.905 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.129999999999995 110.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.319999999999993 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 41.43 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.439999999999998 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.095 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 72.140000000000001 110.262 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CB ' HG21 ' A' ' 62' ' ' ILE . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 70.019999999999996 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 71.019999999999996 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.219999999999999 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 53' ' ' ARG . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 70.040000000000006 110.007 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.14 1.79 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.319999999999993 111.436 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 51' ' ' ILE . 26.9 mtt-85 -113.49 103.69 55.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 121.029 -0.269 . . . . 75.409999999999997 111.095 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' O ' ' C4 ' ' A' ' 174' ' ' N22 . 44.0 Cg_endo -76.02 -166.58 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.275 1.983 . . . . 73.129999999999995 111.294 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.2 114.14 36.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.315 -0.554 . . . . 73.510000000000005 111.374 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -69.38 2.78 3.02 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.579 1.519 . . . . 74.030000000000001 110.849 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 58' ' ' ARG . . . -76.69 2.52 58.73 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.917 -1.273 . . . . 60.009999999999998 109.917 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER 157.48 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 61.310000000000002 109.939 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 70.319999999999993 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 1.1 p30 -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.450000000000003 110.446 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.420000000000002 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.44 HG21 ' CB ' ' A' ' 48' ' ' TYR . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.319999999999993 110.582 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 78' ' ' HIS . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.79 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 76' ' ' VAL . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.536 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 53.039999999999999 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 4.3 m120 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 74.409999999999997 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.310000000000002 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.340000000000003 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 71.439999999999998 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 62.229999999999997 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.049999999999997 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 72.349999999999994 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 64' ' ' THR . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.753 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.530000000000001 110.659 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.599 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 74.140000000000001 110.67 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.409999999999997 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 51.530000000000001 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 60.399999999999999 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.420000000000002 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 63.439999999999998 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' CD ' ' N ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.209999999999994 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.349999999999994 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 72.109999999999999 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.975 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.530000000000001 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.420000000000002 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 70.109999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.746 HE22 ' H8A' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.450000000000003 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.683 HD11 ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.230000000000004 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.519999999999996 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.239999999999995 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.430000000000007 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.340000000000003 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.210000000000001 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 5' ' ' PHE . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 64.030000000000001 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.200000000000003 110.647 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 64.109999999999999 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD22 HD11 ' A' ' 114' ' ' ILE . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 73.230000000000004 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 62.420000000000002 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 54.210000000000001 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.310000000000002 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 73.109999999999999 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.239999999999995 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.52 ' C ' HD22 ' A' ' 12' ' ' ASN . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 71.030000000000001 110.921 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.420000000000002 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.120000000000005 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.795 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 73.310000000000002 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.464 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.646 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 15.7 t80 -101.62 123.32 44.62 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.340000000000003 109.775 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.646 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 41.0 Cg_endo -71.7 -164.71 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.276 1.984 . . . . 73.150000000000006 112.22 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -130.76 105.94 8.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 64.349999999999994 110.458 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 10.4 mtt -134.37 -75.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 52.200000000000003 110.578 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -175.05 165.46 3.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 74.349999999999994 110.84 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -151.05 26.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 72.420000000000002 110.47 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 133' ' ' THR . 1.8 t -75.88 -28.5 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.607 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -41.63 -44.68 3.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 110.631 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.425 ' CZ3' ' N ' ' A' ' 160' ' ' LYS . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 51.119999999999997 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' ' HD3' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 53.140000000000001 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 54.539999999999999 110.684 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 140' ' ' VAL . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 52.140000000000001 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.450000000000003 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.530000000000001 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.510000000000005 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.200000000000003 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 145' ' ' THR . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.519999999999996 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.140000000000001 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 53.299999999999997 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 55.109999999999999 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 53.420000000000002 112.073 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 70.400000000000006 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.420000000000002 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.528 ' OH ' HD13 ' A' ' 25' ' ' LEU . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.230000000000004 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 65.109999999999999 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.219999999999999 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 73.540000000000006 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 43.149999999999999 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 53.350000000000001 110.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.095 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.786 ' HN7' ' HG2' ' A' ' 6' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.010000000000005 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.604 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HB2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.400000000000006 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.310000000000002 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 114' ' ' ILE . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 61.229999999999997 111.394 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.825 ' HB2' H72N ' A' ' 173' ' ' NAP . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.200000000000003 110.683 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 61.130000000000003 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 112.072 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 13' ' ' ARG . 3.5 m-20 -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.340000000000003 111.397 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' NH2' ' H ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 72.319999999999993 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 125' ' ' THR . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 74.519999999999996 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.675 HD12 ' O4D' ' A' ' 173' ' ' NAP . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 64.409999999999997 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 45.43 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 122' ' ' GLU . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.618 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 62.140000000000001 110.356 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.585 HD22 ' HA ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.230000000000004 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.848 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.310000000000002 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 63.210000000000001 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 25' ' ' LEU . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.530000000000001 110.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.399999999999999 109.979 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 43.43 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 64.239999999999995 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 62.25 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 53.130000000000003 109.677 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 73.540000000000006 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 73.510000000000005 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 62.43 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 62.240000000000002 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.400000000000006 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.608 ' OG1' ' CG ' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.349999999999994 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.319999999999993 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 64.519999999999996 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.608 ' CG ' ' OG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 70.25 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.519999999999996 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.310000000000002 110.116 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 73.099999999999994 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.340000000000003 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.77 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.209999999999994 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.319999999999993 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.11 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.207 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.019999999999996 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 65.319999999999993 111.136 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.585 ' HA ' HD22 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 55.439999999999998 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.88 -137.47 41.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 73.329999999999998 111.273 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' N ' ' CD ' ' A' ' 53' ' ' ARG . 7.6 mpt_? 61.91 150.25 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 53.049999999999997 110.387 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.75 -155.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.714 2.276 . . . . 74.450000000000003 112.406 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -146.87 58.58 4.42 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 121.1 0.476 . . . . 53.509999999999998 110.555 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' ARG . 22.8 Cg_endo -63.06 119.06 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.046 2.497 . . . . 64.230000000000004 112.57 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.6 22.42 0.09 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.909 -0.876 . . . . 73.120000000000005 110.909 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' PRO . 4.2 ttt-85 -110.83 164.34 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.034 -0.358 . . . . 72.129999999999995 110.034 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.239999999999995 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.495 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 1.2 p-10 -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.219999999999999 110.534 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 61.509999999999998 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 62' ' ' ILE . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.540000000000006 110.543 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 78' ' ' HIS . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 60.299999999999997 110.611 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.77 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.476 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 2.3 m-20 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.509999999999998 110.571 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.230000000000004 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 61.439999999999998 110.561 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 50.140000000000001 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.495 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.119999999999997 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.41 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 70.510000000000005 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.400000000000006 110.269 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.099999999999994 110.554 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.771 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.209999999999994 111.04 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.430000000000007 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 61.020000000000003 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 71.510000000000005 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.010000000000005 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 72.409999999999997 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.049999999999997 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 53.32 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.430000000000007 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.409999999999997 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 95' ' ' ILE . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.703 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.509 ' HB2' HD22 ' A' ' 41' ' ' LEU . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 73.409999999999997 110.36 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 93' ' ' ILE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 70.400000000000006 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' HB3' ' H5N' ' A' ' 173' ' ' NAP . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 70.310000000000002 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.140000000000001 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.120000000000005 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.439999999999998 110.673 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.694 ' NE2' ' H8A' ' A' ' 173' ' ' NAP . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.219999999999999 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.540000000000006 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.230000000000004 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.802 HD23 ' C ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.549999999999997 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 72.140000000000001 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 5' ' ' PHE . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 62.200000000000003 110.056 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 64.439999999999998 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.200000000000003 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.666 ' CE1' HG13 ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.904 HD13 ' CE1' ' A' ' 156' ' ' HIS . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 8' ' ' ALA . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 52.32 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 73.120000000000005 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 71.439999999999998 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.239999999999995 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 70.209999999999994 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.099999999999994 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.530000000000001 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 64.230000000000004 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.120000000000005 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.47 134.93 2.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.530000000000001 110.476 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.11 -170.35 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.494 2.129 . . . . 61.439999999999998 112.456 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.93 160.48 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 75.549999999999997 110.296 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 15.1 ptm -155.08 -161.55 1.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 71.310000000000002 110.68 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.1 145.95 40.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.45 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.487 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.8 mtp -141.52 35.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 74.439999999999998 110.729 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -50.33 -10.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 74.439999999999998 110.463 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' MET . 6.0 m120 -67.06 -17.52 64.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.131 -0.486 . . . . 63.32 111.033 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 64.430000000000007 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 63.229999999999997 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.540000000000006 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 70.040000000000006 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.409999999999997 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.120000000000005 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.310000000000002 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 64.120000000000005 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 74.510000000000005 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.310000000000002 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.010000000000005 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.109999999999999 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.239999999999995 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 0.8 OUTLIER -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.109999999999999 110.625 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.039999999999999 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 63.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.319999999999993 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 72.25 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.445 ' HH ' ' HD1' ' A' ' 113' ' ' TYR . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 73.030000000000001 110.441 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.904 ' CE1' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.109999999999999 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 71.299999999999997 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.409999999999997 110.439 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.109999999999999 110.538 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.11 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.615 ' H2 ' HD11 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.329999999999998 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.562 HG12 HG23 ' A' ' 109' ' ' VAL . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.58 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.129999999999995 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.140000000000001 110.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.319999999999993 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' ALA . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.340000000000003 111.252 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' H ' H72N ' A' ' 173' ' ' NAP . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.340000000000003 110.032 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 73.310000000000002 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 40.130000000000003 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 63.210000000000001 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.219999999999999 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.494 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.140000000000001 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.821 HG23 ' CA ' ' A' ' 126' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 43.210000000000001 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.64 HG21 H71N ' A' ' 173' ' ' NAP . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.219999999999999 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 54.130000000000003 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.711 ' N ' ' O2D' ' A' ' 173' ' ' NAP . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 64.319999999999993 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.838 ' OD1' ' H2B' ' A' ' 174' ' ' N22 . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.036 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.549999999999997 110.365 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.109999999999999 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.494 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 60.340000000000003 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.409999999999997 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 63.229999999999997 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.666 ' H ' HD12 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.200000000000003 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.916 ' CB ' ' H7 ' ' A' ' 174' ' ' N22 . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 71.329999999999998 110.671 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.430000000000007 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG11 ' HN8' ' A' ' 174' ' ' N22 . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.946 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' N ' HG13 ' A' ' 32' ' ' VAL . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.120000000000005 110.733 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.510000000000005 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.019999999999996 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 5.1 m-70 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 62.350000000000001 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.510000000000005 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 72.040000000000006 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.030000000000001 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.430000000000007 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.816 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 54.009999999999998 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.521 ' NH1' ' HZ3' ' A' ' 46' ' ' LYS . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.209999999999994 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.989 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 0.7 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.400000000000006 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CE2' HG11 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.420000000000002 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.230000000000004 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.871 HG13 H11A ' A' ' 174' ' ' N22 . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 73.329999999999998 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 51' ' ' ILE . . . 83.8 40.59 8.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 53.109999999999999 111.706 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.17 139.31 96.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.82 -0.352 . . . . 71.120000000000005 110.486 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.7 -91.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.547 2.165 . . . . 64.430000000000007 111.737 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tp 172.94 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 71.420000000000002 110.778 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 11.8 Cg_endo -55.63 93.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.434 2.089 . . . . 73.349999999999994 112.019 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.14 -32.37 1.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.85 -0.691 . . . . 53.539999999999999 111.381 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -159.59 141.14 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 75.510000000000005 111.048 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 72.409999999999997 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.723 ' C ' HD13 ' A' ' 61' ' ' ILE . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 54.32 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.65 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' TYR . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 71.019999999999996 110.85 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.219999999999999 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 64' ' ' THR . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.519999999999996 110.636 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.219999999999999 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 64.430000000000007 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 22.25 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 72.140000000000001 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HA ' HG21 ' A' ' 76' ' ' VAL . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 110.373 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 64.420000000000002 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.049999999999997 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 33.520000000000003 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' ILE . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.216 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 70' ' ' HIS . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 44.32 111.155 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 55.340000000000003 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.129999999999995 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.340000000000003 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 80' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 61.0 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.140000000000001 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 63' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 53.229999999999997 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.310000000000002 111.075 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 62.43 110.656 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 45.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.099999999999994 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 54.109999999999999 110.413 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.430000000000007 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.430000000000007 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.430000000000007 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.150000000000006 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.626 ' HB3' ' H4N' ' A' ' 173' ' ' NAP . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.549999999999997 110.344 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' O ' ' C5N' ' A' ' 173' ' ' NAP . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.120000000000005 111.714 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 52.509999999999998 110.15 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 31.199999999999999 110.582 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.027 ' OE1' H52A ' A' ' 173' ' ' NAP . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 71.239999999999995 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 55.439999999999998 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.129999999999995 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.400000000000006 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 111.272 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 65.299999999999997 111.452 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 71.420000000000002 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.109999999999999 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.539999999999999 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 3' ' ' VAL . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.969 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.040000000000006 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.209999999999994 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 114' ' ' ILE . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 72.310000000000002 111.136 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.742 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 73.040000000000006 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD11 HD21 ' A' ' 112' ' ' LEU . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 72.430000000000007 110.616 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 54.43 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 42.450000000000003 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 153' ' ' TYR . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.129999999999995 110.745 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 117' ' ' ILE . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 55.240000000000002 110.667 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.129999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.219999999999999 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.446 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 61.200000000000003 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.450000000000003 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 99' ' ' ALA . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.821 ' CA ' HG23 ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.219999999999999 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.777 ' HB2' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -115.97 137.26 23.23 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.340000000000003 109.955 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.35 176.79 3.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.468 2.112 . . . . 52.109999999999999 112.517 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -69.08 86.86 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 75.010000000000005 110.588 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.463 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 24.0 ptm -159.56 162.22 35.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.338 -0.392 . . . . 43.520000000000003 110.67 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 130' ' ' MET . 0.4 OUTLIER -167.52 119.75 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 65.239999999999995 110.334 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 32.1 mtt -153.1 59.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 75.340000000000003 110.538 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 134' ' ' ASN . 2.0 t -48.14 -53.11 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 73.450000000000003 110.367 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.582 ' H ' HG23 ' A' ' 133' ' ' THR . 7.2 t-20 65.03 14.98 9.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 111.165 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.329999999999998 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 60.399999999999999 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 63.43 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 72.400000000000006 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG23 ' ND1' ' A' ' 156' ' ' HIS . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.03 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 64.239999999999995 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.239999999999995 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 52.210000000000001 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 53.020000000000003 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 71.349999999999994 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 153' ' ' TYR . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.65 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 54.130000000000003 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 63.229999999999997 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 52.229999999999997 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.486 ' ND1' HG23 ' A' ' 140' ' ' VAL . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.140000000000001 110.869 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.742 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.109999999999999 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 71.299999999999997 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 110.821 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 74.25 110.565 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.027 H52A ' OE1' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.916 ' H7 ' ' CB ' ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.219999999999999 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 HD11 ' A' ' 93' ' ' ILE . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.230000000000004 110.544 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 64.439999999999998 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 95' ' ' ILE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.349999999999994 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.400000000000006 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.230000000000004 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.654 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.329999999999998 110.557 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HB2' HG22 ' A' ' 114' ' ' ILE . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 111.037 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.329999999999998 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 72.319999999999993 111.349 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.517 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.420000000000002 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 ' CA ' ' A' ' 126' ' ' PHE . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.400000000000006 110.82 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.887 HD12 ' H1D' ' A' ' 173' ' ' NAP . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.409999999999997 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.510000000000005 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.239999999999995 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 71.109999999999999 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.2 p-10 -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 110.799 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.933 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 71.299999999999997 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 63.210000000000001 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 53.039999999999999 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.898 ' NE ' ' H8B' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.409999999999997 109.947 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 54.210000000000001 110.314 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 53.43 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.140000000000001 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 54.329999999999998 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 61.420000000000002 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 71.120000000000005 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.030000000000001 111.086 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 32' ' ' VAL . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 64.010000000000005 110.761 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.299999999999997 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 42.200000000000003 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.219999999999999 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.200000000000003 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.450000000000003 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 52.100000000000001 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.832 ' CG ' HD21 ' A' ' 47' ' ' ASN . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 61.140000000000001 110.869 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 64.430000000000007 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.519999999999996 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.439999999999998 110.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.832 HD21 ' CG ' ' A' ' 43' ' ' MET . 56.0 t30 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.150000000000006 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.340000000000003 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 55.420000000000002 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 60.340000000000003 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.92 -114.7 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.129999999999995 110.862 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -153.26 67.18 6.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 73.530000000000001 110.449 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HG2' HD22 ' A' ' 60' ' ' ASN . 57.9 Cg_endo -78.85 154.11 26.09 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.008 2.472 . . . . 64.340000000000003 112.799 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' H ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER 176.39 -47.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.487 -0.779 . . . . 71.430000000000007 110.635 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' A' ' 55' ' ' LEU . 45.4 Cg_endo -71.86 88.32 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.688 1.592 . . . . 73.140000000000001 111.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.7 9.14 55.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.816 -0.914 . . . . 71.400000000000006 110.816 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' HD2' ' H4 ' ' A' ' 174' ' ' N22 . 1.5 mpp_? -118.77 -53.76 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 65.150000000000006 110.379 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' HH11 ' A' ' 59' ' ' ARG . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.431 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.425 HD22 ' HG2' ' A' ' 54' ' ' PRO . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.349999999999994 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 75' ' ' GLU . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.310000000000002 110.214 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' A' ' 74' ' ' CYS . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 71.25 110.989 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 78' ' ' HIS . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 110.929 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' THR . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 70.510000000000005 110.43 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 61.140000000000001 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 3.9 m120 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.019999999999996 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.329999999999998 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.109999999999999 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.5 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 55.520000000000003 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 62' ' ' ILE . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 51.340000000000003 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HB3' HG23 ' A' ' 61' ' ' ILE . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.119999999999997 110.152 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 65.530000000000001 111.227 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 109.871 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.340000000000003 110.657 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.645 ' HA ' ' H2A' ' A' ' 173' ' ' NAP . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 65.030000000000001 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.099999999999994 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 64.530000000000001 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 72.510000000000005 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.439999999999998 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HG ' HG12 ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 64.120000000000005 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.465 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.150000000000006 110.69 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.530000000000001 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 72.340000000000003 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 62.210000000000001 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 41.43 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.89 ' CD ' H52A ' A' ' 173' ' ' NAP . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.549999999999997 110.582 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.487 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 35.340000000000003 110.237 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.140000000000001 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 72.5 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 72.109999999999999 111.407 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 102' ' ' TYR . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 73.0 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.430000000000007 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 70.540000000000006 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.723 ' N ' HG22 ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.409999999999997 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 65.209999999999994 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 114' ' ' ILE . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 63.549999999999997 110.695 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.794 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 119' ' ' HIS . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.099999999999994 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.514 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.019999999999996 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 70.329999999999998 110.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 61.100000000000001 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.540000000000006 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.509999999999998 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.430000000000007 110.082 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.673 ' CA ' HG23 ' A' ' 14' ' ' VAL . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.040000000000006 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 128' ' ' PRO . 1.7 p90 -142.27 136.6 14.96 Favored Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.340000000000003 110.128 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 127' ' ' PHE . 61.1 Cg_endo -74.5 -160.65 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.627 2.218 . . . . 64.219999999999999 112.709 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.46 90.37 6.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 64.129999999999995 110.385 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.9 ptp -153.95 24.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 75.030000000000001 110.687 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.38 85.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 71.409999999999997 110.472 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.18 35.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.806 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 134' ' ' ASN . 1.5 t -56.64 -53.63 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 71.120000000000005 110.296 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.615 ' H ' HG23 ' A' ' 133' ' ' THR . 1.8 t30 57.97 16.57 3.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 61.539999999999999 110.835 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.049999999999997 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 72.409999999999997 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.019999999999996 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 42.310000000000002 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 74.439999999999998 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.589 ' CB ' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 70.530000000000001 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 61.539999999999999 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.209999999999994 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.310000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 149' ' ' ASN . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.329999999999998 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.439999999999998 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 73.329999999999998 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 149' ' ' ASN . 2.8 p-10 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.400000000000006 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 53.399999999999999 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.510000000000005 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 63.439999999999998 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.040000000000006 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 65.109999999999999 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.120000000000005 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 61.43 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.89 H52A ' CD ' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.898 ' H8B' ' NE ' ' A' ' 24' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 2' ' ' ILE . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.901 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.1 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 70.200000000000003 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 42.520000000000003 110.608 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 70.040000000000006 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.744 ' OD1' ' HB2' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 70.540000000000006 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.149999999999999 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.239999999999995 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.779 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 64.310000000000002 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 55.240000000000002 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 71.5 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.299999999999997 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.310000000000002 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.329999999999998 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.140000000000001 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.099999999999994 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.686 HD11 ' H1D' ' A' ' 173' ' ' NAP . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 62.219999999999999 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.219999999999999 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.239999999999995 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.530000000000001 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.400000000000006 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.120000000000005 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 63.240000000000002 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 64.420000000000002 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.881 HD12 ' H7 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 62.409999999999997 110.401 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.459 ' N ' HD23 ' A' ' 29' ' ' LEU . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 65.25 111.045 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.239999999999995 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 36' ' ' THR . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.230000000000004 110.284 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 60.450000000000003 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.400000000000006 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.551 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.319999999999993 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 45.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.663 ' HG2' HG22 ' A' ' 93' ' ' ILE . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 41.030000000000001 112.621 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 64.040000000000006 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.209999999999994 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.549999999999997 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 73.219999999999999 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.25 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.84 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 65.439999999999998 110.755 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.540000000000006 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 62.100000000000001 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.519999999999996 110.466 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.399 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' ARG . . . 76.99 158.42 8.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.219999999999999 110.979 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 51.56 152.88 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 110.063 -0.347 . . . . 74.109999999999999 110.063 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -67.22 -175.82 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.643 2.229 . . . . 71.409999999999997 113.147 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.75 123.78 40.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.749 -0.66 . . . . 61.009999999999998 110.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.47 -38.24 94.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.781 1.654 . . . . 73.140000000000001 112.697 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.37 -14.31 1.41 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.158 -0.777 . . . . 71.340000000000003 111.158 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER 68.37 160.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 52.350000000000001 111.045 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 71.439999999999998 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.540000000000006 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 64.450000000000003 110.807 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.200000000000003 110.118 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 78' ' ' HIS . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 111.554 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.239999999999995 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.483 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 4.3 m-20 -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.009999999999998 110.441 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.200000000000003 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.430000000000007 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 72.329999999999998 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.439999999999998 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.099999999999994 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 52.340000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.450000000000003 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 64.430000000000007 110.854 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 54.030000000000001 110.09 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.624 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.862 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.667 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 63.329999999999998 111.577 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 63.130000000000003 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.039999999999999 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' N ' ' OE1' ' A' ' 82' ' ' GLU . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.120000000000005 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 70.129999999999995 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 53.210000000000001 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 63.229999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' C ' HD13 ' A' ' 93' ' ' ILE . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.741 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 63.200000000000003 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.439999999999998 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.109999999999999 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.664 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.671 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.109999999999999 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 62.439999999999998 110.422 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 71.420000000000002 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 1.03 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.200000000000003 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 62.420000000000002 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.310000000000002 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 62.420000000000002 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 72.400000000000006 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 71.430000000000007 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PHE . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' H ' HG23 ' A' ' 3' ' ' VAL . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.109999999999999 110.311 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 73.319999999999993 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.616 ' N ' HD13 ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 52.219999999999999 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 51.329999999999998 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.010000000000005 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 64.25 110.585 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 70.150000000000006 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.140000000000001 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 55.32 110.696 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.779 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 54.409999999999997 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 52.229999999999997 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.420000000000002 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.340000000000003 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.503 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.519999999999996 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.430000000000007 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.68 121.4 0.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.130000000000003 110.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 -166.21 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.314 2.01 . . . . 61.229999999999997 112.165 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.94 115.52 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 73.140000000000001 110.633 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.401 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 1.1 mtt -77.27 -69.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.256 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' A' ' 133' ' ' THR . 1.0 OUTLIER -172.52 -55.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 110.543 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 131' ' ' ASP . 4.0 ptt? 27.86 35.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 60.439999999999998 110.535 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.653 ' N ' ' O ' ' A' ' 131' ' ' ASP . 11.9 t -69.67 -13.98 62.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.989 -0.55 . . . . 54.340000000000003 110.747 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -49.14 -35.59 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.742 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.430000000000007 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 62.200000000000003 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 64.140000000000001 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 53.130000000000003 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.354 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 60.549999999999997 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.439999999999998 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 62.109999999999999 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 65.319999999999993 109.774 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.340000000000003 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.400000000000006 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 149' ' ' ASN . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 61.109999999999999 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 144' ' ' LEU . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.530000000000001 110.403 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.429 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.420000000000002 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.040000000000006 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.010000000000005 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.439999999999998 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.310000000000002 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 71.019999999999996 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 71.430000000000007 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.540000000000006 110.572 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.84 ' H6N' ' HB2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.881 ' H7 ' HD12 ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 50.530000000000001 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 61.130000000000003 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.120000000000005 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.329999999999998 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.307 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 63.240000000000002 110.702 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB2' HG22 ' A' ' 114' ' ' ILE . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 110.917 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 63.299999999999997 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.310000000000002 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 61.439999999999998 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 72.420000000000002 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 125' ' ' THR . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.230000000000004 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.619 ' O ' ' H2N' ' A' ' 173' ' ' NAP . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.109999999999999 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.657 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.219999999999999 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 44.130000000000003 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.627 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.319999999999993 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.631 ' HE1' ' C2 ' ' A' ' 174' ' ' N22 . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 153' ' ' TYR . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.346 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 55.030000000000001 110.279 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 25' ' ' LEU . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 63.25 111.727 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.299999999999997 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 34.229999999999997 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 52.329999999999998 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 73.030000000000001 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.456 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 50.210000000000001 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.120000000000005 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.409999999999997 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 70.209999999999994 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.52 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 53.520000000000003 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.439999999999998 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' HG22 ' A' ' 93' ' ' ILE . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.439999999999998 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.140000000000001 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 63' ' ' VAL . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.230000000000004 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.587 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 50.43 110.6 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.140000000000001 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.045 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 2.0 m-80 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 65.209999999999994 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.540000000000006 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 52.530000000000001 110.327 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 53' ' ' ARG . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 55.039999999999999 110.15 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.53 1.34 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 112.217 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.804 ' H ' HG22 ' A' ' 51' ' ' ILE . 10.3 mtp180 -110.07 147.7 36.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 117.224 0.512 . . . . 71.310000000000002 110.951 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.12 -159.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.074 2.516 . . . . 73.409999999999997 112.901 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 58' ' ' ARG . 20.4 tp 179.78 71.81 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 121.209 0.528 . . . . 64.200000000000003 110.216 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.5 16.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.955 2.436 . . . . 75.310000000000002 112.928 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.74 -10.75 18.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.462 -1.055 . . . . 71.450000000000003 110.462 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 -150.51 125.44 9.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.326 -0.249 . . . . 75.430000000000007 110.326 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.310000000000002 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 50.520000000000003 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 64.340000000000003 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 78' ' ' HIS . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 71.010000000000005 111.043 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.507 ' OG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.530000000000001 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 72.109999999999999 110.631 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.219999999999999 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.209999999999994 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.400000000000006 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 52.329999999999998 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 43.340000000000003 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 64.519999999999996 110.657 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.420000000000002 110.266 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.654 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.56 ' HB2' ' H2A' ' A' ' 173' ' ' NAP . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.349999999999994 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.319999999999993 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 43.130000000000003 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 71.519999999999996 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 54.329999999999998 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 82' ' ' GLU . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 53.219999999999999 110.536 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 61.340000000000003 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.200000000000003 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 93' ' ' ILE . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.030000000000001 110.279 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.319999999999993 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 64.329999999999998 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 110.751 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 65.420000000000002 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.468 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.129999999999995 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.450000000000003 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.010000000000005 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.887 ' NE2' H52A ' A' ' 173' ' ' NAP . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.099999999999994 110.548 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.458 HG21 ' HA3' ' A' ' 97' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 53.299999999999997 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 63.109999999999999 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.619 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 63.149999999999999 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.120000000000005 110.755 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 109' ' ' VAL . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 71.230000000000004 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 72.109999999999999 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 65.430000000000007 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 106' ' ' LEU . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 63.109999999999999 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 109' ' ' VAL . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.420000000000002 110.238 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 5' ' ' PHE . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 64.140000000000001 111.563 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.417 ' C ' HD12 ' A' ' 114' ' ' ILE . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 109.993 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.961 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 64.319999999999993 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 52.210000000000001 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 9' ' ' MET . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 64.150000000000006 110.844 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' OD1' ' A' ' 10' ' ' ASP . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.209999999999994 109.96 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.129999999999995 111.227 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' H ' HG22 ' A' ' 117' ' ' ILE . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.414 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.299999999999997 111.118 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.25 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.310000000000002 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 52.43 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 54.039999999999999 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.329999999999998 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.530000000000001 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.53 95.47 0.83 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.040000000000006 109.854 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 130' ' ' MET . 53.8 Cg_endo -76.32 174.02 13.51 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.445 2.097 . . . . 60.530000000000001 112.158 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.4 89.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 75.049999999999997 110.512 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.441 ' N ' ' O ' ' A' ' 128' ' ' PRO . 7.6 mtp -87.22 -53.59 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.472 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.26 113.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 62.340000000000003 110.445 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.1 0.75 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 53.030000000000001 110.68 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -47.19 -21.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.385 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -57.79 -25.54 60.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 73.450000000000003 110.247 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.435 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 72.140000000000001 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 71.099999999999994 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.109999999999999 110.606 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.239999999999995 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.319999999999993 110.974 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.340000000000003 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 55.25 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.329999999999998 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.239999999999995 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.049999999999997 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.510000000000005 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 72.099999999999994 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 72.030000000000001 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.409999999999997 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.230000000000004 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 65.209999999999994 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 72.5 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.010000000000005 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 63.140000000000001 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 65.549999999999997 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.150000000000006 110.558 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.045 ' H6N' ' CG ' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.667 ' H2 ' HD13 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 44.109999999999999 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.419 ' H ' ' HB3' ' A' ' 1' ' ' MET . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 110.298 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.549999999999997 110.893 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.530000000000001 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.540000000000006 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.150000000000006 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 114' ' ' ILE . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 71.319999999999993 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.400000000000006 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 44.439999999999998 112.088 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 2.4 m120 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.340000000000003 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.25 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 125' ' ' THR . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 55.130000000000003 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 HG13 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.329999999999998 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.329999999999998 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 70.319999999999993 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.329999999999998 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.409999999999997 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD11 ' H11' ' A' ' 174' ' ' N22 . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.409999999999997 110.368 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.129999999999995 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 63.420000000000002 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 31.440000000000001 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 72.540000000000006 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 71.129999999999995 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.239999999999995 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 72.430000000000007 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.129999999999995 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.239999999999995 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 36' ' ' THR . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.109999999999999 110.605 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 35' ' ' THR . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.430000000000007 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.099999999999994 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.109999999999999 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.239999999999995 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.200000000000003 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 64.200000000000003 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 61.299999999999997 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.140000000000001 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.729 HH21 ' CB ' ' A' ' 64' ' ' THR . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 63.130000000000003 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 2.5 t30 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.030000000000001 110.227 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.450000000000003 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.329999999999998 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.539 HG23 ' C15' ' A' ' 174' ' ' N22 . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 43.01 -147.5 0.74 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 54.130000000000003 110.454 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.666 ' CG ' ' H4A' ' A' ' 174' ' ' N22 . 17.6 tpp180 50.94 92.74 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 C-N-CA 120.721 -0.392 . . . . 63.340000000000003 110.718 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.95 149.58 13.84 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.998 2.465 . . . . 64.340000000000003 112.119 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -129.69 96.26 27.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 63.140000000000001 110.437 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.27 20.43 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.183 1.922 . . . . 72.329999999999998 111.702 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -113.08 -12.21 12.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.464 -1.054 . . . . 61.130000000000003 110.464 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.512 ' NE ' HD12 ' A' ' 41' ' ' LEU . 26.4 mtp180 -129.81 113.07 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.126 -0.324 . . . . 64.310000000000002 110.126 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.010000000000005 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 72.409999999999997 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 62.530000000000001 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 61.329999999999998 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 78' ' ' HIS . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.729 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 64.150000000000006 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 64.549999999999997 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 42.25 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 61.149999999999999 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 61.219999999999999 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.299999999999997 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.239999999999995 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.200000000000003 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 62.109999999999999 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.430000000000007 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.526 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.310000000000002 110.652 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.120000000000005 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 52.399999999999999 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 71.409999999999997 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 63.140000000000001 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.549999999999997 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 64.219999999999999 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 64.219999999999999 110.882 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.319999999999993 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.450000000000003 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' ILE . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 71.230000000000004 110.509 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 41.399999999999999 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.310000000000002 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 95' ' ' ILE . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 63.219999999999999 110.717 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.828 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 61.219999999999999 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.340000000000003 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.049999999999997 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 52.420000000000002 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.678 HG22 ' CZ ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 41.32 110.302 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 65.340000000000003 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.450000000000003 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 104' ' ' LEU . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 62.340000000000003 111.157 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 62.219999999999999 111.915 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.564 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 64.430000000000007 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 63.32 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 3' ' ' VAL . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 71.129999999999995 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 70.150000000000006 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 54.32 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 71.230000000000004 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 54.130000000000003 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 60.229999999999997 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 117' ' ' ILE . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 74.319999999999993 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.120000000000005 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.040000000000006 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 12' ' ' ASN . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 41.130000000000003 110.332 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 17' ' ' LYS . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 71.129999999999995 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 61.109999999999999 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 64.450000000000003 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 -166.49 133.61 2.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.209999999999994 110.2 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.71 176.34 8.33 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.306 2.004 . . . . 72.219999999999999 112.332 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -91.86 69.71 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 75.310000000000002 110.43 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 13.8 mmm -114.18 -174.05 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.638 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 43.06 64.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 44.340000000000003 110.777 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.436 ' HG3' ' N ' ' A' ' 133' ' ' THR . 24.3 ptt? -120.53 -33.14 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.42 . . . . 72.400000000000006 110.586 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 132' ' ' MET . 1.9 t -49.0 -33.43 11.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.542 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -59.3 -21.68 60.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 63.329999999999998 110.382 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 70.530000000000001 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.229999999999997 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.140000000000001 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 71.310000000000002 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 62.439999999999998 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 54.109999999999999 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 71.310000000000002 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.430000000000007 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 65.030000000000001 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 70.420000000000002 110.846 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 61.299999999999997 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.129999999999995 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 70.530000000000001 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 73.239999999999995 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.140000000000001 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 72.5 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 60.119999999999997 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.696 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 1.1 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.319999999999993 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.319999999999993 110.615 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.828 ' H5N' ' O ' ' A' ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.818 ' H11' HD11 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 63.43 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 64.340000000000003 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 93' ' ' ILE . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.019999999999996 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.099999999999994 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.400000000000006 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.239999999999995 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.140000000000001 110.077 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.420000000000002 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 24.1 m-20 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 42.340000000000003 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.109999999999999 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 125' ' ' THR . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 52.25 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.833 HG13 ' H1D' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.430000000000007 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 70.129999999999995 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.049999999999997 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.7 OUTLIER 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -179.051 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.430000000000007 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 63.109999999999999 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.643 ' NE1' ' C14' ' A' ' 174' ' ' N22 . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.329999999999998 111.28 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.150000000000006 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.674 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.109999999999999 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 72.109999999999999 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.120000000000005 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.629 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.209999999999994 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.778 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.400000000000006 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.340000000000003 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 33' ' ' LYS . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 64.530000000000001 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' N ' HG13 ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 70.0 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 72.109999999999999 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 64.439999999999998 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 54.450000000000003 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 64.200000000000003 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 53.43 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 62.009999999999998 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 62.030000000000001 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 95' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.751 ' SD ' ' H4 ' ' A' ' 174' ' ' N22 . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.979 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.530000000000001 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 74.140000000000001 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.120000000000005 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.206 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.120000000000005 111.057 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 62.219999999999999 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 73.109999999999999 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 62.329999999999998 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.22 -99.83 0.26 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 71.239999999999995 110.673 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 66.63 2.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.991 0.424 . . . . 64.109999999999999 110.464 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HB3' ' H16' ' A' ' 174' ' ' N22 . 68.3 Cg_endo -78.71 178.84 7.08 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 122.982 2.455 . . . . 74.239999999999995 112.174 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.9 tp -176.3 51.27 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 116.428 -0.351 . . . . 55.140000000000001 110.868 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 43.8 Cg_endo -68.81 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 73.010000000000005 111.89 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.14 5.63 49.53 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.405 -0.678 . . . . 65.329999999999998 111.405 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 50.14 47.06 24.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.911 0.386 . . . . 63.100000000000001 110.444 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.129999999999995 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.510000000000005 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 65.120000000000005 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 74' ' ' CYS . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 53.539999999999999 110.442 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 78' ' ' HIS . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 63.310000000000002 110.872 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 70.540000000000006 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 63.509999999999998 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 60.8 m-20 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.519999999999996 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.140000000000001 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 74.209999999999994 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 62.229999999999997 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 63.329999999999998 111.203 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.129999999999995 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 72.329999999999998 110.795 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.540000000000006 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.784 ' H ' ' H2A' ' A' ' 173' ' ' NAP . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 72.109999999999999 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.439999999999998 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.299999999999997 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 85' ' ' GLU . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 110.978 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 63.420000000000002 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 64.010000000000005 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 61.549999999999997 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.329999999999998 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.230000000000004 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.099999999999994 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.200000000000003 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 42' ' ' ILE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.947 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 62.039999999999999 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.771 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 62.030000000000001 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 42.240000000000002 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 43.329999999999998 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.73 ' NE2' ' O2N' ' A' ' 173' ' ' NAP . 0.8 OUTLIER -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 72.109999999999999 110.637 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.461 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.239999999999995 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.109999999999999 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.776 ' O ' HG12 ' A' ' 109' ' ' VAL . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.577 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 72.540000000000006 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.150000000000006 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 105' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.447 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.409999999999997 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.430000000000007 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.495 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 62.299999999999997 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 112' ' ' LEU . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 71.230000000000004 110.641 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 119' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 71.129999999999995 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.964 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.636 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.099999999999994 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 62.43 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 70.010000000000005 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.821 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 74.239999999999995 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.120000000000005 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.803 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.491 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 -106.69 137.64 19.53 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.329 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.71 176.39 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.345 2.03 . . . . 62.130000000000003 111.224 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.44 179.74 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.615 -0.434 . . . . 64.400000000000006 110.218 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.0 mtp 61.27 102.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 74.219999999999999 110.653 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 132' ' ' MET . 0.4 OUTLIER -127.98 178.23 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 61.340000000000003 110.359 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.55 ' C ' ' O ' ' A' ' 131' ' ' ASP . 7.0 ptt? 27.6 45.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 70.140000000000001 110.543 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.4 t -62.31 -34.02 75.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.747 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.41 50.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 63.109999999999999 110.469 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 70.140000000000001 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.310000000000002 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 62.32 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.200000000000003 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.728 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.239999999999995 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 54.43 110.753 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.150000000000006 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 63.039999999999999 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.230000000000004 110.727 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.507 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.120000000000005 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.627 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.310000000000002 110.538 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.530000000000001 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.120000000000005 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 71.349999999999994 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.540000000000006 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 42.200000000000003 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 62.450000000000003 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 74.109999999999999 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.439999999999998 110.51 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.530000000000001 110.567 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.206 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.751 ' H4 ' ' SD ' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 63.130000000000003 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 63.25 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 93' ' ' ILE . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 54.520000000000003 110.358 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 55.100000000000001 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 110.418 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 63.039999999999999 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.73 ' HB3' ' N7N' ' A' ' 173' ' ' NAP . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.219999999999999 110.74 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 71.129999999999995 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 63.43 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.825 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.129999999999995 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 125' ' ' THR . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.030000000000001 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.420000000000002 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 54.329999999999998 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.030000000000001 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 64.219999999999999 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.140000000000001 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 51.219999999999999 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.129999999999995 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' OD1' ' A' ' 149' ' ' ASN . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 61.340000000000003 110.36 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.310000000000002 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.140000000000001 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 60.229999999999997 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 72.340000000000003 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG11 ' N8 ' ' A' ' 174' ' ' N22 . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 32.200000000000003 110.573 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 70.030000000000001 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 62.240000000000002 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 65.530000000000001 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.150000000000006 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.530000000000001 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.369 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.430000000000007 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 42' ' ' ILE . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 71.140000000000001 109.988 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.430000000000007 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 60.020000000000003 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.91 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.329999999999998 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.099999999999994 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 54.420000000000002 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.711 HG23 ' C14' ' A' ' 174' ' ' N22 . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 72.420000000000002 110.948 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.96 51.04 0.34 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.430000000000007 111.366 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD2' HH11 ' A' ' 53' ' ' ARG . 6.3 ttp180 58.79 76.06 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.996 0.427 . . . . 74.409999999999997 111.014 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' A' ' 51' ' ' ILE . 42.5 Cg_endo -89.01 172.29 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.431 2.754 . . . . 64.530000000000001 112.106 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -164.75 49.29 0.21 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 120.843 -0.343 . . . . 63.329999999999998 111.319 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 17.7 Cg_endo -59.76 69.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.202 2.601 . . . . 73.150000000000006 112.807 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 130.98 14.73 1.8 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 111.518 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 59.72 11.55 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.316 0.579 . . . . 73.209999999999994 109.979 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 65.049999999999997 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 74' ' ' CYS . 0.8 OUTLIER -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.662 179.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 72.25 110.715 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 63.310000000000002 110.113 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 78' ' ' HIS . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.120000000000005 110.986 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.547 HG21 ' CD2' ' A' ' 69' ' ' TYR . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.200000000000003 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 64.340000000000003 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 64' ' ' THR . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 64.120000000000005 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 62.200000000000003 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.200000000000003 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.476 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.099999999999994 110.409 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.120000000000005 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 51.119999999999997 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 30.129999999999999 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.585 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.239999999999995 110.65 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.685 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.219999999999999 110.878 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 70.540000000000006 110.597 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 42.210000000000001 110.634 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 86' ' ' LEU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 53.109999999999999 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 110.752 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 72.439999999999998 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.230000000000004 110.71 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.431 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.530000000000001 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 64.540000000000006 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.109999999999999 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.310000000000002 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 3' ' ' VAL . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.577 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 42.329999999999998 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.624 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 54.200000000000003 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 63.420000000000002 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.98 ' OE1' H52A ' A' ' 173' ' ' NAP . 4.7 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 51.140000000000001 110.189 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.310000000000002 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.198 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.875 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.420000000000002 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.219999999999999 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 70.329999999999998 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.540000000000006 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.010000000000005 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.109999999999999 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 5' ' ' PHE . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 73.230000000000004 110.787 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.616 HG21 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.150000000000006 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 55.439999999999998 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 60.219999999999999 110.657 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.349999999999994 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.140000000000001 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.825 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 62.229999999999997 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 44.539999999999999 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.319999999999993 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.753 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 65.329999999999998 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 -165.6 151.92 8.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.120000000000005 109.753 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.21 -174.78 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.425 2.084 . . . . 41.049999999999997 111.901 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 130' ' ' MET . 3.2 pt-20 -131.59 167.68 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 62.210000000000001 110.776 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 129' ' ' GLU . 76.4 mtp 38.73 62.38 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 64.109999999999999 110.603 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.82 101.02 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 110.678 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 5.1 mtp 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 60.530000000000001 110.665 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.486 HG23 ' N ' ' A' ' 134' ' ' ASN . 1.7 t -61.49 -49.61 76.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 55.109999999999999 110.62 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 133' ' ' THR . 32.4 t30 78.27 -8.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 73.319999999999993 110.813 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 72.019999999999996 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 64.450000000000003 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.310000000000002 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 73.299999999999997 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 54.119999999999997 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.409999999999997 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 64.140000000000001 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 144' ' ' LEU . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 63.100000000000001 110.444 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.239999999999995 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.150000000000006 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.140000000000001 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.450000000000003 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.430000000000007 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.230000000000004 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 62.149999999999999 110.4 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.530000000000001 110.679 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.230000000000004 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.329999999999998 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.427 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 0.4 OUTLIER -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 63.310000000000002 110.576 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.030000000000001 110.515 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.98 H52A ' OE1' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.711 ' C14' HG23 ' A' ' 51' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 44.219999999999999 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.340000000000003 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 45.020000000000003 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 71.299999999999997 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 52.0 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 72.040000000000006 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.510000000000005 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.140000000000001 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 42.350000000000001 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 125' ' ' THR . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 73.230000000000004 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.724 HG13 ' H2N' ' A' ' 173' ' ' NAP . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 54.340000000000003 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.239999999999995 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 63.329999999999998 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.999 HD21 ' H2A' ' A' ' 174' ' ' N22 . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 70.329999999999998 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.897 ' OD1' ' H8B' ' A' ' 174' ' ' N22 . 0.5 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 63.520000000000003 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 63.409999999999997 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.209999999999994 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.200000000000003 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 1.034 ' HE ' ' H8A' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 71.409999999999997 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.755 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 73.310000000000002 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 64.140000000000001 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.450000000000003 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.711 ' OE2' ' N8 ' ' A' ' 174' ' ' N22 . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 53.340000000000003 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.230000000000004 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.230000000000004 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 110.592 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.510000000000005 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.219999999999999 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 63.100000000000001 110.48 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 32' ' ' VAL . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.140000000000001 110.455 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.049999999999997 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 65.010000000000005 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.109999999999999 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 63.200000000000003 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 95' ' ' ILE . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 64.140000000000001 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 54.109999999999999 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 44.310000000000002 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 72.049999999999997 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 54.109999999999999 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.823 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 11.8 m120 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.420000000000002 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 71.010000000000005 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.319999999999993 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 HD11 ' ND2' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 45.420000000000002 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.6 -111.83 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.209999999999994 110.487 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -126.94 54.65 12.6 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.376 . . . . 73.340000000000003 110.759 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 56.6 Cg_endo -72.33 156.0 55.23 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.949 2.433 . . . . 65.209999999999994 111.937 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.6 pt? -161.25 38.45 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.655 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 11.1 Cg_endo -57.51 79.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.967 2.445 . . . . 74.409999999999997 112.38 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 137.3 0.19 2.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.952 -0.859 . . . . 64.430000000000007 110.952 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 48.17 44.86 19.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 110.841 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 70.319999999999993 110.878 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.456 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.299999999999997 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' HIS . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.420000000000002 111.546 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 72.030000000000001 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.473 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 5.1 m120 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 70.400000000000006 110.531 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.200000000000003 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 61.119999999999997 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 63.5 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 61.549999999999997 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 64.25 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 70.540000000000006 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 54.43 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 72.420000000000002 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.799 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.409999999999997 110.741 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.403 ' HB2' ' C2A' ' A' ' 173' ' ' NAP . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.299999999999997 110.715 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.129999999999995 110.413 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.140000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.299999999999997 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 83' ' ' VAL . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 70.510000000000005 110.534 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.439999999999998 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.109999999999999 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 61.039999999999999 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 93' ' ' ILE . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 62.210000000000001 111.016 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.510000000000005 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.129999999999995 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.532 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' ILE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CZ ' ' H4N' ' A' ' 173' ' ' NAP . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 54.039999999999999 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.200000000000003 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 55.439999999999998 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.909 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.636 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 55.049999999999997 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.120000000000005 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 72.140000000000001 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.537 ' CD2' HG11 ' A' ' 80' ' ' VAL . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.407 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 60.109999999999999 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 54.310000000000002 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.019999999999996 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 109' ' ' VAL . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 53.329999999999998 110.733 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.4 ' N ' HG22 ' A' ' 109' ' ' VAL . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.040000000000006 109.819 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 72.549999999999997 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' CD2' HD11 ' A' ' 114' ' ' ILE . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 74.239999999999995 110.708 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.200000000000003 110.546 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 112' ' ' LEU . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 110.753 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 50.43 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.299999999999997 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.430000000000007 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.420000000000002 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.530000000000001 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' H ' HH21 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.409999999999997 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.439999999999998 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 62.109999999999999 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 71.340000000000003 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.693 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.420000000000002 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.511 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 -166.12 130.57 1.73 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.239999999999995 110.149 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.81 176.92 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.456 2.104 . . . . 73.0 112.226 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -98.16 107.92 20.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 72.109999999999999 110.519 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 39.6 mmm -96.83 -58.17 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.599 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 132' ' ' MET . 13.1 t70 -177.02 161.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 110.414 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.781 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -161.15 42.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 72.209999999999994 110.642 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 135' ' ' TRP . 5.9 t -68.39 -23.09 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 64.230000000000004 110.337 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -57.0 -0.99 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 73.219999999999999 110.543 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.529 ' H ' ' C ' ' A' ' 133' ' ' THR . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.535 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.120000000000005 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.150000000000006 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 71.230000000000004 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 71.140000000000001 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.200000000000003 110.685 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 61.310000000000002 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.209999999999994 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 62.439999999999998 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.319999999999993 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.573 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 71.439999999999998 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 64.109999999999999 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.420000000000002 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.691 ' OH ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.546 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 110.919 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.420000000000002 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 63.020000000000003 110.292 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 73.239999999999995 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.391 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 3.8 pm0 -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.209999999999994 110.618 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 44.119999999999997 110.647 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 0.903 ' H2D' ' H ' ' A' ' 19' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 1.034 ' H8A' ' HE ' ' A' ' 24' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.010000000000005 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 93' ' ' ILE . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 71.329999999999998 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.598 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.439999999999998 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 44.450000000000003 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' HH21 ' A' ' 24' ' ' ARG . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 64.25 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 54.25 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.319999999999993 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 72.010000000000005 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 70.310000000000002 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 125' ' ' THR . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 63.409999999999997 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 HG13 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.510000000000005 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.310000000000002 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 63.210000000000001 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 55.340000000000003 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.450000000000003 109.891 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.595 ' ND2' ' C2 ' ' A' ' 174' ' ' N22 . 6.2 t30 -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.219999999999999 110.306 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.978 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.409999999999997 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.439999999999998 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HE1' ' C15' ' A' ' 174' ' ' N22 . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.040000000000006 110.535 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.598 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.209999999999994 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 153' ' ' TYR . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 110.466 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.109999999999999 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.439999999999998 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.439999999999998 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 61.210000000000001 111.096 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 60.5 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 73.25 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.519999999999996 111.301 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.420000000000002 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.150000000000006 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.230000000000004 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 110.59 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.030000000000001 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.439999999999998 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 55.439999999999998 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 71.109999999999999 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.020000000000003 110.53 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 71.439999999999998 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 42.100000000000001 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' O3X' ' A' ' 173' ' ' NAP . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.310000000000002 110.454 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 63.200000000000003 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.112 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.230000000000004 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.439999999999998 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 64.239999999999995 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 72.310000000000002 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 72.140000000000001 109.793 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.27 141.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.319999999999993 111.382 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 53' ' ' ARG . 2.7 mtp180 61.79 86.82 0.14 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 53.140000000000001 111.274 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -80.24 168.03 18.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.143 2.562 . . . . 61.140000000000001 112.151 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 55' ' ' LEU . 2.4 mm? -96.24 118.31 65.61 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 63.43 110.295 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 55' ' ' LEU . 33.3 Cg_endo -71.15 40.46 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.17 1.914 . . . . 65.430000000000007 111.752 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -131.81 -22.23 0.95 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.2 -1.16 . . . . 55.039999999999999 110.2 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -116.18 105.91 13.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.513 0.197 . . . . 73.140000000000001 110.713 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.319999999999993 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.239999999999995 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 63.149999999999999 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 74' ' ' CYS . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.210000000000001 111.03 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 78' ' ' HIS . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 64.420000000000002 110.86 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.541 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.541 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 12.3 m-20 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 52.039999999999999 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.519999999999996 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.450000000000003 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.519999999999996 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 70.019999999999996 110.536 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.140000000000001 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 74.409999999999997 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.099999999999994 110.645 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 64' ' ' THR . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 51.340000000000003 110.703 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 60.020000000000003 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.120000000000005 110.824 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.6 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 33.109999999999999 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.6 ' N ' ' OG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 61.030000000000001 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.140000000000001 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.433 HG21 HG21 ' A' ' 63' ' ' VAL . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.931 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 55.509999999999998 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 70.400000000000006 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 63.420000000000002 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.329999999999998 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 71.439999999999998 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.099999999999994 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 3' ' ' VAL . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 72.519999999999996 110.118 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.109999999999999 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 42' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 54.530000000000001 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.726 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.140000000000001 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' HA3' ' O1A' ' A' ' 173' ' ' NAP . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.329999999999998 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 45.539999999999999 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.120000000000005 111.27 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 73.120000000000005 111.15 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 64.439999999999998 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.219999999999999 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 105' ' ' PHE . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 65.409999999999997 111.172 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 65.340000000000003 111.172 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 62.049999999999997 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.439999999999998 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 61.329999999999998 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 105' ' ' PHE . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 65.439999999999998 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.511 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.129999999999995 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.010000000000005 110.673 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.140000000000001 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 112' ' ' LEU . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 60.329999999999998 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.129999999999995 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.040000000000006 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.349999999999994 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 64.519999999999996 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.447 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.140000000000001 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.120000000000005 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.439999999999998 111.038 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.329999999999998 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.69 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 2.1 t80 -100.59 127.53 32.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.420000000000002 109.901 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.69 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 35.7 Cg_endo -68.35 -162.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.292 1.995 . . . . 55.310000000000002 112.553 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 9.2 pt-20 -97.45 70.66 2.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 62.020000000000003 110.563 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 28.2 mtp -126.62 57.36 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 55.399999999999999 110.547 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -66.49 110.25 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 110.367 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 ptm -178.25 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 61.420000000000002 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.9 t -46.19 -49.23 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 74.200000000000003 110.311 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.628 ' N ' HG23 ' A' ' 133' ' ' THR . 12.8 m-20 60.86 54.73 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 70.239999999999995 110.561 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.497 ' CZ2' HD12 ' A' ' 112' ' ' LEU . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.019999999999996 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.109999999999999 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 61.030000000000001 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 73.230000000000004 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 54.530000000000001 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.210000000000001 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 73.019999999999996 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 72.329999999999998 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 62.32 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.530000000000001 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 62.049999999999997 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.530000000000001 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.310000000000002 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 74.5 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 25' ' ' LEU . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.109999999999999 111.434 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.439999999999998 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 92.2 m-70 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 72.219999999999999 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 64.349999999999994 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.319999999999993 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 65.25 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 62.539999999999999 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.040000000000006 110.572 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.112 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.817 ' H8B' ' C9 ' ' A' ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.219999999999999 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.430000000000007 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.150000000000006 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CE1' HG13 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 71.140000000000001 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.219999999999999 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.150000000000006 109.317 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.439999999999998 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.129999999999995 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 65.209999999999994 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.319999999999993 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG12 ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 72.450000000000003 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.519999999999996 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 52.329999999999998 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.0 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.319999999999993 109.336 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 18' ' ' ASP . 1.1 p-10 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.349999999999994 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.864 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.129999999999995 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 62.219999999999999 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 72.019999999999996 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.752 ' CD ' ' H8A' ' A' ' 174' ' ' N22 . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.400000000000006 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.040000000000006 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.32 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 73.530000000000001 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.510000000000005 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 70.510000000000005 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.450000000000003 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 33' ' ' LYS . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.510000000000005 110.366 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 32' ' ' VAL . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 62.350000000000001 111.274 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.299999999999997 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.530000000000001 110.527 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 35' ' ' THR . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.140000000000001 110.95 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 62.109999999999999 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.450000000000003 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 71.519999999999996 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.430000000000007 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.319999999999993 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.010000000000005 110.578 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.209999999999994 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' HD22 ' A' ' 47' ' ' ASN . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 25.149999999999999 110.771 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 71.400000000000006 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 72.450000000000003 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.022 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 3.0 m-80 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 62.119999999999997 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.230000000000004 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 70.120000000000005 110.662 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.95 -94.18 0.2 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.230000000000004 111.147 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -136.69 68.49 59.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 61.310000000000002 110.669 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.8 130.67 5.1 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 123.005 2.47 . . . . 74.420000000000002 112.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD1' ' NH2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -146.16 49.41 0.87 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.189 179.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 20.2 Cg_endo -63.32 58.4 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.178 2.586 . . . . 74.319999999999993 112.231 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 58' ' ' ARG . . . 150.13 32.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.346 -0.702 . . . . 62.350000000000001 111.346 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.681 ' NH2' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 26.12 52.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.687 0.279 . . . . 70.409999999999997 111.291 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.420000000000002 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 110.964 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 77' ' ' ALA . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 51.030000000000001 110.307 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' HIS . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 52.399999999999999 111.067 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 73.299999999999997 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' O ' ' OD1' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 72.129999999999995 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 65' ' ' ARG . 3.0 m120 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 43.009999999999998 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 34.109999999999999 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 62.130000000000003 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.019999999999996 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 32.329999999999998 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.349999999999994 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 55.420000000000002 109.99 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.657 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 73.200000000000003 110.877 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 64.420000000000002 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.420000000000002 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.329999999999998 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.109999999999999 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 62.25 110.654 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.010000000000005 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.340000000000003 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 52.219999999999999 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.549999999999997 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.430000000000007 110.502 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 65.329999999999998 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.57 ' CD1' HD13 ' A' ' 42' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.099999999999994 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.209999999999994 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.492 ' H ' HD11 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 41.210000000000001 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.74 ' CD ' H52A ' A' ' 173' ' ' NAP . 1.3 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 65.310000000000002 111.105 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.239999999999995 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.019999999999996 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.400000000000006 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.635 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 61.43 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.040000000000006 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 63.310000000000002 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 71.439999999999998 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 72.209999999999994 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 51.530000000000001 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 73.200000000000003 110.394 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 72.549999999999997 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.719 HD11 HD13 ' A' ' 112' ' ' LEU . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 52.399999999999999 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 63.119999999999997 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.546 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.109999999999999 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 62.43 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.420000000000002 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.140000000000001 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.430000000000007 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.679 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.010000000000005 110.4 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 70.209999999999994 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 3.9 t80 -104.61 124.42 37.07 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 70.329999999999998 109.689 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 39.8 Cg_endo -70.8 -171.5 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.068 1.846 . . . . 53.109999999999999 112.332 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' O ' ' SD ' ' A' ' 130' ' ' MET . 2.9 pt-20 -86.74 64.99 8.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 42.310000000000002 110.76 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 129' ' ' GLU . 21.9 mmt -132.84 59.48 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 60.420000000000002 110.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.28 89.33 7.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 72.209999999999994 110.686 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.5 mmt -133.09 33.29 3.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 110.605 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 134' ' ' ASN . 1.2 t -45.74 -59.77 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.584 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.737 ' H ' HG23 ' A' ' 133' ' ' THR . 32.2 t-20 75.46 -0.23 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 71.040000000000006 110.804 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 110.483 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.510000000000005 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 61.049999999999997 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.340000000000003 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.519999999999996 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.099999999999994 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.409999999999997 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 145' ' ' THR . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 72.239999999999995 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.049999999999997 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.140000000000001 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 65.409999999999997 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.209999999999994 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 70.439999999999998 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 65.310000000000002 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.450000000000003 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.692 ' C ' ' ND1' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.310000000000002 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.540000000000006 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 70.299999999999997 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.310000000000002 110.591 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.022 ' H6N' ' CG ' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.794 ' H2B' ' H11' ' A' ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.239999999999995 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 2' ' ' ILE . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.651 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.530000000000001 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 55.119999999999997 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 64.25 110.249 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 61.310000000000002 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' ALA . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 60.539999999999999 110.747 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.84 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 110.891 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.040000000000006 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.400000000000006 111.858 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 74.129999999999995 111.9 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.85 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.349999999999994 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.692 HG13 HG12 ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.319999999999993 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.733 ' HB ' H71N ' A' ' 173' ' ' NAP . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.319999999999993 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.099999999999994 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.349999999999994 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.150000000000006 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.510000000000005 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.497 HD22 ' HA ' ' A' ' 51' ' ' ILE . 4.4 m-20 -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.393 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.581 HD21 ' H11' ' A' ' 174' ' ' N22 . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 62.439999999999998 110.017 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.310000000000002 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.019999999999996 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 61.119999999999997 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.329999999999998 110.224 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 71.430000000000007 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.129999999999995 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 74.109999999999999 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.409999999999997 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 36' ' ' THR . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 65.140000000000001 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' N ' HG13 ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.150000000000006 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 72.349999999999994 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.530000000000001 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.439999999999998 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.544 ' O ' ' CG ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.519999999999996 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.350000000000001 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.409999999999997 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.420000000000002 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.486 HG23 HG23 ' A' ' 63' ' ' VAL . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.230000000000004 110.54 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 64.239999999999995 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 25.449999999999999 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.67 ' NH2' ' O3X' ' A' ' 173' ' ' NAP . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 1.032 ' OD1' ' H2D' ' A' ' 173' ' ' NAP . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 55.229999999999997 110.604 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.420000000000002 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 44.039999999999999 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' HA ' HD22 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 71.109999999999999 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.94 -104.07 2.1 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.209999999999994 110.71 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -127.87 69.23 76.44 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-O 120.967 0.413 . . . . 74.239999999999995 110.729 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' A' ' 51' ' ' ILE . 52.4 Cg_endo -74.6 162.8 37.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.712 2.274 . . . . 72.099999999999994 112.084 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.0 tp -158.27 42.85 0.15 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.282 -0.417 . . . . 75.200000000000003 110.962 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -67.34 134.12 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.469 2.113 . . . . 65.129999999999995 111.044 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.18 69.6 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.822 -0.911 . . . . 71.409999999999997 110.822 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 69.89 -6.25 1.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.699 0.285 . . . . 73.409999999999997 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 63.539999999999999 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 71.030000000000001 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 65.129999999999995 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 72.340000000000003 110.649 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 78' ' ' HIS . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.030000000000001 110.697 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.585 ' CA ' ' HE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 61.299999999999997 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.794 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 72.519999999999996 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.230000000000004 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 64' ' ' THR . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.239999999999995 110.518 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.209999999999994 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.420000000000002 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 63.450000000000003 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 62.450000000000003 110.595 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.673 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 60.399999999999999 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 64.510000000000005 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 70.510000000000005 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.200000000000003 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.894 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.530000000000001 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.420000000000002 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.420000000000002 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.662 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.540000000000006 110.211 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.755 ' CZ ' ' N7 ' ' A' ' 174' ' ' N22 . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.310000000000002 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.530000000000001 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 43.509999999999998 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' OE1' ' O3 ' ' A' ' 173' ' ' NAP . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 65.120000000000005 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.442 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.219999999999999 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.140000000000001 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 109' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.340000000000003 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.409999999999997 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 63.549999999999997 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 105' ' ' PHE . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.302 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.430000000000007 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 63.340000000000003 110.06 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.139 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 55.509999999999998 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 112' ' ' LEU . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.519999999999996 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 62.420000000000002 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.340000000000003 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 70.329999999999998 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.129999999999995 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 54.5 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 71.299999999999997 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 55.439999999999998 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.85 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 61.32 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 64.019999999999996 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.643 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.099999999999994 110.574 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.109999999999999 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 -96.02 138.81 21.62 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.227 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 -166.19 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.491 2.128 . . . . 74.319999999999993 112.028 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 130' ' ' MET . 4.7 pt-20 -107.22 -160.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.454 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.473 ' C ' ' O ' ' A' ' 129' ' ' GLU . 25.6 ptt? 34.62 38.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 63.229999999999997 110.703 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.7 p30 -57.62 150.95 18.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 72.430000000000007 110.353 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.08 62.79 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 54.119999999999997 110.813 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.638 HG23 ' N ' ' A' ' 134' ' ' ASN . 5.4 t -61.96 -51.62 67.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 65.450000000000003 110.457 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.638 ' N ' HG23 ' A' ' 133' ' ' THR . 59.7 t30 57.79 15.27 2.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 64.420000000000002 110.781 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.467 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.400000000000006 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 61.119999999999997 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.340000000000003 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 63.119999999999997 111.012 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.219999999999999 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.109999999999999 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.310000000000002 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.530000000000001 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.010000000000005 110.427 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.200000000000003 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.540000000000006 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.230000000000004 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.430000000000007 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 62.420000000000002 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 71.049999999999997 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 45.350000000000001 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.530000000000001 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.409999999999997 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 71.230000000000004 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 70.530000000000001 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 173' ' ' NAP . . . . . 1.032 ' H2D' ' OD1' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' N22 . . . . . 0.755 ' N7 ' ' CZ ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.200000000000003 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 53.530000000000001 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.120000000000005 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 54.009999999999998 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' A' ' 112' ' ' LEU . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 72.310000000000002 110.134 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 62.399999999999999 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 70.329999999999998 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 42.32 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 55.219999999999999 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.030000000000001 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 63.219999999999999 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 125' ' ' THR . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.450000000000003 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 99' ' ' ALA . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 54.130000000000003 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 61.420000000000002 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 71.329999999999998 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.430000000000007 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.439999999999998 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.420000000000002 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 65.219999999999999 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CH2' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 71.140000000000001 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' HD21 ' A' ' 149' ' ' ASN . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.310000000000002 111.471 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 63.43 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.019999999999996 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.829 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.450000000000003 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 44.210000000000001 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 70.319999999999993 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 72.319999999999993 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 72.219999999999999 110.727 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 65.439999999999998 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 71.340000000000003 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.099999999999994 110.596 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.409999999999997 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 62.43 110.386 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.41 ' HB3' HD21 ' A' ' 47' ' ' ASN . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.420000000000002 110.483 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.79 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 52.149999999999999 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.099999999999994 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.79 ' ND2' ' H ' ' A' ' 44' ' ' GLY . 6.1 p30 -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.340000000000003 110.486 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CE1' ' O ' ' A' ' 52' ' ' GLY . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 64.430000000000007 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 53.039999999999999 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.474 HD11 HD11 ' A' ' 21' ' ' LEU . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.615 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 51.43 110.891 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 73.129999999999995 110.456 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.219999999999999 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.450000000000003 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.430000000000007 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 63.219999999999999 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.420000000000002 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 65.049999999999997 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 63.310000000000002 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 71.319999999999993 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.209999999999994 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 71.349999999999994 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.402 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.150000000000006 110.781 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.9 m-70 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.230000000000004 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.319999999999993 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.239999999999995 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.510000000000005 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.430000000000007 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 70.549999999999997 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 70' ' ' HIS . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.736 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.399999999999999 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.119999999999997 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.129999999999995 110.611 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 62.520000000000003 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.219999999999999 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.040000000000006 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 86' ' ' LEU . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.219999999999999 110.61 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 65.400000000000006 110.728 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 64.409999999999997 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.040000000000006 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.149999999999999 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.439999999999998 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.0 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.209999999999994 111.268 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.439999999999998 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 44.420000000000002 110.89 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.978 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.472 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 72.430000000000007 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 64.209999999999994 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 52.409999999999997 110.584 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.510000000000005 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 65.420000000000002 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 105' ' ' PHE . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 70.129999999999995 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 70.109999999999999 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 64.230000000000004 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 5' ' ' PHE . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 52.200000000000003 111.175 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 54.130000000000003 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.239999999999995 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.340000000000003 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 72.5 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 70.219999999999999 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.239999999999995 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.329999999999998 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.698 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 43.229999999999997 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 64.109999999999999 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 109.889 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.785 0.326 . . . . 71.239999999999995 110.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 63.310000000000002 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 50.310000000000002 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 72.420000000000002 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 63.549999999999997 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 70.239999999999995 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.149999999999999 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 54.219999999999999 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 53.130000000000003 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.423 HD21 ' HD3' ' A' ' 26' ' ' PRO . 25.2 m-80 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 60.200000000000003 110.617 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.150000000000006 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.420000000000002 110.566 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.549999999999997 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.019999999999996 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.299999999999997 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 74.319999999999993 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 61.200000000000003 110.394 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.540000000000006 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.420000000000002 110.512 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 63.109999999999999 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 93' ' ' ILE . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.884 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 62.020000000000003 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.936 ' CE1' HG22 ' A' ' 109' ' ' VAL . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 73.219999999999999 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 70.150000000000006 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 53.229999999999997 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.049999999999997 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 70.230000000000004 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 71.409999999999997 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 44.329999999999998 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.230000000000004 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 99' ' ' ALA . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.409999999999997 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 24.449999999999999 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 70.0 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 63.210000000000001 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 7.7 m-20 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.540000000000006 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.409999999999997 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.897 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.219999999999999 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.699 ' CG ' ' N ' ' A' ' 24' ' ' ARG . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.209999999999994 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.67 ' CD ' HD21 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.129999999999995 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.439999999999998 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 32' ' ' VAL . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.319999999999993 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' HB2' ' NE1' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 62.049999999999997 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 45.32 111.598 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 71.319999999999993 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 71.239999999999995 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.030000000000001 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 74.340000000000003 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 32' ' ' VAL . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.140000000000001 110.789 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 44.140000000000001 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 41' ' ' LEU . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.450000000000003 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.319999999999993 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 70.120000000000005 110.637 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.219999999999999 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 24.219999999999999 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 40.43 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 71.150000000000006 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 109.982 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.230000000000004 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.319999999999993 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.409999999999997 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HA ' HD21 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 53.43 110.975 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.120000000000005 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.040000000000006 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 71' ' ' VAL . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.120000000000005 110.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 78' ' ' HIS . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 110.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.424 HG23 HD21 ' A' ' 66' ' ' ASN . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.010000000000005 110.615 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.637 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.219999999999999 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 50.130000000000003 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 61.210000000000001 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 62' ' ' ILE . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 61.340000000000003 110.654 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 61.25 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 52.229999999999997 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.129999999999995 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.130000000000003 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.010000000000005 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.439999999999998 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.717 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 62.140000000000001 110.569 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 54.520000000000003 110.958 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.299999999999997 110.716 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.219999999999999 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.229999999999997 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.400000000000006 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.549999999999997 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.917 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.349999999999994 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 43.43 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.219999999999999 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.239999999999995 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 71.549999999999997 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.400000000000006 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 64.140000000000001 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.020000000000003 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.565 ' O ' ' O ' ' A' ' 96' ' ' PHE . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 30.149999999999999 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.420000000000002 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 110.322 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.510000000000005 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.705 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.209999999999994 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' A' ' 106' ' ' LEU . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 54.350000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 63.030000000000001 111.056 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 70.120000000000005 111.356 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.319999999999993 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.430000000000007 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 71.239999999999995 110.408 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.936 HG22 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.010000000000005 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 74.230000000000004 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 114' ' ' ILE . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 54.140000000000001 110.94 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 157' ' ' VAL . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 50.109999999999999 110.666 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.209999999999994 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 53.409999999999997 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 52.229999999999997 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.553 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 61.240000000000002 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.430000000000007 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.010000000000005 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.319999999999993 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.755 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.239999999999995 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.219999999999999 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.540000000000006 111.176 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.469 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.140000000000001 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 71.120000000000005 110.093 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.838 0.351 . . . . 74.25 110.43 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CH2' ' HG3' ' A' ' 160' ' ' LYS . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 110.515 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 71.420000000000002 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.319999999999993 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 61.240000000000002 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 64.519999999999996 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.219999999999999 110.3 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.430000000000007 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.239999999999995 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.230000000000004 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.67 HD21 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 64.510000000000005 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.540000000000006 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.299999999999997 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.349999999999994 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 62.43 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 73.420000000000002 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.129999999999995 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 113' ' ' TYR . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.519999999999996 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG3' ' CH2' ' A' ' 135' ' ' TRP . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 70.129999999999995 110.294 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.668 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 3.0 mp0 -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 64.540000000000006 110.706 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 50.329999999999998 110.588 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.109999999999999 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 73.219999999999999 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 64.230000000000004 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 73.349999999999994 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.450000000000003 110.705 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 44.119999999999997 110.457 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 64.420000000000002 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 65.439999999999998 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.645 ' H ' HD22 ' A' ' 12' ' ' ASN . 0.1 OUTLIER -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.93 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 63.210000000000001 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 HG12 ' A' ' 15' ' ' ILE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 65.450000000000003 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.842 HG12 HG13 ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.409999999999997 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.140000000000001 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 65.409999999999997 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.629 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 4.1 m120 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 110.094 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 64.400000000000006 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.086 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.430000000000007 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' CH2' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 71.200000000000003 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 70.430000000000007 109.901 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 65.129999999999995 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 73.5 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.150000000000006 110.163 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.021 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.420000000000002 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.409999999999997 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 51.43 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.420000000000002 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.329999999999998 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.420000000000002 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.299999999999997 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.430000000000007 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.230000000000004 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 71.540000000000006 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 72.040000000000006 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.109999999999999 110.905 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.129999999999995 110.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.319999999999993 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 41.43 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.439999999999998 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 72.140000000000001 110.262 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CB ' HG21 ' A' ' 62' ' ' ILE . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 70.019999999999996 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 71.019999999999996 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.219999999999999 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 70.040000000000006 110.007 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.319999999999993 111.436 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 61.310000000000002 109.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 70.319999999999993 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.450000000000003 110.446 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.420000000000002 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.44 HG21 ' CB ' ' A' ' 48' ' ' TYR . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.319999999999993 110.582 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 78' ' ' HIS . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.79 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 76' ' ' VAL . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.536 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.569 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 53.039999999999999 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 14.6 m-80 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 74.409999999999997 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.310000000000002 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.340000000000003 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 71.439999999999998 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 62.229999999999997 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.049999999999997 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 72.349999999999994 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 64' ' ' THR . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.753 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.530000000000001 110.659 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 83' ' ' VAL . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 74.140000000000001 110.67 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.409999999999997 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 51.530000000000001 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 60.399999999999999 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.420000000000002 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 63.439999999999998 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' CD ' ' N ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.209999999999994 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.349999999999994 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 72.109999999999999 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.530000000000001 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.420000000000002 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 70.109999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.683 ' OE1' HD11 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.450000000000003 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.683 HD11 ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.230000000000004 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.519999999999996 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.239999999999995 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.430000000000007 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.340000000000003 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.210000000000001 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 5' ' ' PHE . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 64.030000000000001 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.200000000000003 110.647 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 64.109999999999999 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD22 HD11 ' A' ' 114' ' ' ILE . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 73.230000000000004 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 62.420000000000002 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 54.210000000000001 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.310000000000002 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 73.109999999999999 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.239999999999995 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.441 ' HB3' ' ND2' ' A' ' 12' ' ' ASN . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.433 ' H ' ' HD3' ' A' ' 17' ' ' LYS . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 71.030000000000001 110.921 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.420000000000002 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.120000000000005 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.795 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 73.310000000000002 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.464 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 15.7 t80 . . . . . 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.340000000000003 109.775 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.349 . . . . 72.540000000000006 110.631 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.425 ' CZ3' ' N ' ' A' ' 160' ' ' LYS . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 51.119999999999997 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' ' HD3' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 53.140000000000001 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 54.539999999999999 110.684 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 140' ' ' VAL . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 52.140000000000001 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.450000000000003 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.530000000000001 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.510000000000005 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.200000000000003 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 145' ' ' THR . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.519999999999996 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.140000000000001 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 53.299999999999997 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 55.109999999999999 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 53.420000000000002 112.073 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 70.400000000000006 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.420000000000002 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.528 ' OH ' HD13 ' A' ' 25' ' ' LEU . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.230000000000004 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 65.109999999999999 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.219999999999999 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 73.540000000000006 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 43.149999999999999 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 53.350000000000001 110.557 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.010000000000005 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.604 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HB2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.400000000000006 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.310000000000002 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 114' ' ' ILE . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 61.229999999999997 111.394 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HA ' HG22 ' A' ' 115' ' ' THR . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.200000000000003 110.683 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 61.130000000000003 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' C ' HD22 ' A' ' 12' ' ' ASN . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 112.072 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.340000000000003 111.397 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' NH2' ' H ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 72.319999999999993 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 125' ' ' THR . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 74.519999999999996 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.525 HG12 HG13 ' A' ' 14' ' ' VAL . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 64.409999999999997 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 45.43 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 122' ' ' GLU . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.618 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 62.140000000000001 110.356 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.52 HD21 ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.230000000000004 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.848 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.310000000000002 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 63.210000000000001 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 25' ' ' LEU . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.530000000000001 110.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.399999999999999 109.979 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 43.43 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 64.239999999999995 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 62.25 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 53.130000000000003 109.677 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 73.540000000000006 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 73.510000000000005 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 62.43 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 62.240000000000002 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.400000000000006 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.608 ' OG1' ' CG ' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.349999999999994 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.319999999999993 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 64.519999999999996 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.608 ' CG ' ' OG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 70.25 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.519999999999996 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.310000000000002 110.116 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 73.099999999999994 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.340000000000003 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.77 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.209999999999994 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.319999999999993 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.207 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.019999999999996 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 65.319999999999993 111.136 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' CG1' HD21 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 55.439999999999998 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 73.329999999999998 111.273 179.667 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 . . . . . 0 N--CA 1.458 -0.066 0 N-CA-C 110.034 -0.358 . . . . 72.129999999999995 110.034 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.239999999999995 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.219999999999999 110.534 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 61.509999999999998 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 62' ' ' ILE . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.540000000000006 110.543 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 78' ' ' HIS . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 60.299999999999997 110.611 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.77 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.509999999999998 110.571 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.230000000000004 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 61.439999999999998 110.561 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 50.140000000000001 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.119999999999997 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 70.510000000000005 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.400000000000006 110.269 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.099999999999994 110.554 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.209999999999994 111.04 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.430000000000007 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 61.020000000000003 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 71.510000000000005 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.010000000000005 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 72.409999999999997 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.049999999999997 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 53.32 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.430000000000007 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.409999999999997 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 95' ' ' ILE . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.703 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.509 ' HB2' HD22 ' A' ' 41' ' ' LEU . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 73.409999999999997 110.36 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 93' ' ' ILE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 70.400000000000006 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 6' ' ' MET . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 70.310000000000002 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.140000000000001 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.120000000000005 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.439999999999998 110.673 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.219999999999999 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.540000000000006 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.230000000000004 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.802 HD23 ' C ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.549999999999997 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 72.140000000000001 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 5' ' ' PHE . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 62.200000000000003 110.056 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 64.439999999999998 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.200000000000003 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.666 ' CE1' HG13 ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.904 HD13 ' CE1' ' A' ' 156' ' ' HIS . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 8' ' ' ALA . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 52.32 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 73.120000000000005 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 71.439999999999998 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.239999999999995 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 70.209999999999994 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.099999999999994 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.530000000000001 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 64.230000000000004 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.120000000000005 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.530000000000001 110.476 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 m120 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.72 0.295 . . . . 63.32 111.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 64.430000000000007 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 63.229999999999997 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.540000000000006 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 70.040000000000006 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.409999999999997 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.120000000000005 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.310000000000002 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 64.120000000000005 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 74.510000000000005 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.310000000000002 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.010000000000005 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.109999999999999 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.239999999999995 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.492 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 10.2 p30 -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.109999999999999 110.625 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.039999999999999 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 63.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.319999999999993 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 72.25 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.445 ' HH ' ' HD1' ' A' ' 113' ' ' TYR . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 73.030000000000001 110.441 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.904 ' CE1' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.109999999999999 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 71.299999999999997 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.566 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.409999999999997 110.439 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.109999999999999 110.538 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.329999999999998 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.562 HG12 HG23 ' A' ' 109' ' ' VAL . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.58 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.129999999999995 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.140000000000001 110.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.319999999999993 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' ALA . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.340000000000003 111.252 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.340000000000003 110.032 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 73.310000000000002 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 40.130000000000003 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 63.210000000000001 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.219999999999999 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.494 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.140000000000001 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.821 HG23 ' CA ' ' A' ' 126' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 43.210000000000001 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG12 ' N ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.219999999999999 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 54.130000000000003 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 64.319999999999993 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.036 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.549999999999997 110.365 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.109999999999999 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.494 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 60.340000000000003 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.409999999999997 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 63.229999999999997 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.666 ' H ' HD12 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.200000000000003 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 71.329999999999998 110.671 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.430000000000007 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.946 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' N ' HG13 ' A' ' 32' ' ' VAL . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.120000000000005 110.733 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.510000000000005 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.019999999999996 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 4.8 m170 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 62.350000000000001 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.510000000000005 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 72.040000000000006 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.030000000000001 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.430000000000007 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.816 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 54.009999999999998 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.521 ' NH1' ' HZ3' ' A' ' 46' ' ' LYS . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.209999999999994 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.816 HD22 ' H ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.400000000000006 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CE2' HG11 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.420000000000002 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.230000000000004 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.784 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 73.329999999999998 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 51' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 53.109999999999999 111.706 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 75.510000000000005 111.048 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 72.409999999999997 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.723 ' C ' HD13 ' A' ' 61' ' ' ILE . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 54.32 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.65 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' TYR . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 71.019999999999996 110.85 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.219999999999999 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 64' ' ' THR . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.519999999999996 110.636 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.219999999999999 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 64.430000000000007 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 22.25 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 72.140000000000001 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HA ' HG21 ' A' ' 76' ' ' VAL . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 110.373 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 64.420000000000002 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.049999999999997 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 33.520000000000003 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' ILE . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.216 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 70' ' ' HIS . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 44.32 111.155 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 55.340000000000003 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.129999999999995 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.340000000000003 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 80' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 61.0 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.140000000000001 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 63' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 53.229999999999997 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.310000000000002 111.075 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 62.43 110.656 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 45.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.099999999999994 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 54.109999999999999 110.413 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.430000000000007 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.430000000000007 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.430000000000007 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.150000000000006 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.549999999999997 110.344 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.425 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.120000000000005 111.714 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 52.509999999999998 110.15 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 31.199999999999999 110.582 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 71.239999999999995 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 55.439999999999998 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.129999999999995 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.400000000000006 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 111.272 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 65.299999999999997 111.452 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 71.420000000000002 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.109999999999999 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.539999999999999 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 3' ' ' VAL . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.969 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.040000000000006 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.209999999999994 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 114' ' ' ILE . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 72.310000000000002 111.136 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.742 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 73.040000000000006 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.529 HD11 HD21 ' A' ' 112' ' ' LEU . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 72.430000000000007 110.616 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 54.43 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 42.450000000000003 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 153' ' ' TYR . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.129999999999995 110.745 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 117' ' ' ILE . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 55.240000000000002 110.667 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.129999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.219999999999999 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.446 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 61.200000000000003 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.450000000000003 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 99' ' ' ALA . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.821 ' CA ' HG23 ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.219999999999999 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.777 ' HB2' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.340000000000003 109.955 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.531 0.205 . . . . 74.319999999999993 111.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.329999999999998 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 60.399999999999999 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 63.43 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 72.400000000000006 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG23 ' ND1' ' A' ' 156' ' ' HIS . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.03 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 64.239999999999995 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.239999999999995 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 52.210000000000001 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 53.020000000000003 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 71.349999999999994 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 153' ' ' TYR . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.65 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 54.130000000000003 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 63.229999999999997 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 52.229999999999997 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.486 ' ND1' HG23 ' A' ' 140' ' ' VAL . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.140000000000001 110.869 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.742 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.109999999999999 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 71.299999999999997 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.806 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 110.821 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 74.25 110.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.219999999999999 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 HD11 ' A' ' 93' ' ' ILE . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.230000000000004 110.544 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 64.439999999999998 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 95' ' ' ILE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.349999999999994 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.400000000000006 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.230000000000004 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.329999999999998 110.557 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.464 ' HB2' HG22 ' A' ' 114' ' ' ILE . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 111.037 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.329999999999998 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 72.319999999999993 111.349 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.517 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.420000000000002 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 ' CA ' ' A' ' 126' ' ' PHE . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.400000000000006 110.82 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG13 ' H ' ' A' ' 16' ' ' GLY . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.409999999999997 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.517 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.510000000000005 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.239999999999995 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 71.109999999999999 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 110.799 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.933 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 71.299999999999997 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 63.210000000000001 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 53.039999999999999 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.409999999999997 109.947 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 149' ' ' ASN . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 54.210000000000001 110.314 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 53.43 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.140000000000001 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 54.329999999999998 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 61.420000000000002 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 71.120000000000005 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.030000000000001 111.086 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 32' ' ' VAL . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 64.010000000000005 110.761 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.299999999999997 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 42.200000000000003 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.219999999999999 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.200000000000003 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.450000000000003 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 52.100000000000001 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 61.140000000000001 110.869 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 64.430000000000007 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.519999999999996 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.439999999999998 110.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.665 ' O ' HD13 ' A' ' 51' ' ' ILE . 12.2 t-20 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.150000000000006 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.340000000000003 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 55.420000000000002 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 60.340000000000003 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.129999999999995 110.862 179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.801 0.334 . . . . 65.150000000000006 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' HH11 ' A' ' 59' ' ' ARG . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.431 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.349999999999994 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 75' ' ' GLU . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.310000000000002 110.214 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' A' ' 74' ' ' CYS . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 71.25 110.989 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 78' ' ' HIS . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 110.929 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' THR . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 70.510000000000005 110.43 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 61.140000000000001 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 13.6 m-20 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.019999999999996 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.329999999999998 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.109999999999999 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.5 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 55.520000000000003 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 62' ' ' ILE . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 51.340000000000003 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HB3' HG23 ' A' ' 61' ' ' ILE . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.119999999999997 110.152 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 65.530000000000001 111.227 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 109.871 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.340000000000003 110.657 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 65.030000000000001 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.099999999999994 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 64.530000000000001 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 72.510000000000005 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.439999999999998 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HG ' HG12 ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 64.120000000000005 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.465 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.150000000000006 110.69 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.530000000000001 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 72.340000000000003 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 62.210000000000001 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 41.43 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.549999999999997 110.582 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.487 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 35.340000000000003 110.237 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.140000000000001 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 72.5 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 72.109999999999999 111.407 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 102' ' ' TYR . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 73.0 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.430000000000007 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 70.540000000000006 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.723 ' N ' HG22 ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.409999999999997 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 65.209999999999994 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 114' ' ' ILE . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 63.549999999999997 110.695 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.794 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 119' ' ' HIS . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.099999999999994 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.514 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.019999999999996 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 70.329999999999998 110.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 61.100000000000001 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.540000000000006 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.509999999999998 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.430000000000007 110.082 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.673 ' CA ' HG23 ' A' ' 14' ' ' VAL . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.040000000000006 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.651 ' HD1' HG22 ' A' ' 14' ' ' VAL . 1.7 p90 . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.340000000000003 110.128 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.78 0.324 . . . . 61.539999999999999 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.049999999999997 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 72.409999999999997 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.019999999999996 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 42.310000000000002 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 74.439999999999998 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.589 ' CB ' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 70.530000000000001 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 61.539999999999999 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.209999999999994 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.310000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' HD21 ' A' ' 149' ' ' ASN . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.329999999999998 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.439999999999998 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 73.329999999999998 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.547 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 9.2 p30 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.400000000000006 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 53.399999999999999 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.510000000000005 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 63.439999999999998 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.040000000000006 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 65.109999999999999 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.120000000000005 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 61.43 110.659 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 2' ' ' ILE . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.901 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.1 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 70.200000000000003 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 42.520000000000003 110.608 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 70.040000000000006 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.744 ' OD1' ' HB2' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 70.540000000000006 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.149999999999999 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.239999999999995 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.779 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 64.310000000000002 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 55.240000000000002 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 71.5 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.299999999999997 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.310000000000002 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.329999999999998 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.140000000000001 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.099999999999994 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' H ' HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 62.219999999999999 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.219999999999999 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.239999999999995 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.530000000000001 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.400000000000006 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.120000000000005 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 63.240000000000002 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 64.420000000000002 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 62.409999999999997 110.401 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.459 ' N ' HD23 ' A' ' 29' ' ' LEU . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 65.25 111.045 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.239999999999995 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 36' ' ' THR . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.230000000000004 110.284 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 60.450000000000003 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.400000000000006 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.551 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.319999999999993 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 45.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.663 ' HG2' HG22 ' A' ' 93' ' ' ILE . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 41.030000000000001 112.621 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 64.040000000000006 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.209999999999994 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.549999999999997 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 73.219999999999999 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.25 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 65.439999999999998 110.755 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.540000000000006 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 62.100000000000001 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.519999999999996 110.466 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.399 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.219999999999999 110.979 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 121.06 0.457 . . . . 52.350000000000001 111.045 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 71.439999999999998 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.540000000000006 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 64.450000000000003 110.807 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.200000000000003 110.118 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 78' ' ' HIS . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 111.554 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.239999999999995 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.009999999999998 110.441 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.200000000000003 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.430000000000007 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 72.329999999999998 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.439999999999998 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.099999999999994 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 52.340000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.450000000000003 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 64.430000000000007 110.854 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 54.030000000000001 110.09 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.624 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.862 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 63.329999999999998 111.577 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 63.130000000000003 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.039999999999999 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' N ' ' OE1' ' A' ' 82' ' ' GLU . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.120000000000005 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 70.129999999999995 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 53.210000000000001 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 63.229999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' C ' HD13 ' A' ' 93' ' ' ILE . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.741 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 63.200000000000003 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.439999999999998 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.109999999999999 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 97' ' ' GLY . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.555 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.109999999999999 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.614 ' CA ' HE22 ' A' ' 100' ' ' GLN . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 62.439999999999998 110.422 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 71.420000000000002 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.971 ' NE2' ' H ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.200000000000003 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 62.420000000000002 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.310000000000002 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 62.420000000000002 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 72.400000000000006 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 71.430000000000007 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PHE . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' H ' HG23 ' A' ' 3' ' ' VAL . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.109999999999999 110.311 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 73.319999999999993 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.616 ' N ' HD13 ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 52.219999999999999 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 51.329999999999998 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.010000000000005 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 64.25 110.585 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 70.150000000000006 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.140000000000001 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 55.32 110.696 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.779 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 54.409999999999997 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 52.229999999999997 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.420000000000002 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.340000000000003 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.503 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.519999999999996 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.430000000000007 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.130000000000003 110.116 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.814 0.34 . . . . 64.409999999999997 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.430000000000007 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 62.200000000000003 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 64.140000000000001 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 53.130000000000003 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.354 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 60.549999999999997 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.439999999999998 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 62.109999999999999 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 65.319999999999993 109.774 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.340000000000003 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.400000000000006 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 149' ' ' ASN . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 61.109999999999999 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 144' ' ' LEU . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.530000000000001 110.403 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.429 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.420000000000002 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.040000000000006 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.010000000000005 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.439999999999998 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.310000000000002 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 71.019999999999996 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 71.430000000000007 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.540000000000006 110.572 179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 50.530000000000001 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 61.130000000000003 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.120000000000005 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.329999999999998 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.307 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 63.240000000000002 110.702 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB2' HG22 ' A' ' 114' ' ' ILE . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 110.917 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 63.299999999999997 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.310000000000002 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 61.439999999999998 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 72.420000000000002 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 125' ' ' THR . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.230000000000004 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' VAL . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.109999999999999 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.657 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.219999999999999 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.618 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 44.130000000000003 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.627 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.319999999999993 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 153' ' ' TYR . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.346 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 55.030000000000001 110.279 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 25' ' ' LEU . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 63.25 111.727 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.299999999999997 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 34.229999999999997 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 52.329999999999998 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 73.030000000000001 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.456 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 50.210000000000001 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.120000000000005 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.652 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.409999999999997 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 70.209999999999994 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.52 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 53.520000000000003 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.439999999999998 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' HG22 ' A' ' 93' ' ' ILE . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.439999999999998 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.140000000000001 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 63' ' ' VAL . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.230000000000004 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.587 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 50.43 110.6 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.140000000000001 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.587 HD22 ' H ' ' A' ' 44' ' ' GLY . 2.0 m-80 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 65.209999999999994 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.540000000000006 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 52.530000000000001 110.327 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 55.039999999999999 110.15 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 112.217 179.365 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.326 -0.249 . . . . 75.430000000000007 110.326 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.310000000000002 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 50.520000000000003 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 64.340000000000003 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 78' ' ' HIS . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 71.010000000000005 111.043 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.507 ' OG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.530000000000001 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 72.109999999999999 110.631 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.219999999999999 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.209999999999994 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.400000000000006 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 52.329999999999998 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 43.340000000000003 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 64.519999999999996 110.657 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.420000000000002 110.266 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.654 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.349999999999994 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.319999999999993 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 43.130000000000003 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 71.519999999999996 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 54.329999999999998 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 82' ' ' GLU . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 53.219999999999999 110.536 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 61.340000000000003 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.200000000000003 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 93' ' ' ILE . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.030000000000001 110.279 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.319999999999993 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 64.329999999999998 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 39' ' ' HIS . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 110.751 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 65.420000000000002 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.129999999999995 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.450000000000003 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.010000000000005 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.099999999999994 110.548 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.458 HG21 ' HA3' ' A' ' 97' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 53.299999999999997 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 63.109999999999999 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.619 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 63.149999999999999 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.120000000000005 110.755 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 109' ' ' VAL . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 71.230000000000004 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 72.109999999999999 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 65.430000000000007 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 106' ' ' LEU . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 63.109999999999999 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 109' ' ' VAL . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.420000000000002 110.238 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 5' ' ' PHE . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 64.140000000000001 111.563 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.417 ' C ' HD12 ' A' ' 114' ' ' ILE . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 109.993 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.961 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 64.319999999999993 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 52.210000000000001 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 9' ' ' MET . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 64.150000000000006 110.844 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' OD1' ' A' ' 10' ' ' ASP . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.209999999999994 109.96 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' C ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.129999999999995 111.227 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.421 ' H ' HG22 ' A' ' 117' ' ' ILE . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.414 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.299999999999997 111.118 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.25 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.310000000000002 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 52.43 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 54.039999999999999 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.329999999999998 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.530000000000001 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.040000000000006 109.854 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.87 0.367 . . . . 73.450000000000003 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.435 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 72.140000000000001 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 71.099999999999994 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.109999999999999 110.606 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.239999999999995 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.319999999999993 110.974 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.340000000000003 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 55.25 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.329999999999998 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.239999999999995 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.049999999999997 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.510000000000005 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 72.099999999999994 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 72.030000000000001 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.409999999999997 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.230000000000004 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 65.209999999999994 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 72.5 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.010000000000005 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 63.140000000000001 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 65.549999999999997 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.150000000000006 110.558 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 44.109999999999999 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.419 ' H ' ' HB3' ' A' ' 1' ' ' MET . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 110.298 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.549999999999997 110.893 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.530000000000001 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.540000000000006 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.150000000000006 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 114' ' ' ILE . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 71.319999999999993 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.400000000000006 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 44.439999999999998 112.088 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 3.9 m-80 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.340000000000003 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.25 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 125' ' ' THR . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 55.130000000000003 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 HG13 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.329999999999998 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.329999999999998 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 70.319999999999993 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.329999999999998 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.409999999999997 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.409999999999997 110.368 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.129999999999995 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.515 ' H ' ' ND2' ' A' ' 149' ' ' ASN . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 63.420000000000002 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 31.440000000000001 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 72.540000000000006 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 71.129999999999995 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.239999999999995 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 72.430000000000007 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.129999999999995 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.239999999999995 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 36' ' ' THR . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.109999999999999 110.605 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 35' ' ' THR . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.430000000000007 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.099999999999994 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.109999999999999 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.239999999999995 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.200000000000003 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 64.200000000000003 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 61.299999999999997 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.140000000000001 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.729 HH21 ' CB ' ' A' ' 64' ' ' THR . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 63.130000000000003 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.476 ' O ' HD13 ' A' ' 51' ' ' ILE . 2.5 t30 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.030000000000001 110.227 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.450000000000003 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.329999999999998 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 54.130000000000003 110.454 -179.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.512 ' NE ' HD12 ' A' ' 41' ' ' LEU . 26.4 mtp180 . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.126 -0.324 . . . . 64.310000000000002 110.126 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.010000000000005 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 72.409999999999997 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 62.530000000000001 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 61.329999999999998 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 78' ' ' HIS . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.729 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 64.150000000000006 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 64.549999999999997 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 42.25 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 61.149999999999999 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 61.219999999999999 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.299999999999997 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.239999999999995 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.200000000000003 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 62.109999999999999 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.430000000000007 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.526 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.310000000000002 110.652 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.120000000000005 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 52.399999999999999 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 71.409999999999997 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 63.140000000000001 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.549999999999997 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 64.219999999999999 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 64.219999999999999 110.882 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.319999999999993 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.450000000000003 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' ILE . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 71.230000000000004 110.509 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 41.399999999999999 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.310000000000002 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 95' ' ' ILE . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 63.219999999999999 110.717 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 61.219999999999999 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.340000000000003 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.049999999999997 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 52.420000000000002 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.678 HG22 ' CZ ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 41.32 110.302 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 65.340000000000003 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.450000000000003 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 104' ' ' LEU . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 62.340000000000003 111.157 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 62.219999999999999 111.915 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.564 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 64.430000000000007 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 63.32 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 3' ' ' VAL . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 71.129999999999995 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 70.150000000000006 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 54.32 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 71.230000000000004 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 54.130000000000003 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 60.229999999999997 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 117' ' ' ILE . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 74.319999999999993 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.120000000000005 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.040000000000006 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 12' ' ' ASN . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 41.130000000000003 110.332 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 17' ' ' LYS . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 71.129999999999995 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 61.109999999999999 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 64.450000000000003 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.209999999999994 110.2 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 63.329999999999998 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 70.530000000000001 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.229999999999997 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.140000000000001 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 71.310000000000002 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 62.439999999999998 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 54.109999999999999 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 71.310000000000002 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.430000000000007 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 65.030000000000001 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 14.6 m-80 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 70.420000000000002 110.846 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 61.299999999999997 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.129999999999995 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 70.530000000000001 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 73.239999999999995 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.140000000000001 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 72.5 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 60.119999999999997 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.696 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 5.8 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.319999999999993 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.319999999999993 110.615 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 63.43 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 64.340000000000003 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 93' ' ' ILE . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.019999999999996 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.099999999999994 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.400000000000006 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.239999999999995 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.140000000000001 110.077 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.420000000000002 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 1.8 m120 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 42.340000000000003 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.109999999999999 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 125' ' ' THR . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 52.25 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.799 HG12 HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.430000000000007 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 70.129999999999995 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.049999999999997 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 10.2 p30 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.430000000000007 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 63.109999999999999 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.329999999999998 111.28 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.150000000000006 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.674 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.109999999999999 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 72.109999999999999 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.120000000000005 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.629 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.209999999999994 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.778 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.400000000000006 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.340000000000003 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 33' ' ' LYS . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 64.530000000000001 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.657 ' N ' HG13 ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 70.0 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 72.109999999999999 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 64.439999999999998 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 54.450000000000003 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 64.200000000000003 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 53.43 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 62.009999999999998 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 62.030000000000001 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 95' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.979 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.530000000000001 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 74.140000000000001 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.120000000000005 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.120000000000005 111.057 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 62.219999999999999 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 73.109999999999999 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 62.329999999999998 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 71.239999999999995 110.673 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.911 0.386 . . . . 63.100000000000001 110.444 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.129999999999995 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.510000000000005 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 65.120000000000005 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 74' ' ' CYS . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 53.539999999999999 110.442 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 78' ' ' HIS . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 63.310000000000002 110.872 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 70.540000000000006 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 63.509999999999998 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 6.1 m120 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.519999999999996 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.140000000000001 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 74.209999999999994 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 62.229999999999997 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 63.329999999999998 111.203 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.129999999999995 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 72.329999999999998 110.795 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.540000000000006 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 72.109999999999999 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.439999999999998 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.299999999999997 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 85' ' ' GLU . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 110.978 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 63.420000000000002 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 64.010000000000005 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 61.549999999999997 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.329999999999998 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.230000000000004 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.099999999999994 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.200000000000003 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 42' ' ' ILE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.592 ' O ' ' CG ' ' A' ' 96' ' ' PHE . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 62.039999999999999 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 62.030000000000001 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 42.240000000000002 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 43.329999999999998 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' ILE . 5.0 pt20 -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 72.109999999999999 110.637 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.461 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.239999999999995 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.109999999999999 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.776 ' O ' HG12 ' A' ' 109' ' ' VAL . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.577 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 72.540000000000006 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.150000000000006 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 105' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.447 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.409999999999997 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.430000000000007 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.495 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 62.299999999999997 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 112' ' ' LEU . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 71.230000000000004 110.641 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 119' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 71.129999999999995 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.964 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.636 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.099999999999994 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 62.43 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 70.010000000000005 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.821 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 74.239999999999995 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.120000000000005 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.803 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.491 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.329 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.823 0.344 . . . . 63.109999999999999 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 70.140000000000001 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.310000000000002 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 62.32 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.200000000000003 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.728 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.239999999999995 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 54.43 110.753 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.150000000000006 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 63.039999999999999 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.230000000000004 110.727 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.507 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.120000000000005 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.561 ' C ' HD22 ' A' ' 149' ' ' ASN . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.627 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.561 HD22 ' C ' ' A' ' 148' ' ' LYS . 2.0 m-80 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.310000000000002 110.538 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.530000000000001 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.120000000000005 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 71.349999999999994 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.540000000000006 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 42.200000000000003 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 62.450000000000003 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 74.109999999999999 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.577 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.439999999999998 110.51 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.530000000000001 110.567 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 63.130000000000003 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 63.25 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 93' ' ' ILE . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 54.520000000000003 110.358 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 55.100000000000001 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 110.418 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 63.039999999999999 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.219999999999999 110.74 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 71.129999999999995 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 63.43 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.825 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.129999999999995 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 125' ' ' THR . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.030000000000001 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.420000000000002 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 54.329999999999998 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.030000000000001 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 64.219999999999999 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.140000000000001 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 51.219999999999999 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.129999999999995 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' OD1' ' A' ' 149' ' ' ASN . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 61.340000000000003 110.36 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.310000000000002 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.140000000000001 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 60.229999999999997 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 72.340000000000003 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 36' ' ' THR . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 32.200000000000003 110.573 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 70.030000000000001 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 62.240000000000002 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 65.530000000000001 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.150000000000006 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.530000000000001 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.369 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.430000000000007 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 42' ' ' ILE . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 71.140000000000001 109.988 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.430000000000007 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 60.020000000000003 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.329999999999998 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.099999999999994 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 54.420000000000002 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 72.420000000000002 110.948 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.430000000000007 111.366 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.316 0.579 . . . . 73.209999999999994 109.979 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 65.049999999999997 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.662 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 72.25 110.715 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 63.310000000000002 110.113 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 78' ' ' HIS . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.120000000000005 110.986 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.547 HG21 ' CD2' ' A' ' 69' ' ' TYR . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.200000000000003 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 64.340000000000003 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 64' ' ' THR . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 64.120000000000005 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 62.200000000000003 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.200000000000003 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.099999999999994 110.409 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.120000000000005 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 51.119999999999997 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 30.129999999999999 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.585 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.239999999999995 110.65 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.219999999999999 110.878 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 70.540000000000006 110.597 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 42.210000000000001 110.634 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 86' ' ' LEU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 53.109999999999999 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 110.752 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 72.439999999999998 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.230000000000004 110.71 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.431 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.530000000000001 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 64.540000000000006 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.109999999999999 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.310000000000002 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 3' ' ' VAL . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.577 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 42.329999999999998 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 54.200000000000003 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 63.420000000000002 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 51.140000000000001 110.189 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.310000000000002 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.198 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.875 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.420000000000002 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.219999999999999 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 70.329999999999998 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.540000000000006 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.010000000000005 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.109999999999999 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 5' ' ' PHE . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 73.230000000000004 110.787 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.616 HG21 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.150000000000006 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 55.439999999999998 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 60.219999999999999 110.657 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.349999999999994 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.140000000000001 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.825 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 62.229999999999997 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 44.539999999999999 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.319999999999993 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.753 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 65.329999999999998 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.120000000000005 109.753 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.4 t30 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.736 0.303 . . . . 73.319999999999993 110.813 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 72.019999999999996 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 64.450000000000003 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.310000000000002 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 73.299999999999997 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 54.119999999999997 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.409999999999997 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 64.140000000000001 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 144' ' ' LEU . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 63.100000000000001 110.444 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.239999999999995 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.150000000000006 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.140000000000001 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.450000000000003 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.430000000000007 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.230000000000004 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.41 ' C ' ' CD2' ' A' ' 156' ' ' HIS . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 62.149999999999999 110.4 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 156' ' ' HIS . 3.2 m-70 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.530000000000001 110.679 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.230000000000004 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.329999999999998 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 1.7 pm0 -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 63.310000000000002 110.576 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.030000000000001 110.515 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 44.219999999999999 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.340000000000003 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 45.020000000000003 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 71.299999999999997 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 52.0 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 72.040000000000006 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.510000000000005 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.140000000000001 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 42.350000000000001 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 125' ' ' THR . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 73.230000000000004 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 125' ' ' THR . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 54.340000000000003 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.239999999999995 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 63.329999999999998 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.67 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 70.329999999999998 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 0.7 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 63.520000000000003 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 63.409999999999997 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.209999999999994 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.200000000000003 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 71.409999999999997 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.755 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 73.310000000000002 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 64.140000000000001 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.450000000000003 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 53.340000000000003 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.230000000000004 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.230000000000004 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 110.592 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.510000000000005 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.219999999999999 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 63.100000000000001 110.48 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 32' ' ' VAL . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.140000000000001 110.455 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.049999999999997 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 65.010000000000005 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.109999999999999 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 63.200000000000003 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 95' ' ' ILE . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 64.140000000000001 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 54.109999999999999 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 44.310000000000002 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 72.049999999999997 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 54.109999999999999 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 97' ' ' GLY . 92.0 m-20 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.420000000000002 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 71.010000000000005 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.319999999999993 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.445 HD11 ' ND2' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 45.420000000000002 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.209999999999994 110.487 -179.556 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 110.841 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 70.319999999999993 110.878 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.456 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.299999999999997 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' HIS . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.420000000000002 111.546 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 72.030000000000001 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 16.0 m-80 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 70.400000000000006 110.531 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.200000000000003 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 61.119999999999997 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 63.5 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 61.549999999999997 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 64.25 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 70.540000000000006 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 54.43 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 72.420000000000002 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.799 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.409999999999997 110.741 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.299999999999997 110.715 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.129999999999995 110.413 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.140000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.299999999999997 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 83' ' ' VAL . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 70.510000000000005 110.534 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.439999999999998 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.109999999999999 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 61.039999999999999 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 93' ' ' ILE . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 62.210000000000001 111.016 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.510000000000005 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.129999999999995 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.532 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' ILE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' O ' ' C ' ' A' ' 97' ' ' GLY . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 54.039999999999999 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.200000000000003 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 55.439999999999998 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.909 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.636 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 55.049999999999997 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.120000000000005 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 72.140000000000001 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.537 ' CD2' HG11 ' A' ' 80' ' ' VAL . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.407 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 60.109999999999999 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 54.310000000000002 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.019999999999996 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 109' ' ' VAL . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 53.329999999999998 110.733 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.4 ' N ' HG22 ' A' ' 109' ' ' VAL . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.040000000000006 109.819 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 72.549999999999997 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.452 ' CD2' HD11 ' A' ' 114' ' ' ILE . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 74.239999999999995 110.708 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.200000000000003 110.546 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 112' ' ' LEU . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 110.753 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 50.43 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.299999999999997 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.430000000000007 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.420000000000002 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.530000000000001 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.637 ' H ' HH21 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.409999999999997 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.439999999999998 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 62.109999999999999 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 71.340000000000003 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.693 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.420000000000002 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.511 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.239999999999995 110.149 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.832 0.349 . . . . 73.219999999999999 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.535 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.120000000000005 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.150000000000006 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 71.230000000000004 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 71.140000000000001 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.200000000000003 110.685 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 61.310000000000002 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.209999999999994 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 62.439999999999998 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.319999999999993 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.573 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 71.439999999999998 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 64.109999999999999 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.420000000000002 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.691 ' OH ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.546 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 110.919 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.420000000000002 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 63.020000000000003 110.292 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 73.239999999999995 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.391 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.209999999999994 110.618 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 44.119999999999997 110.647 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.010000000000005 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 93' ' ' ILE . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 71.329999999999998 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.598 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.439999999999998 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 44.450000000000003 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' HH21 ' A' ' 24' ' ' ARG . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 64.25 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 54.25 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.319999999999993 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 72.010000000000005 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 70.310000000000002 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 125' ' ' THR . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 63.409999999999997 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 HG13 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.510000000000005 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.310000000000002 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 63.210000000000001 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 55.340000000000003 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.450000000000003 109.891 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.552 HD21 ' CG1' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.219999999999999 110.306 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.978 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.409999999999997 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.439999999999998 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.040000000000006 110.535 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.598 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.209999999999994 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 153' ' ' TYR . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 110.466 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.109999999999999 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.439999999999998 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.439999999999998 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 61.210000000000001 111.096 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 60.5 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 73.25 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.519999999999996 111.301 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.420000000000002 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.150000000000006 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.230000000000004 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 110.59 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.030000000000001 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.439999999999998 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 55.439999999999998 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 71.109999999999999 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.020000000000003 110.53 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 71.439999999999998 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 42.100000000000001 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.310000000000002 110.454 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 63.200000000000003 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.456 ' OD1' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.230000000000004 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.439999999999998 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 64.239999999999995 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 72.310000000000002 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' ASN . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 72.140000000000001 109.793 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.319999999999993 111.382 179.448 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.513 0.197 . . . . 73.140000000000001 110.713 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.319999999999993 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.239999999999995 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 63.149999999999999 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 74' ' ' CYS . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.210000000000001 111.03 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 78' ' ' HIS . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 64.420000000000002 110.86 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.641 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 1.2 m120 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 52.039999999999999 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.519999999999996 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.450000000000003 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.519999999999996 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 2.3 p80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 70.019999999999996 110.536 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.140000000000001 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 74.409999999999997 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.099999999999994 110.645 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 64' ' ' THR . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 51.340000000000003 110.703 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 60.020000000000003 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.120000000000005 110.824 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.6 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 33.109999999999999 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.6 ' N ' ' OG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 61.030000000000001 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.140000000000001 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.433 HG21 HG21 ' A' ' 63' ' ' VAL . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.931 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 55.509999999999998 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 70.400000000000006 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 63.420000000000002 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.329999999999998 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 71.439999999999998 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.099999999999994 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 3' ' ' VAL . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 72.519999999999996 110.118 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.109999999999999 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 42' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 54.530000000000001 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 97' ' ' GLY . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.140000000000001 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.329999999999998 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 45.539999999999999 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.120000000000005 111.27 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 73.120000000000005 111.15 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 64.439999999999998 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.219999999999999 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 105' ' ' PHE . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 65.409999999999997 111.172 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 65.340000000000003 111.172 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 62.049999999999997 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.439999999999998 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 61.329999999999998 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 105' ' ' PHE . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 65.439999999999998 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.511 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.129999999999995 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.010000000000005 110.673 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.140000000000001 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 112' ' ' LEU . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 60.329999999999998 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.129999999999995 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.040000000000006 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.349999999999994 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 64.519999999999996 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.447 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.140000000000001 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.120000000000005 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.439999999999998 111.038 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.329999999999998 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.425 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.420000000000002 109.901 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.848 0.356 . . . . 70.239999999999995 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.497 ' CZ2' HD12 ' A' ' 112' ' ' LEU . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.019999999999996 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.109999999999999 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 61.030000000000001 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 73.230000000000004 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 54.530000000000001 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.210000000000001 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 73.019999999999996 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 72.329999999999998 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 62.32 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.530000000000001 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 62.049999999999997 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.530000000000001 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.310000000000002 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 74.5 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 25' ' ' LEU . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.109999999999999 111.434 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.439999999999998 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 74.4 m80 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 72.219999999999999 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 64.349999999999994 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.319999999999993 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 65.25 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 62.539999999999999 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.040000000000006 110.572 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.219999999999999 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.430000000000007 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.150000000000006 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CE1' HG13 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 71.140000000000001 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.219999999999999 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.150000000000006 109.317 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.439999999999998 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.129999999999995 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 65.209999999999994 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.319999999999993 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG12 ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 72.450000000000003 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.519999999999996 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 52.329999999999998 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.0 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.319999999999993 109.336 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 18' ' ' ASP . 9.0 p30 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.349999999999994 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.864 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.129999999999995 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 62.219999999999999 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 72.019999999999996 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 25' ' ' LEU . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.400000000000006 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.040000000000006 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.32 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 73.530000000000001 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.510000000000005 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 70.510000000000005 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.450000000000003 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 33' ' ' LYS . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.510000000000005 110.366 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 32' ' ' VAL . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 62.350000000000001 111.274 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.299999999999997 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.530000000000001 110.527 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 35' ' ' THR . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.140000000000001 110.95 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 62.109999999999999 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.450000000000003 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 71.519999999999996 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.430000000000007 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.319999999999993 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.010000000000005 110.578 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.209999999999994 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' HD22 ' A' ' 47' ' ' ASN . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 25.149999999999999 110.771 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 71.400000000000006 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 72.450000000000003 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 44' ' ' GLY . 3.0 m-80 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 62.119999999999997 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.230000000000004 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 70.120000000000005 110.662 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.230000000000004 111.147 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 58' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.687 0.279 . . . . 70.409999999999997 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.420000000000002 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 110.964 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 77' ' ' ALA . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 51.030000000000001 110.307 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' HIS . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 52.399999999999999 111.067 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 73.299999999999997 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 72.129999999999995 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 9.4 m-80 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 43.009999999999998 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 34.109999999999999 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 62.130000000000003 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.019999999999996 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 32.329999999999998 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.349999999999994 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 55.420000000000002 109.99 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.657 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 73.200000000000003 110.877 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 64.420000000000002 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.420000000000002 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.329999999999998 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.109999999999999 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 62.25 110.654 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.010000000000005 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.340000000000003 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 52.219999999999999 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.549999999999997 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.430000000000007 110.502 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 65.329999999999998 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.57 ' CD1' HD13 ' A' ' 42' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.099999999999994 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.209999999999994 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.492 ' H ' HD11 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 41.210000000000001 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 65.310000000000002 111.105 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.239999999999995 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.019999999999996 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.400000000000006 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.635 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 61.43 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.040000000000006 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 63.310000000000002 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 71.439999999999998 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 72.209999999999994 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 51.530000000000001 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 73.200000000000003 110.394 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 72.549999999999997 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.719 HD11 HD13 ' A' ' 112' ' ' LEU . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 52.399999999999999 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 63.119999999999997 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.546 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.109999999999999 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 62.43 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.420000000000002 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.140000000000001 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.430000000000007 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.679 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.010000000000005 110.4 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 70.209999999999994 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.9 t80 . . . . . 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 70.329999999999998 109.689 179.036 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.751 0.31 . . . . 71.040000000000006 110.804 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 110.483 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.510000000000005 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 61.049999999999997 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.340000000000003 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.519999999999996 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.099999999999994 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.409999999999997 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 145' ' ' THR . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 72.239999999999995 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.049999999999997 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.140000000000001 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 65.409999999999997 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.209999999999994 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 70.439999999999998 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 65.310000000000002 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.450000000000003 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.692 ' C ' ' ND1' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.310000000000002 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.540000000000006 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 70.299999999999997 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.310000000000002 110.591 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.239999999999995 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 2' ' ' ILE . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.651 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.530000000000001 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 55.119999999999997 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 64.25 110.249 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 61.310000000000002 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' ALA . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 60.539999999999999 110.747 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 7' ' ' VAL . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 110.891 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.040000000000006 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD22 ' A' ' 12' ' ' ASN . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.400000000000006 111.858 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 11' ' ' GLU . 3.2 m-80 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 74.129999999999995 111.9 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.85 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.349999999999994 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.692 HG13 HG12 ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.319999999999993 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.692 HG12 HG13 ' A' ' 14' ' ' VAL . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.319999999999993 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.435 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.099999999999994 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.349999999999994 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.150000000000006 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.510000000000005 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.511 HD21 HG12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.393 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 62.439999999999998 110.017 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.310000000000002 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.019999999999996 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 61.119999999999997 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.329999999999998 110.224 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 71.430000000000007 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.129999999999995 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 74.109999999999999 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.409999999999997 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 36' ' ' THR . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 65.140000000000001 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.68 ' N ' HG13 ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.150000000000006 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 72.349999999999994 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.530000000000001 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.439999999999998 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.544 ' O ' ' CG ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.519999999999996 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.350000000000001 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.409999999999997 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.420000000000002 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.486 HG23 HG23 ' A' ' 63' ' ' VAL . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.230000000000004 110.54 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 64.239999999999995 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 25.449999999999999 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 55.229999999999997 110.604 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.420000000000002 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 44.039999999999999 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.511 HG12 HD21 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 71.109999999999999 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.209999999999994 110.71 -179.788 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.699 0.285 . . . . 73.409999999999997 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 63.539999999999999 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 71.030000000000001 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 65.129999999999995 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 72.340000000000003 110.649 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 78' ' ' HIS . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.030000000000001 110.697 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.585 ' CA ' ' HE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 61.299999999999997 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 8.9 m-80 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.794 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 72.519999999999996 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.230000000000004 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 64' ' ' THR . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.239999999999995 110.518 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.209999999999994 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.420000000000002 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 63.450000000000003 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.596 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 62.450000000000003 110.595 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.673 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 60.399999999999999 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 64.510000000000005 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 70.510000000000005 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.200000000000003 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.894 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.530000000000001 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.420000000000002 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.420000000000002 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.662 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.540000000000006 110.211 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.579 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.310000000000002 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.530000000000001 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 43.509999999999998 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 65.120000000000005 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.442 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.219999999999999 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.140000000000001 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 109' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.340000000000003 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.409999999999997 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 63.549999999999997 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 105' ' ' PHE . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.302 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.430000000000007 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 63.340000000000003 110.06 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.139 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 55.509999999999998 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 112' ' ' LEU . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.519999999999996 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 62.420000000000002 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.340000000000003 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 70.329999999999998 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.129999999999995 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 54.5 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 71.299999999999997 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 55.439999999999998 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.85 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 61.32 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 64.019999999999996 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.643 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.099999999999994 110.574 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.109999999999999 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.421 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.227 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.727 0.299 . . . . 64.420000000000002 110.781 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.467 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.400000000000006 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 61.119999999999997 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.340000000000003 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 63.119999999999997 111.012 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.219999999999999 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.109999999999999 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.310000000000002 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.530000000000001 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.010000000000005 110.427 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.200000000000003 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.540000000000006 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.230000000000004 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.430000000000007 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 62.420000000000002 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 71.049999999999997 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 45.350000000000001 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.530000000000001 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.409999999999997 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 71.230000000000004 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 70.530000000000001 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.406 -0.59 . . . . 74.200000000000003 109.406 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.7 mt -124.58 120.26 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.387 . . . . 53.530000000000001 110.678 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -108.79 114.67 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 74.120000000000005 110.464 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.4 p -102.13 142.69 32.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 54.009999999999998 110.851 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' A' ' 112' ' ' LEU . 4.1 t80 -132.45 129.85 39.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 72.310000000000002 110.134 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.596 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 14.9 ttt -113.46 123.69 50.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.735 0.302 . . . . 62.399999999999999 110.935 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -143.66 143.65 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.418 . . . . 70.329999999999998 110.971 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.701 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -92.58 -176.54 4.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 63.25 110.126 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.533 ' C ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -154.75 102.08 2.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.528 -0.305 . . . . 42.32 110.664 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.9 131.05 36.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.981 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -58.24 -30.19 66.34 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.03 -0.532 . . . . 55.219999999999999 111.867 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 23.7 m-80 -109.83 -7.08 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 74.030000000000001 110.544 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -134.78 -132.31 0.16 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.646 -0.872 . . . . 63.219999999999999 108.646 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 125' ' ' THR . 3.6 p -154.04 -42.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.042 -0.412 . . . . 74.450000000000003 109.914 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 99' ' ' ALA . 25.4 pt -152.8 -45.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.552 -0.459 . . . . 54.130000000000003 110.725 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -87.27 86.66 1.53 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.264 -1.135 . . . . 61.420000000000002 110.264 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.0 pttm -75.3 -32.39 60.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.758 0.313 . . . . 71.329999999999998 110.83 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 20' ' ' ASN . 46.1 t0 -168.13 70.56 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 65.430000000000007 110.341 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 51.0 t30 74.99 -15.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 109.841 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 18' ' ' ASP . 12.2 p30 -151.4 179.75 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 75.439999999999998 110.491 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -101.57 154.63 37.14 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.938 -0.574 . . . . 71.420000000000002 110.7 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' CG ' ' CD1' ' A' ' 117' ' ' ILE . 10.0 Cg_endo -57.1 -161.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.729 2.286 . . . . 65.219999999999999 112.134 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 1.182 ' CD1' ' H2B' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -167.65 144.29 4.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 110.055 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.03 157.77 44.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.865 0.364 . . . . 71.140000000000001 110.871 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 ' H ' ' A' ' 25' ' ' LEU . 3.7 mm? 38.43 66.17 2.7 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.663 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.423 ' HD3' HD21 ' A' ' 149' ' ' ASN . 9.7 Cg_endo -55.76 -17.95 19.72 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.246 1.964 . . . . 73.310000000000002 111.471 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 m -78.95 -43.06 25.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 63.43 109.936 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -59.51 -37.65 78.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 74.019999999999996 110.173 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.829 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -59.09 -31.8 69.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 72.319999999999993 110.696 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 55.6 mm-40 -78.03 -47.01 19.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 55.43 110.842 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -57.39 -51.27 70.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.306 -0.406 . . . . 71.450000000000003 110.737 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -63.66 -45.39 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 44.210000000000001 110.787 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.587 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.4 tmmt? -61.42 -35.19 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 70.319999999999993 110.967 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -73.86 -35.22 64.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.377 -0.374 . . . . 72.319999999999993 111.183 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.57 -27.91 28.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.829 -0.348 . . . . 72.219999999999999 110.727 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 37' ' ' MET . 52.2 p -96.61 -15.28 21.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 74.040000000000006 110.312 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.451 ' C ' ' O ' ' A' ' 36' ' ' THR . 0.3 OUTLIER -33.67 110.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 65.439999999999998 110.519 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.11 -14.5 6.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.971 -0.852 . . . . 71.340000000000003 110.971 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -79.2 146.02 66.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.848 0.356 . . . . 64.099999999999994 110.596 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.26 134.5 27.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.837 2.358 . . . . 74.409999999999997 112.206 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -126.71 121.09 31.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 110.523 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.8 mp -105.89 125.35 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 62.43 110.386 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.41 ' HB3' HD21 ' A' ' 47' ' ' ASN . 15.6 mtm -137.46 163.01 32.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 74.420000000000002 110.483 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.79 ' H ' ' ND2' ' A' ' 47' ' ' ASN . . . -83.28 143.42 21.89 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.684 -0.966 . . . . 52.149999999999999 110.684 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.543 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 37.4 ptt85 -61.47 -31.13 71.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 74.099999999999994 110.649 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -64.68 -48.55 74.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.527 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.008 ' CB ' ' H2D' ' A' ' 173' ' ' NAP . 6.1 p30 -71.17 -42.63 68.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 71.340000000000003 110.486 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CE1' ' O ' ' A' ' 52' ' ' GLY . 85.4 t80 -66.53 -31.3 71.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.568 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 45' ' ' ARG . 7.7 mm-40 -68.71 -52.58 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.068 -0.514 . . . . 64.430000000000007 110.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.62 -52.37 64.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 53.039999999999999 110.553 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.56 HD13 ' NH2' ' A' ' 53' ' ' ARG . 14.3 mt -70.33 -55.0 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.615 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.624 ' O ' ' CE1' ' A' ' 48' ' ' TYR . . . 96.83 -70.02 0.82 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.891 -0.884 . . . . 51.43 110.891 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.082 ' NH2' H11A ' A' ' 174' ' ' N22 . 60.1 mtt180 55.01 138.58 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 121.008 -0.277 . . . . 71.239999999999995 110.548 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' O ' HD12 ' A' ' 55' ' ' LEU . 53.4 Cg_endo -74.25 -85.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.288 1.992 . . . . 73.030000000000001 111.897 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -152.93 61.44 3.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.313 0.578 . . . . 72.239999999999995 109.972 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.39 116.81 4.41 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.714 2.276 . . . . 74.209999999999994 111.556 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.76 3.51 73.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.313 -1.115 . . . . 61.200000000000003 110.313 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 54.08 17.78 1.52 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.999 0.428 . . . . 73.129999999999995 110.456 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 59' ' ' ARG . 18.4 mmt-85 -151.03 60.79 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.302 -0.559 . . . . 73.219999999999999 111.017 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.461 ' ND2' ' SG ' ' A' ' 74' ' ' CYS . 21.2 p-10 -85.74 109.04 18.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 72.450000000000003 110.387 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 41' ' ' LEU . 3.8 mt -114.06 129.11 70.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.116 -0.493 . . . . 75.430000000000007 110.337 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -113.64 132.24 63.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 63.219999999999999 111.13 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -85.87 120.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.814 -0.63 . . . . 73.420000000000002 110.391 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.1 t -151.47 141.59 22.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.329 -0.396 . . . . 65.049999999999997 110.734 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -103.78 108.87 20.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 63.310000000000002 110.386 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 p30 179.2 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 71.319999999999993 110.538 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.73 131.92 50.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.209999999999994 110.619 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.67 4.71 63.57 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.191 -0.764 . . . . 71.349999999999994 111.191 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.402 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 49.0 t80 -108.77 145.45 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 73.150000000000006 110.781 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HA ' HG21 ' A' ' 76' ' ' VAL . 55.9 m-70 -149.28 133.63 17.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 75.230000000000004 110.324 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.16 111.9 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.392 . . . . 74.319999999999993 110.693 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -68.52 127.83 34.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 70.239999999999995 110.425 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.97 -11.77 41.08 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.756 -0.938 . . . . 74.510000000000005 110.756 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' SG ' ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -146.64 160.55 42.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.748 0.309 . . . . 73.430000000000007 110.504 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -90.59 145.3 24.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 70.549999999999997 110.455 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 70' ' ' HIS . 69.5 t -95.16 134.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.736 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 155.89 45.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 61.399999999999999 110.41 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -177.8 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 60.119999999999997 110.624 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.467 ' OG ' ' C2A' ' A' ' 173' ' ' NAP . 4.4 t -56.66 -173.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 71.129999999999995 110.611 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.412 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -57.37 -21.18 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.776 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -57.48 -45.76 84.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.892 0.377 . . . . 73.319999999999993 110.148 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -75.54 -46.48 31.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.97 -0.559 . . . . 62.520000000000003 110.489 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 t -58.97 -34.05 51.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 70.219999999999999 110.722 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -55.16 24.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.104 -0.498 . . . . 75.040000000000006 110.535 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 86' ' ' LEU . 13.8 pt-20 -73.16 -37.68 66.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 75.219999999999999 110.61 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.9 OUTLIER -53.24 -25.31 13.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 65.400000000000006 110.728 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.05 -49.82 75.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.708 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.36 -6.44 7.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 64.409999999999997 110.676 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -75.96 -28.88 58.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.636 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -137.01 139.31 41.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 75.040000000000006 110.6 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 110.812 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -97.08 117.21 30.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 60.149999999999999 110.763 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -119.18 145.53 25.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.364 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.07 132.64 51.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.842 0.353 . . . . 70.439999999999998 110.683 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 mm -122.15 138.82 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 74.340000000000003 110.787 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.817 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.1 OUTLIER -127.84 -44.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 64.0 110.295 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . 40.69 -96.6 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.268 -0.733 . . . . 70.209999999999994 111.268 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 96' ' ' PHE . . . 175.42 -151.32 11.85 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.896 -0.882 . . . . 72.439999999999998 110.896 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -70.85 -62.52 1.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 44.420000000000002 110.89 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.065 ' NE2' H52A ' A' ' 173' ' ' NAP . 0.8 OUTLIER -62.43 -37.93 87.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.978 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.485 HG22 ' CD2' ' A' ' 105' ' ' PHE . 2.9 mm -61.54 -52.8 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 63.420000000000002 110.472 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.33 -41.44 60.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.230000000000004 110.252 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -54.94 -55.19 33.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 72.430000000000007 111.184 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -71.26 -20.11 62.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.864 -0.334 . . . . 64.209999999999994 111.037 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 109' ' ' VAL . 3.4 m-85 -86.75 3.79 43.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.773 0.32 . . . . 52.409999999999997 110.584 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 3.1 tp -56.78 -52.48 73.46 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.275 -0.42 . . . . 73.209999999999994 110.853 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 71.0 Cg_endo -74.69 -11.1 22.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.346 2.031 . . . . 75.510000000000005 112.695 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.446 ' CD1' ' HG2' ' A' ' 107' ' ' PRO . 97.0 m-85 -99.19 -9.32 23.87 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.833 -0.347 . . . . 65.420000000000002 111.282 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 105' ' ' PHE . 93.9 t -98.64 143.49 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 70.129999999999995 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -102.49 -40.68 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.039 -0.528 . . . . 70.109999999999999 110.057 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -137.07 129.83 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.576 . . . . 64.230000000000004 109.977 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 5' ' ' PHE . 2.9 tt -124.89 152.36 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 52.200000000000003 111.175 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -123.51 143.21 50.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.929 -0.578 . . . . 54.130000000000003 109.986 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.695 ' CD1' ' CG ' ' A' ' 158' ' ' TYR . 2.7 mp -132.19 132.32 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.79 -0.364 . . . . 75.239999999999995 110.821 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.407 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 87.3 m -115.82 114.56 24.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 110.391 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -91.93 123.0 34.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 74.340000000000003 110.322 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' CG ' ' A' ' 22' ' ' PRO . 38.7 mt -112.27 142.09 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.52 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -95.67 50.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.272 -0.422 . . . . 72.5 110.667 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -165.88 113.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 73.239999999999995 110.528 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.23 136.28 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.537 . . . . 70.219999999999999 110.259 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -154.24 129.21 9.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.357 -0.383 . . . . 71.5 110.641 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 121' ' ' PHE . 55.7 mt-10 44.2 106.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.441 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 16' ' ' GLY . . . -137.32 -154.83 6.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.867 -0.683 . . . . 75.239999999999995 111.525 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -112.57 -33.22 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.57 0.224 . . . . 73.329999999999998 111.121 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.698 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.5 m -128.16 114.33 16.86 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 120.804 -0.358 . . . . 43.229999999999997 110.91 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.482 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 4.2 p90 -116.59 132.81 56.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.581 -0.736 . . . . 64.109999999999999 111.021 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -165.66 95.93 0.81 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 109.889 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.16 179.84 6.13 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.442 2.095 . . . . 71.239999999999995 112.637 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -59.48 94.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.802 -0.635 . . . . 55.420000000000002 110.796 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 12.8 mtp -106.66 -49.17 3.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.439999999999998 110.455 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -159.76 111.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 110.599 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.456 ' SD ' ' OH ' ' A' ' 158' ' ' TYR . 26.8 ptt? -131.09 19.64 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 73.519999999999996 110.317 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -68.87 -23.41 64.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 52.420000000000002 110.645 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -59.03 -24.26 62.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.57 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.424 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 80.8 m95 -105.9 166.4 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 64.340000000000003 110.705 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 110.9 8.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 74.209999999999994 110.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.6 148.19 49.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.5 -23.51 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 63.310000000000002 110.799 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -154.44 147.43 24.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 72.299999999999997 110.368 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.4 128.86 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.39 . . . . 50.310000000000002 110.72 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 21.1 tp10 -121.42 145.17 48.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.365 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.75 154.34 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.717 -0.393 . . . . 72.420000000000002 110.533 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.88 -148.54 19.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.04 -0.824 . . . . 63.549999999999997 111.04 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 145' ' ' THR . 33.6 tp -170.36 147.25 3.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.779 0.324 . . . . 70.239999999999995 110.505 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -58.53 -179.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 55.149999999999999 110.403 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -173.96 176.65 2.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 54.219999999999999 110.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -69.21 -44.47 72.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.132 -0.485 . . . . 53.130000000000003 110.635 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.08 -13.97 42.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 75.129999999999995 110.655 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.423 HD21 ' HD3' ' A' ' 26' ' ' PRO . 25.2 m-80 -132.91 76.82 69.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 60.200000000000003 110.617 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.25 34.01 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.664 2.243 . . . . 73.150000000000006 111.945 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -133.29 137.55 46.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.003 -0.544 . . . . 75.420000000000002 110.566 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 100.0 m -87.46 137.05 32.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.549999999999997 110.647 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.5 OUTLIER -142.55 173.94 11.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 75.019999999999996 110.715 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 26.1 m-85 -141.18 143.07 34.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 72.299999999999997 110.652 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.407 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 2.9 t80 -101.46 136.99 40.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 63.219999999999999 110.263 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -127.4 146.76 50.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 110.62 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -110.58 111.8 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 72.450000000000003 110.419 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CG ' ' CD1' ' A' ' 114' ' ' ILE . 2.1 m-85 -102.61 134.22 46.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 110.013 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -131.67 147.25 52.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.95 0.405 . . . . 74.319999999999993 110.982 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.404 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 2.1 mmmt -113.12 174.99 5.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 61.200000000000003 110.394 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -91.55 -52.09 4.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.540000000000006 110.583 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.046 -0.978 . . . . 71.420000000000002 110.512 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.065 H52A ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 1.182 ' H2B' ' CD1' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.576 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.466 -0.568 . . . . 63.109999999999999 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 93' ' ' ILE . 2.6 mt -106.16 117.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 110.884 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.436 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 1.6 t -116.2 103.0 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 70.5 110.278 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.88 152.17 18.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.31 -0.404 . . . . 62.020000000000003 111.012 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.936 ' CE1' HG22 ' A' ' 109' ' ' VAL . 24.1 m-85 -130.77 127.33 38.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 73.219999999999999 110.465 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 ttm -106.69 109.62 21.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 70.150000000000006 110.51 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.41 145.37 33.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.962 0.41 . . . . 53.229999999999997 110.966 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.12 170.01 9.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.51 ' C ' ' SD ' ' A' ' 9' ' ' MET . 7.7 tpp -138.8 107.12 5.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.049999999999997 110.622 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 42.4 m-20 -80.88 131.86 35.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.701 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.11 -27.2 65.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.833 -0.622 . . . . 70.230000000000004 111.971 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -114.14 -2.1 13.51 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.568 -0.453 . . . . 71.409999999999997 111.619 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.755 HH11 ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -142.0 -114.05 0.12 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.592 -0.521 . . . . 44.329999999999998 109.592 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 15' ' ' ILE . 7.3 p -164.38 -41.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 O-C-N 122.091 -0.381 . . . . 70.230000000000004 110.272 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 99' ' ' ALA . 8.8 pt -159.68 -48.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 120.611 -0.435 . . . . 65.409999999999997 110.519 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -72.34 94.55 0.64 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.282 -1.127 . . . . 24.449999999999999 110.282 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' O ' ' CA ' ' A' ' 123' ' ' GLY . 24.9 tttt -92.23 -51.31 5.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.703 0.287 . . . . 70.0 110.736 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.28 76.99 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 63.210000000000001 110.049 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.554 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 7.7 m-20 67.72 5.54 4.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.608 -0.516 . . . . 71.540000000000006 109.608 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 19' ' ' ASN . 13.3 m-20 -170.36 -171.58 1.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.482 -0.781 . . . . 70.409999999999997 110.13 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.897 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -121.24 146.29 44.2 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 110.523 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.68 146.25 88.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.73 2.287 . . . . 70.219999999999999 112.624 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 1.098 ' CD2' ' H7 ' ' A' ' 174' ' ' N22 . 22.2 t-105 -120.33 -175.18 2.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.93 -0.577 . . . . 74.25 110.176 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.699 ' N ' ' CG ' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -148.89 132.85 17.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 74.349999999999994 110.504 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 27' ' ' SER . 2.9 mt 56.82 63.05 5.65 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.018 -0.537 . . . . 74.209999999999994 110.866 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.67 ' CD ' HD21 ' A' ' 149' ' ' ASN . 11.1 Cg_exo -41.61 -18.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.339 2.026 . . . . 71.129999999999995 111.203 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 25' ' ' LEU . 10.8 m -75.63 -44.37 43.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 71.439999999999998 109.921 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' O ' HG12 ' A' ' 32' ' ' VAL . 4.0 tm-20 -60.92 -31.88 71.39 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.245 -0.65 . . . . 75.319999999999993 109.245 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD1' ' H7A' ' A' ' 174' ' ' N22 . 0.1 OUTLIER -57.71 -41.51 81.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.145 -0.934 . . . . 62.049999999999997 110.697 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 30' ' ' GLN . 0.4 OUTLIER -77.77 -36.7 50.27 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 45.32 111.598 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -72.64 -40.09 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.705 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.6 p -70.36 -44.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.413 -0.358 . . . . 71.319999999999993 111.738 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -72.66 -34.3 67.16 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.647 -0.421 . . . . 71.239999999999995 111.803 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -76.04 -25.69 55.87 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.873 -0.331 . . . . 74.030000000000001 111.59 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -89.53 -22.74 22.27 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.752 -0.379 . . . . 74.340000000000003 111.161 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 32' ' ' VAL . 4.4 t -109.62 0.43 19.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.859 -0.336 . . . . 71.140000000000001 110.789 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.6 ptp -36.95 152.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.943 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.33 2.6 63.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.174 -0.77 . . . . 44.140000000000001 111.174 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' NE2' HD11 ' A' ' 41' ' ' LEU . 3.4 p-80 -93.79 139.61 22.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.888 -0.325 . . . . 74.450000000000003 110.464 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.95 119.8 6.75 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.642 2.228 . . . . 75.319999999999993 112.783 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD11 ' NE2' ' A' ' 39' ' ' HIS . 30.4 mt -111.26 98.31 7.41 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.779 -0.646 . . . . 74.239999999999995 110.057 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.2 mp -87.64 102.43 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 70.120000000000005 110.637 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -111.48 166.56 11.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.219999999999999 110.839 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.63 140.62 19.74 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.522 -1.031 . . . . 24.219999999999999 110.522 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.518 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.29 -34.61 61.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.057 -0.257 . . . . 40.43 110.854 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -66.85 -51.22 58.17 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.882 -0.414 . . . . 71.150000000000006 109.882 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.605 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 2.1 t-20 -57.19 -33.85 67.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 109.982 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -72.33 -34.63 68.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 74.230000000000004 110.051 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -72.15 -32.82 67.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.976 -0.556 . . . . 74.319999999999993 110.345 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -47.73 19.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.938 -0.574 . . . . 55.409999999999997 110.572 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.486 ' HA ' HD21 ' A' ' 20' ' ' ASN . 99.1 mt -66.8 -47.55 82.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.540000000000006 110.658 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.86 -122.51 3.05 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.975 -0.85 . . . . 53.43 110.975 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -131.06 61.41 59.47 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 73.019999999999996 110.776 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.52 151.92 33.34 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 123.049 2.5 . . . . 75.230000000000004 112.137 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.689 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -137.32 35.72 0.26 Allowed Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 120.647 -0.421 . . . . 64.140000000000001 111.737 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.689 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 5.8 Cg_endo -49.49 109.7 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.791 2.327 . . . . 62.200000000000003 112.071 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.33 4.94 63.98 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.137 -0.785 . . . . 53.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 49.48 38.11 13.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 74.420000000000002 110.64 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -159.92 58.0 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.123 0.487 . . . . 73.120000000000005 110.334 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -97.67 118.68 34.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.617 -0.72 . . . . 74.040000000000006 110.666 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.49 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 71.040000000000006 110.667 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 71' ' ' VAL . 15.2 pt -111.62 141.25 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 75.120000000000005 110.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 78' ' ' HIS . 54.8 t -93.57 119.25 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 61.100000000000001 110.734 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.424 HG23 HD21 ' A' ' 66' ' ' ASN . 8.9 t -153.28 141.13 20.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 74.010000000000005 110.615 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -96.83 118.23 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 110.587 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER 172.09 85.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.637 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.61 131.91 52.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 70.219999999999999 110.433 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.06 6.35 63.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.841 -0.903 . . . . 50.130000000000003 110.841 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -110.67 141.94 43.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 61.210000000000001 110.575 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 -139.83 133.16 29.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.52 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 62' ' ' ILE . 16.1 t -100.09 110.74 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 61.340000000000003 110.654 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.22 126.7 30.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 61.25 110.485 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.62 -10.7 59.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.892 -0.883 . . . . 52.229999999999997 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 158.99 44.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 73.129999999999995 110.541 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -94.98 132.1 40.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.130000000000003 110.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.7 p -88.14 138.16 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 74.010000000000005 110.668 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.26 178.38 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 64.439999999999998 110.369 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.717 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.41 -176.32 3.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 62.140000000000001 110.569 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.736 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 67.1 m -62.4 -175.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 54.520000000000003 110.958 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.8 p -52.42 -22.95 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 74.299999999999997 110.716 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -58.82 -50.83 72.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.101 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 33.3 tp10 -75.72 -36.93 59.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 63.219999999999999 111.249 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.06 -33.78 64.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.954 0.407 . . . . 61.32 110.572 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -47.41 81.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.99 -0.55 . . . . 63.229999999999997 110.961 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.5 pt-20 -71.4 -47.73 54.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.526 -0.306 . . . . 72.400000000000006 111.364 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -48.27 -32.96 7.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.803 0.335 . . . . 74.549999999999997 110.818 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -49.89 -43.06 49.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.917 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 1.2 ptmm? -68.88 -8.34 43.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.349999999999994 110.618 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.76 -7.35 55.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 73.0 110.659 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -154.74 138.41 16.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 43.43 110.345 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.84 -50.83 71.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.052 -0.522 . . . . 74.219999999999999 110.836 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -121.76 124.03 43.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 73.239999999999995 110.854 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -128.87 147.75 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.973 -0.558 . . . . 71.549999999999997 110.308 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -107.12 140.68 39.58 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.799 -0.361 . . . . 73.400000000000006 110.336 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 5' ' ' PHE . 16.2 mm -122.1 123.29 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 64.140000000000001 110.978 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.565 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 t80 -119.41 19.17 12.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 62.020000000000003 110.569 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.803 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -33.8 -100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.028 -0.829 . . . . 30.149999999999999 111.028 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.638 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 178.92 -171.18 43.26 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.535 -1.026 . . . . 53.420000000000002 110.535 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HB2' HD11 ' A' ' 15' ' ' ILE . . . -52.96 -62.75 1.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 110.322 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -55.7 -49.34 73.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 75.510000000000005 111.945 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.705 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 4.7 mm -56.34 -52.8 47.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 120.908 -0.317 . . . . 72.209999999999994 110.443 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 9.3 m-30 -52.13 -50.38 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.175 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.466 ' HA ' HD13 ' A' ' 106' ' ' LEU . 60.2 t0 -48.78 -49.61 37.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 54.350000000000001 110.903 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.4 mp -72.37 -18.85 61.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 63.030000000000001 111.056 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.2 m-85 -94.59 1.05 55.62 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.844 -0.342 . . . . 70.120000000000005 111.356 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER -48.83 -54.71 25.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.584 -0.446 . . . . 71.319999999999993 110.472 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 38.1 Cg_endo -71.82 11.8 0.64 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 73.430000000000007 112.073 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -135.92 2.12 2.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 71.239999999999995 110.408 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.936 HG22 ' CE1' ' A' ' 5' ' ' PHE . 53.1 t -93.61 116.31 34.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.325 -0.398 . . . . 72.010000000000005 111.035 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 110' ' ' ASP . 3.0 m-20 -86.64 -50.13 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 74.200000000000003 109.804 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -111.84 136.77 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 74.230000000000004 109.664 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 114' ' ' ILE . 11.7 tp -126.26 124.89 41.39 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.781 -0.368 . . . . 54.140000000000001 110.94 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 157' ' ' VAL . 27.1 m-85 -119.12 124.66 47.41 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.062 -0.517 . . . . 50.109999999999999 110.666 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 158' ' ' TYR . 1.8 mt -127.17 140.96 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 73.209999999999994 110.601 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.604 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 75.7 m -128.03 117.37 21.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 53.409999999999997 110.801 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -87.8 141.02 28.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 110.475 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.5 mt -135.52 129.08 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 52.229999999999997 110.662 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.553 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 56.9 t-80 -82.72 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 61.240000000000002 110.976 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.19 112.5 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 73.430000000000007 110.484 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.02 140.65 2.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 110.576 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.632 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.4 t80 -154.88 132.21 11.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.649 0.261 . . . . 74.010000000000005 110.798 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.632 ' O ' ' O ' ' A' ' 121' ' ' PHE . 1.9 pt-20 27.84 110.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.92 -0.582 . . . . 75.319999999999993 111.969 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.755 ' H ' HH11 ' A' ' 13' ' ' ARG . . . -137.92 -146.69 5.09 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.853 -0.689 . . . . 75.239999999999995 111.632 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.75 -23.25 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.987 -0.285 . . . . 72.219999999999999 111.666 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.479 ' HB ' ' H ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.25 112.23 12.07 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.052 0.453 . . . . 75.540000000000006 111.176 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.469 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 40.6 p90 -121.16 132.79 55.05 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.511 -0.768 . . . . 75.140000000000001 110.903 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.406 ' O ' ' O ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -165.13 133.59 2.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 71.120000000000005 110.093 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.09 -163.53 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.343 2.028 . . . . 63.140000000000001 112.004 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.74 122.71 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 70.310000000000002 110.45 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 27.4 mtp -129.7 -55.01 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 63.020000000000003 110.728 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 131' ' ' ASP . 4.0 m-20 -73.22 82.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 72.109999999999999 110.694 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -124.15 -23.36 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 70.329999999999998 110.549 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.0 t -79.08 -31.96 44.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 63.020000000000003 110.676 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.96 -27.94 54.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 74.25 110.43 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.418 ' CH2' ' HG3' ' A' ' 160' ' ' LYS . 27.2 m95 -88.66 149.75 23.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.087 -0.506 . . . . 74.230000000000004 110.515 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 137' ' ' GLU . 1.3 tmtm? -99.15 137.38 37.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 71.420000000000002 110.479 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -107.07 152.1 24.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 71.319999999999993 110.755 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 23.3 m -129.39 -26.06 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.141 -0.481 . . . . 61.240000000000002 110.836 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -146.29 148.23 32.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.937 0.399 . . . . 64.519999999999996 110.962 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 140' ' ' VAL . 8.5 p -149.62 128.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 74.219999999999999 110.3 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -121.97 134.8 54.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 72.430000000000007 110.891 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 126.25 52.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.502 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.98 34.96 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.9 -0.88 . . . . 64.239999999999995 110.9 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.8 tp -159.39 -160.95 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 110.541 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -96.21 143.99 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 75.230000000000004 110.466 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.11 170.8 15.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.779 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.14 -46.28 91.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 70.230000000000004 110.721 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 148' ' ' LYS . 1.6 mppt? -73.01 -43.4 62.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.655 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.67 HD21 ' CD ' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -126.48 88.28 54.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 64.510000000000005 110.335 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.46 32.29 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.81 2.34 . . . . 71.540000000000006 112.531 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -111.55 177.91 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 71.299999999999997 110.568 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 99.2 m -116.38 139.54 50.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.349999999999994 110.322 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -156.98 154.63 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.431 . . . . 62.43 111.158 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -128.26 143.52 51.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 73.420000000000002 109.963 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.604 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.5 OUTLIER -112.43 129.99 56.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 110.877 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -117.75 155.03 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 64.129999999999995 110.349 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 113' ' ' TYR . 99.0 t -128.05 111.39 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 74.519999999999996 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.534 ' CD2' ' CD1' ' A' ' 114' ' ' ILE . 12.3 m-30 -112.07 156.55 22.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.226 -0.443 . . . . 72.140000000000001 110.077 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -152.92 155.14 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.796 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.418 ' HG3' ' CH2' ' A' ' 135' ' ' TRP . 9.6 mmmt -119.93 151.41 38.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.053 -0.521 . . . . 70.129999999999995 110.294 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.668 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 3.0 mp0 -84.25 -43.61 14.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 64.540000000000006 110.706 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.012 -0.994 . . . . 50.329999999999998 110.588 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 0.803 ' H5N' ' O ' ' A' ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 1.098 ' H7 ' ' CD2' ' A' ' 23' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.492 -0.559 . . . . 74.109999999999999 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.8 mt -131.43 119.59 43.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.032 0.444 . . . . 73.219999999999999 110.958 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.67 121.34 62.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 64.230000000000004 110.565 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.44 145.81 43.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.15 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.47 146.2 48.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.912 -0.585 . . . . 73.349999999999994 110.062 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.786 ' HG2' ' HN7' ' A' ' 174' ' ' N22 . 2.9 tpt -130.35 110.84 11.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.822 0.344 . . . . 70.450000000000003 110.705 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 5.1 p -140.81 146.35 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 64.310000000000002 110.739 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.812 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -98.33 177.68 5.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.726 -0.39 . . . . 44.119999999999997 110.457 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.22 105.96 4.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.469 -0.332 . . . . 73.349999999999994 110.785 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.9 126.91 31.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 64.420000000000002 110.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -54.1 -21.36 8.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 65.439999999999998 111.765 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.645 ' H ' HD22 ' A' ' 12' ' ' ASN . 0.1 OUTLIER -118.63 -13.29 9.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.929 0.395 . . . . 73.209999999999994 110.93 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.603 ' NH1' ' N ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -135.51 -137.08 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.824 -0.806 . . . . 63.210000000000001 108.824 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG13 HG12 ' A' ' 15' ' ' ILE . 7.6 p -136.75 -39.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.22 -0.659 . . . . 65.450000000000003 109.22 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.842 HG12 HG13 ' A' ' 14' ' ' VAL . 1.2 pt -161.72 -55.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.097 -0.501 . . . . 71.409999999999997 110.475 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.2 73.97 0.86 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.901 -0.879 . . . . 74.140000000000001 110.901 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -79.04 -17.83 54.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 65.409999999999997 110.124 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 20' ' ' ASN . 14.9 t0 -179.66 77.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 110.046 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.629 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 4.1 m120 68.49 -5.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 71.209999999999994 110.094 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 18' ' ' ASP . 8.0 p30 -169.26 -165.04 0.49 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 64.400000000000006 110.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.086 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -115.06 159.88 36.01 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 110.237 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.56 134.4 15.26 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.686 1.591 . . . . 70.430000000000007 112.335 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.641 ' HA ' ' H8 ' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -75.29 173.02 11.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.674 -0.694 . . . . 71.200000000000003 111.075 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.602 ' HG2' ' H7 ' ' A' ' 174' ' ' N22 . 12.7 ptm180 -129.88 -167.54 1.82 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.793 -0.64 . . . . 70.430000000000007 109.901 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OH ' ' A' ' 153' ' ' TYR . 0.5 OUTLIER -49.95 127.63 20.74 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.801 -0.359 . . . . 65.129999999999995 110.252 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.69 -28.29 86.28 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.926 1.75 . . . . 73.5 111.825 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.4 t -69.68 -38.24 76.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.102 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.682 ' OE1' ' N8 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER -65.94 -36.31 83.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.108 -0.496 . . . . 64.150000000000006 110.163 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.021 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -67.28 -26.34 66.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.918 -0.583 . . . . 71.420000000000002 110.072 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.28 -44.83 15.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.629 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -59.1 -47.02 86.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.097 -0.501 . . . . 74.409999999999997 110.75 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.1 p -66.28 -48.56 80.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 51.43 110.707 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 18.6 tttt -51.64 -37.57 50.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.358 -0.383 . . . . 75.420000000000002 110.663 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.402 ' O ' ' SD ' ' A' ' 37' ' ' MET . 6.0 ttmt -74.82 -30.08 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.503 . . . . 70.329999999999998 111.497 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -79.15 -34.81 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.918 -0.313 . . . . 72.420000000000002 111.354 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.9 t -85.18 -22.1 28.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 74.299999999999997 110.766 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.435 ' O ' ' CG ' ' A' ' 37' ' ' MET . 15.6 ptm -41.09 128.97 2.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.394 -0.366 . . . . 74.430000000000007 110.531 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.88 2.74 26.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.929 -0.868 . . . . 74.230000000000004 110.929 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -129.49 144.97 54.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 121.082 -0.247 . . . . 71.540000000000006 110.405 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.23 154.34 46.43 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.5 2.133 . . . . 72.040000000000006 112.114 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 41' ' ' LEU . 2.9 mm? -112.44 130.6 55.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.858 -0.61 . . . . 71.109999999999999 110.905 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -117.13 106.53 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 72.129999999999995 110.204 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.2 mtt -115.81 165.67 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 72.319999999999993 111.2 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.25 153.15 44.49 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 41.43 110.59 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' CG ' ' O3B' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -62.03 -40.17 94.8 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.905 -0.318 . . . . 73.439999999999998 110.44 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 57.9 tttm -79.26 -23.19 43.83 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.561 -0.533 . . . . 74.219999999999999 109.561 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.095 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 0.8 OUTLIER -74.65 -34.47 62.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.621 -0.718 . . . . 72.140000000000001 110.262 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' CB ' HG21 ' A' ' 62' ' ' ILE . 30.4 t80 -79.43 -32.83 42.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 70.019999999999996 110.532 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.5 pt-20 -67.64 -36.19 80.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 71.019999999999996 110.281 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -80.37 -52.36 7.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 64.219999999999999 110.427 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.802 HG22 ' H ' ' A' ' 53' ' ' ARG . 85.8 mt -65.69 -37.48 80.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.919 0.39 . . . . 70.040000000000006 110.007 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.14 1.79 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.436 -0.666 . . . . 71.319999999999993 111.436 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.802 ' H ' HG22 ' A' ' 51' ' ' ILE . 26.9 mtt-85 -113.49 103.69 55.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 121.029 -0.269 . . . . 75.409999999999997 111.095 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' O ' ' C4 ' ' A' ' 174' ' ' N22 . 44.0 Cg_endo -76.02 -166.58 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.275 1.983 . . . . 73.129999999999995 111.294 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.2 114.14 36.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.315 -0.554 . . . . 73.510000000000005 111.374 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -69.38 2.78 3.02 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 121.579 1.519 . . . . 74.030000000000001 110.849 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 58' ' ' ARG . . . -76.69 2.52 58.73 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.917 -1.273 . . . . 60.009999999999998 109.917 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 1.0 OUTLIER 157.48 -160.74 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.939 -0.393 . . . . 61.310000000000002 109.939 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -74.69 165.65 24.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.025 0.441 . . . . 70.319999999999993 110.961 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' O ' ' OE1' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -132.48 123.62 26.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.785 -0.643 . . . . 53.450000000000003 110.446 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.91 127.62 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.342 -0.39 . . . . 75.420000000000002 110.874 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.44 HG21 ' CB ' ' A' ' 48' ' ' TYR . 8.6 pt -104.68 132.52 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 72.319999999999993 110.582 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 78' ' ' HIS . 41.3 t -85.88 130.86 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 110.79 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.57 HG22 HG23 ' A' ' 76' ' ' VAL . 10.8 t -154.28 139.7 17.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.536 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.569 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -97.85 94.37 6.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 53.039999999999999 110.548 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 14.6 m-80 -170.05 119.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 74.409999999999997 110.611 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.8 111.73 8.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 71.310000000000002 110.721 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.19 -5.06 38.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.283 -0.727 . . . . 71.340000000000003 111.283 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.33 140.03 58.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.811 -0.356 . . . . 71.439999999999998 110.643 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.06 133.43 15.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.456 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' CYS . 62.9 t -126.92 117.11 46.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 62.229999999999997 110.846 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -70.02 132.64 46.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.428 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.78 -10.94 68.44 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.657 -0.977 . . . . 54.049999999999997 110.657 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -146.17 148.15 32.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 72.349999999999994 110.524 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.556 ' OE1' ' O ' ' A' ' 60' ' ' ASN . 23.5 mp0 -87.4 143.11 27.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 61.310000000000002 110.144 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 64' ' ' THR . 8.9 p -99.28 143.09 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 61.43 111.025 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.61 175.29 9.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.937 -0.574 . . . . 63.32 110.231 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.753 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -90.76 -171.02 2.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 75.530000000000001 110.659 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.599 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 75.1 m -64.41 -176.8 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 74.510000000000005 110.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -52.7 -25.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 74.140000000000001 110.67 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.98 -54.37 45.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.812 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 45.1 tp10 -70.09 -37.87 75.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.299999999999997 110.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 29.0 t -58.57 -39.26 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 71.409999999999997 110.793 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -53.1 -54.12 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.709 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 8.9 pt-20 -69.65 -44.06 71.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 51.530000000000001 111.049 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.436 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -50.86 -27.19 6.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 60.399999999999999 110.559 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 62.7 m -64.71 -43.95 91.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.546 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -68.34 2.34 2.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.373 . . . . 74.420000000000002 110.527 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 87' ' ' CYS . 3.4 t-20 -81.78 -26.5 34.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 74.25 110.395 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -134.84 146.6 49.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 63.439999999999998 110.519 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.44 ' CB ' ' OE1' ' A' ' 92' ' ' GLU . 64.7 mt-10 -53.66 -77.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.855 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' CD ' ' N ' ' A' ' 92' ' ' GLU . 2.4 mp0 -97.0 125.84 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 70.209999999999994 110.732 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -133.85 139.9 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 71.349999999999994 110.517 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -108.53 141.7 40.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 72.109999999999999 110.567 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -125.31 111.21 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 73.5 111.511 -179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.975 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -89.51 -22.87 22.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 110.226 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 13.34 -96.81 0.01 OUTLIER Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.743 -0.662 . . . . 73.530000000000001 111.948 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.25 -169.33 41.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.64 -0.984 . . . . 70.420000000000002 110.64 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.1 -61.49 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.931 -0.308 . . . . 70.109999999999999 110.698 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.746 HE22 ' H8A' ' A' ' 173' ' ' NAP . 0.0 OUTLIER -54.95 -33.01 61.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.838 -0.345 . . . . 74.450000000000003 110.697 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.683 HD11 ' OE1' ' A' ' 100' ' ' GLN . 34.5 mm -76.87 -31.55 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.318 -0.401 . . . . 75.230000000000004 110.465 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.609 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -71.07 -28.69 64.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 75.519999999999996 110.658 -179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 22.4 t0 -81.49 -48.22 12.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 74.239999999999995 110.584 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.11 -31.95 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.673 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 108' ' ' TYR . 8.7 t80 -92.71 9.99 32.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.48 -0.327 . . . . 75.430000000000007 110.545 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.711 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 13.9 tp -64.35 -35.25 13.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.625 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.711 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 19.1 Cg_endo -86.53 7.37 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.077 2.518 . . . . 74.340000000000003 112.396 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.425 ' HB2' ' CD1' ' A' ' 105' ' ' PHE . 57.6 m-85 -121.49 -16.4 7.81 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.947 -0.301 . . . . 62.210000000000001 110.75 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 5' ' ' PHE . 5.9 p -93.68 155.76 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 64.030000000000001 110.499 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.94 -41.84 3.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.266 -0.425 . . . . 72.200000000000003 110.647 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -110.5 125.55 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 64.109999999999999 110.595 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD22 HD11 ' A' ' 114' ' ' ILE . 2.0 mt -111.43 128.95 56.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 54.43 110.557 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -124.34 109.43 13.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.852 -0.425 . . . . 73.230000000000004 109.852 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 114' ' ' ILE . 3.8 mp -122.82 140.8 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 72.450000000000003 111.354 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 t -130.5 124.88 32.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.89 -0.596 . . . . 62.420000000000002 110.854 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.42 143.67 28.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.882 -0.599 . . . . 54.210000000000001 110.104 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 mt -123.33 125.68 72.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.648 -0.421 . . . . 71.310000000000002 111.08 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -74.35 49.39 0.37 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 73.109999999999999 110.703 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -176.95 114.9 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 74.239999999999995 110.933 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.441 ' HB3' ' ND2' ' A' ' 12' ' ' ASN . . . -166.83 148.43 6.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 73.5 110.416 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.433 ' H ' ' HD3' ' A' ' 17' ' ' LYS . 27.5 m-85 -116.5 153.52 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 71.030000000000001 110.921 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' A' ' 17' ' ' LYS . 7.3 pt-20 -39.84 145.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.568 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -150.57 -95.66 0.13 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.411 -0.675 . . . . 53.420000000000002 111.411 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.603 ' N ' ' NH1' ' A' ' 13' ' ' ARG . 10.6 t70 -157.92 -39.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.953 -0.299 . . . . 71.120000000000005 111.216 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.795 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -101.59 116.87 33.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.906 0.384 . . . . 73.310000000000002 111.16 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.464 ' N ' HG12 ' A' ' 14' ' ' VAL . 8.8 p90 -122.58 153.44 39.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.574 -0.739 . . . . 71.329999999999998 111.534 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.646 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 15.7 t80 -101.62 123.32 44.62 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 115.882 -0.599 . . . . 72.340000000000003 109.775 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.646 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 41.0 Cg_endo -71.7 -164.71 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.276 1.984 . . . . 73.150000000000006 112.22 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -130.76 105.94 8.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.077 -0.511 . . . . 64.349999999999994 110.458 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 10.4 mtt -134.37 -75.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 52.200000000000003 110.578 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -175.05 165.46 3.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.374 . . . . 74.349999999999994 110.84 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -151.05 26.55 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 72.420000000000002 110.47 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 133' ' ' THR . 1.8 t -75.88 -28.5 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.607 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -41.63 -44.68 3.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 72.540000000000006 110.631 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.425 ' CZ3' ' N ' ' A' ' 160' ' ' LYS . 36.6 m95 -91.76 165.79 13.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 110.694 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 137' ' ' GLU . 2.1 tmtt? -124.52 127.84 48.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 51.119999999999997 110.72 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' ' HD3' ' A' ' 136' ' ' LYS . 10.7 pt-20 -83.53 135.06 34.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 53.140000000000001 110.502 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.4 m -117.33 -35.76 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.269 -0.423 . . . . 54.539999999999999 110.684 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 12.8 t80 -133.98 154.36 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 73.530000000000001 110.549 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 140' ' ' VAL . 3.3 p -152.12 113.42 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.317 -0.401 . . . . 52.140000000000001 110.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -105.06 139.84 39.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 70.450000000000003 110.461 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 2.5 mppt? -106.24 141.3 37.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 71.530000000000001 110.555 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -98.26 -170.23 31.99 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.949 -0.86 . . . . 73.510000000000005 110.949 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -153.59 172.97 16.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.746 0.308 . . . . 71.200000000000003 110.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 145' ' ' THR . 5.1 t -89.66 166.68 13.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.44 . . . . 61.219999999999999 110.756 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -163.9 178.6 7.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.002 -0.544 . . . . 64.519999999999996 110.112 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.61 -46.07 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.838 -0.345 . . . . 74.140000000000001 110.503 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -22.65 67.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 53.299999999999997 110.391 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -152.12 92.05 3.59 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.561 . . . . 55.109999999999999 110.403 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.53 65.8 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.526 2.151 . . . . 53.420000000000002 112.073 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -152.14 160.15 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 70.400000000000006 110.265 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 58.6 m -121.0 135.8 55.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 71.420000000000002 110.671 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.528 ' OH ' HD13 ' A' ' 25' ' ' LEU . 3.0 p90 -141.13 167.39 22.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 71.230000000000004 110.965 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 6.3 m-85 -132.64 142.6 49.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.988 -0.551 . . . . 65.109999999999999 110.668 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -98.72 153.66 18.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 73.219999999999999 110.727 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -139.59 132.27 28.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 52.439999999999998 110.53 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.8 t -116.57 120.87 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 73.540000000000006 110.593 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 46.4 m-85 -118.69 142.71 47.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.662 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.61 139.97 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.483 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.674 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 0.5 OUTLIER -76.88 -70.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.781 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.674 ' NE2' ' O ' ' A' ' 160' ' ' LYS . 2.5 pp0? 23.55 51.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.185 -0.461 . . . . 43.149999999999999 110.819 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' LYS . 55.7 mt-30 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.981 -1.009 . . . . 53.350000000000001 110.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.095 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.786 ' HN7' ' HG2' ' A' ' 6' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.422 -0.585 . . . . 74.010000000000005 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.2 mt -126.11 125.9 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 63.340000000000003 110.698 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -124.45 127.02 72.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 75.219999999999999 110.604 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.3 m -117.7 152.59 34.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.978 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.603 ' HB2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -116.91 152.85 33.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.052 -0.522 . . . . 72.400000000000006 110.177 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -144.1 103.94 4.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.974 -0.29 . . . . 74.310000000000002 110.995 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 114' ' ' ILE . 17.2 m -135.85 148.75 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-O 121.542 0.687 . . . . 61.229999999999997 111.394 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.825 ' HB2' H72N ' A' ' 173' ' ' NAP . . . -80.05 172.27 14.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.983 -1.008 . . . . 63.200000000000003 110.683 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -145.2 93.4 2.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 61.130000000000003 110.411 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 58.9 m-20 -76.22 123.12 25.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.867 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' C ' HD22 ' A' ' 12' ' ' ASN . 7.3 pt-20 -52.23 -29.32 22.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 112.072 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -110.08 -14.9 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.312 -0.555 . . . . 75.340000000000003 111.397 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' NH2' ' H ' ' A' ' 122' ' ' GLU . 9.1 mpt_? -119.71 -110.02 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.654 -0.499 . . . . 72.319999999999993 109.654 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 125' ' ' THR . 4.2 p -172.79 -42.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.951 -0.3 . . . . 74.519999999999996 110.666 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.675 HD12 ' O4D' ' A' ' 173' ' ' NAP . 49.1 pt -151.91 -38.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 120.247 -0.581 . . . . 64.409999999999997 110.597 178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -102.79 98.73 1.71 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.791 -0.923 . . . . 45.43 110.791 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.584 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -84.82 -29.79 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.365 -179.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 122' ' ' GLU . 9.6 m-20 -160.43 76.69 0.6 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 110.756 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.618 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 3.9 m-20 65.74 -4.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.995 -0.548 . . . . 62.140000000000001 110.356 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.52 HD21 ' CG1' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -164.84 -178.24 5.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.045 -0.525 . . . . 74.230000000000004 110.4 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.848 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -102.3 145.82 31.2 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 75.310000000000002 110.514 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 21' ' ' LEU . 26.3 Cg_endo -64.66 -146.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.839 2.359 . . . . 63.210000000000001 112.018 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.572 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -171.62 169.44 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 74.420000000000002 111.317 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HD12 ' A' ' 25' ' ' LEU . 17.4 ttt85 -97.39 -67.67 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.725 -0.67 . . . . 74.530000000000001 110.222 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -138.78 122.04 10.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.399999999999999 109.979 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.79 -33.08 98.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.864 1.709 . . . . 43.43 112.002 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 m -68.7 -37.83 79.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.3 -0.409 . . . . 64.239999999999995 110.148 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -63.84 -35.64 81.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.191 -0.459 . . . . 62.25 110.01 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -66.03 -31.5 72.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.627 -0.715 . . . . 53.130000000000003 109.677 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 34' ' ' LYS . 43.0 mt-30 -77.25 -29.4 53.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.866 -0.606 . . . . 73.540000000000006 110.962 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -79.32 -52.88 7.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 73.510000000000005 111.06 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 33' ' ' LYS . 9.8 p -58.41 -48.66 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.946 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' N ' HG13 ' A' ' 32' ' ' VAL . 4.7 pttm -65.75 -42.33 91.07 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.697 -0.401 . . . . 62.43 110.427 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 11.2 ttpt -70.37 -13.16 62.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 62.240000000000002 110.312 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.99 -29.55 19.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 74.400000000000006 110.37 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.608 ' OG1' ' CG ' ' A' ' 39' ' ' HIS . 8.9 t -125.95 13.87 7.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 74.349999999999994 110.657 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 33' ' ' LYS . 16.9 ptt? -37.08 143.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.332 -0.395 . . . . 71.319999999999993 110.252 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.72 57.68 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.172 -0.771 . . . . 64.519999999999996 111.172 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.608 ' CG ' ' OG1' ' A' ' 36' ' ' THR . 0.2 OUTLIER -103.33 154.79 37.48 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.367 . . . . 70.25 110.372 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.42 107.38 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.798 2.332 . . . . 73.519999999999996 112.535 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -116.91 104.57 11.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 75.310000000000002 110.116 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 42' ' ' ILE . 4.0 mp -88.56 137.48 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.093 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 18.0 mtm -144.0 166.65 24.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.504 . . . . 73.099999999999994 110.642 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.6 143.69 17.37 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.205 -1.158 . . . . 73.340000000000003 110.205 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.77 HH12 ' CB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -46.1 -40.27 10.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.576 -0.45 . . . . 73.209999999999994 110.658 -179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 80.5 tttt -66.94 -36.35 82.04 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.821 -0.352 . . . . 71.319999999999993 110.276 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.11 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 1.0 OUTLIER -65.38 -42.08 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 73.230000000000004 110.207 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -69.16 -35.22 76.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.067 -0.515 . . . . 75.019999999999996 110.213 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -64.56 -46.41 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 75.310000000000002 110.686 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -79.64 -29.46 40.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.505 . . . . 65.319999999999993 111.136 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' CG1' HD21 ' A' ' 20' ' ' ASN . 32.1 mt -74.31 -53.86 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.467 -0.333 . . . . 55.439999999999998 110.495 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.88 -137.47 41.45 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.273 -0.731 . . . . 73.329999999999998 111.273 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' N ' ' CD ' ' A' ' 53' ' ' ARG . 7.6 mpt_? 61.91 150.25 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.813 0.34 . . . . 53.049999999999997 110.387 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.75 -155.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.714 2.276 . . . . 74.450000000000003 112.406 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 tp -146.87 58.58 4.42 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 121.1 0.476 . . . . 53.509999999999998 110.555 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 58' ' ' ARG . 22.8 Cg_endo -63.06 119.06 5.98 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 123.046 2.497 . . . . 64.230000000000004 112.57 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 41.6 22.42 0.09 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.909 -0.876 . . . . 73.120000000000005 110.909 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 56' ' ' PRO . 4.2 ttt-85 -110.83 164.34 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.034 -0.358 . . . . 72.129999999999995 110.034 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.57 100.77 4.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.875 0.369 . . . . 74.239999999999995 110.577 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -114.22 132.54 56.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.066 -0.516 . . . . 74.219999999999999 110.534 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.0 mp -121.02 118.55 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 61.509999999999998 110.672 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 62' ' ' ILE . 12.5 pt -90.98 134.72 28.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.195 -0.457 . . . . 75.540000000000006 110.543 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 78' ' ' HIS . 78.7 t -92.77 125.52 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 60.299999999999997 110.611 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.77 ' CB ' HH12 ' A' ' 45' ' ' ARG . 10.9 t -161.88 144.93 11.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.0 0.428 . . . . 71.310000000000002 110.991 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.626 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 7.3 ptm180 -98.1 115.03 27.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 71.329999999999998 110.439 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.626 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER 176.18 115.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.509999999999998 110.571 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.73 117.2 13.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.295 -0.411 . . . . 75.109999999999999 110.684 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.58 47.11 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.352 -0.699 . . . . 74.230000000000004 111.352 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.18 130.12 40.1 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.86 -0.336 . . . . 61.439999999999998 110.561 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -151.19 129.91 12.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.604 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 t -124.39 120.29 58.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.38 120.38 13.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 75.310000000000002 110.671 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 106.17 -22.52 31.06 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.047 -0.821 . . . . 50.140000000000001 111.047 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.498 ' HA ' HD21 ' A' ' 60' ' ' ASN . 57.1 m -128.66 145.25 51.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 61.119999999999997 110.773 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 76' ' ' VAL . 13.7 tp10 -87.76 147.78 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.42 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.41 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 22.1 t -100.5 145.14 11.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.323 -0.399 . . . . 70.510000000000005 110.747 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.58 161.64 37.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 72.400000000000006 110.269 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.58 -174.66 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 75.099999999999994 110.554 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.771 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 73.9 m -58.68 -176.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.209999999999994 111.04 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.49 -24.41 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.634 . . . . 75.430000000000007 110.609 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -58.72 -49.69 76.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.978 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' OE2' ' CD ' ' A' ' 85' ' ' GLU . 10.4 tp10 -72.48 -31.94 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 61.020000000000003 110.896 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.48 -34.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.913 0.387 . . . . 71.510000000000005 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -54.4 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 110.922 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 12.1 pt-20 -69.81 -44.96 68.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 74.010000000000005 111.238 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -48.22 -30.09 4.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.475 -0.33 . . . . 72.409999999999997 110.969 -179.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' C ' ' H ' ' A' ' 89' ' ' ASN . 1.8 t -56.91 -45.38 82.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.859 0.361 . . . . 75.049999999999997 110.638 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -65.52 6.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 53.32 111.077 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 87' ' ' CYS . 9.7 t-20 -92.98 -21.82 19.55 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.803 -0.359 . . . . 73.430000000000007 110.731 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -132.28 144.27 50.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 110.579 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.04 -49.83 74.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 75.409999999999997 110.602 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -125.78 124.7 41.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 110.59 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 95' ' ' ILE . 43.4 pt -125.54 162.5 28.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 110.703 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.509 ' HB2' HD22 ' A' ' 41' ' ' LEU . 19.3 m-85 -124.06 120.93 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.246 -0.433 . . . . 73.409999999999997 110.36 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 93' ' ' ILE . 15.6 mm -108.65 112.79 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 70.400000000000006 111.225 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' HB3' ' H5N' ' A' ' 173' ' ' NAP . 3.9 m-85 -100.16 -36.5 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 70.310000000000002 109.716 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 32.63 -98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.303 -0.719 . . . . 74.140000000000001 111.303 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.81 -152.61 12.55 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.771 -0.932 . . . . 72.120000000000005 110.771 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 15' ' ' ILE . . . -69.86 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.891 0.377 . . . . 63.439999999999998 110.673 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.694 ' NE2' ' H8A' ' A' ' 173' ' ' NAP . 12.8 pt20 -62.8 -41.39 99.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 64.349999999999994 110.768 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 4.8 mm -59.14 -33.95 52.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.887 0.375 . . . . 75.219999999999999 110.508 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -46.64 72.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.546 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -65.51 -42.75 91.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.983 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.5 -26.09 67.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.383 -0.371 . . . . 75.540000000000006 110.967 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.59 15.44 17.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.44 -0.345 . . . . 74.230000000000004 110.644 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.802 HD23 ' C ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -68.32 -33.47 4.79 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.257 -0.429 . . . . 74.230000000000004 110.961 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.6 Cg_endo -88.45 0.55 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.733 2.289 . . . . 71.549999999999997 112.152 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -106.75 -39.26 5.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.341 -0.39 . . . . 72.140000000000001 110.511 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.603 HG21 ' HB2' ' A' ' 5' ' ' PHE . 9.8 p -67.02 146.08 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 72.420000000000002 111.235 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -99.99 -42.27 6.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 62.200000000000003 110.056 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -104.55 125.01 50.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.877 -0.601 . . . . 64.439999999999998 109.893 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 5.4 tp -121.17 113.6 20.22 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.793 -0.363 . . . . 64.200000000000003 110.93 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.666 ' CE1' HG13 ' A' ' 157' ' ' VAL . 65.9 m-85 -110.11 125.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 109.904 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.904 HD13 ' CE1' ' A' ' 156' ' ' HIS . 1.8 mp -136.93 135.55 48.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 110.891 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 8' ' ' ALA . 14.2 t -111.81 132.77 54.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.384 -0.526 . . . . 52.32 110.64 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.2 tptt -91.5 133.72 35.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 73.120000000000005 110.602 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.6 mm -111.08 135.32 50.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -101.79 37.51 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 71.439999999999998 110.052 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -170.07 116.75 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 72.239999999999995 110.443 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.09 137.3 3.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 70.209999999999994 110.77 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 122' ' ' GLU . 39.7 t80 -155.57 137.23 14.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 73.420000000000002 110.602 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 17' ' ' LYS . 9.9 mt-10 44.76 98.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 72.530000000000001 110.376 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.58 8.09 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.212 -0.755 . . . . 64.099999999999994 111.212 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -120.76 -15.0 8.47 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.949 -0.3 . . . . 72.530000000000001 111.208 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.0 m -139.97 106.1 5.23 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.059 0.457 . . . . 64.230000000000004 111.059 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -114.65 141.25 48.04 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.417 -0.811 . . . . 74.120000000000005 110.601 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.47 134.93 2.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.865 -0.334 . . . . 72.530000000000001 110.476 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.11 -170.35 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.494 2.129 . . . . 61.439999999999998 112.456 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.93 160.48 43.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 75.549999999999997 110.296 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 15.1 ptm -155.08 -161.55 1.21 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 71.310000000000002 110.68 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.1 145.95 40.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.45 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.487 ' C ' ' H ' ' A' ' 134' ' ' ASN . 1.8 mtp -141.52 35.73 1.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.415 . . . . 74.439999999999998 110.729 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -50.33 -10.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 74.439999999999998 110.463 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 132' ' ' MET . 6.0 m120 -67.06 -17.52 64.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.131 -0.486 . . . . 63.32 111.033 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.496 ' CB ' ' CD2' ' A' ' 158' ' ' TYR . 26.2 m95 -116.48 166.76 11.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 64.430000000000007 110.755 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 127.53 53.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 63.229999999999997 110.98 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 7.4 pt-20 -74.04 118.68 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.373 -0.603 . . . . 75.540000000000006 109.373 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 -40.75 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.456 -0.338 . . . . 70.040000000000006 111.225 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -157.4 137.09 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.717 -0.393 . . . . 73.409999999999997 110.897 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.12 138.47 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 65.120000000000005 110.694 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -136.85 158.13 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 74.510000000000005 110.363 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -96.01 172.01 8.26 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.359 . . . . 72.310000000000002 110.247 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -109.4 -157.7 17.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.174 -0.771 . . . . 64.120000000000005 111.174 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 tp -168.87 149.3 4.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.3 . . . . 74.510000000000005 110.206 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -90.69 152.81 20.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.367 . . . . 74.310000000000002 110.775 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.64 179.23 7.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 65.010000000000005 110.248 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.11 -48.93 40.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 74.109999999999999 110.836 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -69.41 -7.1 34.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.405 -0.361 . . . . 75.239999999999995 110.657 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.492 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 10.2 p30 -160.23 78.6 2.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.411 . . . . 74.109999999999999 110.625 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 54.0 Cg_endo -75.28 76.9 3.36 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.716 2.277 . . . . 62.039999999999999 112.291 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 91.6 m-85 -158.24 163.52 37.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 73.239999999999995 110.162 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.416 ' C ' ' CD1' ' A' ' 153' ' ' TYR . 4.2 m -113.12 149.07 34.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 63.43 110.746 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -156.71 176.3 12.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.319999999999993 110.911 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -141.82 145.92 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 72.25 109.88 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.445 ' HH ' ' HD1' ' A' ' 113' ' ' TYR . 10.9 t80 -110.46 124.36 51.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.891 0.377 . . . . 73.030000000000001 110.441 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.904 ' CE1' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -123.5 140.13 53.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.991 -0.55 . . . . 74.230000000000004 110.926 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' CE1' ' A' ' 113' ' ' TYR . 9.7 t -117.2 128.79 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 111.346 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.673 ' CD1' ' NE2' ' A' ' 156' ' ' HIS . 1.2 m-30 -118.93 142.85 47.4 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.011 -0.54 . . . . 71.109999999999999 110.261 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.84 149.62 51.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.354 -0.385 . . . . 71.299999999999997 110.525 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -92.73 148.03 22.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.562 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.566 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -79.14 52.39 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 71.409999999999997 110.439 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.984 -1.007 . . . . 73.109999999999999 110.538 -179.943 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.11 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.615 ' H2 ' HD11 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 63.329999999999998 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.97 114.65 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.651 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.562 HG12 HG23 ' A' ' 109' ' ' VAL . 3.3 t -107.82 114.56 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.58 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -111.42 152.57 27.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.038 0.447 . . . . 73.129999999999995 111.205 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.5 t80 -121.19 152.15 39.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 73.140000000000001 110.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.41 94.95 2.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 72.319999999999993 110.404 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' ALA . 3.4 p -129.02 146.13 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.045 0.45 . . . . 64.340000000000003 111.252 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' H ' H72N ' A' ' 173' ' ' NAP . . . -85.17 165.31 17.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.832 -0.622 . . . . 65.340000000000003 110.032 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 tpt -138.91 112.05 7.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.342 . . . . 73.310000000000002 110.692 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -90.07 128.19 36.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 40.130000000000003 110.286 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -59.4 -17.75 33.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.184 -0.462 . . . . 63.210000000000001 111.207 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -122.71 -5.11 8.64 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.811 -0.355 . . . . 74.219999999999999 111.507 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.494 HH21 ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtt85 -144.06 -127.66 0.08 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 74.140000000000001 109.939 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.821 HG23 ' CA ' ' A' ' 126' ' ' PHE . 12.2 t -136.99 -52.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 109.259 -0.645 . . . . 43.210000000000001 109.259 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.64 HG21 H71N ' A' ' 173' ' ' NAP . 0.1 OUTLIER -142.9 -35.51 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.771 -0.649 . . . . 71.25 111.248 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' HG12 ' A' ' 15' ' ' ILE . . . 141.79 -147.93 19.54 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.745 -0.74 . . . . 41.219999999999999 111.462 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 13.1 ptpt -83.38 -29.82 27.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.613 0.244 . . . . 75.430000000000007 110.863 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 32.3 p30 -157.09 76.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.743 -0.383 . . . . 54.130000000000003 110.793 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.711 ' N ' ' O2D' ' A' ' 173' ' ' NAP . 0.2 OUTLIER 69.29 -1.61 2.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 64.319999999999993 110.535 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.838 ' OD1' ' H2B' ' A' ' 174' ' ' N22 . 0.5 OUTLIER -172.11 173.56 4.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.036 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -94.94 154.4 39.72 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.578 -0.737 . . . . 72.549999999999997 110.365 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.34 9.47 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.412 2.074 . . . . 74.109999999999999 111.952 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 112.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.494 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -158.84 -37.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.540000000000006 110.492 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -176.58 77.23 0.26 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-O 121.281 0.563 . . . . 60.340000000000003 110.257 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -53.17 -22.73 20.47 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.848 2.365 . . . . 73.409999999999997 111.838 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.22 -38.19 24.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 63.229999999999997 111.125 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.666 ' H ' HD12 ' A' ' 25' ' ' LEU . 10.6 tm-20 -58.78 -50.32 74.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.486 -0.325 . . . . 73.200000000000003 110.824 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.916 ' CB ' ' H7 ' ' A' ' 174' ' ' N22 . 3.4 pp -54.33 -28.68 44.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.28 -0.568 . . . . 71.329999999999998 110.671 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -75.04 -42.04 57.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 75.430000000000007 110.775 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -65.15 -52.72 53.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 110.88 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG11 ' HN8' ' A' ' 174' ' ' N22 . 11.5 p -61.65 -39.0 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.946 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' N ' HG13 ' A' ' 32' ' ' VAL . 44.1 mtpt -62.63 -43.79 97.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.349 -0.387 . . . . 71.120000000000005 110.733 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -73.12 -18.16 61.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 73.200000000000003 110.717 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.88 -28.51 17.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 73.510000000000005 110.393 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.2 p -99.52 -2.78 34.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.514 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.4 ptm -55.2 142.26 31.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.493 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.46 74.92 0.29 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.813 -0.915 . . . . 71.019999999999996 110.813 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 4.8 m170 -171.34 149.11 2.49 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.968 0.413 . . . . 62.350000000000001 110.555 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.52 106.88 0.45 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.958 2.439 . . . . 72.510000000000005 112.22 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.98 113.83 23.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.91 -0.587 . . . . 72.040000000000006 110.41 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.65 120.17 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 64.030000000000001 110.683 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.4 mtt -130.61 175.67 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.244 -0.435 . . . . 71.430000000000007 110.668 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.816 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -91.06 152.26 21.58 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.972 -1.251 . . . . 54.009999999999998 109.972 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.521 ' NH1' ' HZ3' ' A' ' 46' ' ' LYS . 31.8 ptt85 -59.31 -38.65 80.78 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.554 -0.459 . . . . 74.209999999999994 110.729 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HZ3' ' NH1' ' A' ' 45' ' ' ARG . 19.9 mmtm -57.43 -38.2 74.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 109.894 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.989 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 0.7 OUTLIER -73.73 -42.45 61.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.608 . . . . 74.400000000000006 110.499 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CE2' HG11 ' A' ' 71' ' ' VAL . 38.6 t80 -60.94 -53.47 56.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 64.230000000000004 110.954 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 17.5 pt-20 -58.51 -33.64 70.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.799 -0.36 . . . . 64.420000000000002 110.54 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.47 38.26 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.922 -0.311 . . . . 73.230000000000004 111.319 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.871 HG13 H11A ' A' ' 174' ' ' N22 . 1.5 mp -84.24 -56.11 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.579 -0.282 . . . . 73.329999999999998 110.858 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 51' ' ' ILE . . . 83.8 40.59 8.72 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.706 -0.557 . . . . 53.109999999999999 111.706 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.17 139.31 96.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.82 -0.352 . . . . 71.120000000000005 110.486 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.7 -91.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.547 2.165 . . . . 64.430000000000007 111.737 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 13.4 tp 172.94 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.353 -0.385 . . . . 71.420000000000002 110.778 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 11.8 Cg_endo -55.63 93.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.434 2.089 . . . . 73.349999999999994 112.019 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.14 -32.37 1.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.85 -0.691 . . . . 53.539999999999999 111.381 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -159.59 141.14 12.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 75.510000000000005 111.048 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -71.43 99.43 2.0 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 72.409999999999997 110.206 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.723 ' C ' HD13 ' A' ' 61' ' ' ILE . 19.6 p-10 -91.53 117.01 29.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.295 -0.411 . . . . 54.32 110.407 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -124.57 137.38 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.013 -0.54 . . . . 73.430000000000007 110.65 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 48' ' ' TYR . 21.2 pt -126.88 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 71.019999999999996 110.85 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 63' ' ' VAL . 36.0 m -104.86 114.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.001 -0.545 . . . . 70.219999999999999 110.675 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 64' ' ' THR . 10.8 t -146.45 127.68 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.298 -0.41 . . . . 73.519999999999996 110.636 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -81.24 111.64 17.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 71.540000000000006 110.491 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 p30 178.04 86.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 72.219999999999999 110.656 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -59.28 130.82 48.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.284 -0.416 . . . . 64.430000000000007 110.686 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.36 1.64 59.19 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.17 -0.772 . . . . 22.25 111.17 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -101.48 143.72 31.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 72.140000000000001 110.66 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.505 ' HA ' HG21 ' A' ' 76' ' ' VAL . 4.1 t-80 -148.89 143.26 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 110.373 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 48' ' ' TYR . 13.4 t -118.09 113.62 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 64.420000000000002 110.759 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.92 117.71 13.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.049999999999997 110.43 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.77 17.64 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.664 -0.974 . . . . 33.520000000000003 110.664 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 60' ' ' ASN . 4.8 t -144.4 160.82 40.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.404 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' ILE . 15.5 tp10 -88.88 148.17 23.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.216 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 70' ' ' HIS . 61.7 t -100.38 132.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.399 . . . . 44.32 111.155 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.42 151.01 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.928 -0.578 . . . . 55.340000000000003 109.869 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -167.98 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.68 -0.408 . . . . 64.129999999999995 110.774 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -64.96 -173.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.809 -0.632 . . . . 74.340000000000003 111.858 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 80' ' ' VAL . 6.6 t -51.15 -53.63 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.302 -0.863 . . . . 61.0 111.232 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -42.62 -32.24 0.55 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.49 -1.232 . . . . 74.140000000000001 110.799 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.3 -41.25 28.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 110.112 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 63' ' ' VAL . 52.1 t -60.15 -31.06 47.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 53.229999999999997 110.67 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -54.68 40.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.615 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 6.8 pt-20 -73.19 -38.76 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 73.310000000000002 111.075 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -55.16 -25.57 33.18 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.785 -0.366 . . . . 62.43 110.656 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 54.0 m -65.24 -43.24 92.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 45.0 110.862 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -64.5 -0.73 1.45 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.497 -0.32 . . . . 74.099999999999994 110.647 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -79.31 -27.03 42.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 54.109999999999999 110.413 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -133.0 144.7 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.044 -0.526 . . . . 74.430000000000007 110.455 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.55 -37.87 76.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.646 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 128.36 27.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 70.430000000000007 110.548 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -133.93 139.29 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.428 . . . . 71.430000000000007 110.949 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.26 136.36 40.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 109.87 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mt -125.24 118.13 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.429 . . . . 73.150000000000006 111.128 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.626 ' HB3' ' H4N' ' A' ' 173' ' ' NAP . 7.1 m-85 -95.4 -32.0 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 74.549999999999997 110.344 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.591 ' O ' ' C5N' ' A' ' 173' ' ' NAP . . . 37.34 -101.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.714 -0.554 . . . . 74.120000000000005 111.714 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' TYR . . . 175.42 -155.12 19.48 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.15 -1.18 . . . . 52.509999999999998 110.15 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' A' ' 125' ' ' THR . . . -70.91 -61.01 1.92 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.014 0.407 . . . . 31.199999999999999 110.582 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.027 ' OE1' H52A ' A' ' 173' ' ' NAP . 15.8 pt20 -62.07 -43.3 99.14 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 71.239999999999995 110.275 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.464 ' N ' ' CG ' ' A' ' 100' ' ' GLN . 5.7 mm -62.7 -31.89 53.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 55.439999999999998 110.065 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -63.62 -50.65 68.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.864 -0.607 . . . . 74.129999999999995 110.411 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 26.1 t70 -67.38 -38.75 85.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.026 -0.534 . . . . 74.400000000000006 111.303 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -71.64 -18.66 62.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 74.319999999999993 111.272 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' CZ ' HG13 ' A' ' 80' ' ' VAL . 6.5 m-85 -97.2 1.94 50.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.796 -0.362 . . . . 65.299999999999997 111.452 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.542 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 1.4 mp -62.48 -48.57 86.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 71.420000000000002 110.537 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 59.5 Cg_endo -81.43 21.01 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.912 2.408 . . . . 72.109999999999999 112.282 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -133.43 -58.89 0.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 62.539999999999999 110.811 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.562 HG23 HG12 ' A' ' 3' ' ' VAL . 6.2 p -58.25 156.8 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.969 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.04 -53.82 3.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 71.040000000000006 110.491 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -99.73 141.31 32.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 72.209999999999994 110.049 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 114' ' ' ILE . 57.8 tp -133.35 118.9 19.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 72.310000000000002 111.136 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.742 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 32.9 m-85 -116.62 123.44 47.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 73.040000000000006 110.379 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.529 HD11 HD21 ' A' ' 112' ' ' LEU . 4.0 mt -126.72 139.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.805 0.336 . . . . 72.430000000000007 110.616 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' CZ ' ' A' ' 155' ' ' TYR . 59.6 m -108.82 117.7 34.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.474 . . . . 54.43 110.594 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -93.05 108.33 19.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 42.450000000000003 110.618 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 153' ' ' TYR . 4.0 mt -94.03 129.21 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.082 -0.508 . . . . 73.129999999999995 110.745 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.35 14.3 1.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.539 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' H ' HG22 ' A' ' 117' ' ' ILE . 82.6 t60 -146.57 142.9 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.272 -0.422 . . . . 55.240000000000002 110.667 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -153.07 155.33 36.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 71.129999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -140.68 151.5 44.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.554 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.494 ' HA ' HH21 ' A' ' 13' ' ' ARG . 4.1 mt-10 -35.67 113.57 0.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.219999999999999 110.676 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.446 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -125.64 -123.36 2.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.964 -0.855 . . . . 61.200000000000003 110.964 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -139.86 -55.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.733 0.302 . . . . 72.450000000000003 110.744 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 99' ' ' ALA . 4.2 m -86.11 107.16 17.71 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.526 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.821 ' CA ' HG23 ' A' ' 14' ' ' VAL . 30.9 p90 -121.63 150.43 41.73 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.518 -0.765 . . . . 74.219999999999999 111.367 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.777 ' HB2' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -115.97 137.26 23.23 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.101 -0.499 . . . . 75.340000000000003 109.955 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.35 176.79 3.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.468 2.112 . . . . 52.109999999999999 112.517 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -69.08 86.86 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.02 -0.536 . . . . 75.010000000000005 110.588 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.463 ' O ' ' OD1' ' A' ' 131' ' ' ASP . 24.0 ptm -159.56 162.22 35.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.338 -0.392 . . . . 43.520000000000003 110.67 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 130' ' ' MET . 0.4 OUTLIER -167.52 119.75 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.05 -0.523 . . . . 65.239999999999995 110.334 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 32.1 mtt -153.1 59.32 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 75.340000000000003 110.538 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.582 HG23 ' H ' ' A' ' 134' ' ' ASN . 2.0 t -48.14 -53.11 17.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 73.450000000000003 110.367 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.582 ' H ' HG23 ' A' ' 133' ' ' THR . 7.2 t-20 65.03 14.98 9.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 111.165 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.455 ' CZ2' ' HG2' ' A' ' 160' ' ' LYS . 5.7 m95 -112.29 165.76 11.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.931 0.396 . . . . 72.329999999999998 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 133.65 49.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.145 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.36 151.78 19.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.354 -0.384 . . . . 60.399999999999999 110.938 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.81 -18.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 63.43 110.984 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -152.86 154.28 34.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.551 -0.295 . . . . 72.400000000000006 110.439 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG23 ' ND1' ' A' ' 156' ' ' HIS . 3.9 p -150.87 131.23 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 73.209999999999994 111.03 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -124.14 149.36 46.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.478 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.578 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -101.59 169.84 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.391 . . . . 64.239999999999995 110.567 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.09 -142.19 12.29 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.466 -0.654 . . . . 72.239999999999995 111.466 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.3 tp -177.09 152.06 0.87 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 52.210000000000001 110.396 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 63.9 p -72.52 172.42 10.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.504 -0.316 . . . . 53.020000000000003 110.429 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.36 -171.95 3.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.456 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -80.24 -47.22 14.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.832 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 14.12 32.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 73.310000000000002 110.894 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -142.91 96.08 6.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.845 -0.342 . . . . 73.319999999999993 111.016 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.402 ' HD2' ' CE2' ' A' ' 151' ' ' TYR . 64.4 Cg_endo -80.66 28.09 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.599 2.2 . . . . 71.349999999999994 111.815 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE2' ' HD2' ' A' ' 150' ' ' PRO . 50.5 m-85 -117.06 168.82 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 110.583 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 153' ' ' TYR . 6.8 m -139.54 165.55 26.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.65 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.486 ' N ' HG22 ' A' ' 152' ' ' THR . 17.8 p90 -147.9 175.28 11.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 54.130000000000003 110.33 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 32.1 m-85 -138.52 139.42 38.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 63.229999999999997 110.91 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.525 ' CZ ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -103.71 129.84 51.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.039 -0.528 . . . . 52.229999999999997 110.16 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.486 ' ND1' HG23 ' A' ' 140' ' ' VAL . 17.9 m-70 -117.64 149.35 40.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 63.140000000000001 110.869 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.742 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 40.7 t -117.39 110.36 30.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.26 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -111.52 141.62 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 74.209999999999994 109.82 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.472 ' OE2' ' O ' ' A' ' 160' ' ' LYS . 0.9 OUTLIER -142.44 145.56 33.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 73.109999999999999 110.754 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -60.83 154.7 21.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 71.299999999999997 110.352 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.806 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.34 -26.62 22.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.4 -0.364 . . . . 74.129999999999995 110.821 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 160' ' ' LYS . 1.2 mp0 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.042 -0.98 . . . . 74.25 110.565 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.027 H52A ' OE1' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.916 ' H7 ' ' CB ' ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.405 -0.591 . . . . 73.219999999999999 109.405 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.06 137.79 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.638 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 HD11 ' A' ' 93' ' ' ILE . 3.7 t -120.2 118.76 57.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.412 . . . . 71.230000000000004 110.544 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.67 153.11 30.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.955 0.407 . . . . 64.439999999999998 111.147 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.498 ' CE2' HG22 ' A' ' 95' ' ' ILE . 2.2 t80 -129.82 128.38 42.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.883 -0.599 . . . . 73.349999999999994 110.325 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.82 113.1 20.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.692 0.282 . . . . 74.400000000000006 110.941 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.55 146.7 20.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.344 -0.389 . . . . 73.230000000000004 110.921 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.654 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -89.99 162.21 15.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.564 -0.289 . . . . 72.329999999999998 110.557 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HB2' HG22 ' A' ' 114' ' ' ILE . 2.0 ttm -139.56 131.3 27.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.849 0.357 . . . . 73.530000000000001 111.037 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 13' ' ' ARG . 3.3 m-20 -101.26 126.31 47.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.123 -0.49 . . . . 63.329999999999998 110.166 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.425 ' OE1' ' ND1' ' A' ' 118' ' ' HIS . 23.5 pt-20 -56.22 -20.19 17.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 71.340000000000003 110.948 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -120.64 -10.1 9.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.738 -0.385 . . . . 72.319999999999993 111.349 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.517 HH22 ' HA2' ' A' ' 16' ' ' GLY . 0.0 OUTLIER -138.12 -128.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.259 -0.576 . . . . 75.420000000000002 111.258 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 ' CA ' ' A' ' 126' ' ' PHE . 39.0 t -135.54 -60.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 CA-C-O 120.9 0.381 . . . . 74.400000000000006 110.82 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.887 HD12 ' H1D' ' A' ' 173' ' ' NAP . 0.5 OUTLIER -141.85 -62.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.89 -0.596 . . . . 72.409999999999997 111.479 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.517 ' HA2' HH22 ' A' ' 13' ' ' ARG . . . -162.27 -174.6 32.36 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.284 -0.96 . . . . 71.510000000000005 111.816 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 1.9 pttt -91.86 -24.13 19.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.608 -0.296 . . . . 74.239999999999995 110.282 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 41.4 m-20 -159.36 -124.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 110.342 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.566 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -57.36 -16.56 9.32 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 71.109999999999999 110.117 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -177.93 -150.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.993 -0.548 . . . . 73.319999999999993 110.799 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.933 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.1 tm? 165.4 -43.71 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.361 -0.836 . . . . 71.299999999999997 109.804 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 21' ' ' LEU . 60.9 Cg_endo -75.45 170.17 20.84 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.761 1.641 . . . . 63.210000000000001 111.777 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -141.22 83.29 1.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 53.039999999999999 111.103 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.898 ' NE ' ' H8B' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -73.1 -175.59 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 72.409999999999997 109.947 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 149' ' ' ASN . 1.0 OUTLIER -74.45 142.79 78.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.796 -0.362 . . . . 54.210000000000001 110.314 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -60.08 -24.94 78.45 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.47 2.113 . . . . 53.43 111.69 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.0 p -81.3 -33.86 32.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.913 -0.585 . . . . 71.140000000000001 110.108 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 32' ' ' VAL . 8.6 tm-20 -62.28 -43.57 98.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 71.030000000000001 110.287 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.876 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -69.08 -21.77 64.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 54.329999999999998 110.357 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -79.78 -46.26 17.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 64.409999999999997 110.331 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.19 -53.24 60.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 61.420000000000002 110.51 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 33' ' ' LYS . 6.4 p -60.08 -50.63 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.150000000000006 110.601 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -49.28 -44.76 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 110.628 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -70.14 -22.11 63.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 71.120000000000005 110.878 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.77 -21.6 23.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.889 -0.325 . . . . 73.030000000000001 111.086 -179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 32' ' ' VAL . 6.2 t -105.97 -3.55 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.955 -0.298 . . . . 64.010000000000005 110.761 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.44 ' O ' ' CG ' ' A' ' 37' ' ' MET . 17.8 ptm -58.56 127.35 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.443 -0.344 . . . . 73.299999999999997 110.168 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 39' ' ' HIS . . . 57.1 80.4 0.08 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.643 -0.983 . . . . 42.200000000000003 110.643 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 3.9 m80 -165.97 157.94 12.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 73.219999999999999 110.289 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.49 98.07 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.657 2.238 . . . . 75.200000000000003 112.375 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 mp -119.26 125.74 49.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 71.450000000000003 110.148 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.8 mp -95.99 114.53 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.039 0.447 . . . . 52.100000000000001 111.268 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' ILE . 11.0 ttp -107.46 168.19 9.41 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.859 -0.609 . . . . 61.140000000000001 110.869 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.28 163.2 37.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.727 -0.949 . . . . 64.430000000000007 110.727 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.2 ttp85 -67.47 -58.25 5.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 73.519999999999996 110.649 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -32.22 73.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.992 0.425 . . . . 75.439999999999998 110.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.981 HD22 ' H3D' ' A' ' 173' ' ' NAP . 12.2 t-20 -67.86 -27.44 66.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.954 -0.566 . . . . 74.150000000000006 110.278 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -71.2 -57.61 4.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 110.536 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 16.4 pt-20 -60.5 -22.49 63.62 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.828 -0.349 . . . . 74.340000000000003 110.495 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.68 -45.86 16.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 55.420000000000002 110.444 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.665 HD13 ' O ' ' A' ' 47' ' ' ASN . 1.4 mp -64.07 -50.41 77.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.108 -0.496 . . . . 60.340000000000003 110.102 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 150.92 -114.7 0.66 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.862 -0.895 . . . . 64.129999999999995 110.862 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -153.26 67.18 6.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 73.530000000000001 110.449 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HG2' HD22 ' A' ' 60' ' ' ASN . 57.9 Cg_endo -78.85 154.11 26.09 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.008 2.472 . . . . 64.340000000000003 112.799 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.573 ' H ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER 176.39 -47.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.487 -0.779 . . . . 71.430000000000007 110.635 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' A' ' 55' ' ' LEU . 45.4 Cg_endo -71.86 88.32 0.8 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.688 1.592 . . . . 73.140000000000001 111.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.7 9.14 55.15 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.816 -0.914 . . . . 71.400000000000006 110.816 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' HD2' ' H4 ' ' A' ' 174' ' ' N22 . 1.5 mpp_? -118.77 -53.76 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.801 0.334 . . . . 65.150000000000006 110.379 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' HH11 ' A' ' 59' ' ' ARG . 11.3 ttm180 58.33 74.88 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 110.431 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.425 HD22 ' HG2' ' A' ' 54' ' ' PRO . 87.6 m-20 -112.95 131.33 55.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 75.349999999999994 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 HG23 ' HB3' ' A' ' 75' ' ' GLU . 3.9 mp -108.32 115.28 48.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 74.310000000000002 110.214 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' A' ' 74' ' ' CYS . 15.7 pt -83.07 139.1 18.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.428 -0.351 . . . . 71.25 110.989 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 78' ' ' HIS . 80.4 t -97.29 120.65 46.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 72.430000000000007 110.929 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' THR . 11.5 t -148.05 128.53 14.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.1 -0.5 . . . . 70.510000000000005 110.43 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 2.7 ptm180 -80.61 107.1 13.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 61.140000000000001 110.675 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.553 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 13.6 m-20 177.24 112.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 110.728 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.07 108.87 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.329999999999998 110.743 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.43 10.45 25.44 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.202 -0.759 . . . . 73.019999999999996 111.202 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.54 141.71 37.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 75.219999999999999 110.71 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -146.73 140.27 25.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.07 -0.514 . . . . 75.329999999999998 110.419 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.9 t -134.79 109.42 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.315 -0.402 . . . . 74.109999999999999 110.692 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -65.31 111.72 3.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.5 110.624 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.96 -19.87 7.73 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.166 -0.774 . . . . 55.520000000000003 111.166 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' A' ' 62' ' ' ILE . 4.4 t -142.11 157.68 44.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 51.340000000000003 110.602 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HB3' HG23 ' A' ' 61' ' ' ILE . 3.5 tp10 -87.6 137.1 32.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 63.119999999999997 110.152 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -98.34 143.72 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 65.530000000000001 111.227 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.66 159.04 43.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 109.871 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.524 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -76.47 -177.1 3.98 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.794 -0.363 . . . . 70.340000000000003 110.657 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.645 ' HA ' ' H2A' ' A' ' 173' ' ' NAP . 2.2 t -55.3 -178.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 110.821 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' N ' ' OG ' ' A' ' 79' ' ' SER . 6.7 p -57.42 -21.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.02 -0.536 . . . . 65.030000000000001 110.472 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 75.099999999999994 110.596 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.28 -44.61 21.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 110.711 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG12 ' HG ' ' A' ' 87' ' ' CYS . 18.7 t -53.81 -35.39 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 64.530000000000001 110.369 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -45.63 83.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 72.510000000000005 109.858 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.23 -55.66 6.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.85 -0.614 . . . . 73.439999999999998 110.629 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mp -53.15 -26.8 18.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 64.329999999999998 110.768 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.481 ' HG ' HG12 ' A' ' 83' ' ' VAL . 6.1 m -59.57 -47.8 84.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.8 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -66.73 -3.24 6.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.329 -0.396 . . . . 64.120000000000005 110.915 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.83 -26.66 44.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 74.25 110.753 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -121.76 127.9 51.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 64.200000000000003 110.705 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 2.6 pm0 -47.95 -89.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 110.454 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.03 115.36 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.465 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.606 HD11 HG22 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -133.75 131.04 56.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 74.150000000000006 110.69 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -112.76 135.32 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.263 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' CE2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -120.47 139.07 48.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 110.812 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.572 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -152.2 15.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.42 -0.354 . . . . 73.530000000000001 111.087 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -16.63 -63.25 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.709 -0.556 . . . . 72.340000000000003 111.709 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.42 -161.92 35.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.579 -1.008 . . . . 62.210000000000001 110.579 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.43 -60.06 3.1 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.837 -0.345 . . . . 41.43 110.47 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.89 ' CD ' H52A ' A' ' 173' ' ' NAP . 9.3 pt20 -57.22 -39.12 74.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 71.549999999999997 110.582 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.487 HG21 ' HA3' ' A' ' 97' ' ' GLY . 4.3 mm -67.92 -33.51 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 35.340000000000003 110.237 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -60.79 -50.36 73.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.85 -0.614 . . . . 62.140000000000001 110.627 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.718 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 47.3 t0 -63.29 -46.13 88.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 72.5 111.114 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.17 -18.53 65.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.389 -0.369 . . . . 72.109999999999999 111.407 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.98 -6.11 23.82 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.378 . . . . 74.0 111.618 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 102' ' ' TYR . 0.8 OUTLIER -53.22 -50.81 80.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.576 -0.449 . . . . 73.0 110.483 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 60.3 Cg_endo -80.98 35.13 0.57 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.901 2.401 . . . . 71.430000000000007 112.111 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -142.92 -51.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 70.540000000000006 110.644 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG22 ' N ' ' A' ' 110' ' ' ASP . 7.4 p -66.11 170.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 64.25 110.899 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.723 ' N ' HG22 ' A' ' 109' ' ' VAL . 2.0 m-20 -110.65 -40.16 4.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.198 -0.456 . . . . 63.409999999999997 110.316 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.91 126.81 53.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.996 -0.547 . . . . 65.209999999999994 109.793 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.535 HD12 HD11 ' A' ' 114' ' ' ILE . 2.1 tm? -120.01 127.3 52.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 63.549999999999997 110.695 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.506 ' CZ ' HG13 ' A' ' 157' ' ' VAL . 19.7 m-85 -126.43 133.69 51.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 111.044 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.794 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -136.59 126.25 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.76 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.581 ' OG1' ' CE1' ' A' ' 155' ' ' TYR . 18.5 m -97.76 100.63 12.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.447 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -75.43 121.26 22.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.681 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 119' ' ' HIS . 70.3 mt -102.21 138.04 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 74.099999999999994 110.445 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.425 ' ND1' ' OE1' ' A' ' 11' ' ' GLU . 32.5 t60 -92.6 31.72 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.747 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.514 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -153.32 118.8 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 74.019999999999996 110.621 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 12' ' ' ASN . . . -164.61 144.88 7.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 70.329999999999998 110.514 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.595 ' O ' ' C ' ' A' ' 122' ' ' GLU . 2.8 t80 -150.87 125.85 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 61.100000000000001 110.748 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.595 ' C ' ' O ' ' A' ' 121' ' ' PHE . 56.9 mt-10 5.66 113.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.761 -0.654 . . . . 72.540000000000006 111.656 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -139.86 -135.15 3.21 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.836 -0.906 . . . . 63.509999999999998 110.836 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -104.18 -71.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.272 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 m -79.76 93.3 5.56 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.28 -0.418 . . . . 75.430000000000007 110.082 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.673 ' CA ' HG23 ' A' ' 14' ' ' VAL . 5.4 p90 -125.7 140.35 52.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.632 -0.713 . . . . 70.040000000000006 111.883 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.685 ' CD2' ' O ' ' A' ' 128' ' ' PRO . 1.7 p90 -142.27 136.6 14.96 Favored Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 110.128 -0.323 . . . . 75.340000000000003 110.128 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.685 ' O ' ' CD2' ' A' ' 127' ' ' PHE . 61.1 Cg_endo -74.5 -160.65 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.627 2.218 . . . . 64.219999999999999 112.709 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -81.46 90.37 6.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 64.129999999999995 110.385 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.9 ptp -153.95 24.48 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 75.030000000000001 110.687 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.38 85.78 1.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 71.409999999999997 110.472 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.18 35.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.806 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 134' ' ' ASN . 1.5 t -56.64 -53.63 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 71.120000000000005 110.296 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.615 ' H ' HG23 ' A' ' 133' ' ' THR . 9.4 t-20 57.97 16.57 3.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.07 -0.513 . . . . 61.539999999999999 110.835 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -66.98 162.97 20.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 75.049999999999997 110.264 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -95.51 128.31 42.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 72.409999999999997 110.778 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 139' ' ' PHE . 5.9 tm-20 -90.91 146.23 24.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.592 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.05 -18.89 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.779 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' N ' ' OE2' ' A' ' 137' ' ' GLU . 48.5 t80 -164.8 154.34 13.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 75.019999999999996 110.747 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.2 135.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 42.310000000000002 110.683 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.42 156.65 35.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 74.439999999999998 110.307 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.589 ' CB ' ' HZ3' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -110.77 169.99 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.334 -0.393 . . . . 70.530000000000001 110.843 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -110.51 -161.99 18.25 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.74 -0.944 . . . . 61.539999999999999 110.74 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -156.44 148.69 23.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.868 0.366 . . . . 74.209999999999994 110.707 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 146' ' ' ASP . 5.0 t -103.47 -175.99 2.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 74.310000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.483 ' HB2' HD21 ' A' ' 149' ' ' ASN . 0.2 OUTLIER 177.82 -177.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.979 -0.555 . . . . 70.329999999999998 110.17 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -73.63 -49.85 24.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.439999999999998 110.298 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -73.94 2.11 9.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 73.329999999999998 110.304 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.547 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 9.2 p30 -163.58 78.26 1.65 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 64.219999999999999 110.592 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.545 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 73.3 Cg_endo -80.81 77.9 3.87 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.944 2.429 . . . . 74.400000000000006 112.216 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 43.6 m-85 -162.96 135.11 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.622 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 20.4 m -111.8 131.32 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.674 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -139.11 -175.43 4.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.539 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -146.5 144.84 29.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 53.399999999999999 110.545 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.581 ' CE1' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -105.52 126.85 52.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 64.510000000000005 110.308 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -105.38 146.04 29.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.669 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG13 ' CZ ' ' A' ' 113' ' ' TYR . 14.9 t -117.88 111.97 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 63.439999999999998 110.492 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 35.3 m-85 -119.32 141.33 49.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.040000000000006 110.318 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -141.31 153.65 45.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 65.109999999999999 110.871 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -113.48 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 71.120000000000005 110.476 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -110.34 79.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.4 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.028 -0.987 . . . . 61.43 110.659 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 0.981 ' H3D' HD22 ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.898 ' H8B' ' NE ' ' A' ' 24' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmm . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 2' ' ' ILE . 45.0 mt -122.16 123.01 67.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.901 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 110' ' ' ASP . 0.0 OUTLIER -115.12 118.09 57.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.064 -0.516 . . . . 62.409999999999997 110.1 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.73 150.34 38.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 65.310000000000002 110.679 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 95' ' ' ILE . 2.7 t80 -132.0 137.44 47.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.299999999999997 110.763 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.6 tpt -115.52 113.93 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.027 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.33 144.65 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 70.200000000000003 110.786 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 15' ' ' ILE . . . -98.17 165.02 12.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 42.520000000000003 110.608 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 ttm -140.28 108.63 5.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 70.040000000000006 110.67 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.744 ' OD1' ' HB2' ' A' ' 120' ' ' ALA . 0.7 OUTLIER -81.42 133.04 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 70.540000000000006 110.866 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.38 -30.41 28.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.863 -0.608 . . . . 63.149999999999999 112.22 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -115.48 -9.12 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.745 -0.382 . . . . 64.239999999999995 110.925 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.779 HH12 ' N ' ' A' ' 121' ' ' PHE . 84.2 mtm-85 -132.91 -121.69 0.19 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.504 -0.554 . . . . 64.310000000000002 109.504 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 15' ' ' ILE . 14.5 p -163.0 -41.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.615 -0.434 . . . . 55.240000000000002 110.342 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -165.37 -84.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 C-N-CA 120.719 -0.393 . . . . 71.5 110.618 179.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -29.16 86.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.531 -0.628 . . . . 64.299999999999997 111.531 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 15' ' ' ILE . 26.6 tttt -73.62 -83.1 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.982 0.42 . . . . 75.310000000000002 109.872 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' O ' ' CG ' ' A' ' 19' ' ' ASN . 52.1 t0 -129.99 95.15 3.87 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.816 -0.629 . . . . 72.329999999999998 109.33 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER 48.97 19.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.06 -0.719 . . . . 75.140000000000001 109.06 -178.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' N ' ' C ' ' A' ' 18' ' ' ASP . 1.9 t30 -179.04 170.95 1.42 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.352 -0.84 . . . . 73.099999999999994 110.539 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.686 HD11 ' H1D' ' A' ' 173' ' ' NAP . 0.9 OUTLIER -91.14 155.2 44.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.038 -0.528 . . . . 62.219999999999999 110.005 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 23' ' ' TRP . 28.9 Cg_endo -71.15 -166.05 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.988 1.792 . . . . 74.219999999999999 111.574 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 22' ' ' PRO . 6.4 m-90 -149.35 131.04 14.99 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.61 -0.436 . . . . 73.239999999999995 111.27 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 24' ' ' ARG . 2.9 ptm180 -96.38 95.38 8.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 74.530000000000001 109.989 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER 60.36 116.39 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.535 -0.543 . . . . 73.400000000000006 109.535 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -60.79 -24.38 78.82 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.689 1.593 . . . . 74.120000000000005 111.676 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -70.28 -41.24 73.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 63.240000000000002 109.79 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.17 -44.77 96.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 64.420000000000002 109.878 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.881 HD12 ' H7 ' ' A' ' 174' ' ' N22 . 0.7 OUTLIER -56.56 -32.2 64.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.789 -0.641 . . . . 62.409999999999997 110.401 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.459 ' N ' HD23 ' A' ' 29' ' ' LEU . 34.5 mt-30 -74.89 -41.71 59.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.949 -0.568 . . . . 65.25 111.045 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.88 -53.98 45.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.383 -0.372 . . . . 72.239999999999995 111.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.736 ' O ' HG22 ' A' ' 36' ' ' THR . 8.1 p -62.67 -32.64 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.58 -0.448 . . . . 75.230000000000004 110.284 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -60.24 -45.45 93.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 60.450000000000003 110.411 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -76.38 -19.18 58.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 110.945 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.5 -23.04 26.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 75.400000000000006 110.598 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 32' ' ' VAL . 9.0 t -106.68 -11.98 15.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.551 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.434 ' O ' ' CG ' ' A' ' 37' ' ' MET . 12.4 ptm -43.87 129.51 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.979 -0.555 . . . . 72.319999999999993 110.847 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.17 -32.11 6.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.21 -0.756 . . . . 45.32 111.21 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -68.25 146.19 97.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 71.129999999999995 110.646 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.663 ' HG2' HG22 ' A' ' 93' ' ' ILE . 41.4 Cg_endo -68.88 120.08 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.764 2.309 . . . . 41.030000000000001 112.621 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.3 mt -112.13 105.44 13.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 64.040000000000006 110.105 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' ILE . 4.4 mp -93.26 102.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 111.311 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.78 165.43 11.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 75.209999999999994 111.001 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' N ' ' HA2' ' A' ' 97' ' ' GLY . . . -71.13 158.53 53.72 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.695 -0.962 . . . . 44.549999999999997 110.695 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -69.97 -37.38 75.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.915 -0.314 . . . . 73.219999999999999 110.686 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 28.6 tttm -70.68 -39.79 73.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.678 -0.409 . . . . 71.25 109.932 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.84 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 43.7 t30 -55.15 -61.87 2.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.803 -0.635 . . . . 65.439999999999998 110.755 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -52.07 -43.21 63.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.296 -0.411 . . . . 74.540000000000006 110.556 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 48' ' ' TYR . 15.7 mt-10 -53.9 -44.9 70.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 62.100000000000001 110.654 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -71.74 -51.4 22.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 72.519999999999996 110.466 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.4 mt -49.96 -45.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 110.399 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' ARG . . . 76.99 158.42 8.98 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.979 -0.848 . . . . 71.219999999999999 110.979 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.6 ' O ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 51.56 152.88 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 110.063 -0.347 . . . . 74.109999999999999 110.063 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -67.22 -175.82 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.643 2.229 . . . . 71.409999999999997 113.147 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.75 123.78 40.03 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.749 -0.66 . . . . 61.009999999999998 110.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.47 -38.24 94.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.781 1.654 . . . . 73.140000000000001 112.697 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.37 -14.31 1.41 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.158 -0.777 . . . . 71.340000000000003 111.158 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER 68.37 160.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.06 0.457 . . . . 52.350000000000001 111.045 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.511 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 58.92 62.66 1.83 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.708 -0.678 . . . . 71.439999999999998 110.503 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.18 118.83 37.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.307 -0.861 . . . . 75.540000000000006 109.973 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 1.9 mp -113.02 133.63 58.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.38 -0.373 . . . . 64.450000000000003 110.807 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.32 137.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.200000000000003 110.118 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 78' ' ' HIS . 33.1 t -90.17 123.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 111.554 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.5 t -151.81 141.73 22.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.019 -0.537 . . . . 71.239999999999995 110.146 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 5.7 ptm180 -101.28 86.28 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.328 -0.396 . . . . 75.420000000000002 110.818 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -154.5 122.91 6.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 60.009999999999998 110.441 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.83 112.8 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 70.200000000000003 110.745 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.22 47.05 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.153 -0.779 . . . . 74.430000000000007 111.153 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.88 132.29 53.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 72.329999999999998 110.568 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.423 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 37.4 p-80 -148.93 126.19 11.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 72.439999999999998 110.439 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 t -123.4 115.2 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 72.099999999999994 110.632 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -64.98 126.45 28.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 72.129999999999995 110.602 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.72 -29.14 13.12 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.892 -0.883 . . . . 52.340000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.28 149.15 46.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 73.450000000000003 110.485 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -89.21 139.01 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.456 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 140.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.032 0.444 . . . . 64.430000000000007 110.854 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.64 169.43 16.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.753 -0.658 . . . . 54.030000000000001 110.09 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.624 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -87.05 -162.84 0.83 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.279 -0.418 . . . . 74.109999999999999 110.862 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.667 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 17.8 m -67.93 -173.64 0.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.314 0.578 . . . . 63.329999999999998 111.577 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 15.4 t -51.85 -53.94 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-O 121.942 0.877 . . . . 63.130000000000003 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -41.72 -33.81 0.54 Allowed 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.953 -1.476 . . . . 63.039999999999999 111.005 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -79.58 -37.92 35.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 110.465 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' N ' ' OE1' ' A' ' 82' ' ' GLU . 96.3 t -63.16 -34.7 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 110.886 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -52.97 59.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.034 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.11 -43.25 78.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.943 -0.303 . . . . 74.120000000000005 111.119 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.9 -29.89 13.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.445 -0.343 . . . . 71.5 110.552 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 83' ' ' VAL . 35.1 m -56.56 -39.78 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 70.129999999999995 110.788 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -68.15 -4.84 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 53.210000000000001 110.866 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.35 -23.45 43.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 75.5 110.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -140.35 143.44 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.418 . . . . 63.229999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.2 pm0 -54.34 -69.44 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 110.641 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' C ' HD13 ' A' ' 93' ' ' ILE . 13.8 mt-10 -103.62 123.73 47.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.741 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -121.84 142.09 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 63.200000000000003 110.635 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -112.47 125.25 54.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 75.439999999999998 110.378 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -106.61 131.02 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 64.109999999999999 110.811 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.664 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 15.4 t80 -124.04 15.36 9.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 110.686 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.671 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -24.7 -95.45 0.01 OUTLIER Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.99 -0.844 . . . . 52.109999999999999 110.99 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.614 ' CA ' HE22 ' A' ' 100' ' ' GLN . . . -176.58 -154.28 11.63 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.422 -1.071 . . . . 62.439999999999998 110.422 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.4 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.459 . . . . 71.420000000000002 110.293 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.971 ' NE2' ' H ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -53.42 -51.67 61.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 74.200000000000003 111.156 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.971 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.6 mm -58.95 -35.73 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.813 0.34 . . . . 62.420000000000002 110.109 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.64 -47.79 83.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.777 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.37 -39.66 74.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 53.5 111.03 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.62 -18.91 62.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 111.533 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.601 ' O ' HG23 ' A' ' 109' ' ' VAL . 4.3 m-85 -99.75 4.83 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.834 -0.346 . . . . 72.310000000000002 111.236 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.603 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -59.05 -44.07 98.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.834 -0.347 . . . . 62.420000000000002 110.678 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 52.0 Cg_endo -85.7 9.15 4.2 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 123.147 2.565 . . . . 72.400000000000006 112.329 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.76 -4.8 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.265 -0.425 . . . . 71.430000000000007 110.313 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PHE . 92.2 t -109.03 144.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 110.797 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' H ' HG23 ' A' ' 3' ' ' VAL . 21.9 m-20 -102.61 -21.32 14.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 74.109999999999999 110.311 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' O ' ' CG1' ' A' ' 109' ' ' VAL . 0.7 OUTLIER -127.14 126.8 43.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.895 -0.593 . . . . 73.319999999999993 109.59 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -122.89 129.51 51.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 65.209999999999994 111.389 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.616 ' N ' HD13 ' A' ' 112' ' ' LEU . 19.4 m-85 -123.85 127.08 47.53 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 109.91 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 mp -134.19 123.3 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.451 -0.34 . . . . 52.219999999999999 110.827 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.9 t -109.16 127.2 54.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 51.329999999999998 110.218 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -98.15 144.87 27.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 75.010000000000005 110.401 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.32 124.15 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 64.25 110.585 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -79.58 40.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.886 -0.597 . . . . 70.150000000000006 111.143 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -163.29 112.97 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 74.140000000000001 110.744 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . . . -169.78 130.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 55.32 110.696 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.779 ' N ' HH12 ' A' ' 13' ' ' ARG . 1.8 t80 -144.96 107.89 4.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 54.409999999999997 110.752 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 121' ' ' PHE . 10.2 mt-10 59.37 129.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.974 -0.557 . . . . 52.229999999999997 110.672 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -163.53 -169.72 27.41 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.093 -0.803 . . . . 71.420000000000002 111.093 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -74.6 -71.09 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.685 0.278 . . . . 75.340000000000003 111.054 -179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.503 ' H ' ' HA3' ' A' ' 16' ' ' GLY . 1.6 m -100.15 122.69 43.39 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.946 0.403 . . . . 74.519999999999996 110.981 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -125.11 137.94 54.17 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 74.430000000000007 111.486 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.68 121.4 0.98 Allowed Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 115.823 -0.626 . . . . 63.130000000000003 110.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 -166.21 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.314 2.01 . . . . 61.229999999999997 112.165 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.94 115.52 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 73.140000000000001 110.633 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.401 ' O ' ' OD2' ' A' ' 131' ' ' ASP . 1.1 mtt -77.27 -69.83 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.256 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.653 ' O ' ' N ' ' A' ' 133' ' ' THR . 1.0 OUTLIER -172.52 -55.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 110.543 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 131' ' ' ASP . 4.0 ptt? 27.86 35.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 60.439999999999998 110.535 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.653 ' N ' ' O ' ' A' ' 131' ' ' ASP . 11.9 t -69.67 -13.98 62.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.989 -0.55 . . . . 54.340000000000003 110.747 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -49.14 -35.59 17.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.742 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -72.99 159.37 33.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 72.409999999999997 110.557 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.16 121.25 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.430000000000007 110.371 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.591 ' OE1' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -74.49 153.13 39.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.756 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.12 -29.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 110.848 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 36.9 t80 -152.32 154.41 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 75.200000000000003 110.851 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.406 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 23.0 t -138.35 133.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.966 -0.561 . . . . 62.200000000000003 110.383 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -128.89 142.91 50.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.38 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 165.04 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 64.140000000000001 110.656 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 153' ' ' TYR . . . -120.9 -157.78 10.23 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.489 -1.045 . . . . 53.130000000000003 110.489 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.471 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.9 OUTLIER -164.02 136.67 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.947 0.403 . . . . 74.549999999999997 110.354 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.3 t -57.82 178.1 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.02 -0.537 . . . . 60.549999999999997 111.019 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -165.03 178.4 7.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.908 -0.587 . . . . 75.439999999999998 110.037 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -71.5 -42.04 68.53 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.535 -0.466 . . . . 62.109999999999999 110.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 60.5 mmtt -68.64 -29.42 67.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.067 0.46 . . . . 65.319999999999993 109.774 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -135.48 91.53 18.46 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.619 -0.719 . . . . 65.340000000000003 109.684 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -74.51 66.12 5.57 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.356 2.037 . . . . 72.400000000000006 112.486 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 149' ' ' ASN . 26.2 p90 -173.08 138.75 0.77 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 61.109999999999999 110.623 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.471 HG23 ' HA ' ' A' ' 144' ' ' LEU . 18.3 m -91.29 159.59 15.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.986 -0.552 . . . . 75.530000000000001 110.403 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.429 ' CE1' ' HA3' ' A' ' 143' ' ' GLY . 8.2 p90 -149.56 171.06 17.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.907 0.384 . . . . 64.420000000000002 110.87 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -133.6 144.13 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 75.040000000000006 110.296 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -105.1 148.07 27.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.010000000000005 110.772 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -133.26 132.87 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.496 . . . . 74.439999999999998 110.673 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.1 t -107.13 111.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.122 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -107.9 139.37 42.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 72.310000000000002 110.156 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -133.99 153.23 51.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.0 0.428 . . . . 71.019999999999996 111.064 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.27 165.09 12.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.811 -0.631 . . . . 71.430000000000007 110.217 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.58 -42.79 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.422 -0.354 . . . . 74.219999999999999 110.554 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.989 -1.005 . . . . 74.540000000000006 110.572 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 0.84 ' H6N' ' HB2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.881 ' H7 ' HD12 ' A' ' 29' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.361 -0.607 . . . . 50.530000000000001 109.361 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.7 mm -114.46 128.13 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.540000000000006 110.837 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.53 112.47 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.972 -0.558 . . . . 61.130000000000003 110.116 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.54 138.16 50.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 75.219999999999999 111.083 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 95' ' ' ILE . 8.4 m-85 -111.04 137.16 49.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 72.120000000000005 110.33 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.0 ttt -118.67 104.43 10.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 73.329999999999998 110.798 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.43 144.28 30.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.307 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.79 122.58 44.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 63.240000000000002 110.702 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.539 ' HB2' HG22 ' A' ' 114' ' ' ILE . 1.4 mmm -95.44 119.04 33.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.303 -0.408 . . . . 73.219999999999999 110.917 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.662 ' OD2' ' NH1' ' A' ' 13' ' ' ARG . 1.3 m-20 -99.8 140.17 34.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.26 -0.576 . . . . 63.299999999999997 110.371 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -62.51 -30.82 71.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.932 0.716 . . . . 72.310000000000002 112.932 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.76 19.37 8.87 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.413 -0.515 . . . . 61.439999999999998 111.107 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' NH1' ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER 175.54 -131.73 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.837 -0.62 . . . . 72.420000000000002 109.623 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 125' ' ' THR . 4.5 p -145.78 -47.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.091 -0.644 . . . . 73.230000000000004 111.323 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.619 ' O ' ' H2N' ' A' ' 173' ' ' NAP . 3.6 pt -157.08 -10.96 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.124 0.787 . . . . 74.109999999999999 113.124 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.657 ' C ' ' HE ' ' A' ' 13' ' ' ARG . . . -126.12 103.03 0.67 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.242 -0.98 . . . . 44.219999999999999 111.955 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.618 ' CB ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -93.14 -38.09 11.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.806 0.336 . . . . 44.130000000000003 110.642 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.2 t0 -165.71 99.0 0.68 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 61.219999999999999 110.39 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.627 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 1.3 m-80 38.0 20.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.19 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.657 ' N ' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.91 -171.11 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 111.147 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -143.73 158.84 55.78 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 115.767 -0.651 . . . . 71.439999999999998 109.734 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.81 ' O ' HD22 ' A' ' 21' ' ' LEU . 35.1 Cg_endo -68.96 -171.93 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.007 1.805 . . . . 74.319999999999993 113.373 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.631 ' HE1' ' C2 ' ' A' ' 174' ' ' N22 . 5.7 m-90 -126.68 157.11 39.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.787 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG3' ' CE1' ' A' ' 153' ' ' TYR . 59.4 ttt-85 -104.82 75.7 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.346 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 72.63 111.56 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.215 -0.448 . . . . 55.030000000000001 110.279 -179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 25' ' ' LEU . 12.3 Cg_endo -62.44 -19.24 66.84 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.717 1.611 . . . . 63.25 111.727 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -82.14 -36.77 27.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 75.299999999999997 110.103 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -62.2 -51.3 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.085 -0.507 . . . . 34.229999999999997 110.472 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.843 ' C ' HD12 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -24.56 37.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.209 -0.451 . . . . 52.329999999999998 110.608 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.6 -38.82 33.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.376 . . . . 73.030000000000001 110.754 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.456 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.2 m-85 -69.43 -47.28 64.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.154 -0.475 . . . . 50.210000000000001 110.952 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 33' ' ' LYS . 12.1 p -62.78 -50.26 80.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 73.120000000000005 111.326 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.652 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.2 pttp -59.64 -42.47 92.84 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.737 -0.385 . . . . 74.409999999999997 110.972 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -74.75 -16.14 60.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 75.129999999999995 110.534 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 92.6 m -82.91 -56.22 3.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.414 . . . . 70.209999999999994 110.461 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.52 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.0 OUTLIER -107.0 24.37 12.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.324 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.486 ' CA ' ' O ' ' A' ' 33' ' ' LYS . 3.1 ttp -32.8 111.31 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.986 -0.552 . . . . 74.519999999999996 110.509 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 125.02 -132.39 8.08 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.858 -0.897 . . . . 53.520000000000003 110.858 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER 55.3 148.39 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.695 0.283 . . . . 71.439999999999998 110.565 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' HG2' HG22 ' A' ' 93' ' ' ILE . 58.4 Cg_endo -74.23 133.31 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.905 2.403 . . . . 75.439999999999998 112.412 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.2 tp -130.65 117.64 19.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.931 -0.577 . . . . 75.140000000000001 110.28 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.495 HG23 HG23 ' A' ' 63' ' ' VAL . 3.0 mp -101.09 135.58 36.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.855 0.36 . . . . 70.230000000000004 111.05 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 28.6 mtp -139.73 159.47 42.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.67 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.587 ' H ' HD22 ' A' ' 47' ' ' ASN . . . -78.84 134.88 14.56 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.6 -1.0 . . . . 50.43 110.6 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -43.77 20.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.67 0.272 . . . . 74.140000000000001 110.688 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -54.15 -53.9 47.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.203 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.045 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 2.0 m-80 -56.23 -57.94 10.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.319 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' HG11 ' A' ' 71' ' ' VAL . 29.2 t80 -46.01 -55.98 6.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.779 -0.452 . . . . 65.209999999999994 109.779 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -51.08 -34.05 28.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 73.540000000000006 109.798 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -72.98 -33.44 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.803 -0.635 . . . . 52.530000000000001 110.327 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 53' ' ' ARG . 65.8 mt -75.6 -33.74 27.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.079 -0.509 . . . . 55.039999999999999 110.15 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 47.53 1.34 0.01 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.739 -0.664 . . . . 71.120000000000005 112.217 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.804 ' H ' HG22 ' A' ' 51' ' ' ILE . 10.3 mtp180 -110.07 147.7 36.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 117.224 0.512 . . . . 71.310000000000002 110.951 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.12 -159.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 123.074 2.516 . . . . 73.409999999999997 112.901 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 58' ' ' ARG . 20.4 tp 179.78 71.81 0.16 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-O 121.209 0.528 . . . . 64.200000000000003 110.216 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.5 16.74 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.955 2.436 . . . . 75.310000000000002 112.928 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.74 -10.75 18.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.462 -1.055 . . . . 71.450000000000003 110.462 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 60' ' ' ASN . 8.2 mtt180 -150.51 125.44 9.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.326 -0.249 . . . . 75.430000000000007 110.326 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.493 HH21 ' HB3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -49.0 91.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.788 -0.365 . . . . 74.310000000000002 110.112 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 5.2 p30 -78.65 123.94 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 50.520000000000003 111.113 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.7 129.1 61.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 64.340000000000003 110.442 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.8 pt -107.64 132.05 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.967 0.413 . . . . 73.120000000000005 110.558 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 78' ' ' HIS . 46.5 t -92.0 122.2 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 71.010000000000005 111.043 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.507 ' OG1' ' ND2' ' A' ' 66' ' ' ASN . 4.4 t -157.56 139.41 14.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 64.530000000000001 110.294 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -95.93 106.55 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.385 -0.37 . . . . 72.109999999999999 110.631 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -175.66 106.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.510000000000005 110.637 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 112.47 5.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.67 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.74 9.34 24.95 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.175 -0.77 . . . . 73.219999999999999 111.175 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.78 139.8 31.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.802 0.334 . . . . 74.209999999999994 110.636 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -146.97 131.13 17.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.468 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG11 ' CE2' ' A' ' 48' ' ' TYR . 94.6 t -126.2 113.36 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.400000000000006 110.588 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.37 122.5 19.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.522 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.63 -10.4 35.34 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.861 -0.895 . . . . 52.329999999999998 110.861 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 48' ' ' TYR . 1.7 t -146.73 154.43 41.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.795 0.331 . . . . 43.340000000000003 110.588 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -92.82 134.51 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 110.369 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -85.23 144.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 64.519999999999996 110.657 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.49 155.23 46.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.025 -0.534 . . . . 71.420000000000002 110.266 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.654 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -79.32 -168.55 1.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 63.5 110.601 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.56 ' HB2' ' H2A' ' A' ' 173' ' ' NAP . 13.0 t -66.15 -177.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 73.450000000000003 111.072 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 4.4 p -55.39 -22.51 11.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 70.349999999999994 110.371 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -59.74 -38.57 82.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 73.319999999999993 110.256 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.799 ' OE2' HD12 ' A' ' 86' ' ' LEU . 1.2 tm-20 -79.16 -43.02 24.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 43.130000000000003 110.488 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -60.59 -35.74 65.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.198 -0.456 . . . . 71.519999999999996 110.724 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -44.98 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 111.347 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 82' ' ' GLU . 8.7 pt-20 -74.54 -48.13 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.815 -0.354 . . . . 54.329999999999998 111.493 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.799 HD12 ' OE2' ' A' ' 82' ' ' GLU . 79.6 mt -59.63 -27.1 66.04 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.827 -0.349 . . . . 53.219999999999999 110.536 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.87 -40.44 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.421 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -74.63 -3.28 30.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 61.340000000000003 110.455 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -83.65 -9.39 58.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 74.200000000000003 110.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 93' ' ' ILE . 19.9 tp10 -146.16 131.92 18.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 72.030000000000001 110.279 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -70.07 0.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 110.702 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.14 115.28 29.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 73.319999999999993 110.724 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -119.39 138.28 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 64.329999999999998 110.21 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.522 ' CE2' ' CD2' ' A' ' 39' ' ' HIS . 22.5 m-85 -105.57 120.38 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 74.510000000000005 110.751 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 5' ' ' PHE . 25.2 mm -104.45 138.73 27.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 65.420000000000002 110.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.468 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -121.23 -49.1 2.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 75.129999999999995 110.428 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 35.25 -101.39 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.354 -0.698 . . . . 53.32 111.354 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . 174.54 -147.82 9.41 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.044 -0.822 . . . . 62.450000000000003 111.044 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -63.19 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.64 0.257 . . . . 75.010000000000005 111.27 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.887 ' NE2' H52A ' A' ' 173' ' ' NAP . 1.8 pt20 -58.54 -44.87 89.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 74.099999999999994 110.548 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.458 HG21 ' HA3' ' A' ' 97' ' ' GLY . 33.0 mm -54.98 -52.32 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 53.299999999999997 110.464 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -55.87 -38.18 69.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 63.109999999999999 110.982 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.49 -55.56 32.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.173 -0.467 . . . . 64.25 111.731 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.619 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.0 pp -72.43 -18.9 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.01 -0.276 . . . . 63.149999999999999 111.519 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.571 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 2.5 m-85 -86.41 -7.44 58.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 74.120000000000005 110.755 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 109' ' ' VAL . 1.9 mt -41.0 -59.49 2.13 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 71.230000000000004 111.131 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 52.5 Cg_endo -70.4 -15.37 34.67 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.81 2.34 . . . . 72.109999999999999 113.114 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -97.08 -1.44 45.28 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.732 -0.387 . . . . 65.430000000000007 111.513 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 106' ' ' LEU . 7.5 p -110.49 153.83 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.689 -0.404 . . . . 63.109999999999999 110.998 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 109' ' ' VAL . 19.5 m-20 -115.87 -43.95 2.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.968 -0.56 . . . . 52.420000000000002 110.238 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -111.63 133.46 53.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.874 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 5' ' ' PHE . 14.8 tp -125.63 118.28 25.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.778 0.323 . . . . 64.140000000000001 111.563 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.417 ' C ' HD12 ' A' ' 114' ' ' ILE . 6.4 m-85 -112.03 122.74 48.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 109.993 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.961 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -126.3 129.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.367 -0.378 . . . . 64.319999999999993 110.608 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -102.28 109.07 20.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.039 -0.528 . . . . 52.210000000000001 110.487 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 9' ' ' MET . 18.6 ttpp -86.56 127.81 34.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 64.150000000000006 110.844 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' OD1' ' A' ' 10' ' ' ASP . 1.4 mt -107.42 139.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 74.209999999999994 109.96 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' C ' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -90.13 -0.88 57.82 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.969 -0.293 . . . . 74.129999999999995 111.227 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' H ' HG22 ' A' ' 117' ' ' ILE . 3.2 t-80 -133.81 117.22 16.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.414 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB2' ' OD2' ' A' ' 10' ' ' ASP . . . -166.31 157.16 12.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.939 0.399 . . . . 65.299999999999997 111.118 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.19 152.76 34.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 73.25 110.579 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -48.8 171.92 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.852 -0.425 . . . . 53.310000000000002 109.852 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.8 -133.91 1.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.267 -0.968 . . . . 52.43 111.929 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -105.33 -49.22 3.5 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.634 0.235 . . . . 54.039999999999999 111.634 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 2.3 m -99.51 96.24 7.54 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.633 -0.427 . . . . 74.329999999999998 110.701 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.97 135.86 53.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.362 0.601 . . . . 71.530000000000001 112.208 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.53 95.47 0.83 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.024 -0.989 . . . . 74.040000000000006 109.854 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 130' ' ' MET . 53.8 Cg_endo -76.32 174.02 13.51 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.445 2.097 . . . . 60.530000000000001 112.158 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.4 89.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 75.049999999999997 110.512 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.441 ' N ' ' O ' ' A' ' 128' ' ' PRO . 7.6 mtp -87.22 -53.59 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.472 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.26 113.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 62.340000000000003 110.445 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.7 ptp -134.1 0.75 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 53.030000000000001 110.68 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -47.19 -21.19 0.23 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.281 -0.418 . . . . 74.329999999999998 110.385 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -57.79 -25.54 60.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 73.450000000000003 110.247 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.435 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 28.0 m95 -107.22 131.63 53.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 72.140000000000001 110.466 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -93.44 147.63 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 71.099999999999994 110.81 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.07 152.79 19.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 72.109999999999999 110.606 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 31.5 m -129.64 -3.93 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 63.229999999999997 110.798 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -176.49 149.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 73.239999999999995 110.527 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.9 p -146.18 128.7 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 74.319999999999993 110.974 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 142' ' ' LYS . 71.5 tt0 -115.5 161.03 19.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.023 -0.535 . . . . 74.340000000000003 110.032 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -119.2 159.98 23.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 55.25 110.798 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.27 -148.68 20.19 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.794 -0.922 . . . . 62.329999999999998 110.794 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.4 tp -175.55 157.12 2.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 75.239999999999995 110.334 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -79.13 159.04 27.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.285 0.564 . . . . 63.149999999999999 111.48 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 149' ' ' ASN . 15.7 m-20 -160.12 156.54 26.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.437 -0.801 . . . . 75.049999999999997 109.789 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.7 -33.54 71.73 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.705 -0.398 . . . . 74.510000000000005 110.615 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -75.14 -25.84 58.69 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.736 -0.468 . . . . 72.099999999999994 109.736 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 146' ' ' ASP . 0.4 OUTLIER -147.96 82.31 7.89 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 72.030000000000001 110.046 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' O ' ' CD1' ' A' ' 151' ' ' TYR . 38.1 Cg_endo -72.31 74.57 2.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.367 2.045 . . . . 72.409999999999997 112.406 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.425 ' CD1' ' O ' ' A' ' 150' ' ' PRO . 74.5 m-85 -153.57 -166.45 2.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 74.230000000000004 110.244 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 m -154.9 117.28 4.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 110.363 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -122.61 170.5 9.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 65.209999999999994 110.465 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 13.3 m-85 -135.98 134.03 38.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.56 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -95.39 129.12 42.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.329999999999998 110.606 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -113.82 145.62 41.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 64.25 110.643 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.1 t -117.61 112.15 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 72.5 110.588 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 150.69 39.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.293 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -155.06 155.78 34.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.337 -0.392 . . . . 74.010000000000005 110.92 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.435 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 13.8 mmtt -99.25 164.35 12.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 63.140000000000001 110.186 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -65.06 -58.79 5.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 65.549999999999997 110.708 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 117.983 -1.008 . . . . 74.150000000000006 110.558 -179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.045 ' H6N' ' CG ' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.667 ' H2 ' HD13 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' H ' ' A' ' 2' ' ' ILE . 14.8 tpp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.332 -0.618 . . . . 44.109999999999999 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.419 ' H ' ' HB3' ' A' ' 1' ' ' MET . 50.1 mt -111.63 111.46 36.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.852 0.358 . . . . 73.129999999999995 110.298 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 62.7 t -112.43 111.07 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 73.549999999999997 110.893 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.5 m -96.56 152.75 18.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.006 0.431 . . . . 71.530000000000001 110.619 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.757 ' CD2' ' CE2' ' A' ' 102' ' ' TYR . 0.6 OUTLIER -121.19 114.51 21.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.714 -0.676 . . . . 73.540000000000006 110.958 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.423 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 61.2 mtp -106.05 89.7 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.686 -0.487 . . . . 74.150000000000006 109.686 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 114' ' ' ILE . 7.2 p -127.63 146.66 32.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.458 0.647 . . . . 75.25 111.396 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . -95.17 145.94 24.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.694 -0.685 . . . . 71.319999999999993 110.636 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.561 ' SD ' ' N ' ' A' ' 10' ' ' ASP . 1.3 tpt -112.96 119.57 38.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 74.400000000000006 110.547 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' N ' ' SD ' ' A' ' 9' ' ' MET . 6.1 m-20 -94.89 132.76 39.36 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 75.340000000000003 110.925 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -60.43 -30.29 69.54 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.012 -0.54 . . . . 44.439999999999998 112.088 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.675 ' O ' ' NE ' ' A' ' 13' ' ' ARG . 3.9 m-80 -115.58 3.0 13.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.043 0.449 . . . . 74.340000000000003 110.542 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.675 ' NE ' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -143.54 -134.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.422 -0.955 . . . . 74.25 108.422 179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 125' ' ' THR . 8.7 p -150.6 -44.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.318 -0.553 . . . . 55.130000000000003 110.445 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG12 HG13 ' A' ' 14' ' ' VAL . 26.4 pt -148.95 -39.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.346 -0.542 . . . . 64.329999999999998 111.096 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -103.12 95.42 1.23 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.767 -0.933 . . . . 61.329999999999998 110.767 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 6.7 pttp -85.03 -35.68 21.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.831 0.348 . . . . 74.420000000000002 110.55 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' C ' ' CG ' ' A' ' 19' ' ' ASN . 37.7 t0 -149.5 57.36 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.077 -0.51 . . . . 70.319999999999993 110.069 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.3 OUTLIER 79.83 -17.31 0.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.384 -0.599 . . . . 75.329999999999998 109.384 -179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 18' ' ' ASP . 0.7 OUTLIER -145.97 172.97 12.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.349 -0.841 . . . . 73.409999999999997 110.053 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.818 HD11 ' H11' ' A' ' 174' ' ' N22 . 0.6 OUTLIER -91.36 148.48 37.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 72.409999999999997 110.368 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.74 137.86 55.89 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.589 2.192 . . . . 73.129999999999995 112.139 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -74.9 169.92 16.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 73.230000000000004 110.858 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -151.7 93.23 1.84 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.461 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.515 ' H ' ' ND2' ' A' ' 149' ' ' ASN . 0.4 OUTLIER 56.08 92.26 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 63.420000000000002 110.228 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -58.92 -28.21 86.83 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.702 1.601 . . . . 31.440000000000001 111.864 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 t -62.81 -41.82 99.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 72.540000000000006 109.956 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.63 -45.0 92.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 74.120000000000005 109.63 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -31.78 51.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.413 -0.812 . . . . 71.129999999999995 109.894 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -78.85 -35.36 44.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.055 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -74.15 -42.32 60.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.463 -0.335 . . . . 72.239999999999995 111.457 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.9 p -67.61 -46.1 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.578 -0.283 . . . . 72.430000000000007 111.178 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.07 -31.68 70.61 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.867 -0.333 . . . . 64.129999999999995 110.931 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 19.2 ttmm -65.65 -40.95 93.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 75.239999999999995 110.962 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 36' ' ' THR . 11.3 t -85.15 -26.09 27.06 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.827 -0.349 . . . . 72.109999999999999 110.605 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.608 HG23 HG23 ' A' ' 35' ' ' THR . 71.2 p -99.78 -1.13 38.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.411 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' LYS . 18.2 ptm -31.33 136.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 72.430000000000007 110.689 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 39' ' ' HIS . . . 92.31 -140.29 15.06 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.927 -0.869 . . . . 70.099999999999994 110.927 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 38' ' ' GLY . 3.8 m170 58.09 148.73 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 63.109999999999999 110.731 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 121.31 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.873 2.382 . . . . 75.239999999999995 112.281 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD12 ' NE ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -121.02 109.26 14.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.996 -0.547 . . . . 73.200000000000003 110.379 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.7 mp -88.15 130.23 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.905 -0.405 . . . . 64.200000000000003 109.905 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.0 mtt -136.63 162.97 31.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.865 0.364 . . . . 61.299999999999997 110.755 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -81.59 147.71 27.03 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.982 -0.847 . . . . 72.140000000000001 110.982 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.729 HH21 ' CB ' ' A' ' 64' ' ' THR . 17.5 ttm105 -59.36 -58.0 10.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 74.340000000000003 110.468 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -60.4 -30.1 69.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 63.130000000000003 110.195 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' HB2' ' H6N' ' A' ' 173' ' ' NAP . 2.5 t30 -63.46 -61.7 2.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.005 -0.543 . . . . 65.030000000000001 110.227 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.93 -39.84 78.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.537 . . . . 74.450000000000003 110.472 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -50.01 -53.32 27.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 74.329999999999998 110.848 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.99 -43.67 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 75.430000000000007 110.879 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.539 HG23 ' C15' ' A' ' 174' ' ' N22 . 1.5 mp -59.53 -26.85 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 64.439999999999998 110.834 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 43.01 -147.5 0.74 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.454 -1.058 . . . . 54.130000000000003 110.454 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.666 ' CG ' ' H4A' ' A' ' 174' ' ' N22 . 17.6 tpp180 50.94 92.74 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.37 0 C-N-CA 120.721 -0.392 . . . . 63.340000000000003 110.718 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.95 149.58 13.84 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.998 2.465 . . . . 64.340000000000003 112.119 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 57' ' ' GLY . 0.7 OUTLIER -129.69 96.26 27.21 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 63.140000000000001 110.437 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.27 20.43 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.183 1.922 . . . . 72.329999999999998 111.702 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -113.08 -12.21 12.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.464 -1.054 . . . . 61.130000000000003 110.464 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.512 ' NE ' HD12 ' A' ' 41' ' ' LEU . 26.4 mtp180 -129.81 113.07 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.126 -0.324 . . . . 64.310000000000002 110.126 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 HH11 ' HB3' ' A' ' 59' ' ' ARG . 7.9 mtm105 -57.78 82.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.486 -0.324 . . . . 74.010000000000005 110.86 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 58' ' ' ARG . 49.5 m-20 -90.07 124.18 34.56 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.827 -0.349 . . . . 72.409999999999997 110.114 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.82 119.54 62.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 62.530000000000001 110.85 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.7 pt -88.82 140.23 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.998 -0.546 . . . . 61.329999999999998 110.667 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 78' ' ' HIS . 69.0 t -92.32 125.14 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 73.5 110.605 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.729 ' CB ' HH21 ' A' ' 45' ' ' ARG . 5.1 t -160.55 142.01 12.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.842 0.353 . . . . 64.150000000000006 110.71 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' O ' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -98.64 100.91 12.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 64.549999999999997 110.419 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -173.88 97.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.595 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 113.55 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.756 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.24 10.88 21.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.542 -0.623 . . . . 42.25 111.542 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.2 145.23 24.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.742 -0.383 . . . . 61.149999999999999 110.514 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -151.33 123.57 8.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.569 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 74' ' ' CYS . 46.8 t -112.88 109.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 61.219999999999999 110.666 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.09 124.85 19.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 72.299999999999997 110.58 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.14 -45.04 1.35 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.985 -0.846 . . . . 72.239999999999995 110.985 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.9 m -111.74 149.6 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.781 0.324 . . . . 53.32 110.573 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.82 149.89 23.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 74.200000000000003 110.328 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.2 t -99.92 150.14 5.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 62.109999999999999 111.042 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.81 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.879 -0.601 . . . . 74.430000000000007 110.423 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.526 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -94.14 -178.37 4.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.893 0.377 . . . . 74.310000000000002 110.652 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.5 p -55.37 -177.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 75.120000000000005 110.993 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -52.49 -22.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.997 -0.547 . . . . 52.399999999999999 110.62 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.24 -43.51 92.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.807 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -78.94 -36.78 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 71.409999999999997 110.876 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.6 t -65.58 -37.28 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.304 -0.407 . . . . 63.140000000000001 110.8 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.94 -54.07 27.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 74.549999999999997 110.799 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 7.1 pt-20 -69.99 -42.77 72.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 64.219999999999999 110.932 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -54.86 -24.58 23.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.15 -0.477 . . . . 64.219999999999999 110.882 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.1 m -67.4 -36.22 80.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 64.219999999999999 110.73 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -71.74 -1.42 13.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.189 -0.459 . . . . 75.319999999999993 110.652 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.18 -16.66 52.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.038 -0.528 . . . . 73.450000000000003 110.982 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' ILE . 34.1 tp10 -147.11 124.18 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 71.230000000000004 110.509 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -52.21 -43.86 64.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 41.399999999999999 110.761 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -110.34 104.0 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.662 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.513 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -118.96 140.67 42.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 110.168 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -104.33 126.48 51.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 65.310000000000002 110.779 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.404 ' HA ' HD13 ' A' ' 95' ' ' ILE . 50.4 mm -105.93 131.64 54.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.809 -0.632 . . . . 63.219999999999999 110.717 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.562 ' O ' ' C ' ' A' ' 97' ' ' GLY . 0.4 OUTLIER -125.1 -36.72 2.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.809 -0.632 . . . . 74.439999999999998 110.131 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.828 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . 18.53 -118.49 0.01 OUTLIER Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.861 -0.609 . . . . 61.219999999999999 111.642 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.71 -159.64 9.58 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.791 -0.924 . . . . 53.340000000000003 110.791 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 -61.04 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 72.049999999999997 110.821 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -57.2 -39.25 75.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.374 -0.375 . . . . 52.420000000000002 110.493 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.678 HG22 ' CZ ' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -66.76 -44.89 89.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 116.109 -0.496 . . . . 41.32 110.302 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.757 ' CE2' ' CD2' ' A' ' 5' ' ' PHE . 1.3 m-85 -50.14 -51.83 40.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 65.340000000000003 109.774 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -59.47 -34.36 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 74.450000000000003 110.555 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 104' ' ' LEU . 6.9 tp -50.52 -49.08 56.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 62.340000000000003 111.157 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.678 ' CZ ' HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -120.44 36.06 4.67 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.997 -0.681 . . . . 62.219999999999999 111.915 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.564 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tp -57.28 -53.87 60.82 Favored Pre-proline 0 C--N 1.333 -0.151 0 C-N-CA 120.862 -0.335 . . . . 64.430000000000007 110.431 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 25.3 Cg_endo -62.94 -6.15 8.9 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.109 1.873 . . . . 63.32 112.11 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -94.58 -27.85 15.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 75.439999999999998 110.719 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.535 HG22 ' CE1' ' A' ' 5' ' ' PHE . 35.5 t -53.81 150.1 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 111.144 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 3' ' ' VAL . 33.8 t0 -118.56 -33.49 4.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.825 -0.625 . . . . 71.129999999999995 110.306 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -129.95 128.92 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.827 -0.624 . . . . 70.150000000000006 109.861 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.42 121.54 45.14 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.428 -0.509 . . . . 54.32 111.343 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.16 118.19 28.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.529 -0.76 . . . . 71.230000000000004 110.078 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.58 138.63 53.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.274 -0.421 . . . . 54.130000000000003 110.813 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 115' ' ' THR . 4.4 t -113.26 107.29 15.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.581 0.705 . . . . 60.229999999999997 110.62 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 117' ' ' ILE . 6.5 tptt -74.12 116.83 15.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.698 -0.683 . . . . 74.319999999999993 110.92 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' N ' ' HD2' ' A' ' 116' ' ' LYS . 21.5 mt -114.78 134.85 56.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 110.311 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 62.4 t-80 -90.25 63.03 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 75.120000000000005 110.842 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -168.56 113.4 0.61 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 74.040000000000006 110.489 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 12' ' ' ASN . . . -168.87 137.87 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 41.130000000000003 110.332 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.466 ' O ' ' O ' ' A' ' 122' ' ' GLU . 1.1 t80 -157.75 120.04 3.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.957 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 17' ' ' LYS . 37.6 mt-10 48.77 103.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.545 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 17' ' ' LYS . . . -134.49 -161.11 9.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.343 -0.703 . . . . 52.32 111.343 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -110.73 -18.01 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.107 -0.237 . . . . 71.129999999999995 111.127 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -141.63 115.65 9.28 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 120.396 -0.522 . . . . 61.109999999999999 111.432 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.348 -0.842 . . . . 64.450000000000003 111.033 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.516 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.0 t80 -166.49 133.61 2.07 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 74.209999999999994 110.2 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -71.71 176.34 8.33 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.306 2.004 . . . . 72.219999999999999 112.332 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -91.86 69.71 5.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 75.310000000000002 110.43 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 13.8 mmm -114.18 -174.05 2.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.638 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 43.06 64.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.016 -0.538 . . . . 44.340000000000003 110.777 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.436 ' HG3' ' N ' ' A' ' 133' ' ' THR . 24.3 ptt? -120.53 -33.14 3.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.275 -0.42 . . . . 72.400000000000006 110.586 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 132' ' ' MET . 1.9 t -49.0 -33.43 11.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 54.0 110.542 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -59.3 -21.68 60.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 63.329999999999998 110.382 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.46 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 62.8 m95 -117.42 145.34 44.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 70.530000000000001 110.175 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.54 142.79 36.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 110.708 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' CD ' ' O ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -91.94 149.47 21.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.982 -0.554 . . . . 62.229999999999997 110.501 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.39 -8.15 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 75.219999999999999 110.75 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -175.27 153.85 1.63 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.372 -0.377 . . . . 71.140000000000001 110.725 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.65 113.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.524 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -102.48 154.83 18.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 71.310000000000002 110.42 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.29 160.22 18.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 62.439999999999998 110.738 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.28 -165.89 13.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.597 -1.001 . . . . 54.109999999999999 110.597 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 144' ' ' LEU . 8.8 tp -154.66 157.43 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.007 0.432 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.6 t -68.42 164.04 21.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 71.310000000000002 111.542 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 9.6 t0 -161.71 167.27 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.432 -0.804 . . . . 70.430000000000007 109.865 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 24.3 mt-10 -61.83 -37.19 83.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.491 -0.322 . . . . 65.030000000000001 111.013 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -82.28 -12.5 57.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.328 -0.396 . . . . 73.340000000000003 110.877 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 14.6 m-80 -149.38 73.39 9.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.501 -0.318 . . . . 70.420000000000002 110.846 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 22.7 Cg_endo -65.54 79.25 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.256 1.97 . . . . 61.299999999999997 111.78 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 2.3 m-85 -178.39 165.59 1.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.512 . . . . 73.129999999999995 110.429 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.5 m -113.37 144.42 42.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.452 -0.34 . . . . 70.530000000000001 110.68 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.665 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 0.3 OUTLIER -142.09 174.74 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.076 0.465 . . . . 73.239999999999995 111.155 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.665 ' CD1' ' O ' ' A' ' 153' ' ' TYR . 9.6 m-85 -144.69 139.58 28.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.68 . . . . 75.140000000000001 110.461 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -97.74 121.37 39.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 110.45 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -103.31 140.03 37.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 65.450000000000003 110.726 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.6 t -121.35 119.53 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 110.526 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 35.8 m-85 -131.63 154.09 49.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 110.402 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -153.93 153.53 32.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.933 0.397 . . . . 72.5 111.108 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.46 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 1.3 mmtm -96.75 138.71 33.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 60.119999999999997 110.155 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.696 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 5.8 mp0 -49.71 -67.97 0.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.407 -0.36 . . . . 74.319999999999993 110.791 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.001 -0.999 . . . . 74.319999999999993 110.615 -179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 0.828 ' H5N' ' O ' ' A' ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.818 ' H11' HD11 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' HG13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.48 -0.563 . . . . 63.43 109.48 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.415 HG13 ' SD ' ' A' ' 1' ' ' MET . 17.6 mt -126.01 134.23 67.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 64.340000000000003 110.567 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 93' ' ' ILE . 1.7 t -123.85 103.82 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 71.019999999999996 110.619 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -102.13 138.46 39.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 72.099999999999994 110.69 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 95' ' ' ILE . 4.6 m-85 -115.42 124.35 50.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 73.030000000000001 110.579 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -100.13 106.57 18.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 74.400000000000006 110.357 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -132.98 146.3 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 74.239999999999995 110.841 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -96.71 170.23 9.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.375 -0.375 . . . . 75.140000000000001 110.077 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 115' ' ' THR . 23.3 ttm -140.48 116.94 10.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.907 -0.317 . . . . 74.420000000000002 110.786 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 2.8 m-20 -92.81 124.11 36.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 71.540000000000006 110.643 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -52.67 -22.33 5.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 112.069 -179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.609 ' N ' ' OE1' ' A' ' 11' ' ' GLU . 1.8 m120 -118.99 -13.94 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.376 -0.529 . . . . 42.340000000000003 111.515 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HE ' ' H ' ' A' ' 123' ' ' GLY . 6.6 mmt-85 -130.7 -117.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.895 -0.322 . . . . 75.109999999999999 110.207 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 125' ' ' THR . 14.7 p -150.7 -43.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 120.916 -0.314 . . . . 52.25 110.65 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.833 HG13 ' H1D' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -164.62 -45.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.845 0.355 . . . . 75.430000000000007 110.347 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -60.02 95.2 0.07 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.729 -0.948 . . . . 70.129999999999995 110.729 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 tttm -85.3 -64.31 1.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.875 0.369 . . . . 74.0 111.026 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' C ' ' N ' ' A' ' 20' ' ' ASN . 32.3 t0 -142.32 91.86 2.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.288 -0.414 . . . . 74.049999999999997 109.951 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 18' ' ' ASP . 10.2 p30 45.84 21.62 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.154 -0.684 . . . . 63.039999999999999 109.154 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -178.48 -178.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.27 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.973 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -97.32 168.6 9.92 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.077 -0.511 . . . . 72.430000000000007 110.648 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' A' ' 117' ' ' ILE . 10.1 Cg_endo -82.62 175.89 8.37 Favored 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.374 2.049 . . . . 63.109999999999999 111.213 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.643 ' NE1' ' C14' ' A' ' 174' ' ' N22 . 0.3 OUTLIER -144.32 161.75 38.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.247 0.546 . . . . 65.329999999999998 111.28 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -108.98 -162.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.369 -0.832 . . . . 74.150000000000006 109.696 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.674 ' H ' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -52.7 131.71 46.78 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 120.429 -0.508 . . . . 62.109999999999999 109.657 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.93 -9.11 9.06 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.811 1.674 . . . . 72.109999999999999 111.507 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 14.6 m -81.21 -46.54 14.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.838 -0.619 . . . . 71.120000000000005 109.849 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.629 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -63.5 -32.06 73.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 109.867 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.778 HD23 ' N ' ' A' ' 30' ' ' GLN . 0.3 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.767 -0.651 . . . . 74.209999999999994 111.556 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.778 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -88.76 -28.93 20.16 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 120.017 -0.673 . . . . 75.400000000000006 110.949 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -66.91 -37.94 85.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.543 -0.463 . . . . 75.340000000000003 109.849 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG13 ' N ' ' A' ' 33' ' ' LYS . 7.7 p -73.54 -51.41 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 64.530000000000001 110.861 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.657 ' N ' HG13 ' A' ' 32' ' ' VAL . 23.6 pttt -58.84 -36.05 73.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.613 -0.435 . . . . 70.0 111.128 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' O ' ' SD ' ' A' ' 37' ' ' MET . 4.8 tppt? -65.77 -49.1 69.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.541 -0.3 . . . . 72.109999999999999 111.491 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 36' ' ' THR . 9.0 t -72.96 -23.58 60.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.775 -0.37 . . . . 44.43 111.213 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 35' ' ' THR . 64.4 p -99.49 -1.5 38.31 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 64.439999999999998 111.058 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 12.8 ptm -46.69 134.27 9.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 54.450000000000003 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.99 -3.88 70.78 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 64.200000000000003 110.98 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.21 144.94 33.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.689 0.28 . . . . 53.43 110.362 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -71.34 117.06 4.96 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 62.009999999999998 112.769 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.21 101.18 10.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 62.030000000000001 110.288 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 95' ' ' ILE . 2.2 mp -88.93 121.55 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 110.639 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.751 ' SD ' ' H4 ' ' A' ' 174' ' ' N22 . 17.6 mtm -128.0 146.4 50.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.979 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.67 136.5 31.55 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.461 -1.056 . . . . 64.530000000000001 110.461 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HG3' ' H ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.06 -49.64 65.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.75 0.309 . . . . 74.140000000000001 110.696 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.46 -32.22 68.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.197 0.522 . . . . 74.120000000000005 109.79 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.206 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 8.1 m-80 -75.45 -38.81 59.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.584 -0.734 . . . . 64.120000000000005 111.057 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 3.5 t80 -64.56 -42.93 95.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 62.219999999999999 110.967 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 5.2 pt-20 -71.16 -30.44 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 73.109999999999999 110.258 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 49' ' ' GLU . . . -71.87 -45.93 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.143 -0.48 . . . . 72.230000000000004 110.495 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 60.2 mt -66.38 -47.03 85.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.036 -0.529 . . . . 62.329999999999998 110.666 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.22 -99.83 0.26 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.673 -0.971 . . . . 71.239999999999995 110.673 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.58 66.63 2.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.991 0.424 . . . . 64.109999999999999 110.464 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HB3' ' H16' ' A' ' 174' ' ' N22 . 68.3 Cg_endo -78.71 178.84 7.08 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 122.982 2.455 . . . . 74.239999999999995 112.174 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 1.9 tp -176.3 51.27 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 116.428 -0.351 . . . . 55.140000000000001 110.868 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 43.8 Cg_endo -68.81 107.1 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 73.010000000000005 111.89 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.14 5.63 49.53 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.405 -0.678 . . . . 65.329999999999998 111.405 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.51 HH11 ' HG3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 50.14 47.06 24.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.911 0.386 . . . . 63.100000000000001 110.444 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 59' ' ' ARG . 2.2 tpt180 -169.72 72.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 74.129999999999995 110.262 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -119.31 113.81 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.8 -0.636 . . . . 74.510000000000005 110.414 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.9 OUTLIER -105.14 130.82 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.112 -0.494 . . . . 65.120000000000005 110.528 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.588 HD11 ' SG ' ' A' ' 74' ' ' CYS . 3.1 pt -110.33 137.39 42.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.117 -0.492 . . . . 53.539999999999999 110.442 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 78' ' ' HIS . 96.2 t -89.02 119.95 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 63.310000000000002 110.872 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -155.93 142.01 18.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.894 -0.594 . . . . 70.540000000000006 110.148 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 0.4 OUTLIER -109.49 104.22 13.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.33 -0.396 . . . . 63.509999999999998 110.802 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 6.1 m120 -171.26 108.41 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 73.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 124.38 23.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 73.519999999999996 110.697 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.07 5.76 65.63 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.265 -0.734 . . . . 61.140000000000001 111.265 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -116.18 116.25 27.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.804 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -147.72 142.72 26.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.461 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 74' ' ' CYS . 1.3 t -92.6 115.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.552 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -60.32 117.65 5.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 72.409999999999997 110.582 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 117.02 -38.24 3.07 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.057 -0.817 . . . . 74.209999999999994 111.057 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -100.7 174.25 6.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.342 . . . . 62.229999999999997 110.658 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -108.35 138.04 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.140000000000001 110.122 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.53 150.44 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 63.329999999999998 111.203 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -139.73 162.51 34.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.754 -0.657 . . . . 72.129999999999995 110.065 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -96.43 -170.64 2.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.924 0.392 . . . . 72.329999999999998 110.795 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -175.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.591 . . . . 72.540000000000006 110.849 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.784 ' H ' ' H2A' ' A' ' 173' ' ' NAP . 2.9 p -55.85 -25.29 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.046 -0.525 . . . . 72.109999999999999 110.681 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -57.89 -44.68 86.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 72.439999999999998 110.529 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -75.94 -51.53 12.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.054 -0.521 . . . . 75.299999999999997 110.696 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.7 t -53.88 -35.39 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.706 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.98 -54.97 27.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.815 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 85' ' ' GLU . 8.0 pt-20 -72.5 -40.1 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.425 . . . . 72.439999999999998 110.978 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.01 -26.47 6.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.388 -0.369 . . . . 63.420000000000002 110.654 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.9 m -63.91 -49.45 72.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 64.010000000000005 110.823 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.17 -6.71 14.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 61.549999999999997 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.58 -22.05 57.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 72.329999999999998 110.677 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -136.43 146.44 46.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.317 -0.401 . . . . 74.230000000000004 110.589 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.71 -78.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 74.5 110.414 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -89.36 110.86 21.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 75.099999999999994 110.584 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -115.51 150.73 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.394 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HB3' ' SD ' ' A' ' 6' ' ' MET . 35.5 m-85 -119.64 125.12 47.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.864 0.364 . . . . 63.200000000000003 110.703 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 HD13 HD13 ' A' ' 42' ' ' ILE . 32.6 mm -112.12 121.89 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.056 -0.52 . . . . 71.25 110.684 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.947 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 59.1 t80 -119.53 7.78 11.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.797 -0.638 . . . . 62.039999999999999 110.397 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.771 ' O ' ' H5N' ' A' ' 173' ' ' NAP . . . -28.45 -87.53 0.01 OUTLIER Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.768 -0.651 . . . . 62.030000000000001 112.463 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.699 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . 177.48 -177.73 48.32 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.957 -0.857 . . . . 42.240000000000002 110.957 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.24 -51.45 62.16 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 121.135 -0.226 . . . . 43.329999999999998 111.546 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.683 HE22 ' H8A' ' A' ' 173' ' ' NAP . 5.0 pt20 -65.75 -42.07 91.39 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.371 -0.531 . . . . 72.109999999999999 110.637 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.461 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 4.7 mm -59.29 -40.36 81.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 109.937 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.699 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 3.5 m-30 -66.83 -30.61 70.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.783 -0.644 . . . . 73.25 110.723 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -72.84 -49.8 28.02 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.827 -0.349 . . . . 72.239999999999995 110.593 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.28 -26.58 68.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 74.109999999999999 110.45 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.776 ' O ' HG12 ' A' ' 109' ' ' VAL . 10.4 m-85 -98.67 19.96 13.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.577 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.715 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 5.3 tt -68.63 -33.1 4.14 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.47 -0.332 . . . . 72.540000000000006 111.005 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.715 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 61.4 Cg_endo -90.38 7.16 3.84 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.861 2.374 . . . . 73.150000000000006 112.186 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -119.83 -40.03 2.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 110.749 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 105' ' ' PHE . 4.8 p -67.59 151.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.902 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.447 ' H ' ' HB ' ' A' ' 3' ' ' VAL . 52.2 m-20 -109.61 -57.88 2.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.055 -0.52 . . . . 72.409999999999997 110.271 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 132.89 44.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.04 -0.527 . . . . 74.430000000000007 110.046 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -129.22 112.86 14.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.495 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.715 ' CE1' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -112.12 123.87 51.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 62.299999999999997 110.079 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.498 HD11 HD21 ' A' ' 112' ' ' LEU . 3.8 mt -120.43 140.48 44.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 71.230000000000004 110.641 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 9' ' ' MET . 1.4 m -115.58 129.95 56.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 110.637 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.52 ' HB3' ' HE2' ' A' ' 156' ' ' HIS . 28.7 ttmt -97.04 146.55 24.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 110.377 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 119' ' ' HIS . 10.3 mt -125.63 143.98 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 71.129999999999995 110.781 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -98.22 45.53 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 110.964 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.636 ' H ' HG22 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -145.94 128.77 16.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 73.099999999999994 110.292 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -129.53 127.13 40.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 71.420000000000002 110.77 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.508 ' O ' ' C ' ' A' ' 122' ' ' GLU . 20.3 m-85 -155.9 103.47 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 62.43 110.504 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 31.85 91.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 70.010000000000005 110.398 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.821 ' H ' ' HE ' ' A' ' 13' ' ' ARG . . . -88.98 159.69 29.17 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.264 -0.735 . . . . 74.239999999999995 111.264 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 16' ' ' GLY . 37.0 t0 -100.77 -24.22 14.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.762 0.315 . . . . 71.120000000000005 110.23 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.803 ' O ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -141.14 132.71 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.329999999999998 110.542 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -125.08 164.72 19.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.458 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.491 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 2.1 t80 -106.69 137.64 19.53 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.329 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -75.71 176.39 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.345 2.03 . . . . 62.130000000000003 111.224 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -63.44 179.74 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.615 -0.434 . . . . 64.400000000000006 110.218 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 67.0 mtp 61.27 102.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 74.219999999999999 110.653 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.55 ' O ' ' C ' ' A' ' 132' ' ' MET . 0.4 OUTLIER -127.98 178.23 6.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 61.340000000000003 110.359 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.55 ' C ' ' O ' ' A' ' 131' ' ' ASP . 7.0 ptt? 27.6 45.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 70.140000000000001 110.543 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.4 t -62.31 -34.02 75.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.747 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.41 50.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 63.109999999999999 110.469 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.431 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 88.6 m95 -127.59 160.25 32.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.400000000000006 110.633 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.58 117.79 19.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.366 -0.379 . . . . 70.140000000000001 110.755 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 3.8 pt-20 -69.89 102.18 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.398 -0.593 . . . . 74.310000000000002 109.398 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -26.12 7.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 62.32 111.638 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -159.94 144.13 14.58 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.794 -0.363 . . . . 74.200000000000003 110.873 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.5 p -143.52 140.08 26.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.728 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 155' ' ' TYR . 23.5 tp10 -142.43 148.1 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 73.239999999999995 110.228 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.454 ' H ' ' CD ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -103.01 151.94 21.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.025 0.44 . . . . 54.43 110.753 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -107.91 -153.94 17.92 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.748 -0.941 . . . . 73.150000000000006 110.748 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' O ' ' A' ' 151' ' ' TYR . 1.8 tp -157.11 -151.61 0.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.817 0.342 . . . . 63.039999999999999 110.476 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.3 t -121.6 144.23 48.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.11 -0.496 . . . . 71.230000000000004 110.727 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -126.04 162.38 25.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.507 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.91 -39.68 95.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.296 -0.411 . . . . 72.120000000000005 110.517 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.561 ' C ' HD22 ' A' ' 149' ' ' ASN . 13.2 mmtt -81.66 -15.56 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 62.350000000000001 110.627 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.561 HD22 ' C ' ' A' ' 148' ' ' LYS . 2.0 m-80 -144.96 79.62 11.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.5 . . . . 71.310000000000002 110.538 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -72.43 74.21 2.65 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.425 2.083 . . . . 72.530000000000001 112.106 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 144' ' ' LEU . 49.9 m-85 -149.06 163.42 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 74.120000000000005 110.559 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 92.3 m -121.61 114.16 20.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.257 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.76 159.6 36.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 71.349999999999994 110.999 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -123.86 144.45 49.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.948 -0.569 . . . . 75.540000000000006 110.385 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.715 ' CZ ' ' CE1' ' A' ' 113' ' ' TYR . 4.0 t80 -99.16 136.47 39.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 74.409999999999997 110.854 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 28.4 m-70 -130.88 147.52 52.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 110.313 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.6 t -132.33 136.19 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.379 . . . . 42.200000000000003 110.69 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.66 163.75 28.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.474 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.4 156.48 48.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.382 . . . . 62.450000000000003 111.11 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.431 ' HG2' ' CZ3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -106.46 153.34 22.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.986 -0.552 . . . . 74.109999999999999 110.347 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.577 ' H ' HE21 ' A' ' 161' ' ' GLN . 0.0 OUTLIER -88.49 -27.04 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 75.439999999999998 110.51 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.066 -0.968 . . . . 75.530000000000001 110.567 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.206 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.751 ' H4 ' ' SD ' ' A' ' 43' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.345 -0.613 . . . . 63.130000000000003 109.345 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 22.6 mt -122.72 110.21 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 63.25 110.608 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 93' ' ' ILE . 43.9 t -113.67 97.52 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 54.520000000000003 110.358 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m -94.38 153.25 18.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 55.100000000000001 110.892 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' HB3' HD12 ' A' ' 112' ' ' LEU . 2.4 t80 -127.66 140.27 52.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 110.418 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.479 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 49.5 mtp -123.98 110.43 14.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 63.039999999999999 110.821 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -143.31 146.24 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 73.0 110.546 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.73 ' HB3' ' N7N' ' A' ' 173' ' ' NAP . . . -91.43 175.01 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 63.219999999999999 110.74 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mmt -142.05 102.53 4.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.856 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' HB2' ' N ' ' A' ' 14' ' ' VAL . 55.2 m-20 -72.17 121.96 20.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 110.083 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' OE1' ' CG ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -50.92 -24.83 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.01 -0.541 . . . . 71.129999999999995 112.239 -178.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.548 ' CG ' ' OE1' ' A' ' 11' ' ' GLU . 57.8 m-20 -116.12 -16.63 10.99 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.94 -0.704 . . . . 63.43 111.352 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.825 HH21 ' N ' ' A' ' 122' ' ' GLU . 5.4 mpt_? -120.1 -118.39 0.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.072 -0.714 . . . . 75.129999999999995 109.072 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 125' ' ' THR . 7.7 p -159.72 -43.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.913 -0.315 . . . . 71.030000000000001 110.443 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.514 HG12 HG13 ' A' ' 14' ' ' VAL . 30.5 pt -158.56 -44.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.505 -0.478 . . . . 73.420000000000002 110.717 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -92.99 97.92 2.32 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.938 -0.865 . . . . 54.329999999999998 110.938 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -91.34 -28.8 17.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 63.0 110.739 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 17' ' ' LYS . 30.1 t0 -171.47 89.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.36 -0.382 . . . . 72.030000000000001 110.527 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 49.22 17.53 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.485 . . . . 63.329999999999998 110.436 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' N ' ' C ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER 170.98 179.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.139 0.495 . . . . 64.219999999999999 111.313 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.015 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -103.71 152.28 38.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.468 -0.787 . . . . 61.140000000000001 110.021 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.02 162.42 41.77 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.234 1.956 . . . . 74.329999999999998 111.948 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.541 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 11.9 m0 -79.43 168.32 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 51.219999999999999 111.363 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.616 ' NE ' HG21 ' A' ' 115' ' ' THR . 57.5 ttp85 -171.03 106.87 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.768 -0.651 . . . . 73.129999999999995 110.224 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' OD1' ' A' ' 149' ' ' ASN . 1.4 mm? 44.33 67.82 3.66 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.249 0.547 . . . . 61.340000000000003 110.36 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.44 -33.82 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.937 2.424 . . . . 74.310000000000002 112.05 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 p -65.8 -47.12 76.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 74.140000000000001 110.701 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -54.83 -43.6 73.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 60.229999999999997 110.342 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -56.34 -31.49 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.318 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mm-40 -74.62 -47.64 31.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 74.239999999999995 110.672 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -58.97 -53.91 53.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.036 0.446 . . . . 72.340000000000003 110.595 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG11 ' N8 ' ' A' ' 174' ' ' N22 . 9.8 p -58.21 -34.99 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 32.200000000000003 110.573 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -62.44 -65.09 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 70.030000000000001 111.055 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -59.59 -12.79 7.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 111.187 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.7 m -77.69 -57.04 4.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.947 -0.301 . . . . 62.240000000000002 111.431 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.9 t -101.12 11.96 38.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.737 -0.385 . . . . 65.530000000000001 111.674 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -45.87 151.47 0.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.703 -0.399 . . . . 75.150000000000006 110.359 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 94.45 -9.62 71.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.935 -0.866 . . . . 60.530000000000001 110.935 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.32 149.66 50.02 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.369 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.56 111.68 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.735 2.29 . . . . 75.430000000000007 112.433 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 42' ' ' ILE . 3.4 mm? -103.86 115.06 29.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.107 -0.497 . . . . 71.140000000000001 109.988 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 42' ' ' ILE . 1.6 mp -98.39 134.23 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.93 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -142.43 166.4 24.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.024 -0.535 . . . . 65.25 110.476 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.87 140.75 15.19 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.658 -0.977 . . . . 74.430000000000007 110.658 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' NH2' ' CZ ' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -49.67 -29.19 6.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.819 0.342 . . . . 60.020000000000003 110.434 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.1 mmtt -72.94 -41.25 64.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 71.340000000000003 110.299 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.91 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 86.9 m-20 -73.15 -23.14 60.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.048 -0.524 . . . . 74.329999999999998 110.285 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD2' ' N ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -69.85 -54.96 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 110.545 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 9.5 pt-20 -70.3 -22.91 62.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 75.099999999999994 110.718 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.7 -40.82 47.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.375 -0.375 . . . . 54.420000000000002 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.711 HG23 ' C14' ' A' ' 174' ' ' N22 . 40.9 mt -70.65 -49.98 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.33 -0.396 . . . . 72.420000000000002 110.948 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.96 51.04 0.34 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.366 -0.694 . . . . 64.430000000000007 111.366 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD2' HH11 ' A' ' 53' ' ' ARG . 6.3 ttp180 58.79 76.06 0.48 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.996 0.427 . . . . 74.409999999999997 111.014 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' A' ' 51' ' ' ILE . 42.5 Cg_endo -89.01 172.29 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.431 2.754 . . . . 64.530000000000001 112.106 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -164.75 49.29 0.21 Allowed Pre-proline 0 CA--C 1.529 0.167 0 C-N-CA 120.843 -0.343 . . . . 63.329999999999998 111.319 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 17.7 Cg_endo -59.76 69.14 0.06 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.202 2.601 . . . . 73.150000000000006 112.807 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 130.98 14.73 1.8 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 111.518 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.638 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 59.72 11.55 2.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.316 0.579 . . . . 73.209999999999994 109.979 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -138.45 75.36 1.52 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.167 -0.469 . . . . 65.049999999999997 111.543 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 55' ' ' LEU . 1.3 p30 -94.94 120.21 34.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.662 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mm -117.48 117.75 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 72.25 110.715 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.4 pt -100.67 139.58 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.328 . . . . 63.310000000000002 110.113 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 78' ' ' HIS . 75.5 t -102.47 115.96 45.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 74.120000000000005 110.986 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.547 HG21 ' CD2' ' A' ' 69' ' ' TYR . 13.6 t -148.88 127.16 12.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.074 -0.512 . . . . 73.200000000000003 110.355 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CG ' ' A' ' 66' ' ' ASN . 10.0 ptt85 -84.07 118.37 24.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.745 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.527 ' CG ' ' O ' ' A' ' 65' ' ' ARG . 11.9 m-20 172.96 119.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.655 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -73.77 116.96 14.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.518 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.87 0.31 55.13 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.112 -0.795 . . . . 64.340000000000003 111.112 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD2' HG21 ' A' ' 64' ' ' THR . 4.7 t80 -67.01 139.19 57.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 64.120000000000005 110.659 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -153.78 125.04 7.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 74.140000000000001 110.403 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 t -116.44 104.49 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 62.200000000000003 110.571 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -62.35 102.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 110.549 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.57 -32.21 2.41 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.941 -0.864 . . . . 71.200000000000003 110.941 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.4 m -130.96 159.05 38.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.704 0.287 . . . . 74.099999999999994 110.409 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -88.62 126.67 35.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 74.120000000000005 110.386 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.8 p -83.33 147.94 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 51.119999999999997 111.22 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.73 163.74 31.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.764 -0.653 . . . . 30.129999999999999 110.045 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.585 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.86 178.98 7.53 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.851 -0.34 . . . . 74.239999999999995 110.65 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.685 ' OG ' ' H2A' ' A' ' 173' ' ' NAP . 1.9 t -54.27 -175.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 73.219999999999999 110.878 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.58 -25.37 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 70.540000000000006 110.597 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -54.32 -56.99 13.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 42.210000000000001 110.634 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 86' ' ' LEU . 9.5 tp10 -66.25 -37.04 84.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 53.109999999999999 110.712 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 79' ' ' SER . 37.0 t -61.77 -34.58 63.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 110.752 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -54.65 -52.44 62.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 72.439999999999998 110.732 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' CD ' ' OE2' ' A' ' 82' ' ' GLU . 5.1 pt-20 -74.74 -40.79 61.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 111.18 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -55.43 -27.63 49.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.367 . . . . 74.230000000000004 110.71 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.431 ' C ' ' H ' ' A' ' 89' ' ' ASN . 28.0 m -67.48 -43.11 81.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 75.530000000000001 111.241 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -63.6 0.42 0.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.001 -0.28 . . . . 64.540000000000006 110.868 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 87' ' ' CYS . 8.0 m-20 -71.79 -28.17 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.829 -0.349 . . . . 74.109999999999999 110.742 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -138.69 146.48 41.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.885 0.374 . . . . 73.310000000000002 110.892 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -67.52 -45.66 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.512 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.7 113.24 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 73.319999999999993 110.676 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 3' ' ' VAL . 18.1 pt -137.43 147.4 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.577 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -112.91 127.92 56.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.261 -0.427 . . . . 73.129999999999995 110.07 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mm -111.97 121.81 65.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.42 . . . . 42.329999999999998 111.308 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.624 ' CE1' ' H4N' ' A' ' 173' ' ' NAP . 0.2 OUTLIER -108.44 -35.78 6.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 109.791 179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . 28.78 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.323 -0.711 . . . . 54.200000000000003 111.323 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.49 -162.74 30.21 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 62.43 110.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.58 -62.92 1.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.723 0.297 . . . . 63.420000000000002 110.598 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 1.13 ' NE2' H52A ' A' ' 173' ' ' NAP . 3.6 pt20 -56.75 -34.69 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 51.140000000000001 110.189 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mt -75.78 -31.4 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 110.264 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.595 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -62.12 -33.1 73.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 72.310000000000002 110.016 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.495 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 43.4 t0 -80.21 -43.53 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 111.057 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.15 -31.08 72.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.198 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.875 ' O ' HG23 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -102.38 15.81 28.1 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.949 -0.3 . . . . 72.420000000000002 110.829 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.722 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 6.3 tp -66.86 -35.81 10.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 73.219999999999999 110.565 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.722 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 37.6 Cg_endo -88.86 5.48 5.04 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.205 2.603 . . . . 70.329999999999998 112.476 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -120.04 -18.61 8.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.540000000000006 110.624 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 105' ' ' PHE . 94.4 t -82.79 144.46 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 110.757 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -97.34 -50.81 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 75.010000000000005 109.728 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.61 136.53 46.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.763 -0.653 . . . . 75.109999999999999 109.958 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 5' ' ' PHE . 41.8 tp -128.68 120.84 27.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 73.230000000000004 110.787 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -116.67 126.2 52.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 110.706 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mp -125.89 133.42 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 73.140000000000001 110.397 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.616 HG21 ' NE ' ' A' ' 24' ' ' ARG . 36.3 m -111.14 109.99 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 72.150000000000006 110.638 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -81.89 118.38 22.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 55.439999999999998 110.424 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 46.6 mt -108.96 132.98 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 60.219999999999999 110.657 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -90.26 58.68 4.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.708 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.22 118.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.343 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.59 155.61 9.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.333 -0.394 . . . . 75.349999999999994 110.687 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.555 ' O ' ' C ' ' A' ' 122' ' ' GLU . 35.1 m-85 -147.93 153.77 39.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.995 -0.548 . . . . 74.140000000000001 110.657 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.825 ' N ' HH21 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -21.43 128.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 62.229999999999997 111.15 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.407 ' C ' ' OD1' ' A' ' 124' ' ' ASP . . . -143.37 -119.8 1.43 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.013 -0.835 . . . . 44.539999999999999 111.013 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 123' ' ' GLY . 5.1 m-20 -131.94 -22.03 2.36 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 74.319999999999993 111.488 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.753 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.8 m -130.56 109.42 10.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.987 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.501 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 47.5 p90 -123.55 133.57 53.96 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 115.462 -0.79 . . . . 65.329999999999998 111.336 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.539 ' O ' ' O ' ' A' ' 13' ' ' ARG . 20.0 m-85 -165.6 151.92 8.76 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 71.120000000000005 109.753 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -70.21 -174.78 1.07 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.425 2.084 . . . . 41.049999999999997 111.901 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 130' ' ' MET . 3.2 pt-20 -131.59 167.68 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.394 -0.366 . . . . 62.210000000000001 110.776 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 129' ' ' GLU . 76.4 mtp 38.73 62.38 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 64.109999999999999 110.603 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.82 101.02 7.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.140000000000001 110.678 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 5.1 mtp 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 60.530000000000001 110.665 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.486 HG23 ' N ' ' A' ' 134' ' ' ASN . 1.7 t -61.49 -49.61 76.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 55.109999999999999 110.62 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.486 ' N ' HG23 ' A' ' 133' ' ' THR . 32.4 t30 78.27 -8.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 73.319999999999993 110.813 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.446 ' CE3' ' HG2' ' A' ' 160' ' ' LYS . 23.3 m95 -69.55 158.0 36.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 72.019999999999996 110.679 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -112.86 137.63 50.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 62.43 110.662 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -94.33 136.38 34.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 64.450000000000003 110.173 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 m -109.81 -20.97 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.374 -0.376 . . . . 74.310000000000002 111.028 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' VAL . 42.8 t80 -166.23 154.32 10.49 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.989 -0.284 . . . . 73.299999999999997 110.592 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 t -137.99 134.43 44.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.399 . . . . 54.119999999999997 110.875 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -126.57 122.59 35.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.515 . . . . 74.120000000000005 110.219 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -88.21 162.45 16.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 74.409999999999997 110.811 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -117.21 -167.88 14.53 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.26 -0.736 . . . . 64.140000000000001 111.26 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 144' ' ' LEU . 13.9 tp -155.0 153.98 31.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.679 0.276 . . . . 63.100000000000001 110.444 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.73 153.6 36.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 71.239999999999995 110.957 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -154.43 161.59 41.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 110.244 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -47.93 -46.83 32.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -38.02 85.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 73.150000000000006 110.074 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.57 ' OD1' ' OH ' ' A' ' 153' ' ' TYR . 0.3 OUTLIER -135.24 79.53 49.32 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.944 -0.571 . . . . 71.140000000000001 110.708 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.7 60.97 6.09 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.62 2.214 . . . . 73.450000000000003 112.29 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.78 163.17 34.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 72.430000000000007 110.403 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 60.7 m -106.86 123.29 47.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.255 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.57 ' OH ' ' OD1' ' A' ' 149' ' ' ASN . 0.6 OUTLIER -143.68 159.25 42.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 73.230000000000004 110.789 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -131.47 152.95 50.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.536 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.41 ' C ' ' CD2' ' A' ' 156' ' ' HIS . 9.8 t80 -114.25 140.74 48.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 62.149999999999999 110.4 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.53 ' N ' ' CD2' ' A' ' 156' ' ' HIS . 3.2 m-70 -127.37 150.67 49.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 74.530000000000001 110.679 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 17.2 t -120.56 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 65.230000000000004 110.354 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -128.31 151.63 49.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 74.329999999999998 110.671 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.464 ' C ' ' CD ' ' A' ' 159' ' ' GLU . 1.1 pp20? -150.74 154.92 38.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 61.119999999999997 110.716 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.446 ' HG2' ' CE3' ' A' ' 135' ' ' TRP . 4.7 mmtt -117.67 159.75 22.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.545 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 1.7 pm0 -113.77 57.33 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.369 -0.378 . . . . 63.310000000000002 110.576 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.01 -0.995 . . . . 74.030000000000001 110.515 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.13 H52A ' NE2' ' A' ' 100' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.711 ' C14' HG23 ' A' ' 51' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 2' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.361 -0.607 . . . . 44.219999999999999 109.361 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 4.4 mm -120.67 133.08 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 74.140000000000001 110.749 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.74 112.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.056 -0.52 . . . . 75.340000000000003 110.419 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.9 p -110.09 136.98 48.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 45.020000000000003 110.826 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CE1' HG13 ' A' ' 95' ' ' ILE . 7.0 m-85 -114.59 144.54 43.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.991 -0.549 . . . . 71.299999999999997 110.253 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.4 mtm -116.46 116.19 27.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 73.140000000000001 110.433 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.38 143.84 28.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 110.942 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.12 158.28 16.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 52.0 110.219 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mmm -120.06 125.72 49.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 72.040000000000006 110.827 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -109.47 125.92 52.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.504 . . . . 73.510000000000005 110.779 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.84 -26.27 68.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 111.487 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -103.07 -9.97 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.754 -0.378 . . . . 75.140000000000001 110.834 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 121' ' ' PHE . 38.2 mtt180 -137.28 -127.68 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.45 -0.574 . . . . 42.350000000000001 109.45 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 125' ' ' THR . 10.2 p -142.68 -42.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.181 -0.607 . . . . 73.230000000000004 111.201 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.724 HG13 ' H2N' ' A' ' 173' ' ' NAP . 8.1 pt -144.48 -30.54 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 119.726 -0.789 . . . . 54.340000000000003 111.835 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.78 -168.87 39.86 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.6 -0.809 . . . . 73.239999999999995 111.234 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' CG ' ' N ' ' A' ' 18' ' ' ASP . 23.1 pttt -117.23 -51.11 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 63.329999999999998 110.674 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -118.43 71.53 0.84 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 63.43 110.309 -179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.999 HD21 ' H2A' ' A' ' 174' ' ' N22 . 0.1 OUTLIER 64.77 10.08 5.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.561 -0.745 . . . . 70.329999999999998 110.002 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 1.049 ' ND2' ' H8B' ' A' ' 174' ' ' N22 . 0.7 OUTLIER 171.58 175.98 0.08 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 63.520000000000003 110.242 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.965 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.97 154.8 38.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.044 -0.526 . . . . 63.409999999999997 110.631 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 21' ' ' LEU . 9.4 Cg_endo -55.76 -154.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.873 2.382 . . . . 73.209999999999994 112.059 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' PRO . 32.1 t-105 -39.69 124.31 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.200000000000003 110.411 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 1.034 ' HE ' ' H8A' ' A' ' 174' ' ' N22 . 0.0 OUTLIER -135.57 -137.65 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.439 -0.346 . . . . 71.409999999999997 110.95 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.755 ' H ' HH11 ' A' ' 24' ' ' ARG . 64.1 tp -103.52 100.74 19.96 Favored Pre-proline 0 C--O 1.237 0.428 0 CA-C-N 116.5 -0.318 . . . . 73.310000000000002 110.799 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.91 -7.39 4.52 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.629 1.553 . . . . 64.140000000000001 111.844 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -80.79 -48.99 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 72.450000000000003 110.061 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.711 ' OE2' ' N8 ' ' A' ' 174' ' ' N22 . 36.9 tt0 -60.77 -30.69 70.18 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.323 -0.992 . . . . 65.0 108.323 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -52.05 -52.96 47.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 53.340000000000003 110.328 178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -79.07 -28.44 43.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.66 -0.7 . . . . 64.230000000000004 111.652 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -65.85 -52.29 51.63 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.643 -0.423 . . . . 74.230000000000004 110.44 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.613 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 p -67.54 -33.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 62.109999999999999 110.592 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -45.01 90.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.474 -0.33 . . . . 74.510000000000005 110.708 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -74.94 -17.8 60.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.876 -0.33 . . . . 75.219999999999999 110.859 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -90.07 -23.54 21.4 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.833 -0.347 . . . . 63.100000000000001 110.48 179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 32' ' ' VAL . 14.4 t -106.63 -8.77 16.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 75.140000000000001 110.455 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.95 130.12 12.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.089 -0.505 . . . . 75.049999999999997 110.131 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 39' ' ' HIS . . . 88.55 -66.34 3.2 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.733 -0.947 . . . . 65.010000000000005 110.733 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 2.0 m-70 -41.15 146.09 0.53 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.099 -0.334 . . . . 72.109999999999999 110.099 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.31 132.8 24.84 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.643 2.229 . . . . 63.200000000000003 112.47 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mt -118.35 107.97 14.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.911 -0.586 . . . . 73.120000000000005 110.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 95' ' ' ILE . 1.9 mp -88.01 102.93 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.378 -0.374 . . . . 64.140000000000001 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.6 mtm -106.26 156.72 18.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 54.109999999999999 110.689 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.15 147.23 44.08 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.81 -0.916 . . . . 44.310000000000002 110.81 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 1.4 tmm_? -60.39 -52.18 66.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.712 0.291 . . . . 72.049999999999997 110.48 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -57.4 -35.17 69.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 54.109999999999999 110.038 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.742 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 92.0 m-20 -64.66 -47.66 77.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 72.420000000000002 110.277 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 4.1 t80 -63.65 -49.22 74.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 71.010000000000005 110.856 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CD ' ' C ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -58.71 -25.52 62.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 74.319999999999993 110.621 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.8 -47.98 17.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.799 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 HD11 ' ND2' ' A' ' 19' ' ' ASN . 67.1 mt -65.49 -54.03 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 45.420000000000002 110.901 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.6 -111.83 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.487 -1.045 . . . . 73.209999999999994 110.487 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.452 ' N ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -126.94 54.65 12.6 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.376 . . . . 73.340000000000003 110.759 179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 56.6 Cg_endo -72.33 156.0 55.23 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.949 2.433 . . . . 65.209999999999994 111.937 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.6 pt? -161.25 38.45 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.024 0.44 . . . . 75.510000000000005 110.655 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 11.1 Cg_endo -57.51 79.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.967 2.445 . . . . 74.409999999999997 112.38 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 137.3 0.19 2.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.952 -0.859 . . . . 64.430000000000007 110.952 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.468 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 27.6 mtt180 48.17 44.86 19.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 110.841 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -171.41 48.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.997 -0.547 . . . . 72.530000000000001 110.314 179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.1 m-80 -93.01 121.69 34.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 70.319999999999993 110.878 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.441 HD13 ' C ' ' A' ' 60' ' ' ASN . 1.4 mm -110.97 129.99 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.456 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 pt -107.87 141.43 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.455 -0.338 . . . . 74.299999999999997 110.313 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' HIS . 50.5 t -98.77 125.8 52.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.286 -0.415 . . . . 74.420000000000002 111.546 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.542 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 5.2 t -158.5 141.85 15.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.119 -0.491 . . . . 72.030000000000001 110.445 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.572 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 4.3 ptm180 -96.39 110.25 22.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.372 -0.376 . . . . 73.150000000000006 110.649 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 16.0 m-80 -177.27 103.95 0.05 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.537 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' GLU . 4.2 mt-10 -63.45 106.84 0.99 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.447 . . . . 70.400000000000006 110.531 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.0 11.77 21.79 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.184 -0.767 . . . . 73.200000000000003 111.184 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -78.77 144.07 35.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 54.25 110.712 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -153.89 132.39 12.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 61.119999999999997 110.404 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -124.53 108.64 20.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 63.5 110.62 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -66.59 113.84 5.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 61.549999999999997 110.469 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.77 -23.03 6.01 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.632 -0.987 . . . . 64.25 110.632 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 m -146.56 161.64 40.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 75' ' ' GLU . 2.8 mp0 -89.28 144.86 25.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.288 -0.415 . . . . 70.540000000000006 110.501 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 147.09 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.127 0.489 . . . . 54.43 111.261 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.28 162.77 32.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.636 -0.711 . . . . 72.420000000000002 109.954 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.799 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -84.58 -169.91 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.877 0.37 . . . . 65.409999999999997 110.741 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.403 ' HB2' ' C2A' ' A' ' 173' ' ' NAP . 1.9 p -63.86 -175.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 62.299999999999997 110.715 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' CD2' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -56.8 -25.61 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 73.129999999999995 110.413 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -56.78 -44.22 81.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.045 -0.525 . . . . 75.140000000000001 110.639 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -78.35 -46.72 19.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 72.299999999999997 110.506 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 83' ' ' VAL . 18.4 t -54.27 -32.13 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 70.510000000000005 110.534 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -55.95 -54.3 46.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 73.439999999999998 110.569 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 8.3 pt-20 -73.8 -36.32 64.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 63.109999999999999 111.019 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.87 59.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.348 -0.387 . . . . 61.039999999999999 110.977 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 93' ' ' ILE . 44.8 t -64.65 -41.68 95.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.466 -0.334 . . . . 62.210000000000001 111.016 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -11.37 60.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.332 -0.395 . . . . 74.120000000000005 110.599 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.02 60.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.576 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -136.34 128.0 28.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.47 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.72 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 75.510000000000005 110.457 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -91.49 118.37 30.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 75.129999999999995 110.569 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.532 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -126.01 142.19 43.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.689 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -106.2 128.02 53.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.571 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' ILE . 19.3 mm -114.07 132.23 63.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.051 -0.522 . . . . 71.299999999999997 110.655 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.638 ' CZ ' ' H4N' ' A' ' 173' ' ' NAP . 63.8 t80 -134.69 16.17 3.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.724 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . -29.05 -93.52 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.118 -0.793 . . . . 54.039999999999999 111.118 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 102' ' ' TYR . . . -177.49 -163.81 29.98 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.437 -1.065 . . . . 63.200000000000003 110.437 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.13 -60.52 3.63 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.618 -0.433 . . . . 55.439999999999998 110.555 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.909 ' H ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -52.78 -40.12 62.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 111.451 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.636 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 5.4 mt -74.3 -43.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.794 -0.362 . . . . 55.049999999999997 111.713 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.697 ' CG ' ' O ' ' A' ' 98' ' ' GLY . 18.3 m-85 -57.37 -43.19 83.34 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.605 -0.438 . . . . 64.120000000000005 110.44 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -43.66 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 72.140000000000001 110.402 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.537 ' CD2' HG11 ' A' ' 80' ' ' VAL . 12.8 tp -67.49 -18.7 65.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.407 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -108.63 0.39 20.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.195 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.623 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 2.6 tp -56.54 -42.25 95.34 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.825 -0.35 . . . . 60.109999999999999 110.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 29.6 Cg_endo -86.82 21.31 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.007 2.471 . . . . 54.310000000000002 111.934 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -132.8 -28.61 1.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 74.019999999999996 110.815 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 109' ' ' VAL . 3.4 p -75.38 152.47 6.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.398 -0.364 . . . . 53.329999999999998 110.733 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.4 ' N ' HG22 ' A' ' 109' ' ' VAL . 27.7 t0 -98.09 -56.87 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 71.040000000000006 109.819 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -106.35 138.21 42.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.907 -0.588 . . . . 72.549999999999997 110.203 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.452 ' CD2' HD11 ' A' ' 114' ' ' ILE . 56.6 tp -127.45 129.66 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 74.239999999999995 110.708 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.31 118.84 34.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 61.200000000000003 110.546 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.452 HD11 ' CD2' ' A' ' 112' ' ' LEU . 3.7 mt -123.43 115.03 44.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.157 -0.474 . . . . 74.209999999999994 110.753 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -105.07 117.72 34.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 50.43 110.417 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.68 146.87 27.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.04 -0.527 . . . . 74.299999999999997 111.014 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.48 128.78 58.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 74.430000000000007 110.53 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -85.31 39.69 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 72.420000000000002 110.803 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.451 ' HB2' ' CD1' ' A' ' 151' ' ' TYR . 8.8 t-80 -157.95 112.83 2.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 73.530000000000001 110.592 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.07 147.75 3.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 110.618 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.637 ' H ' HH21 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -130.36 130.45 44.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.062 -0.517 . . . . 73.409999999999997 110.111 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' O ' ' A' ' 121' ' ' PHE . 7.3 pt-20 -21.72 115.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.097 -0.501 . . . . 71.439999999999998 111.062 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -122.35 -116.79 2.38 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.195 -0.762 . . . . 62.109999999999999 111.195 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -116.25 -49.24 2.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.728 0.299 . . . . 71.340000000000003 110.857 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.693 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -96.1 92.31 6.37 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 110.562 -179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 126' ' ' PHE . 32.7 p90 -120.88 143.95 48.66 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.356 -0.838 . . . . 75.420000000000002 111.302 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.511 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.9 t80 -166.12 130.57 1.73 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.843 -0.617 . . . . 72.239999999999995 110.149 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.81 176.92 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.456 2.104 . . . . 73.0 112.226 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -98.16 107.92 20.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.259 -0.428 . . . . 72.109999999999999 110.519 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 39.6 mmm -96.83 -58.17 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.599 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' CG ' ' N ' ' A' ' 132' ' ' MET . 13.1 t70 -177.02 161.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 63.210000000000001 110.414 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.781 ' N ' ' SD ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -161.15 42.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 72.209999999999994 110.642 -179.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 135' ' ' TRP . 5.9 t -68.39 -23.09 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 64.230000000000004 110.337 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -57.0 -0.99 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 73.219999999999999 110.543 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.529 ' H ' ' C ' ' A' ' 133' ' ' THR . 53.9 m95 -130.88 166.66 20.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 72.019999999999996 110.535 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.17 130.36 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.415 -0.357 . . . . 75.120000000000005 110.886 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -77.57 102.28 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.705 -0.48 . . . . 70.150000000000006 109.705 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.14 -14.33 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.078 -0.51 . . . . 71.230000000000004 111.268 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -169.77 146.61 3.26 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.643 -0.423 . . . . 71.140000000000001 111.126 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.45 144.69 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 110.235 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -137.46 157.24 46.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.385 -0.37 . . . . 75.200000000000003 110.685 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 164.87 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.420000000000002 110.349 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.36 -141.61 6.35 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.379 -0.688 . . . . 61.310000000000002 111.379 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.38 -172.98 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.744 0.307 . . . . 73.209999999999994 110.205 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.629 ' OG1' ' N ' ' A' ' 151' ' ' TYR . 1.3 t -125.5 155.6 40.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.267 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.65 -166.97 1.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 62.439999999999998 110.787 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -82.73 -43.14 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 75.319999999999993 110.44 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.7 15.79 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 65.239999999999995 110.323 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.573 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 17.5 p30 -172.36 72.88 0.45 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 110.692 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' O ' ' CG ' ' A' ' 151' ' ' TYR . 47.3 Cg_endo -72.47 82.21 1.43 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.524 2.149 . . . . 71.439999999999998 112.02 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.64 ' CG ' ' O ' ' A' ' 150' ' ' PRO . 31.8 m-85 -168.57 152.88 5.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.535 . . . . 64.109999999999999 110.325 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 62.3 m -111.97 139.59 47.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 75.420000000000002 110.673 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.691 ' OH ' HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -133.57 165.02 25.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.546 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.29 139.5 44.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 74.019999999999996 110.285 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.0 144.82 27.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 110.919 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -132.27 140.59 48.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.956 -0.565 . . . . 72.420000000000002 110.305 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.71 111.29 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.925 0.393 . . . . 63.020000000000003 110.292 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -104.08 142.02 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.054 -0.521 . . . . 73.239999999999995 110.32 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.64 151.11 51.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.517 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -88.29 -174.15 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.391 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 161' ' ' GLN . 0.0 OUTLIER -154.05 16.35 0.49 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 75.209999999999994 110.618 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.934 -1.031 . . . . 44.119999999999997 110.647 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 0.903 ' H2D' ' H ' ' A' ' 19' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 1.049 ' H8B' ' ND2' ' A' ' 20' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.421 -0.585 . . . . 75.010000000000005 109.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.2 mt -124.63 123.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 74.25 110.543 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 93' ' ' ILE . 87.1 t -115.95 103.96 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.579 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -86.39 144.85 27.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.736 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -127.67 118.47 23.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 71.329999999999998 111.231 -179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.598 ' CE ' HH12 ' A' ' 24' ' ' ARG . 0.0 OUTLIER -98.55 117.2 32.45 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.236 -0.653 . . . . 73.439999999999998 109.236 178.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 41.8 t -142.78 147.17 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.004 0.431 . . . . 44.450000000000003 111.781 -178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' HB2' HH21 ' A' ' 24' ' ' ARG . . . -100.05 165.93 11.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 75.200000000000003 109.956 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.4 ' SD ' ' HD3' ' A' ' 116' ' ' LYS . 0.7 OUTLIER -139.18 104.64 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 64.25 110.84 -179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -81.14 132.14 35.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 54.25 110.397 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.33 -28.79 65.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 71.319999999999993 111.907 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -113.96 -2.54 13.53 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.9 -0.32 . . . . 72.010000000000005 111.526 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -138.57 -128.96 0.12 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.92 -0.77 . . . . 70.310000000000002 108.92 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 125' ' ' THR . 4.9 p -149.47 -43.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.901 -0.407 . . . . 63.409999999999997 109.901 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG12 HG13 ' A' ' 14' ' ' VAL . 2.9 pt -155.22 -50.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.815 -0.354 . . . . 74.510000000000005 110.548 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -76.9 93.23 1.05 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.205 -1.158 . . . . 71.310000000000002 110.205 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 18' ' ' ASP . 3.3 pttm -84.24 -28.34 27.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.993 0.425 . . . . 63.210000000000001 110.734 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 45.3 t0 -170.43 75.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.827 -0.624 . . . . 55.340000000000003 109.873 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 15.0 t-20 64.17 8.45 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.548 . . . . 74.450000000000003 109.891 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.552 HD21 ' CG1' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -170.74 176.58 4.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.664 -0.698 . . . . 72.219999999999999 110.306 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.978 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -106.34 154.16 39.97 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.037 -0.529 . . . . 74.409999999999997 110.24 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.2 140.47 64.98 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.7 2.267 . . . . 71.439999999999998 112.347 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.651 ' HE1' ' C15' ' A' ' 174' ' ' N22 . 27.1 m-90 -74.28 156.1 37.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 74.040000000000006 110.535 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.598 HH12 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -123.97 85.07 2.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.291 -0.413 . . . . 75.209999999999994 110.457 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 153' ' ' TYR . 31.3 mt 60.06 100.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 110.466 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.95 -16.44 49.72 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.683 1.589 . . . . 75.109999999999999 111.757 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 7.1 m -78.91 -40.01 33.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 73.439999999999998 109.951 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -66.19 -31.54 72.44 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.231 -0.655 . . . . 74.439999999999998 109.231 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -57.36 -37.52 72.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.866 -1.061 . . . . 61.210000000000001 111.096 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.9 -33.06 27.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.382 -0.527 . . . . 60.5 110.896 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -69.71 -40.24 76.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.45 -0.341 . . . . 73.25 110.957 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 33' ' ' LYS . 8.1 p -74.16 -38.35 48.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.433 -0.348 . . . . 74.519999999999996 111.301 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' N ' HG13 ' A' ' 32' ' ' VAL . 1.1 pttt -74.47 -37.19 63.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.648 -0.421 . . . . 75.420000000000002 111.277 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' O ' ' SD ' ' A' ' 37' ' ' MET . 16.4 ptmt -76.53 -26.7 55.47 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.783 0.29 . . . . 74.150000000000006 111.783 -179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -84.36 -34.3 23.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.826 -0.349 . . . . 64.230000000000004 111.272 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -79.61 -32.04 41.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.841 0.353 . . . . 73.319999999999993 110.59 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.639 ' SD ' ' O ' ' A' ' 34' ' ' LYS . 18.2 mmm 47.14 82.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 74.030000000000001 110.939 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.93 -112.72 4.54 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.304 -0.719 . . . . 43.439999999999998 111.304 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.61 130.78 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 110.09 -0.337 . . . . 55.439999999999998 110.09 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.55 126.3 13.94 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.406 2.071 . . . . 71.109999999999999 112.344 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HG ' ' HE ' ' A' ' 58' ' ' ARG . 1.1 mm? -118.51 120.47 37.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.113 -0.494 . . . . 63.109999999999999 110.58 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.8 mp -106.69 102.62 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.020000000000003 110.53 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.22 150.49 37.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 71.439999999999998 110.975 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' CA ' ' OD1' ' A' ' 47' ' ' ASN . . . -72.85 133.85 19.48 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.255 -1.138 . . . . 42.100000000000001 110.255 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' CD ' ' O3X' ' A' ' 173' ' ' NAP . 9.0 ptm180 -45.66 -29.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.358 . . . . 72.310000000000002 110.454 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -67.64 -50.65 56.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.228 -0.442 . . . . 63.200000000000003 110.1 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.112 ' ND2' ' H6N' ' A' ' 173' ' ' NAP . 0.3 OUTLIER -62.41 -30.08 70.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.959 -0.564 . . . . 72.230000000000004 110.972 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -70.31 -48.78 55.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.46 -0.336 . . . . 73.439999999999998 110.676 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 50' ' ' ALA . 4.1 pt-20 -66.19 -27.32 67.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 64.239999999999995 110.115 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -77.31 -45.39 26.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 72.310000000000002 109.989 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' ASN . 52.3 mt -67.11 -51.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.962 -0.563 . . . . 72.140000000000001 109.793 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.27 141.99 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.382 -0.687 . . . . 65.319999999999993 111.382 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 53' ' ' ARG . 2.7 mtp180 61.79 86.82 0.14 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.942 0.401 . . . . 53.140000000000001 111.274 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -80.24 168.03 18.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 123.143 2.562 . . . . 61.140000000000001 112.151 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 55' ' ' LEU . 2.4 mm? -96.24 118.31 65.61 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.339 -0.391 . . . . 63.43 110.295 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 55' ' ' LEU . 33.3 Cg_endo -71.15 40.46 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.17 1.914 . . . . 65.430000000000007 111.752 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 55' ' ' LEU . . . -131.81 -22.23 0.95 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.2 -1.16 . . . . 55.039999999999999 110.2 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.684 ' O ' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -116.18 105.91 13.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.513 0.197 . . . . 73.140000000000001 110.713 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 58' ' ' ARG . 7.5 mtt85 -37.8 85.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 73.319999999999993 110.038 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -81.41 117.64 22.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 71.239999999999995 111.172 -179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.8 mt -126.59 125.99 68.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.83 -0.623 . . . . 63.149999999999999 109.778 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.434 HG23 ' SG ' ' A' ' 74' ' ' CYS . 34.8 pt -109.94 139.87 31.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.919 0.39 . . . . 62.210000000000001 111.03 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 78' ' ' HIS . 87.9 t -94.68 130.88 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.609 . . . . 64.420000000000002 110.86 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 64' ' ' THR . 14.4 t -162.02 122.21 2.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.553 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.641 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -78.15 120.48 23.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.612 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 1.2 m120 170.03 116.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 52.039999999999999 110.151 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.82 118.78 15.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 70.519999999999996 110.807 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.58 6.82 58.27 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.261 -0.736 . . . . 74.450000000000003 111.261 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -72.85 133.57 44.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 73.519999999999996 110.647 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 2.3 p80 -147.2 125.98 12.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.51 . . . . 70.019999999999996 110.536 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.78 114.15 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 74.019999999999996 110.575 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -69.94 113.66 7.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.140000000000001 110.553 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.72 -14.98 11.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 74.409999999999997 110.965 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.434 ' SG ' HG23 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -144.75 152.97 41.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 73.099999999999994 110.645 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.32 131.53 34.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.399999999999999 110.492 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 64' ' ' THR . 7.5 p -89.47 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 51.340000000000003 110.703 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.87 169.18 18.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 60.020000000000003 110.318 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.728 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -85.96 179.86 6.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 75.120000000000005 110.824 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.6 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 3.1 t -54.56 -176.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 33.109999999999999 110.995 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.6 ' N ' ' OG ' ' A' ' 79' ' ' SER . 1.6 p -59.88 -22.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.953 -0.567 . . . . 61.030000000000001 110.635 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.41 -42.02 90.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.355 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.73 -43.78 21.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 71.140000000000001 110.717 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.433 HG21 HG21 ' A' ' 63' ' ' VAL . 90.0 t -60.31 -34.23 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 73.329999999999998 110.931 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.02 -54.4 24.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 55.509999999999998 110.645 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 85' ' ' GLU . 5.7 pt-20 -71.67 -46.77 57.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 63.43 111.132 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 89' ' ' ASN . 1.4 mm? -49.34 -31.38 9.16 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.022 -0.271 . . . . 70.400000000000006 110.564 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 20.7 m -54.55 -48.49 71.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 63.420000000000002 110.754 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -8.69 26.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.741 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 10.1 t-20 -68.78 -18.31 64.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.683 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -142.23 131.11 22.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 70.329999999999998 110.718 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' A' ' 91' ' ' GLU . 2.0 pm0 -46.98 -83.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 71.439999999999998 110.648 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -89.64 118.97 29.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 71.099999999999994 110.831 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 3' ' ' VAL . 24.7 pt -126.55 158.88 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.007 -0.542 . . . . 72.519999999999996 110.118 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.24 126.83 52.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.102 0.477 . . . . 74.109999999999999 111.069 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 42' ' ' ILE . 15.9 mm -106.41 139.21 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.78 -0.645 . . . . 54.530000000000001 110.7 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.726 ' O ' ' H5N' ' A' ' 173' ' ' NAP . 13.0 t80 -136.09 11.21 3.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.120000000000005 110.779 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 101' ' ' ILE . . . -29.18 -89.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.199 -0.76 . . . . 73.140000000000001 111.199 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' HA3' ' O1A' ' A' ' 173' ' ' NAP . . . 165.55 -166.36 38.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.39 -1.084 . . . . 54.329999999999998 110.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -56.25 -63.2 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.913 -0.315 . . . . 45.539999999999999 111.585 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' NE2' H52A ' A' ' 173' ' ' NAP . 1.7 pt20 -60.7 -43.47 97.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.120000000000005 111.27 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 ' HA3' ' A' ' 97' ' ' GLY . 5.3 mm -57.81 -46.95 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.299 -0.41 . . . . 73.120000000000005 111.15 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -63.42 -28.86 70.27 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.95 -0.3 . . . . 64.439999999999998 110.634 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -61.52 -56.35 21.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.499 -0.319 . . . . 74.219999999999999 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 105' ' ' PHE . 2.4 pp -73.54 -18.98 61.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 65.409999999999997 111.172 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.629 ' O ' HG23 ' A' ' 109' ' ' VAL . 1.9 m-85 -85.06 1.63 46.89 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.956 -0.298 . . . . 65.340000000000003 111.172 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 1.1 mp -45.76 -53.37 20.54 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 62.049999999999997 111.181 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 106' ' ' LEU . 43.9 Cg_endo -74.24 -9.1 21.61 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.762 2.308 . . . . 74.439999999999998 113.307 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -108.92 2.32 21.36 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.526 -0.47 . . . . 61.329999999999998 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 105' ' ' PHE . 57.9 t -113.13 145.96 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 65.439999999999998 110.392 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.511 ' HB2' ' H ' ' A' ' 3' ' ' VAL . 4.6 m-20 -110.57 -52.8 2.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.839 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp -111.83 137.81 49.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.156 0.503 . . . . 75.129999999999995 111.028 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.752 HD22 HD11 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -125.14 128.13 47.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.6 -0.727 . . . . 74.010000000000005 110.673 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -126.32 98.81 5.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.513 -0.312 . . . . 65.140000000000001 110.501 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.752 HD11 HD22 ' A' ' 112' ' ' LEU . 2.8 mp -111.53 138.66 39.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.681 -0.408 . . . . 60.329999999999998 110.756 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.82 133.38 53.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 73.129999999999995 110.534 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' SD ' ' A' ' 9' ' ' MET . 2.8 mmmt -92.38 121.22 33.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 74.430000000000007 110.475 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 51.1 mt -112.23 138.34 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.318 -0.401 . . . . 75.040000000000006 110.912 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.14 59.27 1.61 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.917 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -172.6 113.19 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.942 0.401 . . . . 71.120000000000005 110.866 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.2 144.06 3.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.923 -0.581 . . . . 73.349999999999994 110.133 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.542 ' CE2' ' OE1' ' A' ' 122' ' ' GLU . 83.0 t80 -156.0 135.57 12.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 110.813 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 27.3 mt-10 36.11 97.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 64.519999999999996 110.688 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.447 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -125.41 -170.09 13.01 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.043 -0.823 . . . . 71.140000000000001 111.043 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -107.57 -19.59 13.51 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.067 -0.253 . . . . 71.120000000000005 111.085 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.9 m -134.27 109.77 9.06 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.048 0.452 . . . . 74.439999999999998 111.038 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -118.03 151.41 37.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.552 -0.749 . . . . 74.329999999999998 110.5 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.69 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 2.1 t80 -100.59 127.53 32.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.901 -0.407 . . . . 74.420000000000002 109.901 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.69 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 35.7 Cg_endo -68.35 -162.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.292 1.995 . . . . 55.310000000000002 112.553 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 9.2 pt-20 -97.45 70.66 2.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.055 -0.52 . . . . 62.020000000000003 110.563 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 28.2 mtp -126.62 57.36 1.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 55.399999999999999 110.547 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -66.49 110.25 3.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 110.367 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.2 ptm -178.25 37.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.371 -0.377 . . . . 61.420000000000002 110.833 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.628 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.9 t -46.19 -49.23 17.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 74.200000000000003 110.311 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.628 ' N ' HG23 ' A' ' 133' ' ' THR . 12.8 m-20 60.86 54.73 3.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 70.239999999999995 110.561 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.497 ' CZ2' HD12 ' A' ' 112' ' ' LEU . 8.0 m95 -118.07 167.0 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.557 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.2 114.06 26.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 74.019999999999996 110.482 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 137' ' ' GLU . 4.8 pt-20 -76.27 116.75 17.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 61.109999999999999 110.352 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 t -101.86 -36.77 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 61.030000000000001 110.654 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -160.94 154.32 21.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.431 -0.35 . . . . 73.230000000000004 110.694 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.4 p -148.14 114.46 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.284 -0.416 . . . . 54.530000000000001 110.895 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -108.15 159.52 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.968 -0.56 . . . . 52.210000000000001 110.248 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -100.51 -179.54 4.13 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.623 -0.431 . . . . 73.019999999999996 110.683 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.32 177.08 17.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.08 -0.808 . . . . 63.539999999999999 111.08 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.88 169.79 16.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 72.329999999999998 110.568 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.37 134.86 41.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.071 -0.513 . . . . 62.32 110.129 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.41 177.6 4.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 75.530000000000001 110.714 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.6 -38.02 55.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 62.049999999999997 110.735 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 -22.17 24.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.275 -0.421 . . . . 72.530000000000001 110.534 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -130.09 76.64 77.72 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 110.624 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.55 84.57 0.97 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.522 2.148 . . . . 71.310000000000002 112.207 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -153.95 155.23 35.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.046 -0.525 . . . . 74.5 110.392 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 46.2 m -115.58 124.42 50.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.13 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 25' ' ' LEU . 8.2 p90 -142.64 174.48 10.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.028 0.442 . . . . 73.109999999999999 111.434 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -131.26 169.04 16.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.745 -0.661 . . . . 75.439999999999998 110.559 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.88 130.96 52.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.7 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 158' ' ' TYR . 74.4 m80 -122.28 137.37 54.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 110.5 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.3 t -115.71 115.65 49.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.306 -0.406 . . . . 72.219999999999999 110.707 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 156' ' ' HIS . 14.0 m-30 -117.67 142.49 47.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.981 -0.554 . . . . 64.349999999999994 110.728 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -135.96 155.37 50.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.97 -0.559 . . . . 74.319999999999993 110.663 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' CG ' ' CH2' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -112.2 162.57 15.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 65.25 110.44 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -89.85 -40.12 12.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 62.539999999999999 110.503 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.059 -0.972 . . . . 73.040000000000006 110.572 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.112 ' H6N' ' ND2' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.817 ' H8B' ' C9 ' ' A' ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.386 -0.598 . . . . 75.219999999999999 109.386 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 59.2 mt -128.17 132.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 72.430000000000007 110.72 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.86 113.73 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 72.150000000000006 110.666 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.0 t -107.73 138.35 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 54.409999999999997 110.551 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.476 ' CE1' HG13 ' A' ' 95' ' ' ILE . 9.8 m-85 -120.31 118.65 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 71.140000000000001 111.033 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.528 ' SD ' ' N ' ' A' ' 7' ' ' VAL . 2.6 tpt -96.04 122.78 39.23 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.31 -0.626 . . . . 73.219999999999999 109.31 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' N ' ' SD ' ' A' ' 6' ' ' MET . 25.2 t -141.96 146.27 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.99 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' CB ' H72N ' A' ' 173' ' ' NAP . . . -100.59 156.55 17.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 72.150000000000006 109.317 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.28 110.74 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.687 -0.405 . . . . 74.439999999999998 110.951 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -88.03 130.89 34.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.693 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -55.94 -25.37 43.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.927 -0.579 . . . . 73.129999999999995 111.575 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -110.13 -13.93 14.29 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.476 -0.49 . . . . 65.209999999999994 111.545 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -138.88 -121.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.831 -0.433 . . . . 75.319999999999993 109.831 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG12 ' A' ' 15' ' ' ILE . 11.7 p -156.61 -51.03 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 120.187 -0.605 . . . . 72.450000000000003 111.769 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 14' ' ' VAL . 6.5 pt -161.23 11.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 117.821 0.282 . . . . 75.519999999999996 111.296 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.34 74.98 0.32 Allowed Glycine 0 CA--C 1.517 0.201 0 N-CA-C 110.049 -1.221 . . . . 52.329999999999998 110.049 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' O ' ' O ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -85.83 -35.76 20.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.781 0.324 . . . . 74.0 110.376 -179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 17' ' ' LYS . 40.5 t0 -141.44 61.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 72.349999999999994 109.897 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 2.5 m120 66.59 -1.16 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.336 -0.616 . . . . 75.319999999999993 109.336 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 18' ' ' ASP . 9.0 p30 -167.77 -166.16 0.72 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.756 -0.656 . . . . 71.349999999999994 111.398 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.864 ' N ' HD22 ' A' ' 21' ' ' LEU . 1.2 mm? -83.29 149.0 57.34 Favored Pre-proline 0 CA--C 1.529 0.143 0 CA-C-N 115.003 -0.999 . . . . 75.129999999999995 111.173 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HB2' ' H ' ' A' ' 23' ' ' TRP . 16.2 Cg_endo -59.48 -137.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.695 2.263 . . . . 62.219999999999999 110.982 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 97.7 m95 -138.83 140.94 38.67 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.696 -0.401 . . . . 72.019999999999996 111.047 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.752 ' CD ' ' H8A' ' A' ' 174' ' ' N22 . 7.2 ptm85 -144.41 174.74 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.112 -0.495 . . . . 75.400000000000006 110.526 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -33.96 102.5 0.22 Allowed Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.833 -179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -64.59 -15.29 49.24 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.676 1.584 . . . . 73.040000000000006 111.447 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -81.5 -38.36 26.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.796 -0.638 . . . . 63.32 109.556 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -62.25 -44.34 96.78 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.877 -0.602 . . . . 73.530000000000001 110.128 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.936 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.510000000000005 110.378 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 17.7 mt-30 -77.48 -45.0 26.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 70.510000000000005 110.821 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -58.42 -53.91 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 73.450000000000003 110.925 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 33' ' ' LYS . 14.7 p -59.92 -41.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.443 . . . . 74.510000000000005 110.366 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' N ' HG13 ' A' ' 32' ' ' VAL . 64.0 tttt -54.35 -63.09 1.26 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.794 -0.639 . . . . 62.350000000000001 111.274 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.33 -17.61 54.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 75.299999999999997 111.313 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -89.77 -29.06 18.94 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.729 -0.388 . . . . 72.530000000000001 110.527 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 35' ' ' THR . 75.3 p -104.04 -1.79 26.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.421 -0.354 . . . . 73.140000000000001 110.95 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -51.52 138.08 22.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 62.109999999999999 110.745 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.85 73.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.991 -0.843 . . . . 53.450000000000003 110.991 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.89 146.56 52.55 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 71.519999999999996 110.608 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.69 103.93 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.63 2.22 . . . . 73.430000000000007 112.016 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.24 108.61 20.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.529 . . . . 74.319999999999993 110.281 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD13 ' CD1' ' A' ' 95' ' ' ILE . 3.2 mp -95.32 114.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 71.010000000000005 110.578 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -120.04 158.79 26.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.357 -0.383 . . . . 75.209999999999994 110.719 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' N ' HD22 ' A' ' 47' ' ' ASN . . . -75.26 136.33 20.15 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.771 -0.932 . . . . 25.149999999999999 110.771 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -53.19 -26.02 15.86 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.894 -0.323 . . . . 71.400000000000006 110.566 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 45' ' ' ARG . 9.3 mttm -68.05 -48.32 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.866 -0.42 . . . . 72.450000000000003 109.866 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.022 ' CG ' ' H6N' ' A' ' 173' ' ' NAP . 3.0 m-80 -57.47 -60.37 3.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 110.046 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 7.8 t80 -45.69 -39.06 7.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.006 -0.543 . . . . 62.119999999999997 110.609 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -71.74 -30.42 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.784 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 19' ' ' ASN . . . -78.04 -46.92 19.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.411 -0.359 . . . . 74.230000000000004 110.957 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.91 -56.38 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 70.120000000000005 110.662 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.95 -94.18 0.2 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.147 -0.781 . . . . 73.230000000000004 111.147 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -136.69 68.49 59.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 61.310000000000002 110.669 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -83.8 130.67 5.1 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 123.005 2.47 . . . . 74.420000000000002 112.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD1' ' NH2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -146.16 49.41 0.87 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.189 179.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 20.2 Cg_endo -63.32 58.4 0.18 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.178 2.586 . . . . 74.319999999999993 112.231 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' A' ' 58' ' ' ARG . . . 150.13 32.14 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.346 -0.702 . . . . 62.350000000000001 111.346 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.681 ' NH2' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER 26.12 52.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.687 0.279 . . . . 70.409999999999997 111.291 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.2 65.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.465 -0.334 . . . . 75.420000000000002 110.388 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 74' ' ' CYS . 1.2 m-80 -105.73 118.2 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 64.510000000000005 110.964 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 77' ' ' ALA . 2.4 mm -108.35 125.06 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.076 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.88 138.1 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 51.030000000000001 110.307 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' HIS . 71.0 t -92.31 124.86 44.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.06 -0.518 . . . . 52.399999999999999 111.067 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 t -159.72 139.49 11.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 73.299999999999997 110.635 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.552 ' O ' ' ND2' ' A' ' 66' ' ' ASN . 0.1 OUTLIER -99.31 110.19 22.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 72.129999999999995 110.445 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 9.4 m-80 -177.75 118.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.673 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -73.5 109.26 6.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 43.009999999999998 110.55 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.03 5.04 33.34 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.22 -0.752 . . . . 34.109999999999999 111.22 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -71.45 142.25 50.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 75.120000000000005 110.52 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -152.55 141.87 21.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 110.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 74' ' ' CYS . 15.1 t -138.9 111.87 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 62.130000000000003 110.679 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -65.94 122.08 16.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.285 -0.416 . . . . 71.019999999999996 110.451 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.7 -15.75 44.76 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.69 -0.964 . . . . 73.25 110.69 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -143.3 147.83 35.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.725 0.297 . . . . 32.329999999999998 110.296 179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -88.44 155.57 19.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.444 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.57 133.22 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.349999999999994 111.037 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 61' ' ' ILE . . . -122.65 159.36 28.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 55.420000000000002 109.99 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.657 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.23 -174.96 5.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.855 0.36 . . . . 73.200000000000003 110.877 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -58.39 -174.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 110.925 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 105' ' ' PHE . 7.7 p -58.29 -21.34 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.038 -0.528 . . . . 64.420000000000002 110.565 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -58.66 -49.05 78.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.585 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.447 ' OE1' ' CD ' ' A' ' 85' ' ' GLU . 8.2 tp10 -73.39 -46.07 51.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.589 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -54.46 -39.75 46.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 62.420000000000002 110.563 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CG ' ' N ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -51.81 -54.79 24.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.515 . . . . 71.329999999999998 110.866 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' CD ' ' OE1' ' A' ' 82' ' ' GLU . 8.9 pt-20 -72.35 -41.18 66.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.373 -0.376 . . . . 70.109999999999999 111.044 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -48.43 -29.42 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.878 0.37 . . . . 62.25 110.654 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.08 -39.26 85.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 74.010000000000005 110.752 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -70.66 -5.26 28.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 72.340000000000003 110.658 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.39 -25.39 57.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 52.219999999999999 110.518 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.86 141.35 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.549999999999997 110.547 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 91' ' ' GLU . 1.2 pm0 -46.4 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 72.430000000000007 110.502 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -99.52 122.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.645 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -117.8 151.77 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.534 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -113.64 126.34 55.16 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.793 0.33 . . . . 65.329999999999998 110.781 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.57 ' CD1' HD13 ' A' ' 42' ' ' ILE . 5.6 mm -117.48 117.42 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.872 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.559 ' O ' ' C ' ' A' ' 97' ' ' GLY . 10.4 m-85 -99.98 -20.43 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 75.099999999999994 110.164 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.559 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 15.33 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.603 -0.726 . . . . 53.25 112.032 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 101' ' ' ILE . . . -175.45 -155.37 12.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.516 -1.033 . . . . 73.209999999999994 110.516 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.492 ' H ' HD11 ' A' ' 15' ' ' ILE . . . -70.45 -61.84 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.883 -0.327 . . . . 41.210000000000001 110.767 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.839 ' NE2' H52A ' A' ' 173' ' ' NAP . 8.6 pt20 -59.81 -34.29 72.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 65.310000000000002 111.105 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 98' ' ' GLY . 6.0 mm -71.31 -31.44 43.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.767 0.317 . . . . 72.239999999999995 110.736 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.645 ' CD1' ' C ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -69.13 -45.96 68.85 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.951 -0.388 . . . . 70.019999999999996 109.951 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -66.45 -39.55 88.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 74.400000000000006 110.291 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 104' ' ' LEU . 2.7 mm? -70.1 -28.68 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.403 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.635 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 4.5 m-85 -102.86 15.88 28.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 61.43 110.455 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.648 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 3.9 tp -64.99 -38.4 28.85 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 75.040000000000006 110.638 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.648 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 89.7 Cg_endo -86.54 6.83 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.747 2.298 . . . . 63.310000000000002 112.217 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -117.35 -18.01 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.437 . . . . 71.439999999999998 110.981 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 110' ' ' ASP . 6.0 p -89.75 162.61 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.94 0.4 . . . . 72.209999999999994 110.906 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 109' ' ' VAL . 7.0 m-20 -120.93 -36.75 3.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 51.530000000000001 110.181 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 131.64 56.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 109.792 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -109.68 120.13 41.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 73.200000000000003 110.394 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.58 98.76 7.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.55 . . . . 72.549999999999997 110.138 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.719 HD11 HD13 ' A' ' 112' ' ' LEU . 4.1 mp -125.14 141.64 44.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 52.399999999999999 111.415 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 t -125.3 125.5 43.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.027 -0.533 . . . . 63.119999999999997 110.451 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -91.4 125.97 36.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 53.43 110.451 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.6 mt -105.03 134.59 46.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.546 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -87.56 45.89 1.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.483 . . . . 74.150000000000006 110.97 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -171.69 121.01 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 71.109999999999999 110.788 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.5 152.72 5.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.921 -0.581 . . . . 73.209999999999994 110.143 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.521 ' O ' ' C ' ' A' ' 122' ' ' GLU . 78.2 t80 -132.76 152.87 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.806 -0.358 . . . . 62.43 110.82 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' O ' ' O ' ' A' ' 17' ' ' LYS . 1.1 mt-10 -28.23 141.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.085 -0.507 . . . . 65.420000000000002 110.547 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.46 -126.36 0.99 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.254 -0.739 . . . . 70.140000000000001 111.254 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -128.99 -44.86 1.28 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.035 -0.266 . . . . 73.430000000000007 111.068 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.679 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -94.05 102.59 14.66 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.955 0.407 . . . . 75.010000000000005 110.4 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -120.73 146.77 46.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.615 -0.72 . . . . 70.209999999999994 111.34 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' PRO . 3.9 t80 -104.61 124.42 37.07 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 70.329999999999998 109.689 179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' PHE . 39.8 Cg_endo -70.8 -171.5 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.068 1.846 . . . . 53.109999999999999 112.332 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' O ' ' SD ' ' A' ' 130' ' ' MET . 2.9 pt-20 -86.74 64.99 8.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 42.310000000000002 110.76 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 129' ' ' GLU . 21.9 mmt -132.84 59.48 1.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.28 -0.418 . . . . 60.420000000000002 110.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.28 89.33 7.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 72.209999999999994 110.686 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.5 mmt -133.09 33.29 3.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 110.605 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 134' ' ' ASN . 1.2 t -45.74 -59.77 2.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.584 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.737 ' H ' HG23 ' A' ' 133' ' ' THR . 32.2 t-20 75.46 -0.23 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 71.040000000000006 110.804 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -61.89 154.59 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 71.019999999999996 110.483 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.78 133.8 36.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 75.510000000000005 110.63 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -93.78 167.98 11.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.530000000000001 110.653 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.53 HG23 ' H ' ' A' ' 139' ' ' PHE . 2.8 m -138.48 -51.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.643 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.53 ' H ' HG23 ' A' ' 138' ' ' VAL . 47.7 t80 -130.0 153.59 48.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 61.049999999999997 110.467 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.18 136.36 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 73.340000000000003 110.743 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -122.99 146.09 47.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 74.519999999999996 110.333 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.621 ' HD2' ' H ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -111.76 152.14 28.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 73.099999999999994 110.524 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -103.5 -156.38 24.56 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.058 -0.817 . . . . 72.409999999999997 111.058 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 tp -172.97 164.63 5.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.692 0.282 . . . . 63.539999999999999 110.333 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.456 ' H ' HG22 ' A' ' 145' ' ' THR . 0.0 OUTLIER -77.88 164.72 24.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 72.239999999999995 110.678 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 147' ' ' GLU . 10.5 t0 -147.32 164.05 34.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.455 . . . . 73.049999999999997 110.384 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.526 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 20.5 tp10 -62.04 -40.24 95.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.289 -0.414 . . . . 75.140000000000001 110.52 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 -19.78 25.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 65.409999999999997 110.697 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -134.64 78.27 56.29 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 110.577 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.85 78.14 2.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.618 2.212 . . . . 74.209999999999994 112.134 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -151.56 -163.7 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.742 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.6 m -154.13 130.69 10.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.014 -0.539 . . . . 70.439999999999998 110.432 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.484 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 3.8 p90 -143.79 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 65.310000000000002 110.878 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 4.0 m-85 -138.58 156.58 47.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 74.450000000000003 110.908 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.24 141.88 48.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.363 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.692 ' C ' ' ND1' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -129.0 133.21 47.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 75.129999999999995 110.342 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.39 114.58 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.723 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.58 ' CG ' ' CE1' ' A' ' 156' ' ' HIS . 7.8 m-30 -110.16 153.59 24.52 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.665 -0.494 . . . . 71.310000000000002 109.665 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 159' ' ' GLU . 0.2 OUTLIER -155.18 145.82 22.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.811 0.339 . . . . 72.540000000000006 110.759 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 162' ' ' GLN . 1.8 ttpp -78.54 157.42 28.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 70.299999999999997 110.41 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.538 ' NE2' ' H ' ' A' ' 161' ' ' GLN . 3.0 mp0 -70.83 13.4 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.420000000000002 110.739 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 160' ' ' LYS . 49.4 mt-30 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.005 -0.998 . . . . 74.310000000000002 110.591 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.022 ' H6N' ' CG ' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.794 ' H2B' ' H11' ' A' ' 174' ' ' N22 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.42 -0.585 . . . . 74.239999999999995 109.42 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 2' ' ' ILE . 54.7 mt -136.62 110.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 71.239999999999995 110.651 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' H ' ' A' ' 110' ' ' ASP . 1.7 p -108.46 124.74 65.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 71.530000000000001 110.471 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.9 p -117.27 150.86 38.09 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.337 -0.392 . . . . 55.119999999999997 110.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' CZ ' HG21 ' A' ' 95' ' ' ILE . 3.2 m-85 -114.89 134.68 54.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 64.25 110.249 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 18.9 ttt -128.6 102.96 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 61.310000000000002 110.71 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' ALA . 2.0 m -138.43 147.47 25.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.286 0.565 . . . . 60.539999999999999 110.747 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.84 ' HB3' H72N ' A' ' 173' ' ' NAP . . . -76.74 172.03 13.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.657 -0.701 . . . . 72.409999999999997 110.891 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 ttm -146.01 102.19 3.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.501 . . . . 74.340000000000003 110.358 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -74.67 135.55 41.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.040000000000006 110.601 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HG3' HD22 ' A' ' 12' ' ' ASN . 14.2 pt-20 -60.07 -27.14 66.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 73.400000000000006 111.858 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 11' ' ' GLU . 3.2 m-80 -117.1 4.22 12.72 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.586 -0.446 . . . . 74.129999999999995 111.9 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.85 ' NH1' ' H ' ' A' ' 123' ' ' GLY . 0.0 OUTLIER -149.26 -137.81 0.08 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.51 -0.552 . . . . 73.349999999999994 109.51 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.692 HG13 HG12 ' A' ' 15' ' ' ILE . 9.4 p -129.36 -43.5 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 120.342 -0.543 . . . . 73.319999999999993 110.759 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.733 ' HB ' H71N ' A' ' 173' ' ' NAP . 1.1 pt -161.2 -59.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 120.733 -0.387 . . . . 71.319999999999993 111.291 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.435 ' H ' ' CG1' ' A' ' 15' ' ' ILE . . . -67.15 92.39 0.21 Allowed Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.125 -1.19 . . . . 74.099999999999994 110.125 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -81.11 -31.2 34.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.702 0.287 . . . . 74.349999999999994 110.978 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 48.1 t0 -165.59 61.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.321 -0.399 . . . . 73.150000000000006 110.196 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 18' ' ' ASP . 33.3 t30 84.76 -4.6 0.97 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 74.510000000000005 109.792 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.511 HD21 HG12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -167.0 172.11 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.393 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.581 HD21 ' H11' ' A' ' 174' ' ' N22 . 0.3 OUTLIER -84.38 150.99 58.58 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.733 -0.667 . . . . 62.439999999999998 110.017 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -67.43 75.35 0.54 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.612 2.208 . . . . 72.310000000000002 113.248 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.715 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 43.5 p90 -56.56 168.41 0.58 Allowed 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.487 -0.931 . . . . 75.019999999999996 108.487 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.806 ' NH2' ' CZ ' ' A' ' 151' ' ' TYR . 0.0 OUTLIER 168.08 158.73 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.409 0.443 . . . . 61.119999999999997 109.814 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER 60.49 76.18 0.43 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.357 -0.383 . . . . 71.329999999999998 110.224 -179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -55.43 -26.18 52.27 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.024 1.816 . . . . 71.430000000000007 112.356 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.8 t -66.46 -39.41 88.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 73.129999999999995 110.55 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.25 -44.09 80.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.388 -0.597 . . . . 73.230000000000004 109.388 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.21 -26.09 26.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.118 -0.946 . . . . 74.109999999999999 109.753 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -84.62 -44.61 13.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.659 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -61.07 -44.45 97.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 75.409999999999997 110.719 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 36' ' ' THR . 11.2 p -70.79 -52.03 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 65.140000000000001 110.742 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.68 ' N ' HG13 ' A' ' 32' ' ' VAL . 8.0 tmtt? -53.05 -33.18 50.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.538 -0.465 . . . . 75.150000000000006 110.018 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -77.17 -27.7 53.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 72.349999999999994 111.429 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -28.89 32.27 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.841 -0.344 . . . . 73.530000000000001 111.296 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.692 HG22 ' O ' ' A' ' 32' ' ' VAL . 1.7 t -93.17 -19.0 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.712 -0.395 . . . . 73.439999999999998 110.713 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.544 ' O ' ' CG ' ' A' ' 37' ' ' MET . 16.9 ptm -38.95 121.01 1.04 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.46 -0.336 . . . . 73.519999999999996 110.478 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.91 -36.52 4.34 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.831 -0.908 . . . . 62.350000000000001 110.831 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' N ' ' ND1' ' A' ' 39' ' ' HIS . 1.6 m-70 -76.0 145.55 77.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.345 -0.243 . . . . 74.409999999999997 110.345 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.4 136.1 17.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.742 2.294 . . . . 74.420000000000002 112.752 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 mt -114.74 118.56 33.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.238 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.486 HG23 HG23 ' A' ' 63' ' ' VAL . 1.9 mp -104.33 107.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 74.230000000000004 110.54 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.7 163.56 14.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 64.239999999999995 110.421 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.73 154.7 51.48 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.933 -0.867 . . . . 25.449999999999999 110.933 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.67 ' NH2' ' O3X' ' A' ' 173' ' ' NAP . 5.5 ttm180 -66.47 -44.74 81.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 110.523 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -60.72 -47.31 86.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 110.477 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 1.032 ' OD1' ' H2D' ' A' ' 173' ' ' NAP . 37.4 t30 -54.21 -59.48 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 55.229999999999997 110.604 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CD1' ' C ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -49.04 -43.37 40.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 74.409999999999997 110.464 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -53.87 -48.16 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 65.420000000000002 110.744 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.74 -51.03 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 44.039999999999999 110.828 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.511 HG12 HD21 ' A' ' 20' ' ' ASN . 82.6 mt -52.4 -36.5 21.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.033 -0.531 . . . . 71.109999999999999 110.751 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.94 -104.07 2.1 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.71 -0.956 . . . . 74.209999999999994 110.71 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -127.87 69.23 76.44 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-O 120.967 0.413 . . . . 74.239999999999995 110.729 179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' A' ' 51' ' ' ILE . 52.4 Cg_endo -74.6 162.8 37.23 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.712 2.274 . . . . 72.099999999999994 112.084 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' N ' ' CD ' ' A' ' 56' ' ' PRO . 3.0 tp -158.27 42.85 0.15 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.282 -0.417 . . . . 75.200000000000003 110.962 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -67.34 134.12 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.469 2.113 . . . . 65.129999999999995 111.044 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.14 0.18 69.6 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.822 -0.911 . . . . 71.409999999999997 110.822 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 69.89 -6.25 1.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.699 0.285 . . . . 73.409999999999997 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -128.16 82.65 2.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.74 -0.384 . . . . 63.539999999999999 110.27 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -93.29 116.55 29.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.391 -0.368 . . . . 71.030000000000001 111.029 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.7 mp -121.97 128.72 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 65.129999999999995 110.352 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 pt -111.48 140.29 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.359 . . . . 72.340000000000003 110.649 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 78' ' ' HIS . 23.9 t -96.22 124.89 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 74.030000000000001 110.697 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.461 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 8.8 t -154.59 139.0 16.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 62.43 110.762 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.585 ' CA ' ' HE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -94.27 106.79 18.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 61.299999999999997 110.405 179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 65' ' ' ARG . 8.9 m-80 -177.28 118.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 74.120000000000005 110.794 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -75.3 110.38 9.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.482 . . . . 72.519999999999996 110.524 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.82 3.7 36.68 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.125 -0.79 . . . . 71.230000000000004 111.125 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.4 ' CD2' HG21 ' A' ' 64' ' ' THR . 1.9 t80 -69.16 141.21 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 74.239999999999995 110.518 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -151.92 138.08 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.43 112.61 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 72.209999999999994 110.621 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -67.79 109.63 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.601 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 123.95 -30.6 4.78 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.961 -0.855 . . . . 74.420000000000002 110.961 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 2.8 t -126.44 159.62 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 63.450000000000003 110.61 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -92.55 140.05 29.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 73.239999999999995 110.359 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.83 139.61 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.953 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.1 160.8 36.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 73.439999999999998 110.229 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' O ' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -84.82 -169.13 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 62.450000000000003 110.595 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.656 ' OG ' ' N ' ' A' ' 80' ' ' VAL . 2.1 t -65.97 -173.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.457 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.673 HG13 ' CZ ' ' A' ' 105' ' ' PHE . 11.6 t -52.07 -54.01 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.836 0.827 . . . . 60.399999999999999 111.05 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -38.6 -33.35 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.13 -1.395 . . . . 64.510000000000005 110.71 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 85' ' ' GLU . 9.9 tp10 -79.55 -47.0 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 61.450000000000003 110.135 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 80' ' ' VAL . 43.5 t -55.12 -33.63 30.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.958 -0.565 . . . . 70.510000000000005 110.661 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -54.46 31.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 73.0 110.641 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.517 ' OE2' ' OE2' ' A' ' 82' ' ' GLU . 6.9 pt-20 -72.68 -43.74 62.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 75.200000000000003 111.131 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 tp -49.31 -25.94 2.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.667 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.2 m -64.62 -36.79 85.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 63.450000000000003 110.894 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -5.5 23.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.652 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -72.24 -26.09 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 75.530000000000001 110.49 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -140.01 149.21 42.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 74.420000000000002 110.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.69 -22.73 64.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.230000000000004 110.314 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' CG ' ' O ' ' A' ' 92' ' ' GLU . 9.8 pt-20 -144.43 121.23 11.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 110.576 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -129.48 149.79 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 54.420000000000002 110.527 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.82 142.44 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.323 -0.399 . . . . 72.109999999999999 111.055 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.662 HG21 ' CZ ' ' A' ' 5' ' ' PHE . 6.3 mm -124.64 132.96 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.979 -0.555 . . . . 75.540000000000006 110.211 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.755 ' CZ ' ' N7 ' ' A' ' 174' ' ' N22 . 0.2 OUTLIER -118.14 -19.06 9.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.416 -0.356 . . . . 73.310000000000002 110.661 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 96' ' ' PHE . . . 8.07 -100.91 0.01 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-N 115.895 -0.593 . . . . 53.530000000000001 111.938 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.11 -161.94 30.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.782 -0.927 . . . . 43.509999999999998 110.782 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.21 -54.29 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.731 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' OE1' ' O3 ' ' A' ' 173' ' ' NAP . 14.0 pt20 -62.48 -45.08 94.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 65.120000000000005 110.872 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.442 ' N ' ' HG3' ' A' ' 100' ' ' GLN . 38.9 mm -58.28 -47.12 88.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.9 0.381 . . . . 70.510000000000005 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -37.26 65.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 71.219999999999999 110.149 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -67.77 -54.24 20.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.035 -0.529 . . . . 74.140000000000001 111.247 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mp -66.24 -18.93 65.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 75.129999999999995 111.573 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 109' ' ' VAL . 8.4 m-85 -98.1 19.22 14.45 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.73 -0.388 . . . . 74.340000000000003 111.319 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 0.8 OUTLIER -62.06 -50.77 78.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 61.409999999999997 110.574 179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 106' ' ' LEU . 72.3 Cg_endo -81.07 19.7 1.12 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.858 2.372 . . . . 63.549999999999997 112.307 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -127.92 -41.51 1.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.873 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 105' ' ' PHE . 3.1 p -73.68 148.58 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.302 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.435 ' H ' HG13 ' A' ' 3' ' ' VAL . 58.6 t0 -112.46 -29.93 7.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.746 -0.661 . . . . 74.430000000000007 109.699 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -119.78 129.43 54.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.729 -0.669 . . . . 63.340000000000003 110.06 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -118.28 117.32 28.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.139 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -120.37 120.05 34.85 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.242 -0.436 . . . . 55.509999999999998 110.368 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 112' ' ' LEU . 1.1 mp -131.03 130.14 63.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 71.519999999999996 110.335 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.32 119.43 38.28 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.618 -0.433 . . . . 62.420000000000002 110.924 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -90.28 131.52 36.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.98 -0.554 . . . . 72.340000000000003 110.613 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.5 mt -119.17 125.59 74.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 70.329999999999998 110.396 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.558 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 77.2 t60 -76.07 65.88 2.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 73.129999999999995 110.918 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -176.14 112.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 54.5 110.369 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -169.44 142.15 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.662 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.602 ' O ' ' O ' ' A' ' 122' ' ' GLU . 9.3 m-85 -158.2 122.46 4.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.524 -0.307 . . . . 71.299999999999997 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.602 ' O ' ' O ' ' A' ' 121' ' ' PHE . 30.8 mt-10 40.4 108.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.186 -0.461 . . . . 55.439999999999998 110.94 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.85 ' H ' ' NH1' ' A' ' 13' ' ' ARG . . . -134.03 -159.59 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.866 -0.683 . . . . 61.32 111.709 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.2 -15.7 13.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.644 0.259 . . . . 64.019999999999996 110.89 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.643 ' C ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -139.29 115.81 10.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.919 0.39 . . . . 72.099999999999994 110.574 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.521 ' HB3' ' NH2' ' A' ' 13' ' ' ARG . 42.8 p90 -123.56 149.25 45.49 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 115.747 -0.66 . . . . 71.109999999999999 111.555 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.421 ' N ' ' HB ' ' A' ' 14' ' ' VAL . 1.1 t80 -96.02 138.81 21.62 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.227 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.48 -166.19 0.23 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.491 2.128 . . . . 74.319999999999993 112.028 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 130' ' ' MET . 4.7 pt-20 -107.22 -160.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.454 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.473 ' C ' ' O ' ' A' ' 129' ' ' GLU . 25.6 ptt? 34.62 38.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 63.229999999999997 110.703 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.7 p30 -57.62 150.95 18.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 72.430000000000007 110.353 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.6 ptp -130.08 62.79 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 54.119999999999997 110.813 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.638 HG23 ' N ' ' A' ' 134' ' ' ASN . 5.4 t -61.96 -51.62 67.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 65.450000000000003 110.457 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.638 ' N ' HG23 ' A' ' 133' ' ' THR . 59.7 t30 57.79 15.27 2.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 64.420000000000002 110.781 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.467 ' CZ3' ' HG2' ' A' ' 160' ' ' LYS . 12.1 m95 -76.9 151.77 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.359 -0.382 . . . . 75.400000000000006 110.498 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.37 128.59 39.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 61.119999999999997 110.745 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.01 150.1 21.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.209 -0.451 . . . . 71.340000000000003 110.607 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.12 -19.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.985 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -163.51 154.77 16.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.491 -0.322 . . . . 64.450000000000003 110.504 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 140' ' ' VAL . 7.5 p -149.06 113.22 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.773 -0.371 . . . . 63.119999999999997 111.012 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 142' ' ' LYS . 30.7 tp10 -100.5 158.35 15.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 73.219999999999999 109.959 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -115.74 173.8 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 65.109999999999999 111.184 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -126.79 173.51 18.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.386 -1.086 . . . . 52.310000000000002 110.386 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.577 ' O ' ' O ' ' A' ' 151' ' ' TYR . 0.5 OUTLIER -143.48 -160.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.023 0.44 . . . . 75.530000000000001 110.895 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -97.75 153.93 17.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.945 -0.57 . . . . 75.010000000000005 110.427 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 147' ' ' GLU . 32.6 t0 -116.96 -177.44 3.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.402 -0.363 . . . . 74.200000000000003 110.542 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.454 ' H ' ' CG ' ' A' ' 146' ' ' ASP . 8.8 mt-10 -83.95 -39.91 19.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 75.540000000000006 110.672 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.77 0.61 20.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.883 0.373 . . . . 72.230000000000004 110.566 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -144.75 77.25 13.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.013 -0.54 . . . . 72.430000000000007 110.271 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.46 82.72 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.545 2.164 . . . . 62.420000000000002 111.988 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.806 ' CZ ' ' NH2' ' A' ' 24' ' ' ARG . 10.3 m-85 -135.04 176.85 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 71.049999999999997 110.887 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 88.7 m -150.82 117.44 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.593 . . . . 45.350000000000001 110.424 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.442 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 2.6 p90 -131.56 -175.75 3.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 75.530000000000001 110.763 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 153' ' ' TYR . 64.2 m-85 -144.53 131.2 20.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 110.749 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -95.81 136.75 35.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 110.168 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -123.66 131.96 53.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.326 . . . . 73.409999999999997 110.971 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.15 111.87 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.140000000000001 110.012 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -123.17 143.59 49.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 71.230000000000004 110.271 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.542 ' CD ' ' O ' ' A' ' 160' ' ' LYS . 0.7 OUTLIER -154.79 156.84 37.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 73.209999999999994 111.034 -179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' O ' ' CD ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -92.39 -178.31 4.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.106 -0.497 . . . . 73.230000000000004 110.168 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.68 -47.48 16.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 70.530000000000001 110.656 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.023 -0.989 . . . . 75.5 110.638 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' NAP . . . . . 1.032 ' H2D' ' OD1' ' A' ' 47' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' N22 . . . . . 0.755 ' N7 ' ' CZ ' ' A' ' 96' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_